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Abstract 
The research in this thesis describes the development of an isothiourea-catalysed enantioselective [2,3]-
rearrangement of allylic ammonium ylides, subsequent mechanistic and collaborative computational 
studies and the its application to the enantioselective synthesis of free α-amino esters. 
Chapter 1 aims to place this work in the context of the previous literature, highlighting a range of 
stereoselective [2,3]-rearrangements of allylic ammonium ylides. Examples of catalytic stereoselective 
[2,3]-rearrangement of allylic ammonium ylides as well as state-of-the-art examples of organocatalytic 
enantioselective variants of the related [2,3]-Wittig rearrangement are discussed. The aims of this 
research project are also set out. 
Chapter 2 describes the discovery and optimisation of the isothiourea-catalysed [2,3]-rearrangement of 
4-nitrophenyl ester quaternary ammonium salts (either isolated or generated in situ) to give a range of 
syn-α-amino acid derivatives in excellent yields (33-89%) and stereocontrol (up to >95:5 dr and >99% 
ee). This represents the first catalytic enantioselective variant of a [2,3]-rearrangement of allylic 
ammonium ylides. 
Chapter 3 describes mechanistic studies. Reaction kinetic analysis by 19F NMR has allowed reaction 
profiles to be built up, orders of each component to be determined and catalyst resting state to be probed. 
A catalytic intermediate has been observed; its constitution was proved unambiguously by 13C and 15N 
isotopic labelling. Isotopic entrainment has proved the observed intermediate to be on-cycle and 
productive towards catalysis. Competition kinetic isotope effects have provided detailed insight into the 
[2,3]-rearrangement step of the process. The effect of HOBt upon stereocontrol and the resting state of 
the catalyst have been probed through in situ 19F NMR. Crossover experiments have given detailed 
insight into the reversibility of each of the proposed catalytic steps. Collaborative computational work 
has elucidated the origins of stereocontrol and has supported the experimentally proposed mechanism.  
Chapter 4 describes the application of this methodology to the enantioselective synthesis of free α-
amino esters via [2,3]-rearrangement of N,N-diallyl allylic ammonium ylides. Enantio- and 
chemoselective [2,3]-rearrangement gave a range of N,N-diallyl α-amino esters, which could be readily 
selectively mono- or bis-N-allyl deprotected. Bis-N-allyl deprotection gave a range of enantioenriched 
free α-amino esters. Selective mono-N-allyl deprotection was employed in the synthesis of a 
functionalised piperidine motif. 
Chapter 5 summarises the work outlined in this thesis and draws conclusions, as well as giving insight 
into potential future projects within the area.
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Chapter 1: Introduction 
1.1 Sigmatropic Rearrangements 
Sigmatropic rearrangements are commonplace within organic synthesis and are routinely utilised in the 
construction of complex molecular architectures.[1] A sigmatropic rearrangement is defined as the 
intramolecular migration of σ-bonds adjacent to multiple π-electron systems. These reorganisation 
processes are a subclass of pericyclic reactions, as they proceed through a transiently conjugated cyclic 
transition state via a concerted reaction mechanism. Sigmatropic rearrangements are classified using 
the Woodward-Hoffmann nomenclature,[2] of the order of [n,m]- where atoms are numbered from the 
bond breaking to the new forming bond (Scheme 1).[3]  
 
Scheme 1: Examples of sigmatropic rearrangements highlighting the Woodward-Hoffmann 
nomenclature.  
Sigmatropic rearrangements typically proceed in a stereospecific manner as a result of having a well-
defined rigid transition state that proceeds in a concerted fashion. Consequently, sigmatropic 
rearrangements can be employed when planning multistep synthesis of complex molecules.[1d] For 
example, the [3,3]-Claisen rearrangement of enolate 6 proceeds with high diastereospecificity (>95:5 
dr) to form acid 7, which is a key intermediate in the total synthesis of the antibiotic (+)-artemisinin 8 
(Scheme 2).[4] 
 
Scheme 2: Example of stereoselective [3,3]-rearrangement employed in total synthesis.[4] 
1.2 Stereoselective [2,3]-Rearrangements 
Stereoselective [2,3]-rearrangements have found particular wide-spread use in the synthesis of complex 
organic molecules. There are two types of [2,3]-rearrangement: anionic and neutral, with neutral [2,3]-
rearrangements involving ylide intermediates (Scheme 3). [2,3]-Rearrangements differ from many 
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thermally mediated rearrangements, as they are typically initiated through either a deprotonation or 
oxidation event to generate the reactive species.  
 
Scheme 3: Classification of neutral and anionic [2,3]-rearrangements. 
Stereoselective variants of these processes are of particular interest to synthetic chemists as they allow 
the construction of up to two stereogenic centres around the newly formed σ-bond as well as (E)- or 
(Z)-selectivity on the new π-bond. [2,3]-Rearrangements offer greater conformational flexibility within 
their five-membered transition state compared with the six-membered transition state of a [3,3]-
rearrangement. As a consequence, [2,3]-rearrangements are often more heavily influenced by 
substituents decorated around the transiently formed five-membered ring, than their [3,3]-
rearrangement counterparts, whose conformational flexibility can often make achieving high levels of 
stereocontrol problematic. The diastereocontrol of many [2,3]-rearrangements is often rationalised by 
extrapolation of transition states calculated by Houk and Marshall for the [2,3]-Wittig rearrangement 
(Scheme 3, X = O).[5] The stereochemical outcome of a [2,3]-rearrangement is typically dependent upon 
the substituents adjoined to both the alkene and the anion, as well as the nature of the heteroatom (X) 
present. The diastereocontrol is dependent upon the relative energies of the exo and endo transition 
states. Many [2,3]-rearrangements are stereospecific, with different alkene geometries leading to the 
opposite relative configurations within the product. For example, (E)-13 leads to the formation of (±)-
anti-16 when proceeding through an exo-transition state, whereas (Z)-18 leads to the formation of (±)-
syn-21 (Scheme 4).  
 
Scheme 4: General stereochemical rationale for [2,3]-rearrangements.[5] 
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[2,3]-Rearrangements are thermally allowed processes under the symmetry guidelines set out by 
Woodward and Hoffmann. The five-membered envelope transition-state structure of the [2,3]-
rearrangement results in direct overlap of the ω2S anion component with the π2S alkene component in 
the formation of the new σ-bond between C(2'), and C(3) in a suprafacial manner, satisfying the 
Woodward-Hoffman rules for a thermally allowed rearrangement. Breaking the σ-bond between C(1) 
and C(1') (σ2S), and migration of the π-system (π2S), both occur in a suprafacial manner. Considering all 
components this satisfies the Woodward-Hoffman equation, resulting in the process being thermally 
allowed (Figure 1).[6] 
 
Figure 1: Woodward-Hoffmann analysis of [2,3]-rearrangements.[6] 
The mechanism for many [2,3]-rearrangements is thought to proceed through a concerted ionic 
mechanism, rather than a radical based mechanism. However, as a result of the often complex nature of 
these reactions making them difficult to study both experimentally and computationally, detailed 
mechanistic information for many [2,3]-rearrangements is unclear. 
Within the area of stereoselective [2,3]-rearrangements there is a wide variety of possible anionic and 
neutral [2,3]-rearrangements (Scheme 5). This thesis focuses on the [2,3]-rearrangement of allylic 
ammonium ylides, thus the remainder of this introduction focuses on the literature relevant to 
stereoselective [2,3]-rearrangement of allylic ammonium ylides.  
 
Scheme 5: Examples of [2,3]-rearrangements. 
1.3 [2,3]-Rearrangements of Allylic Ammonium Ylides 
The [2,3]-rearrangement and competitive [1,2]-rearrangement of allylic ammonium ylides is a powerful 
route to form α-amino acid derivatives bearing multiple defined stereocentres in a single transformation. 
The base mediated [1,2]-rearrangement of allylic ammonium ylides was first discovered in 1928 by 
Stevens.[7] Treatment of isolated N-benzyl ammonium salt 29 with NaOH resulted in [1,2]-
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rearrangement of the N-benzyl group to C(2), which is thought to proceed through homolytic cleavage 
of the ammonium ylide to form a radical pair, which can readily recombine to form rearrangement 
product 30.[7] The competing [2,3]-rearrangement of allylic ammonium ylides was developed in the late 
1960’s by Ollis.[8] Treatment of isolated N-cinnamyl ammonium salt 31 under basic conditions resulted 
in exclusive [2,3]-rearrangement to form α-amino ketone 32 (Scheme 6).[8]  
 
Scheme 6: Competitive [1,2]- and [2,3]-rearrangement of allylic ammonium ylides.[8] 
aDiastereoselectivity of crude material not reported. 
1.3.1 Generation of Ammonium Ylides 
The most commonly utilised method for the in situ generation of ammonium ylides is through 
deprotonation of the corresponding quaternary ammonium salt adjacent to the nitrogen atom. 
Quaternary ammonium salts are themselves prepared through alkylation of the requisite tertiary amine. 
Whilst this methodology is often employed in the [2,3]-rearrangement of allylic ammonium ylides, 
there are significant drawbacks with this methodology such as the isolation of reactive ammonium salts. 
In some cases, isolation can be aided through counterion exchange to non-coordinating counterions, 
although many quaternary ammonium salts undergo facile N-dealkylation to return the corresponding 
tertiary amine upon attempted ammonium ylide formation.[1f] An example of this methodology is 
highlighted in Scheme 6. 
 
Scheme 7: Generation of ammonium ylides from ammonium salts. 
Alternatively, ammonium ylides can be directly generated in a catalytic manner from tertiary amines 
and diazo compounds in the presence of a copper or rhodium catalyst.[1b] Decomposition of a diazo 
compound 37 mediated by a transition metal catalyst generates the corresponding metal carbenoid 38, 
which can be subsequently intercepted by a Lewis basic tertiary amine to access the desired ammonium 
ylide 39 or metal bound equivalent 40 (Scheme 8).  
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Scheme 8: Generation of ammonium ylides from tertiary amine and diazo compounds.  
Clark has extensively examined this type of ammonium ylide generation methodology in an 
intramolecular manner. This methodology has been employed in the synthesis of a number of cyclic 
amines, of varying ring size, for example, treatment of N-allyl diazoketone 41 with a catalytic amount 
of Cu(acac)2 (2 mol%), forms ammonium ylide 42. Subsequent [2,3]-rearrangement of allylic 
ammonium ylide 42 formed cyclic amine 43 in 72% yield (Scheme 9).[9] 
 
Scheme 9: Copper catalysed ammonium ylide formation and [2,3]-rearrangement.[9] 
A less commonly used strategy for the generation of ammonium ylides is the desilylation of ammonium 
salts bearing a trimethylsilyl substituent. For example, treating β-substituted trimethylsilyl ammonium 
salt 44 with cesium fluoride results in desilylation to form the corresponding ammonium ylide 45 
(Scheme 10).[10] 
 
Scheme 10: Ammonium ylide generation through desilylation. 
This type of ammonium ylide generation was utilised by Martinez et. al. in 1980.[10-11] Treatment of β-
trimethylsilyl substituted ammonium salt 46 with cesium fluoride, readily generates the desired 
ammonium ylide 47, which can undergo [2,3]-rearrangement to give homoallylic amine 48 in 54% yield 
(Scheme 11).  
 
Scheme 11: Utilisation of fluoride mediated ammonium ylide generation.[10-11] 
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1.3.2 Stereoselective [2,3]-Rearrangements of Allylic Ammonium Ylides 
Since the initial work in the area by Ollis and co-workers, a significant body of research has been 
undertaken to develop stereoselective variants of this reaction. Numerous methods of inducing 
stereocontrol have been employed in recent years, with the induction of enantiocontrol in these process 
a particular challenge. A series of key examples of diastereo- and enantioselective [2,3]-rearrangements 
of allylic ammonium ylides will be highlighted.  
In 2005 Sweeney and co-workers[12] reported the asymmetric [2,3]-rearrangement of allylic ammonium 
ylides utilising Oppolzer’s camphorsultam auxiliary[13] to induce diastereo- and enantiocontrol (Scheme 
11). A range of isolated ammonium salts bearing a camphorsultam auxiliary 49 undergo base-mediated 
[2,3]-rearrangement when treated with sodium hydride, giving allyl-glycine derivatives 50, with 
excellent levels of diastereocontrol (up to >99:1 dr).  
 
Scheme 11: Sweeney’s auxiliary approach to stereoselective [2,3]-rearrangements.[12] 
Additionally, the authors demonstrated that this methodology could be applied to the synthesis of (R)-
allyl glycine 53. Diastereoselective [2,3]-rearrangement of triallyl ammonium salt 51 gave N,N-diallyl 
glycine 52 (97:3 dr). Subsequent Pd-catalysed N,N-deallylation, followed by hydroxide mediated 
auxiliary cleavage, gave (R)-allyl glycine 53 in 86% yield over the three steps with excellent 
enantiocontrol (>95% ee) (Scheme 12).[12]  
 
Scheme 12: Application of Sweeney’s camphorsultam controlled [2,3]-rearrangement to the synthesis 
of (R)-allyl glycine 53.[12] 
In 2012 Zhu and Xu[14] also employed a chiral auxiliary approach for the synthesis of quaternary α-
amino acids through a diastereoselective [2,3]-rearrangement of isolated ammonium salts 56. Double 
reductive amination of α-amino ester 55 with axially chiral di-aldehyde 54, followed by treatment with 
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allyl bromide gave axially chiral allylic ammonium salt 56. Treatment of 56 with sodium hydride in 
DME facilitated diastereoselective [2,3]-rearrangement to give a range of α-aryl and α-alkyl amino 
esters in excellent yield with excellent levels of diastereocontrol (typically >95:5 dr) (Scheme 13).[14] 
 
Scheme 13: Zhu and Xu’s chiral biaryl auxiliary-controlled [2,3]-rearrangement.[14] 
Furthermore, the auxiliary could be readily removed from two α-allyl examples through treatment with 
CAN, and N-benzoyl protection gave α-quaternary amino esters 58 in good yield and with excellent 
levels of enantiocontrol (96-98% ee) (Scheme 14). Notably, chiral dialdehyde 54 could be recovered 
and recycled once cleaved from the α-amino ester product.[14] 
 
Scheme 14: Removal of biaryl chiral auxiliary.[14] 
In 1995, Gawley and co-workers demonstrated that proline-derived enantioenriched organostannane 
ammonium salts could readily undergo lithium-tin exchange to form the corresponding ammonium 
ylide, which can undergo [2,3]-rearrangement. For example, treatment of stereodefined N,N-diprenyl 
ammonium stannane 59 (94% ee) with n-BuLi at −80 °C resulted in smooth lithium-tin exchange 
followed by enantiospecific [2,3]-rearrangement to give N-prenyl proline derivative 61 in good yield 
with complete retention of enantiopurity (94% ee) (Scheme 15).[15] 
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Scheme 15: Chirality transfer through Li-Sn exchange of enantioenriched organostannane ammonium 
salts.[15] 
In 1999, West and co-workers[16] reported the [1,2]- and [2,3]-rearrangements of proline and threonine-
derived ammonium ylides with excellent levels of chirality transfer. For example, diastereoselective 
quarternisation of N-benzyl L-proline methyl ester with prenyl bromide gave ammonium salt 64, which 
upon treatment with potassium tert-butoxide selectively gave [2,3]-rearrangement product 65 in 
excellent yield (93%) with complete chirality transfer. In contrast the treatment of N-methyl,N-benzyl 
ammonium salt 62 under the same rection conditions gave exclusive [1,2]-rearrangement to give N-
methyl L-proline methyl ester 63 in reduced enantiopurity (54% ee). This methodology was utilised in 
the rearrangement of N-prenyl L-proline and L-threonine derived ammonium salts (Scheme 16).[16] 
 
 
Scheme 16: Chirality transfer in the [2,3]-rearrangement of N-prenyl L-proline derived ammonium 
salts.[16] 
Somfai and co-workers[17] reported the use of stoichiometric boron tribromide as a Lewis acid to mediate 
the [2,3]-rearrangement of allylic α-amino amides 66. Treatment of 66 with boron tribromide forms 
ammonium salt 67, which upon treatment with aq. sodium hydroxide undergoes rapid [2,3]-
rearrangement to form α-amino amides 68 in excellent yield with excellent levels of diastereocontrol. 
This proof of concept methodology was demonstrated to proceed well when N-crotyl and N-cinnamyl 
substituents were incorporated into 68 (Scheme 17).[17] 
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Scheme 17: BBr3 mediated [2,3]-rearrangement of α-amino amides.[17] 
In 2005 Somfai and co-workers[18] subsequently reported a highly enantioselective version of this 
process. Enantiomerically pure diamine 70 and boron tribromide were used in stoichiometric amounts 
to facilitate the enantioselective [2,3]-rearrangement of α-amino amides to form the corresponding 
homoallylic amines with excellent levels of stereocontrol (up to 95:5 dr and up to 99% ee). For example, 
treatment of CH2OBn substituted N-allyl amine 69 with BBr3 (2.0 equiv.) and 70 (2.0 equiv.) followed 
by NEt3 resulted in [2,3]-rearrangement of 69 to form homoallylic amine 71 in 70% yield and 88:12 dr 
(anti:syn) and 93% ee (Scheme 18). A number of C(3)-substituted alkyl and aryl allylic amines were 
tolerated within the reaction, and notably chiral amine 70 could be readily recovered in quantitative 
yield. The observed anti-diastereoselectivity can be rationalised by the [2,3]-rearrangement step 
proceeding through the kinetically preferred exo-transition state 72. The enantiocontrol is a 
consequence of the allyl group rearranging anti to the N-Ts group on the chiral diamine ligand.[18-19]  
 
Scheme 18: Enantioselective [2,3]-rearrangement of N-allyl amine 69.[18-19] 
1.3.3 Catalytic Stereoselective [2,3]-rearrangements of allylic ammonium ylides 
Previous examples have showcased the use stoichiometric auxiliaries or ligands to effect stereocontrol 
in the [2,3]-rearrangement of allylic ammonium ylides. This next section will highlight a range of 
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catalytic stereoselective [2,3]-rearrangements of allylic ammonium ylides. In this context the term 
“catalytic” is used to refer to the use of a substoichiometric quantity of catalyst either in the generation 
of ammonium ylide/salt or to facilitate the [2,3]-rearrangement step of the process.  
1.3.3.1 Intermolecular Generation of Ammonium Salts/Ylides 
In 1981 Doyle and co-workers[20] reported the first diastereoselective intermolecular ammonium ylide 
formation and [2,3]-rearrangement utilising the catalytic decomposition of a diazo compound. 
Treatment of ethyl diazoacetate 73 with Rh2(OAc)4 (0.5 mol%) in the presence of excess N,N-dimethyl 
tertiary amine 74 gave α-amino acid derivative 75 in 59% yield and 75:25 dr (anti:syn) (Scheme 19). 
Che and co-workers have also reported a similar reaction employing a ruthenium-porphyrin catalyst, 
obtaining 75 with the same level of diastereocontrol.[20] 
 
Scheme 19: Doyle’s Rh-catalysed ammonium ylide generation and [2,3]-rearrangement.[20] 
In 2003 Sweeney and co-workers[21] reported ammonium ylide generation and subsequent [2,3]-
rearrangement using N-methyl tetrahydropyridine 76, ethyl diazoacetate 73 and Cu(acac)2 (20 mol%). 
Notably, the use of Rh2(OAc)4 resulted in a complex mixture of products, likely due to a competing 
cyclopropanation reaction on the alkene. The reaction of ethyl diazoacetate 73 with N-methyl 
tetrahydropyridine 76 resulted in the formation of syn-pyrrolidine 78 in 59% yield with excellent 
diastereocontrol (>95:5 syn:anti). α-Keto diazoacetates could also be used in this process, allowing 
access to pyrrolidine 80 bearing a quaternary stereocentre in moderate yield (56%) and diastereocontrol 
(75:25 dr syn:anti) (Scheme 20).[21]  
 
Scheme 20: Copper-catalysed ammonium ylide formation [2,3]-rearrangement using N-methyl 
tetrahydropyridines.[21] 
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In 2011, Tambar and co-workers[22] reported the catalytic generation of ammonium salts and subsequent 
stereoselective [2,3]-rearrangement utilising Pd-catalysed allylic substitution chemistry. Reaction of 
allyl carbonate 82 with Pd0Ln forms PdIILn allyl complex 83, which upon interception with tertiary 
amino esters 81 forms the corresponding quaternary ammonium salt 84. Which undergo rapid 
deprotonation into ammonium ylides 85, and subsequent diastereoselective [2,3]-rearrangement forms 
anti-α-amino esters 86 in excellent yield and diastereocontrol. Reaction optimisation found the catalyst 
ligand combination of Pd2dba3·CHCl3 and P(2-furyl)3 to be optimal for good yields of the rearranged 
product. The reaction was general across a range of aryl, heteroaryl, and alkyl substituted allylic 
carbonates, as well as for a number of substituted α-amino esters and ketones, forming the 
corresponding anti-α-amino acid derivatives. This methodology could be rendered enantioselective 
through employment of Oppolzer’s camphorsultam auxiliary, generating enantiomerically enriched α-
amino acid derivatives such as 89 in excellent yield and diastereocontrol. The observed anti-
diastereocontrol is thought to be a result of an exo-transition state 86 during the stereodetermining [2,3]-
rearrangement step of the process (Scheme 21).[22] 
 
Scheme 21: Pd-catalysed generation of ammonium salts and subsequent diastereoselective [2,3]-
rearrangement.[22] 
Tambar[23] subsequently applied this methodology to the formal total synthesis of marine alkaloid (±)-
amathaspiramide F 92 (Scheme 22). Treatment of proline derived α-amino ester 90 with decorated aryl 
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carbonate 91 under the previously optimised reaction conditions resulted in the formation of the 
corresponding [2,3]-rearrangement product in good yield (75%) albeit with preferential formation of 
the undesired diastereoisomer 94 (75:25 dr). Examination of a simplified substrate found that the 
presence of an ortho-substituent led to preferential formation of the undesired diastereomer. Adjustment 
in the synthetic route resulted in the use of 3-OMOM substituted allylic carbonate, giving preferentially 
the desired diastereoisomer 93 in excellent yield and moderate diastereocontrol (78:22 dr). Subsequent 
derivatisation of the rearrangement product 93 gave an advanced intermediate in the formal total 
synthesis of (±)-amathaspiramide F 92 (Scheme 22).[23] 
 
Scheme 22: Pd-catalysed ammonium salt formation-[2,3]-rearrangement of proline derived tertiary 
amine and formal synthesis of (±)-amathaspiramide F 92.[23] 
This methodology was further applied to the diastereoselective synthesis of a range of cyclic α-amino 
acid derivatives through a tandem ammonium salt formation-[2,3]-rearrangement followed by ring-
closing metathesis.[24] For example, treatment of N-methyl-N-homoallyl amino ester 95 with cinnamyl 
carbonate 96 under the previously optimised conditions, followed by ring-closing metathesis using 
Hoveyda-Grubbs II catalyst 102 using p-TsOH as an additive, gave cyclic α-amino ester 97 in 85% 
yield with good diastereocontrol (89:11 dr). This methodology could be used to access an 
enantioenriched α-amino acid 101 using an α-amino ester 98 bearing Oppolzer’s camphorsultam as the 
starting material, followed by subsequent N-methyl deprotection and auxiliary cleavage (Scheme 23).[24]  
Chapter 1: Introduction 
 
 
13 
 
Scheme 23: Application of Pd-catalysed ammonium salt formation-[2,3]-rearrangement to the 
synthesis of cyclic α-amino acids, aHoveyda-Grubbs II 102 added in two portions (2 × 5 mol%).[24] 
1.3.3.2 Intramolecular Generation of Ammonium Salts/Ylides 
In 1994, Clark and co-workers reported the first example of intramolecular ammonium ylide generation-
[2,3]-rearrangement.[9] Reaction of diazoketone 103 with Cu(acac)2 (2 mol%) generated ammonium 
ylide 104 via the corresponding metal carbenoid. Subsequent diastereoselective [2,3]-rearrangement 
gave indolizidine 105 as a single diastereomer, however treatment with silica gel resulted in complete 
epimerisation into the opposite diastereoisomer 106, which was isolated in 72% yield. This strategy was 
applied to the diastereoselective synthesis of a range of pyrrolizidine, indolizidine, and quinolizidine 
architectures. A range of acyclic substrates containing a stereogenic centre on the alkyl tether 
connecting the allylic amine and the diazoketone was also examined in this methodology. Ylide-
formation and [2,3]-rearrangement gave the corresponding cyclic amines, but with low diastereocontrol 
(Scheme 24).[9] 
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Scheme 24: Intramolecular copper-catalysed ammonium ylide generation-diastereoselective-[2,3]-
rearrangement.[9] 
Clark and co-workers[25] subsequently applied this methodology to the asymmetric synthesis of the CE 
ring system of the manzamine and ircinal families of marine alkaloids. Diazoketone 107 was readily 
prepared from (S)-prolinol in four steps. Diazoketone 107 was then reacted with Cu(acac)2 (2 mol%) 
forming bicycle 108 in 56% yield. Reduction with L-Selectride® gave alcohol 109 as a single 
diastereoisomer with excellent levels of enantiocontrol (>98% ee), demonstrating full chirality transfer 
within the copper-catalysed ammonium ylide-[2,3]-rearrangement process (Scheme 25).[25] 
 
Scheme 25: Asymmetric synthesis of CE ring utilising copper catalysed ammonium ylide 
generation-[2,3]-rearrangement.[25]  
In 1996 McMills and co-workers[26] reported a similar approach to the synthesis of medium-sized 
azacane rings. (S)-Proline derived diazo ketoester 110 was treated with a catalytic amount of 
Cu(hfacac)2 (15 mol%), to form azacane 111 in excellent yield (70%) with high levels of enantiocontrol 
(98% ee). The authors also observed competing [1,2]-rearrangement to give 112 (70:30 [2,3]:[1,2]), 
which is likely due to the increase in tether length relative to 108 (Scheme 25), the relative and absolute 
configurations of [1,2]-product 112 were not reported.[26] 
 
Scheme 26: Asymmetric synthesis of azacane ring 111, using ammonium ylide generation-
[2,3]-rearrangement.[26] 
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Rowlands and Barnes[27] have reported the copper-catalysed aziridinium ylide generation-[2,3]-
rearrangement of diazoketone 113. The reaction of 113 with a catalytic amount of Cu(acac)2 resulted in 
the formation of two aziridinium ylides 114 and 115, due to slow rate of inversion of configuration at 
nitrogen in the aziridine starting material 113 (43:57 mixture of N-invertomers). Selective [2,3]-
rearrangement of 114 resulted in the formation of bicyclic amine 116 in modest yield (21%) with 
excellent levels of diastereocontrol (>95:5 dr). The opposite ammonium ylide invertomer 115 is unable 
to undergo [2,3]-rearrangement, accounting for the low yield of rearrangement product 116 (Scheme 
27).[27] 
 
Scheme 27: Copper-catalysed aziridinium ylide formation-[2,3]-rearrangement.[27] 
1.4 Conclusions and Aims 
Whilst there are a number of elegant methodologies to achieve catalytic stereoselective [2,3]-
rearrangements of allylic ammonium ylides, at the onset of this thesis there were no catalytic 
enantioselective variants of this reaction. It is the aim of this thesis to develop and fully investigate an 
organocatalytic enantioselective [2,3]-rearrangement of allylic ammonium ylides.  
Although there are no organocatalytic enantioselective [2,3]-rearrangements of allylic ammonium 
ylides, there have been a few reports of related organocatalytic [2,3]-Wittig rearrangements. In 2006 
Gaunt and co-workers[28] reported their efforts towards an enantioselective organocatalytic variant of 
the [2,3]-Wittig rearrangement using secondary-amine catalysis. Initial work in the racemic series 
showed that employing pyrrolidine 118 as a catalyst, α-allyloxy ketone 117 reacts to form enamine 121, 
which can undergo diastereoselective [2,3]-rearrangement into homoallylic alcohol 119 in good yield 
with excellent levels of diastereocontrol (87:13 dr). The reaction was applied to a wide range of aliphatic 
ketones, as well as a number of allylic ethers incorporating alkyl, aryl, alkynyl and alkenyl substituents 
all reacting smoothly to give a suite of homoallylic alcohols in excellent yield with modest to excellent 
diastereocontrol. The authors noted that the diastereoselectivity of the reaction could be improved 
through lowering the reaction temperature to −25 °C, however this resulted in significantly longer 
reaction times to achieve complete substrate conversion. Using methanol as the solvent was essential 
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to achieve diastereocontrol, suggesting that the protic solvent is intimately involved in hydrogen-
bonding to the substrate during the [2,3]-rearrangement step. The observed syn-diastereoselectivity was 
rationalised by syn-pre transition state assembly 123, where the (E)-geometry of the enamine dictates 
the relative configuration of the products (Scheme 28).[28]  
 
Scheme 28: Pyrrolidine-catalysed [2,3]-Wittig rearrangement.[28] 
Notably, the use of enantioenriched allylic ether 125 (94% ee) resulted in good-levels of chirality 
transfer into rearrangement product 126 (4:1 dr, 92% ee), suggesting that the [2,3]-rearrangement 
proceeds through a concerted mechanism (Scheme 28). In addition, a single example of an 
enantioselective variant was reported using (S)-proline derived diamine 128 (20 mol%) as the catalyst. 
Treatment of α-allyloxy ketone 127 with 128 in methanol for five days resulted in enantioselective 
rearrangement, forming 129 in 75% yield with modest diastereocontrol and encouraging enantiocontrol 
(60% ee) (Scheme 29).[28]  
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Scheme 29: A) Chirality transfer in pyrrolidine-catalysed [2,3]-Wittig rearrangement B) 
Enantioselective variant of organocatalysed [2,3]-Wittig rearrangement.[28] 
In 2015, Denmark and co-workers[29] reported an enantioselective [2,3]-Wittig rearrangement utilising 
chiral quaternary ammonium salts as phase-transfer catalysts. A range of 3-(alkenyloxy)-1-protected-
2-oxindoles was evaluated with various cinchonidine-derived quaternary ammonium salt catalysts. For 
example, prenyl-ether oxindole 130 was treated with a catalytic amount of 131 (10 mol%) in the 
presence of aq. 5 M KOH, resulting in full conversion of 130 into rearranged product 132 with modest, 
albeit encouraging enantiocontrol (46% ee). This methodology was applied to a range of allyl- and 
prenyl-oxy ether substituted and N-protected oxindoles, all proceeding with good conversion into the 
rearrangement products with modest levels of enantiocontrol (Scheme 30).  
 
Scheme 30: Enantioselective phase-transfer-catalysed [2,3]-Wittig rearrangement of alkenyloxy 
oxindoles, absolute configuration of the major enantiomer not determined.[29] 
In 2016 Jacobsen and co-workers[30] reported an enantioselective catalytic [2,3]-Wittig rearrangement 
of α-allyloxy carbonyl compounds using a chiral thiourea catalyst to give a range of homoallylic 
alcohols with excellent levels of enantiocontrol. For example, reaction of cinnamyl di-tert butyl 
malonate 133 with in situ generated cesium di-tert-butyl malonate in the presence of chiral thiourea 134 
resulted in [2,3]-rearrangement to form homoallylic alcohol 135 in 92% yield and 92% ee (Scheme 31). 
This methodology was applied to a range of aryl, heteroaryl and alkyl substituted allylic ethers giving 
a suite of homoallylic alcohols in excellent yield and levels of enantiocontrol (72-93% ee).  
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Scheme 31: Jacobsen’s thiourea-catalysed enantioselective [2,3]-Wittig rearrangement.[30] 
The authors also conducted rigorous mechanistic and computational studies. Reaction Progress Kinetic 
Analysis, a series of crossover experiments, and kinetic isotope effects resulted in the following 
mechanistic proposal (Scheme 32). Substrate 133 undergoes reversible deprotonation by 
CsCH(CO2
tBu)2 136 to form cesium enolate 138 with thiourea catalyst 134 binding to enolate 139 to 
facilitate irreversible enantiodetermining and turnover-limiting [2,3]-rearrangement. Release of anion 
141 and subsequent protonation by di-tert butyl malonate 137 forms product 135 and regenerates 
thiourea catalyst 134. DFT calculations have elucidated the origins of stereocontrol, with cation-π 
interactions between the Cs+ and both pyrrole and aryl units of the catalyst leading to a favoured endo-
type transition state 142.  
 
Scheme 32: Proposed catalytic cycle for thiourea catalysed [2,3]-Wittig rearrangement and cartoon 
representation of the proposed transition state. 
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1.4.1 Project Aims 
This thesis aims to develop a highly enantioselective catalytic [2,3]-rearrangement of allylic ammonium 
ylides. It was postulated that a chiral Lewis basic tertiary amine based catalyst, such as an isothiourea, 
could facilitate such a process. Isothiourea catalysts have been extensively used as effective catalysts 
for a wide range of enantioselective acylative catalytic processes, including the kinetic resolutions of 
alcohols, kinetic resolutions of carboxylic acids and Steglich rearrangements.[31] Isothioureas have also 
been employed in enantioselective silylations and in the activation of α,β-unsaturated substrates, 
however probably the most prominent use of isothioureas by the Smith group and others, is in the 
generation of C(1)-ammonium enolates (Figure 2).[31]  
 
 
Figure 2: Isothiourea reactive intermediates utilised in catalysis. 
C(1)-Ammonium enolates 146 are typically generated in situ from either ketenes, acid chlorides, 
carboxylic acids or anhydrides and react in inter or intramolecular formal cycloaddition processes with 
suitable π-systems to form a wide range of stereodefined heterocyclic products (Scheme 33).  
 
Scheme 33: Use of C(1)-ammonium enolates in catalysis.[31] 
In these processes, intramolecular cyclisation is essential to release the isothiourea catalyst to continue 
in the catalytic cycle. This internal cyclisation turnover methodology has been extensively explored by 
the Smith group and others. For example, Smith and co-workers[32] demonstrated that HyperBTM 160 
efficiently catalyses the intermolecular Michael addition-cyclisation of arylacetic acid and α-keto-β,γ-
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unsaturated esters to give a range of anti-dihydropyranones with diastereo- and enantiocontrol (up to 
98:2 dr, up to 99% ee). Mechanistically in situ activation of the arylacetic with pivaloyl chloride to form 
the corresponding mixed anhydride, provides a suitable C(1)-ammonium enolate precursor 162. 
Acylation of HyperBTM 160 forms acyl ammonium 163, deprotonation via the pivalate counterion 
forms C(1)-ammonium enolate 164. Enantioselective Michael addition forms acyl ammonium 166, 
internal cyclisation through the generated enolate forms the anti-dihydropyranone 167 and releases the 
isothiourea catalyst. The observed stereocontrol can be rationalised by pre-transition state assembly 
168, with a key non-bonding 1,5 oxygen sulfur interaction stabilising this assembly allowing for high 
levels of enantiocontrol. This key interaction with be discussed in detail in the context of [2,3]-
rearrangements in chapters 2 & 3.[32]  
 
Scheme 34: Example of the use of C(1)-ammonium enolates in an intermolecular Michael addition 
internal cyclisation process.[32] 
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At the on-set of this work there were no examples of isothiourea-derived ammonium enolates 
undergoing catalyst turnover using external nucleophiles, which is a significant challenge within the 
area of tertiary amine-based Lewis base catalysis.[31] 
1.4.2 Concept 
As previously noted in this chapter, prior to this work there were no reports of catalytic enantioselective 
variants of a [2,3]-rearrangement of allylic ammonium ylides. To tackle this problem an 
enantioselective isothiourea-catalysed strategy was developed. It was thought that a quaternary 
ammonium salt 171 bearing a suitable activated ester could be generated either in situ or isolated from 
the reaction of the corresponding allylic amine 170 and bromoacetate 169. Subsequent addition of a 
chiral isothiourea followed by deprotonation could form isothiourea-bound allylic ammonium ylide 
172, which may undergo stereoselective [2,3]-rearrangement. Subsequent catalyst turnover, ideally by 
the alkoxide displaced in the initial step, would provide an efficient route to stereodefined α-amino acid 
derivatives 173 (Scheme 35).  
 
Scheme 35: Isothiourea-catalysed enantioselective [2,3]-rearrangement concept 
The aim was to develop a robust methodology applicable to a range of substrates, which could be readily 
scaled to produce valuable synthetic building blocks. Gaining detailed mechanistic insight into the 
developed methodology, though experimental and computational analysis is also a key goal of this 
research program. 
Acyl 4-nitrophenyl (PNP) esters were considered to be suitable substrates for Lewis base activation and 
catalyst turnover for this process due to considerable literature precedent. Chi and co-workers have 
previously demonstrated the use of 4-nitrophenyl esters as azolium enolate precursors in a range of 
stereoselective N-heterocyclic carbene (NHC)-catalysed processes.[33] For example, a range of alkyl 
substituted acetic activated esters 174 has been used in a NHC-catalysed formal [4+2] cycloaddition 
Chapter 1: Introduction 
 
 
22 
with N-tosyl ketimines 175 to form a number of anti-dihydropyridinones 178 in excellent yields (43-
96%) and stereocontrol (67:33 to 94:6 dr, 96->99% ee) (Scheme 36).[33c]  
 
Scheme 36: An example of the use of PNP esters as azolium enolate precrusors.[33c] 
Scheidt and co-workers[34] have previously used 4-nitrophenoxide as an effective catalyst-turnover 
agent in a related NHC-catalysed enantioselective Mannich reaction, utilising a “bound-rebound” 
strategy. For example, the reaction of 4-nitrophenoxyacetaldehyde 179 with N-Ts imine 180 in the 
presence of a catalytic amount of triazolium salt 181 and stoichiometric sodium 4-nitrophenoxide gave 
β-amino acid derivative 182, after addition of benzylamine, in excellent yield (72%) and enantiocontrol 
(94% ee). Mechanistically it is postulated that treating 4-nitrophenoxyacetaldehyde 179 with a Lewis 
basic NHC generates Breslow intermediate 184, with subsequent elimination of 4-nitrophenoxide 
forming azolium enol 185. Enantioselective Mannich reaction addition into a range of N-tosyl aryl 
imines 186 forms acyl azolium 187. The 4-nitrophenoxide eliminated from Breslow intermediate 184 
can then turnover acyl azolium 187 to form a number of β-amino 4-nitrophenyl esters 188, with in situ 
derivatisation giving a range of β-amino acid derivatives 189 (Scheme 37).[34]  
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Scheme 37: Scheidt’s “Bound-Rebound” strategy for azolium enol generation and external 
turnover.[34] 
After the completion of the work described in this chapter Fu and co-workers[35] reported the use of 
pentafluorophenoxide (C6F5O−) to effect external turnover of acyl ammonium intermediates. For 
example, reaction of ethyl phenyl ketene 190 with NFSI and sodium pentafluorophenoxide in the 
presence of chiral DMAP derivative (−)-PPY* 191 (3 mol%) gave tertiary alkyl fluoride 192 in 
excellent yield and enantiocontrol (Scheme 38). This methodology was applied to a range of aryl alkyl 
substituted ketenes, proceeding with excellent yields (up to 98%) and enantiocontrol (up to 99% ee).[35] 
Mechanistically, treating isolated ketene 190 with (−)-PPY* 191 generates C(1)-ammonium enolate 
193, with enantioselective fluorination by NFSI forming α-fluoro acyl ammonium 194. 
Pentafluorophenoxide is able to intercept acyl ammonium 194 and facilitate catalyst turnover to 
generate the pentafluorophenyl ester product 192 and release the catalyst.  
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Scheme 38: (−)-PPY*-catalysed synthesis of tertiary alkyl fluorides from ketenes 
In 2016, Snaddon and co-workers[36] reported an enantioselective α-allylation of electron deficient aryl 
acetic esters, utilising the combination of Pd-catalysed allylic substitution and isothiourea catalysis. 
Treatment of pentafluorophenyl ester 195 with allyl mesylate 196 and iPr2NEt in the presence of (+)-
BTM 197 (20 mol%) and Buchwald Xantphos based PdII pre-catalyst 198 (4 mol%) resulted in the 
formation of α-allyl ester 199 in excellent yield (88%) and excellent enantiocontrol (92% ee). PdII pre-
catalyst 198 forms the active Pd0Ln catalyst via deprotonation of the palladium-bound amine to give a 
Pd-amido complex which reductively eliminates to form Pd0Ln, carbazole and a methanesulfonate 
salt.[37] Reaction of allyl mesylate 203 with Pd0Ln catalyst forms PdII allyl complex 201, which can be 
intercepted by C(1)-ammonium enolate 200, generated from the reaction of pentafluorophenyl ester 195 
with (+)-BTM 197 in the presence of iPr2NEt, to give enantioenriched α-allyl acyl ammonium 202. 
Acyl ammonium 202 can release the catalyst and form the α-allyl ester product 199, through 
displacement with C6F5O−. This methodology has been applied to a range of aryl acetic esters and a 
number of allylic coupling partners (mesylates and carbonates) with excellent yields (up to 91%) and 
enantioselectivies (up to 98% ee).[36]  
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Scheme 39: Dual catalytic α-allylation of pentafluorophenyl aryl acetic esters. 
This chapter has aimed to place the concepts explored in this thesis within the context of previous 
literature. Chapter 2 describes synthetic studies into these concepts, chapter 3 describes subsequent 
mechanistic and stereochemical studies and chapter 4 describes an application of the developed 
methodology. 
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Chapter 2: Synthetic Studies 
2.1 Summary 
This chapter describes the discovery and reaction development of the isothiourea-catalysed 
enantioselective [2,3]-rearrangement of 4-nitrophenyl ester quaternary ammonium salts 204 (either 
isolated or generated in situ from 4-nitrophenyl bromoacetate and the corresponding allylic amine) to 
give a range of syn-α-amino acid derivatives 206 in excellent yield and stereocontrol (up to >95:5 dr, 
>99% ee) (Scheme 40). This represents the first catalytic enantioselective variant of a [2,3]-
rearrangement of allylic ammonium ylides.  
 
Scheme 40: Catalytic enantioselective [2,3]-rearrangement of allylic ammonium ylides. 
2.2 Concept and Aims 
As outlined Chapter 1, prior to this work there were no reports of catalytic enantioselective variants of 
a [2,3]-rearrangement of allylic ammonium ylides. To tackle this problem an enantioselective Lewis 
base-catalysed strategy was developed (Scheme 41). It was thought that a quaternary ammonium salt 
171 bearing a suitable activated ester could be generated either in situ or isolated from the reaction of 
the corresponding allylic amine 170 and bromoacetate 169. Subsequent addition of a chiral isothiourea 
followed by deprotonation could form isothiourea-bound allylic ammonium ylide 172, which may 
undergo stereoselective [2,3]-rearrangement. Subsequent catalyst turnover, ideally by the alkoxide 
displaced in the initial step, would provide an efficient route to α-amino acid derivatives 173.  
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Scheme 41: Isothiourea-catalysed enantioselective [2,3]-rearrangement concept 
2.3 Initial Studies 
2.3.1 Model Substrate Synthesis 
In order to conduct initial proof of concept studies into the catalytic enantioselective [2,3]-
rearrangement of allylic ammonium ylides, a model substrate 211 was chosen. This ammonium salt was 
chosen as it could be readily synthesised from commercially available starting materials. Firstly, an 
EDC·HCl mediated coupling of N,N-dimethylglycine 207 with 4-nitrophenol 208 gave 4-nitrophenyl 
ester 209. Notably a large excess (2.0 equiv.) of N,N-dimethylglycine was required to achieve full 
conversion of 4-nitrophenol 208. Direct treatment of 209 with excess cinnamyl bromide 210 gave the 
desired ammonium salt 211 in 79% yield over two steps (Scheme 42). 
 
Scheme 42: Initial synthesis of model ammonium salt 211. 
It became apparent that this initial synthesis was not suitable for the synthesis of multi-gram quantities 
of ammonium salt 211, due to the need to use large excesses of reagents and the unreliable nature of 
the EDC·HCl coupling step. Hence, efforts were made to develop an alternative route for the synthesis 
of ammonim salt 211, in conjunction with post-doctoral co-worker Dr. David S. B. Daniels. Direct 
substitution of cinnamyl bromide 210 with aq. dimethylamine provided N,N-dimethyl cinnamyl amine 
212 in 91% yield. Alkylation of 212 with 4-nitrophenyl bromoacetate 213 gave ammonium salt 211 
bearing an 4-nitrophenyl ester in 90% yield as a bench stable white solid. The synthesis of 211 could 
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be readily performed on a multi-gram scale, with the ammonium salt isolated by simple filtration 
(Scheme 43). 
 
Scheme 43: 2nd generation synthesis of ammonium salt 211 on multi-gram scale. 
2.3.2 Optimisation Studies 
Having developed an efficient synthesis of model substrate 211, the proposed catalytic enantioselective 
[2,3]-rearrangement could be investigated. Pleasingly, treatment of 211 with commercially available 
Lewis base isothiourea catalyst (−)-tetramisole·HCl 214 (20 mol %) and iPr2NH (1.6 equiv.) in MeCN 
at rt led to [2,3]-rearrangement, with subsequent addition of benzylamine giving benzylamide (−)-215 
in 89:11 dr and an encouraging 81% ee (Scheme 44).  
 
Scheme 44: Initial proof of concept. aDetermined by 1H NMR in comparison with internal standard, 
4-nitrotoluene. bDetermined by 1H NMR analysis. cDetermined by chiral HPLC analysis. 
The enantiomeric excess of the reaction was determined by chiral phase HPLC, through comparison 
with the HPLC trace of a genuine sample racemic product, synthesised in analogous route using (±)-
tetramisole·HCl 214 as an isothiourea catalyst at rt 
With a promising initial hit in hand, the reaction was optimised to improve the stereoselectivity. 
Addition of co-catalytic hydroxybenzotriazole (HOBt) (20 mol %) led to an improvement in both 
diastereocontrol and enantiocontrol (Table 1 entry 2). Other amine bases such as iPr2NEt or NEt3 could 
be used without affecting the diastereo- or enantiocontrol. However, the use of N-methylmorpholine 
(NMM) resulted in a loss of stereocontrol (Table 1, entries 3 - 5). Lowering the reaction temperature to 
−20 °C led to further improvements in enantiocontrol (entries 6 & 7). Variation of the isothiourea 
catalyst found that (+)-benzotetramisole ((+)-BTM) 197 was optimal, giving 215 in 76% yield, >95:5 
dr and 99% ee (Table 1 entry 9). HOBt was again essential for maximal stereocontrol at −20 °C, while 
use of hydroxyazabenzotriazole (HOAt) as an alternative co-catalyst resulted in a loss of 
diastereocontrol (Table 1 entry 11). Notably, the reaction could be performed using lower catalyst 
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loading of both isothiourea and HOBt with diminished, but still acceptable, stereocontrol (Table 1 
entries 12 & 13). 
 
Entry Isothiourea 
(mol %) 
Additive 
(mol %) 
Base (equiv.) T (°C) Yield (%)a,b drb eec 
1 214 (20) - iPr2NH (1.6) rt (83) 89:11 81(ent) 
2 214 (20) 216 (20) iPr2NH (1.6) rt 68 93:7 84(ent) 
3 214 (20) 216 (20) iPr2NEt (1.6) rt (76) 89:11 81(ent) 
4 214 (20) 216 (20) NEt3 (1.6) rt (75) 90:10 83(ent) 
5 214 (20) 216 (20) NMM (1.6) rt (45) 63:37 ND 
6 214 (20) 216 (20) iPr2NH (1.6) 0 to rt 88 92:8 89(ent) 
7 214 (20) 216 (20) iPr2NH (1.6) −20 65 91:9 93(ent) 
8 197 (20) - iPr2NH (1.4) −20 (61) 92:8 95 
9 197 (20) 216 (20) iPr2NH (1.4) −20 76 >95:5 99  
10 160 (20) 216 (20) iPr2NH (1.4) −20 (33) 72:28 ND 
11 197 (20) 217 (20) iPr2NH (1.4) −20 49 90:10 98  
12 197 (10) 216 (10) iPr2NH (1.4) −20 62 88:12 96  
13 197 (5) 216 (5) iPr2NH (1.4) −20 41
d 79:21 92 
a Yields in parentheses determined by 1H NMR using 4-nitrotoluene as an internal standard, b Isolated 
yield after flash column chromatography, >95:5 dr. b Determined by 1H NMR analysis of crude 
material. c Determined by HPLC analysis. d 84:16 mixture of diastereoisomers (isolated). 
Table 1: Optimisation of reaction conditions 
The optimal conditions for the enantioselective [2,3]-rearrangement of allylic ammonium salt 211 were 
(+)-BTM 197 (20 mol %), HOBt 216 (20 mol %), iPr2NH (1.4 equiv.) in MeCN at −20 °C, followed by 
the addition of benzylamine (5.0 equiv.) to give (+)-215 in 76% yield with excellent stereocontrol 
(>95:5 dr, 99% ee).  
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Direct isolation of the rearranged 4-nitrophenyl ester is possible prior to the addition of an external 
nucleophile. However, diminished yields of ester (±)-218 were observed, which is likely to be due to 
partial hydrolysis of the activated ester upon work-up (Scheme 45). The enantiopurity of (±)-218 could 
not be directly determined due to decomposition upon treatment with iPrOH during HPLC analysis. 
 
Scheme 45: Direct isolation of rearranged 4-nitrophenyl ester (±)-218. 
2.3.3 Evaluation of Activated Esters as Ammonium Ylide Precursors 
With optimal conditions in hand, alternative activated esters were evaluated to access the electronic 
requirements for reactivity and to determine if a non-toxic alternative to 4-nitrophenyl ester could be 
employed. A number of cinnamyl ammonium salts were synthesised using the method developed for 
the synthesis of model substrate 211. Treatment of N,N-dimethyl cinnamyl amine 212 with the requisite 
bromoacetate 219 gave a number of ammonium salts bearing a range of alternative esters in excellent 
yields (Scheme 46). 
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Scheme 46: Synthesis of N,N-dimethyl cinnamyl ammonium salts. aSynthesised by Dr David S. B. 
Daniels. 
With a range of alternative ester ammonium salts in hand, the electronic requirements of ester on the 
ammonium salt were assessed. Under the optimal conditions it was found that t-butyl 221, phenyl 222 
and 4-fluoro-phenyl 223 esters were unreactive and returned starting material after exposure to the 
reaction conditions (Table 2, entries 1-3). The use of 3,4,5-F3CH2 ester 224 led to formation of 
rearranged product (+)-215 with good levels of stereocontrol (>95:5 dr, 91% ee) albeit in poor yield 
(15%) (Table 2, entry 4). The rearrangement of 3,5-(CF3)2C6H3 ester 227 and 2,4,6-Cl3C6H2 ester 226 
gave (+)-215 in modest yield and comparable stereocontrol to 4-nitrophenyl ester 211 (Table 2, entries 
5 & 7). The use of pentafluoro phenyl ester ammonium salt 225 gave the rearrangement product with 
poor levels of diastereocontrol, likely a result of significant base-mediated background reaction. The 4-
nitrophenyl ester was still found to give optimal yield and stereocontrol. From these studies it is clear 
that a strongly electron-withdrawing aryl ester is a requirement for efficient reactivity within the 
isothiourea-catalysed [2,3]-rearrangement of allylic ammonium ylides. 
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Entry Act Yield (%)a drb eec 
1 tBu - - - 
2e Ph - - - 
3e p-FC6H4 - - - 
4e 3,4,5-F3C6H2 15 >95:5 91 
5e 3,5-(CF3)2C6H3 49 >95:5 93 
6 C6F5 ND 66:44 ND 
7 2,4,6-Cl3C6H2 41 >95:5 93 
8 4-NO2C6H4 76 >95:5 99 
Reactions performed on 0.24 mmol scale aIsolated yield after chromatographic purification of >95:5 
dr. bDetermined by 1H NMR analysis of crude material. cDetermined by Chiral HPLC analysis. dND = 
Not Determined. ePerformed by Dr. David S. B. Daniels. 
Table 2: Evaluation of alternative activated esters. 
2.4 Scope of Nucleophilic Derivatisation and Scale Up 
The scope of the reaction under the previously optimised conditions was initially examined through 
variation of the nucleophile used in the in situ derivatisation step. The [2,3]-rearrangement product of 
cinnamyl ammonium salt 211 could be in situ derivatised with sodium methoxide, pyrrolidine, N,O-
dimethylhydroxylamine or LiAlH4 to access a range of α-amino acid derivatives 229-232 in good yields 
and excellent stereocontrol (up to >95:5 dr and >99% ee). This process was readily performed on a 
multi-gram scale with maintenance of stereocontrol, with 1.95 g (8.3 mmol) of amino ester 231 (86%, 
95:5 dr, 95% ee) being generated from 4.0 g (9.6 mmol) of ammonium salt 211 (Scheme 47).  
In situ derivatisation with sodium ethoxide after [2,3]-rearrangement using racemic (±)-BTM, gave 
literature known ethyl ester (±)-233. The 1H NMR spectrum is consistent with provided by Doyle and 
co-workers[38] for the syn-diastereoiomser confirming the relative configuration of the rearrangement 
products.  
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Scheme 47: Scope of the nucleophilic in situ derivatisation, aperformed at rt using (±)-BTM. 
2.5 Synthesis of Allylic Ammonium Salts 
To examine the tolerance of the reaction towards a variety of N- and aryl substituents, a general route 
for the synthesis of a range of allylic amines was developed. Substituted allylic amines could be 
synthesised through a four-step route, from either the requisite cinnamic acid 234 (if readily available) 
or substituted benzaldehyde 235. Esterification of the cinnamic acid 234 with either methanol or ethanol 
gave the corresponding α,β-unsaturated ester 236. Alternatively, a Wittig olefination between the 
requisite benzaldehyde and ethyl 2-(triphenylphosphoranylidene)acetate gave 236 in excellent yields. 
Subsequent reduction with DIBAL-H gave the corresponding allylic alcohol 237. Bromination of 237 
using phosphorus tribromide gave the corresponding allylic bromide, which was subsequently 
substituted using the corresponding secondary amine. Alternatively, cinnamyl amines 239-242 were 
synthesised in a single step from commercially available cinnamyl bromide 210. 
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Scheme 48: Synthesis of allylic amines. aSynthesised by David S. B. Daniels 
With a range of allylic amines in hand the corresponding 4-nitrophenyl ester ammonium salts were 
synthesised. As noted in Chapter 1, a major challenge in the use of allylic ammonium salts in synthesis 
is their preparation and isolation. Pleasingly, allylic ammonium salts 254-258 were directly isolated, 
and routinely recrystallized where required. A range of N,N-dimethyl ammonium salts were synthesised 
bearing both electron-releasing and electron-withdrawing C(3)-aryl substituents, allowing a range of 
aryl substituents to be evaluated within the isothiourea-catalysed [2,3]-rearrangement. Treatment of the 
requisite allylic amine 238 with a slight excess (1.2 equiv.) of 4-nitrophenyl bromoacetate 213 gave the 
desired ammonium salts 253 in modest to excellent yields (Scheme 49). 
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Scheme 49: Synthesis of N,N-dimethyl ammonium salts, aEt2O/CH2Cl2 (4:1v:v) used in place of 
MeCN. 
In order to evaluate the substrate of the isothiourea-catalysed [2,3]-rearrangement with respect to the 
N-substituent, a range of ammonium salts bearing cyclic medicinally interesting motifs were 
synthesised. Allylic amines bearing cyclic N-substituents were found to be significantly less 
nucleophilic than their N,N-dimethyl counterparts, so a greater excess of 4-nitrophenyl bromoacetate 
213 was employed to facilitate ammonium salt formation. This strategy allowed the synthesis of a range 
of cyclic N-substituents ammonium salts 259-263 in good yields (64-70%) (Scheme 50).  
 
Scheme 50: Synthesis of 4-nitrophenyl ester allylic ammonium salts. aSynthesised by David S. B. 
Daniels. 
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2.6 Reaction Scope: N-Substituent Variation 
First, the reaction scope with respect to the N-substituents was assessed under the previously optimised 
conditions. A range of simple and medicinally relevant N-substituents such as piperidine, morpholine 
and N-Boc piperazines were well accommodated, giving the corresponding α-amino acid derivatives in 
good yields and outstanding stereocontrol (up to >95:5 dr, >99% ee). Interestingly, unsymmetrical 
4,5,6,7-tetrahydrothieno[3,2-c]pyridine substituent was also well tolerated to give 268 in excellent yield 
(80%) and stereocontrol (>95:5 dr, >99% ee).  
 
Scheme 51: Reaction substrate scope, N-variation. aSynthesised by David S. B. Daniels. 
2.7 Reaction Scope: Aryl-Substituent Variation 
Variation of C(3)-substituent within the allylic ammonium salt demonstrated that both electron-
withdrawing and electron-releasing substituents are well tolerated within the C(3)-aryl substituent, 
giving 271, 272 and 273 in good yield and excellent stereocontrol (up to >95:5 dr, >99% ee). Ortho-
substitution of the C(3)-aryl group is also accommodated forming rearrangement products 274 and 275 
with excellent stereocontrol, although accompanied by significantly diminished yields (33-55%). 
Chapter 2: Synthetic Studies 
 
 
39 
 
Scheme 52: Reaction scope, C(3)-aryl variation. 
The relative and absolute configuration of α-amino amide 274 bearing an ortho-bromo aryl substituent 
was confirmed through X-ray crystallographic analysis. Analysis of the crystalline material confirmed 
the relative syn-configuration between the C(2)-NMe2 and C(3)-aryl substituents, with a (2S,3S) 
absolute configuration. All other rearrangement products were assigned by analogy. 
 
Figure 3: X-ray analysis of 274, showing the relative (syn) and absolute configurations (2S,3S). X-ray 
analysis performed by Prof. Alexandra M. Z. Slawin. 
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2.8 Catalytic Enantioselective [2,3]-Rearrangement from in situ Generated Ammonium Salts 
Whilst a number of ammonium salts (scheme 49) could be isolated and purified by recrystallization (if 
required), many of them formed ionic liquids or oily gels which could not be readily isolated or purified. 
For example, treatment of meta-bromo cinnamyl amine 246 with 4-nitrophenyl bromoacetate 213 
resulted in formation of a hydroscopic gel which could not be isolated or purified. This meant that full 
examination of the reaction substrate scope was impeded as many of the desired ammoniums salts could 
not be isolated. To circumvent this problem a new strategy was required, and in situ formation of the 
ammonium salt, was postulated. Treating 4-nitrophenyl bromoacetate 213 with a slight excess (1.05 
equiv.) of allylic amine 212, formed the desired ammonium salt 211 in situ. Cooling the reaction to −20 
°C before adding ((+)-BTM (20 mol %), HOBt (20 mol %) and iPr2NH (1.4 equiv.), in MeCN, resulted 
in [2,3]-rearrangement and subsequent addition of benzylamine allowed benzylamide 215 to be isolated 
in 60% yield with excellent stereocontrol (>95:5 dr, 92% ee) (Scheme 53). It was also found that methyl 
ester 231 could be readily synthesised through the in situ protocol, with comparable yield and 
stereocontrol (Scheme 54).  
 
Scheme 53: In situ ammonium salt formation and subsequent catalytic enantioselective [2,3]-
rearrangement. 
Gratifyingly the in situ protocol allowed the incorporation of a wider range of C(3) substituents within 
the ammonium salt. The substrate scope was extended to include a heteroaromatic substituent, a styryl 
substituent and other cinnamyl derivatives 279-282, whose ammonium salts could not be isolated, all 
with excellent stereocontrol (up to >95:5 dr, 96% ee) and good yields (51-70%) (Scheme 54). 
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Scheme 54: Reaction scope of in situ generated ammonium salts. 
2.9 Reaction Stereospecificity 
Next, the reaction stereospecificity was assessed by comparing (E)- and (Z)-allylic ammonium salts to 
see if the opposite diastereoisomer is obtained. (Z)-Cinnamyl ammonium salt (Z)-284 could not be 
isolated and so the in situ protocol was utilised. Treating (Z)-283 under the previously optimised 
reaction conditions resulted in the same major, syn-diastereoisomer of 215 (87:13, syn:anti) being 
formed, albeit with reduced enantiocontrol (64% ee) and very poor isolated yield. This indicates a lack 
of stereospecificity, as both (E)- and (Z)-ammonium salts result in the same diastereomer of the product. 
However due to the low yield, isomerisation from (Z)-284 to the (E)-211 under the reaction conditions 
cannot be ruled out.  
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Scheme 55: Examination of reaction stereospecificity, study performed by David S. B. Daniels 
2.10 Requirement of the C(3)-Aryl Substituent 
Further evaluation of the substrate scope investigated the requirement of the C(3)-aryl unit within the 
ammonium salt. Synthesis of substrate 288 required the use of an N-Boc piperazyl N-substituent to 
make the resulting allyl ammonium salt 288 sufficiently crystalline to allow for its isolation. Following 
the previously developed synthetic route ammonium salt 288 was synthesised in good yield across the 
two steps (Scheme 56). 
 
Scheme 56: Synthesis of N-allyl ammonium salt. 
Rearrangement of 288 under previously optimised reaction conditions proceeded smoothly, giving 
product 289 in good yield, albeit with low enantioselectivity (56% ee) (scheme 57). This suggests that 
the C(3)-π system within the ammonium salt is a key structural requirement to obtain high levels of 
enantioselectivity (Scheme 57).  
 
Scheme 57: Evaluation of the requirement of a C(3)-π system. 
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2.11 Postulated Mechanism 
A number of potential mechanisms for this process proceeding though either Lewis base or Brønsted 
base catalysis can be postulated. Whilst a Brønsted base mechanism, where the isothiourea directly 
deprotonates ammonium salt 253 to form a chiral ion-pair, cannot be discounted at this point, a tentative 
Lewis basic mechanism is proposed (Scheme 58). Dicationic acyl ammonium ion 291 can be formed 
through direct N-acylation of (+)-BTM 197 with activated ester ammonium salt 253 before 
deprotonation of 291 with a suitable base generates ammonium ylide 292. Alternatively, ylide 292 can 
be accessed through base-mediated elimination of 4-nitrophenol from 253 to form ammonium ketene 
290, followed by addition of (+)-BTM 197. Subsequent [2,3]-rearrangement of ylide 292 generates acyl 
ammonium 293, which can be intercepted directly by 4-nitrophenoxide to form the isolable PNP ester 
295. Alternatively, 293 can be intercepted by nucleophilic co-catalyst HOBt to form 294, which can be 
transesterified to 295 in a secondary catalytic cycle as previously described by Rovis and co-workers.[39] 
PNP ester 295 can then be derivatised in situ to form a range of α-amino acid derivatives 296 in good 
yields and stereoselectivities.  
 
Scheme 58: Proposed catalytic cycle. 
2.12 Stereochemical Rationale  
The observed syn-diastereoselectivity is thought to arise from the stereodetermining [2,3]-
rearrangement step occurring preferentially through endo-type pre-transition-state assembly 297. In this 
assembly, the carbonyl oxygen preferentially aligns syn to the sulfur atom of the acyl ammonium ion, 
allowing for a stabilising n0 to σ*C-S interaction. This n0 to σ*C-S interaction is thought to provide the 
origin of stereocontrol in a range of isothiourea catalysed processes and has been studied extensively 
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both computationally and crystallographically.[40] The stereocontrolling phenyl substituent on the acyl 
ammonium, sits in a pseudoaxial orientation to minimise 1,2-steric interactions, with [2,3]-
rearrangement occurring anti to this unit. A key π-cation interaction between the acyl ammonium ion 
and the allylic C(3)-aryl or styryl unit is postulated, further stabilising the endo-type array 297, 
rationalising the key C(3)-aryl structural requirement for stereocontrol. This type of interaction has 
previously been proposed in other enantioselective isothiourea-catalysed reactions.[41] 
 
Figure 4: Proposed pre-transition state assembly 
2.13 Conclusions 
The first catalytic enantioselective variant of the [2,3]-rearrangement of allylic ammonium ylides has 
been discovered and developed. The isothiourea (+)-benzotetramisole 197 catalyses the [2,3]-
rearrangement of quaternary ammonium salts bearing activated 4-nitrophenyl esters to form a range of 
syn-α-amino acid derivatives in good yield and excellent stereoselectivities (up to >95:5 dr, >99% ee). 
The substrate scope of the reaction has been examined for over 20 examples, including on a multi-gram 
scale. For ammonium salts which were not isolable an in situ formation protocol has been developed to 
enable further exploration of the substrate scope of the reaction.[42] 
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Chapter 3: Mechanistic and Stereochemical Studies 
3.1 Summary 
This chapter describes mechanistic investigations into the isothiourea-catalysed enantioselective [2,3]-
rearrangement developed in chapter 2. Reaction kinetic analysis of the process by 19F NMR has allowed 
a kinetic profile to be built up, and analysed under different conditions. This has allowed the catalyst 
resting state, the reaction orders with respect to each component, and the effect of various additives, 
including HOBt, to be studied. Furthermore, a catalyst substrate adduct has been identified and 
characterised by 13C and 15N isotopic labelling experiments. This adduct is both a genuine intermediate 
and is on the productive cycle as determined through isotopic entrainment. Kinetic isotope effects and 
collaborative computational work has provided detailed insight into the stereodetermining [2,3]-
rearrangement step, while Hammett analysis has given experimental insight into the susceptibility of 
the transition state to electronic effects. Collaborative computational studies have probed the origins of 
stereocontrol, giving insight into key cation-π and 1,5 n0 – σ*c-s interactions. Computational reaction 
coordinate modelling has excluded potential mechanistic possibilities and has provided further support 
for the experimentally proposed mechanism. 
3.2 Introduction and Aims 
As detailed in chapter 1, the [2,3]-rearrangement of allylic ammonium ylides is an elegant method for 
the synthesis of stereodefined α-amino acid derivatives.[43] The mechanism of such processes and 
related [1,2]-Stevens rearrangements have been the subject of much discussion in the literature. It is 
thought that [2,3]-rearrangements proceed through an ionic concerted thermal sigmatropic 
rearrangement and the competitive [1,2]-rearrangement proceeds via radical bond cleavage (Scheme 
59).[43]  
 
Scheme 59: Competitive [1,2]- and [2,3]-rearrangements of allylic ammonium ylides. 
Currently there are surprisingly few detailed mechanistic analyses of [2,3]-rearrangement processes, 
and there is no mechanistic understanding of enantioselective [2,3]-rearrangements of allylic 
ammonium ylides. Current state-of-the-art within this area is the elegant studies performed by Singleton 
and co-workers,[44] focusing on the competition between [2,3]- and [1,2]-rearrangements from allylic 
ammonium ylides generated using DBU. Through the use of natural abundance 13C kinetic isotope 
effects, computational modelling, and crossover experiments the authors were able to show that in cases 
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of competitive [1,2]- and [2,3]-rearrangement that both processes proceed through a common formal 
[2,3]-transition state such as 301 (Scheme 59).[44] 
 
Scheme 60: Singleton’s investigation into competing [1,2]- and [2,3]-rearrangements.[44] 
Jacobsen and co-workers have recently reported a detailed mechanistic and computational investigation 
into the related thiourea-catalysed [2,3]-Wittig rearrangement detailed in chapter 1.[45] The observed 
diastereocontrol of general [2,3]-rearrangements is often rationalised by the relative energies of the exo 
and endo transition states. These general transition states are typically based upon those calculated by 
Marshall and Houk[46] for the [2,3]-Wittig rearrangement (Scheme 61). The stereochemical outcome of 
many [2,3]-rearrangement processes is informed by the steric and stereoelectronic properties of the 
substituents (R1 and R2) and also the heteroatom present. Whilst the diastereocontrol of many [2,3]-
rearrangements can be rationalised through these transition states, the origins of enantioselectivity of 
the majority of [2,3]-rearrangements is unclear. 
 
Scheme 61: Generalised diastereoselectivity rationale, based upon Marshall and Houk’s calculated 
transition states.[46]  
In chapter 2 a Lewis base-catalysed mechanism is proposed for the isothiourea-catalysed 
enantioselective [2,3]-rearrangement of allylic ammonium ylides previously described. However, a 
number of alternative possibilities cannot be initially excluded, including Lewis or Brønsted base-
catalysed pathways that would proceed through a variety of different reactive intermediates. For 
example, if a Lewis base-catalysed pathway is operative the reaction could pass through ammonium 
ketene 307 en route to the reactive Lewis base-bound ammonium ylide 306. Alternatively, the 
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isothiourea catalyst could act as a Brønsted base-catalyst which could directly deprotonate the substrate 
to form chiral ion pair 308. 
 
Figure 5: Potential reaction intermediates. 
This chapter aims to gain detailed mechanistic and stereochemical insight into the isothiourea -catalysed 
enantioselective [2,3]-rearrangement developed and described in chapter 2. We aimed to gain 
information regarding the overall process through kinetic and reaction order analysis, to look at the 
reversibility of each of the key reaction steps, identify any potential catalytic intermediates, probe the 
turnover-limiting step of the process, and to assess the role of the co-catalyst HOBt. Through 
collaboration with computational chemists Prof. Paul Ha Yeon-Cheong and Daniel Walden at Oregon 
State University, we aimed to probe the origins of stereochemical control within the process and validate 
any experimental mechanistic hypotheses.  
3.3 Kinetic Reaction Profiling 
Initial efforts were focused on establishing a kinetic profile of the previously developed [2,3]-
rearrangement using 19F NMR as an in situ method to monitor the concentrations of substrate and 
product to identify any potential catalytic intermediates. The “standard” reaction chosen was the [2,3]-
rearrangement of isolated ammonium salt 309, which under the previously optimised reaction 
conditions, (+)-BTM 197 (20 mol %), HOBt (20 mol %) and iPr2NH (1.4 equiv.) in MeCN at −20 °C, 
gives 310 in excellent yield and stereoselectivity (95%, >95:5 dr, 98% ee) after the addition of NaOMe. 
 
Scheme 62: Reaction chosen for kinetic analysis. 
The 4-fluoro substituent on 309 allows direct monitoring of any species derived from the substrate by 
19F NMR in situ over time. To analyse this process by 19F NMR some modulation of reaction conditions 
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had to be made from the original synthetic conditions as ammonium salt 309 is only partially soluble in 
d3-MeCN at the synthetic reaction concentration (68 mM). Therefore, the reaction solvent was changed 
to d3-MeCN/d6-DMSO (9:1) and the concentrated halved (34 mM) to allow for full solubility of 309 at 
−20 °C. Using α,α,α-trifluorotoluene (PhCF3) as an internal standard, a reaction profile could be readily 
obtained through monitoring of the concentrations of all species containing fluorine over a time period 
of 4 h at −20 °C, acquiring a 19F{1H} NMR spectrum every ten minutes ns = 1, (Scheme 63A). 19F{1H} 
single scan was chosen to avoid issues of T1 relaxation. [47] A typical 19F{1H} NMR spectrum of a kinetic 
analysis is shown in chapter 6. Scheme 63A shows a typical reaction profile monitoring substrate 309 
and product 311, acid formed from hydrolysis of 309, anti-311 and HOBt esters are not plotted for 
clarity. During the early stages of the reaction (<1000 s) a large consumption of substrate (δF = −113.1 
ppm) is observed, however as the reaction proceeds it enters a pseudo-steady state period (~3000 s 
onwards) where the substrate decays with good pseudo-first order kinetics. The rearrangement product 
311 (δF = −117.6 ppm) builds up to high concentrations (~20 mM, >80% conversion) over 4 h. During 
this kinetic analysis an unknown intermediate species (δF = −117.0 ppm) was also observed over the 
course of the reaction, which builds up to maximum concentration of ~5.2 mM during the initial stages 
of the reaction and slowly decays as the reaction progresses. Reactive intermediates are rarely observed 
in kinetic profiles obtained by NMR, so efforts were focused on the identification of this species. If the 
[2,3]-rearrangement of 309 is performed in the absence of the HOBt additive a similar reaction profile 
is observed, but slightly lower diastereo- and enantiocontrol is obtained (88:12 dr, 92% ee). Notably, in 
the absence of HOBt the observed intermediate builds up to higher maximum concentrations (7.1 mM) 
(Scheme 63B) and therefore to facilitate identification of this intermediate further investigations were 
performed in the absence of HOBt.  
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Scheme 63: Reaction profiles monitored by 19F{1H} NMR, initial concentrations: 309 (34 mM), (+)-
BTM 197 (6.8 mM), iPr2NH (47 mM), d3-MeCN:d6-DMSO (9:1), −20 °C, 4 h. A) HOBt (6.8 mM), B) 
No HOBt. Acid formed from hydrolysis of 309, anti-311 and HOBt ester not plotted for clarity. 
3.4 Identification of the observed intermediate  
3.4.1 Catalyst Speciation 
To monitor all catalyst derived species, the resting state of the catalyst and determine if the observed 
intermediate is catalyst derived a fluorinated version of (+)-BTM, F-(+)-BTM 315, was synthesised. F-
(+)-BTM 315 was synthesised in two steps from the corresponding chlorobenzothiazole 312 using the 
chromatography-free route of Daniels et.al.[48] (Scheme 64). 
 
Scheme 64: Synthesis of F-(+)-BTM 315. 
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F-(+)-BTM 315 is a competent catalyst for the [2,3]-rearrangement of 309, giving rearranged product 
310, after the addition of NaOMe, in comparable stereocontrol (92:8 dr, 97% ee) to the reaction using 
(+)-BTM 197 (>95:5 dr, 98% ee) (Scheme 65).  
 
Scheme 65: Demonstration of catalytic competency of F-(+)-BTM 315, in the [2,3]-rearrangement of 
309. 
In situ monitoring of the F-(+)-BTM 315 catalysed process by 19F{1H} NMR revealed the presence of 
free F-(+)-BTM 315 (δF = −123.3 ppm) and an additional catalyst derived species containing two 
fluorine signals (δF = −113.4 and −117.0 ppm), which integrate equally through the course of the 
reaction. The latter displayed analogous kinetic behaviour to that of the previously observed reaction 
intermediate when (+)-BTM 197 is used (Scheme 66), suggesting that it is one species derived from a 
combination of catalyst and substrate. Monitoring of F-(+)-BTM throughout the reaction also revealed 
the catalyst resting state. The catalyst exists as a mixture of free F-(+)-BTM 315 and catalyst derived 
intermediate. At the onset of the pseudo-steady-state section of the reaction (>3000 s, 40% conversion), 
the catalyst exists predominately as the intermediate; as the reaction progresses and the concentration 
of substrate decreases the resting-state changes to the free F-(+)-BTM (~10000 s, 66% conversion) 
(Scheme 66). Notably, the chemical shift of F-(+)-BTM 315 (δF = −123.3 ppm) remains constant 
throughout the course of the reaction indicating the free catalyst does not become partially protonated. 
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Scheme 66: Catalyst speciation and identification of reaction intermediate, inset graphic shows the 
monitoring of substrate derived species, initial concentrations; 309 (29.5 mM), F-(+)-BTM 315 (6.8 
mM), iPr2NH (47 mM), d3-MeCN/d6-DMSO (9:1), −20 °C, 4 h. 
To help elucidate the identity of the catalyst derived reaction intermediate, simplified model species 
were synthesised. F-(+)-BTM·HCl 316 (δF = −118.1 pm) and an N-benzoyl acyl ammonium 317 (δF = 
−113.3 pm) were synthesised from F-(+)-BTM 315, through reaction with ethereal HCl and benzoyl 
chloride, respectively (Scheme 67). Based upon the chemical shift of the fluorine signals it is postulated 
that the observed intermediate (δF = −113.4 ppm) is an acylated isothiourea (model 317 δF = −113.3 
pm).  
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Scheme 67: Synthesis of catalyst derived model substrates. 
3.4.2 Intermediate identification by isotopic labelling 
Given that the observed intermediate is thought to be acyl ammonium derived, based on our previous 
mechanistic hypotheses, the intermediate could be dication 318, ammonium ylide 319 or acyl 
ammonium 320 (Figure 6). The nature of the counterion on the observed intermediate is not obvious 
and is thought to be tough to probe experimentally. 
 
Figure 6: Possible constitution of observed intermediate, possible counterions omitted for clarity. 
To fully elucidate the constitution of the observed intermediate an isotopic labelling strategy was 
employed. In order to utilise this strategy an 15N labelled catalyst, 15N-F-BTM 15N-321, and 13C2 
ammonium salt substrate 13C2-322 were identified as necessary (Figure 7). 
 
Figure 7: Isotopic labelling strategy. 
Double labelling of the substrate 13C2-322 with 13C allowed facile in situ monitoring of the reaction by 
13C{1H} NMR, also necessary to allow identification of potential C-N bond connectivity within the 
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intermediate. The 13C nucleus has a nuclear spin of I = ½ and a natural abundance of 1.1%, meaning 
13C2-322 will exhibit doublets for the 13C=O and 13CH2 signals (number of lines = 2nI + 1 = 2(1)(1/2) 
+ 1 = 2) in 13C{1H} NMR. The 15N nucleus also has a nuclear spin of I = ½ and a natural abundance of 
0.37%, hence if there is 15N-13C connectivity within the observed intermediate a doublet of doublets 
would be observed within the 13C{1H} NMR for the 13C=O signal. This due to the 15N atom causing 
further splitting of the doublet into a doublet of doublets (Figure 8). 
 
Figure 8: Expected coupling pattern for the presence of 15N-13C connectivity.  
3.4.3 Synthesis of isotopically labelled catalyst and substrate 
Racemic 15N-F-BTM 15N-321 was synthesised in six steps from 15NH4Cl and benzaldehyde 324. Firstly, 
a three-component Strecker reaction between benzaldehyde, 15NH4Cl and potassium cyanide gave 15N-
α-amino nitrile 15N-325 in modest yield, with subsequent hydrolysis under acidic conditions giving 15N-
phenylglycine 15N-326 in quantitative yield. Methyl ester formation and LiAlH4 reduction gave 15N-
phenylglycinol 15N-328. SNAr with 2-chloro-6-fluoro-benzothiazole 312 gave 15N-amino alcohol 15N-
329 in poor yield, with subsequent cyclisation using methanesulfonyl chloride and NEt3 giving 15N-F-
BTM 15N-321 in 42% yield (Scheme 68). 
 
Scheme 68: Synthesis of 15N-F-BTM 15N-321. 
Doubly 13C labelled ammonium salt 13C2-333 was synthesised over two steps from commercially 
available 13C2-bromoacetic acid 13C2-330. DCC coupling with 4-nitrophenol gave 13C2-4-nitrophenyl 
bromoacetate 13C2-331, which was reacted with N,N-dimethyl 4-fluorocinnamyl amine 332 to give 13C2 
labelled ammonium salt 13C2-333.  
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Scheme 69: Synthesis of 13C2 ammonium salt 13C2-333 
3.4.4 In situ reaction monitoring by 13C NMR Spectroscopy 
Using isotopically 15N labelled catalyst 15N-321 and 13C2 labelled ammonium salt 13C2-333 the reaction 
was monitored in situ by 13C{1H} NMR. Modulation of the concentration of iPr2NH (23.8 mM) 
prolonged the lifetime of the observed intermediate and facilitated its identification. Following the 
reaction by 13C{1H} NMR, the 13C=O region of the spectrum displayed a doublet of doublets at δC = 
173.1 ppm (1JCC = 51.9 Hz, 1JCN = 5.2 Hz), which is consistent with the presence of an acyl ammonium 
motif within the observed intermediate (Scheme 70A). Analysis of the 13CH/13CH2 region of the 13C{1H} 
NMR spectrum (60-73 ppm) displayed a doublet of doublets at δC = 67.8 ppm (1JCC = 51.5 Hz, 2JCN = 
7.0 Hz) for the intermediate species, further confirming the presence of an acyl ammonium motif within 
the intermediate (Scheme 70B). 
 
  
Chapter 3: Mechanistic and Stereochemical Studies 
 
 
56 
 
Chapter 3: Mechanistic and Stereochemical Studies 
 
 
57 
Scheme 70: Isotopic labelling studies employing 15N-F-BTM 15N-321 and 13C2 ammonium salt 13C2-
333, initial concentrations; 13C2-333 (34 mM), 15N-F-BTM 15N-321 (6.8 mM), iPr2NH (23.8 mM), with 
partial 13C{1H} NMR (101 MHz, d3-MeCN/d6-DMSO (9:1), 273 K) spectra: A) (162 -175 ppm), B) 
(60 -74 ppm)  
To ascertain the presence of any C(2)-C(3) connectivity within the intermediate, a 1H coupled 13C NMR 
spectrum was acquired. A doublet of doublets (1JCH = 138.6 Hz, 1JCC = 51.7 Hz) at δC = 67.8 ppm was 
observed, consistent with the intermediate containing a C(2)H unit, however longer range 2JCH coupling 
could not unambiguously confirm or exclude C(2)-C(3) connectivity due to significant line broadening 
within the intermediate in the 13CH/13CH2 region. Notably, long range 2JCH coupling could be readily 
observed within rearranged product 13C2-335 in the 13CH region, (ddd, 1JCH =143.2 Hz, 1JCC = 56.9 Hz, 
2JCH = 2.8 Hz) at δC = 70.7 ppm, indicating C(2)-C(3) connectivity within the rearranged product 13C2-
333. 
 
Figure 9: Isotopic labelling studies employing 15N-F-BTM 15N-321 and 13C2 ammonium salt 13C2-333 
with partial 1H coupled 13C NMR (101 MHz, d3-MeCN/d6-DMSO (9:1), 273 K) spectrum (58 -75 
ppm). Initial concentrations; 13C2-333 (34 mM), 15N-F-BTM (6.8 mM), iPr2NH (23.8 mM). 
To allow unambiguous elucidation of the constitution of the intermediate an additional 13C isotopic 
label was installed at the C(3) position of the ammonium salt 13C3-341. Triply labelled 13C3 ammonium 
salt 13C3-341 was prepared from commercially available α-13C benzoic acid 13C3-336 in seven steps, 
starting with LiAlH4 reduction to 13C labelled benzyl alcohol 13C3-337 and PCC oxidation to give α-13C 
benzaldehyde 13C3-338. Wittig olefination yielded 13C(3)-ethyl cinnamate 13C3-339, with DIBAL-H 
reduction followed by bromination and amination giving 13C-N,N-dimethyl cinnamyl amine 13C3-340. 
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Reaction of 13C3-340 with 13C2-4-nitrophenyl bromoacetate 13C2-331 gave the desired 13C3 ammonium 
salt 13C3-341 (Scheme 71).  
 
Scheme 71: Synthesis of 13C3-ammonium salt 13C3-341 
Reacting 13C3-ammonium salt 13C3-341 with (+)-F-BTM 315 (20 mol%, 6.8 mM) and iPr2NH (23.8 mM) 
and monitoring the reaction via in situ 13C{1H} NMR, the C(2) region (59-72 ppm) displayed a doublet 
of doublets (1JCC = 51.4 Hz, 1JCC = 35.8 Hz) at δC = 68.0 ppm that is consistent with C(2)-C(3) bond 
formation (Scheme 72). These isotopic labelling studies indicate that the observed intermediate is post-
rearrangement acyl ammonium 13C3-342.  
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Scheme 72: Isotopic labelling studies employing F-(+)-BTM 315 and 13C3 ammonium salt 13C3-341 
with partial 13C{1H} NMR ((101 MHz, d3-MeCN/d6-DMSO (9:1) 273 K) spectrum (60 -74 ppm). 
Initial concentrations; 13C3-341 (34 mM), F-(+)-BTM 315 (6.8 mM), iPr2NH (23.8 mM). 
3.5 Reversibility of Intermediate Formation 
Having fully elucidated the constitution of the observed reaction intermediate, the reversibility of its 
formation and hence the reversibility of the [2,3]-rearrangement step were probed. In situ 13C{1H} NMR 
was once again employed to monitor the process, 13C3 ammonium salt 13C3-341 was treated with a 
stoichiometric amount of F-(+)-BTM 315 (34 mM, 1.0 equiv.) and iPr2NH (23.8 mM, 0.7 equiv.) at rt 
to effect full conversion of 13C3-341 into a mixture of 13C3-343 and intermediate 13C3-342 (Scheme 
73B). Once full conversion of 13C3-341 was achieved, an equivalent of 13C1-344 (34 mM, 1.0 equiv.), 
synthesised from 13C1 bromoacetic acid, was added and the system allowed to equilibrate in the 
spectrometer at 273 K for 1 h (Scheme 73C). Over this time period no 13C3 material was observed to 
revert back into 13C3-341 from either the intermediate or product. The reaction was subsequently treated 
with additional iPr2NH (23.8 mM then 47.6 mM) and still no 13C3 material was observed reversing into 
substrate; remaining 13C3 intermediate was converted into product 13C3-343 (Scheme 73D). This is 
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consistent with the irreversible formation of the intermediate 13C3-342 and hence the [2,3]-
rearrangement step of the process is highly irreversible (Scheme 73). 
 
Scheme 73: Intermediate reversibility studies, A)13C{1H} NMR spectrum (101 MHz, d3-MeCN/d6-
DMSO (9:1), 273K) of the 13C(2)-H region (59-73 ppm). Conditions, 13C3-341 (34 mM), (+)-F-BTM 
315 (6.8 mM), iPr2NH (23.8 mM), B) 13C3-341 (34 mM), (+)-F-BTM 315 (34 mM), iPr2NH (23.8 mM), 
C) 13C3-341 (34 mM), (+)-F-BTM 315 (34 mM), iPr2NH (23.8 mM) and 13C1-344 (34 mM), 273K, 1 h., 
D) After the addition of further iPr2NH (23.8 mM, then a further 47.6 mM). 
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3.6 Intermediate On or Off Productive Pathway? 
Isotopic entrainment studies 
To ascertain if the observed acyl ammonium intermediate 342 is off (figure 10, Case A) or on (figure 
10, Cases B-D) the productive catalytic cycle, an isotopic entrainment experiment was performed to 
distinguish between these four cases. Isotopic entrainment is an experiement in which, once a catalytic 
reaction has reached pseudo-steady-state, a labelled substrate is added into the reaction and followed 
through the catalytic cycle. Analysis of the changes of labelled populations within the substrate, 
intermediate and product allows distinction between each of the four proposed cases. (Figure 10).  
 
Figure 10: Possible productive and non-productive cases for the observed intermediate 342.  
Applying this strategy, 13C1-ammonium salt 13C1-344 (0.5 equiv., 17 mM, δC = 164.1 (13C=O)) was 
treated with (+)-BTM 197 (20 mol%, 6.8 mM) and iPr2NH (1.4 equiv., 47 mM) in 9:1 d3-MeCN/d6-
DMSO at −20 °C and monitored by in situ quantitative (ns = 16, d1 = 30 s) 13C{1H} NMR spectroscopy. 
Once the reaction had reached the pseudo-steady-state period of the reaction ~2700 s, 13C2-
ammonium salt 13C2-333 (0.5 equiv., 17 mM, δC = 60.9 (d, 1JCC 64.6, 13CH2)) was added to the reaction, 
and the 13C2-matieral monitored by in situ quantitative (ns = 16, d1 =30 s) 13C{1H} NMR, 13C2-
intermediate 13C2-345 (δC = 67.6 (d, 1JCC 51.5, 13C(2)H)) and 13C2-product 13C2-335 (δC = 70.5 (d, 1JCC 
55.8, 13C(2)H)).  
At the point of addition of 13C2-333, there has been 32% net conversion of substrate (13C1-344 and 13C2-
333), but neither the product nor the intermediate yet contain any 13C2-labelled material. All 13C2-
material exists as unreacted substrate with is made up of 28% 13C1-344 and 72% 13C2-333. Analysis of 
the 13C2-populations in substrate, intermediate and products allowed us to distinguish between cases A-
D (figure 10). Regardless of case (A-D) the 13C2-population of the product must finally rise from 0 to 
50%, as equal amounts of 13C1-344 and 13C2-333 were used. For case A where intermediate 342 is non-
productive and is in equilibrium with the product, the 13C2-incorportation with be lower or equal to that 
of the product (≤50%). For case B where the intermediate is productive but is in equilibrium with the 
substrate, the 13C2-population of the substrate will be reduced, from 72% to 55%, as 13C1-material 
reverses from the intermediate back into the substrate. For case C where the formation of the 
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intermediate ([2,3]-rearrangement) is irreversible, the 13C2-population in the substrate will remain 
constant (72%).The 13C2-population of the intermediate will be limited to 50% as it is in full equilibrium 
with the product. For case D the 13C2-population in the substrate will also remain constant (72%), the 
13C2-population in the intermediate will rise to reach 72%, due to its irreverisble decay, the 13C2-
population in the intermediate will rise in advance of that of the product, due to it being on the 
productive pathway. Analysis of experimental and predicted 13C2-populations as a function of net 
conversion (Scheme 74), confirms that intermediate 342 is a productive catalytic intermediate and 
occurs from two irreversible first-order interconversions (figure 10, Case D).  
 
 
 
Scheme 74: Entrainment of 13C2 substrate 13C2-333 into 13C1 catalytic cycle 
aConditions, 13C1-344 
(17 mM), (+)-BTM 197 (6.8 mM), iPr2NH (47.6 mM), d3-MeCN/d6-DMSO (9:1), 13C2-333 (17 mM) 
added at 32% net conversion of substrate. Open circles: experimental (13C{1H} NMR) data, dashed 
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lines: kinetic simulation where 342 is a productive intermediate in two-irreversible pseudo-first order 
interconverisons. Kinetic simulations performed by Prof. Guy C. Lloyd-Jones. 
 
3.7 Effect of HOBt on the Acyl Ammonium Intermediate 
To gain insight into the role of the co-catalytic HOBt used within the synthetic reaction, its effect upon 
the observed acyl ammonium intermediate 342 and kinetic profile was studied. Firstly, the 
rearrangement was studied in the presence of a stoichiometric amount of HOBt (34 mM, t= 0), which 
resulted in the suppression of acyl ammonium 342 formation and formation of the corresponding HOBt 
ester 346 was observed (Scheme 75).  
 
0 5000 10000 15000
0
5
10
15
20
25
30
35
 309 (
F
 = -113.1 ppm)  Intermediate (
F
 = -117.0 ppm)
 311 (
F
 = -117.6 ppm)  346 (
F
 = -117.2 ppm)
C
o
n
c
e
n
tr
a
ti
o
n
 (
m
M
)
time (s)
 
Scheme 75: Addition of stoichiometric HOBt (34 mM) at t=0, initial concentrations 309 (34 mM), (+)-
BTM 197 (6.8 mM), HOBt (34 mM) iPr2NH (47.6 mM), d3-MeCN/d6-DMSO (9:1). 
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The identity of the HOBt ester 346 was confirmed through synthesis of an authentic sample, obtained 
through hydrolysis of 311 under acidic conditions followed by EDC·HCl mediated coupling with HOBt 
(Scheme 76). 
 
Scheme 76: Synthesis of racemic authentic sample of HOBt ester 346. 
To further examine the effect of HOBt upon acyl ammonium intermediate 342, a stoichiometric amount 
of HOBt (34 mM) was added once the reaction has reached its pseudo-steady state (t= 3920 s) at which 
acyl ammonium 342 has reached its maximum concentration. This resulted in immediate formation of 
the HOBt ester 346 through esterification of acyl ammonium 342. After this HOBt addition no further 
acyl ammonium intermediate 342 was observed by 19F{1H} NMR.   
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Scheme 77: Addition of stoichiometric HOBt (34 mM) at t = 3920 s, initial concentrations 309 (34 
mM), (+)-BTM 197 (6.8 mM), iPr2NH (47.6 mM), d3-MeCN/d6-DMSO (9:1). 
Examination of the reaction profiles of reactions with and without HOBt indicates that the addition of 
high concentrations of HOBt (13.6-34 mM) changes the resting state of the catalyst from acyl 
ammonium 342 to free (+)-BTM 197 (Scheme 78). This suggests that HOBt accelerates the breakdown 
of acyl ammonium 342 through transesterification, enabling product release via the corresponding 
HOBt ester 346. 
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Scheme 78: Cartoon representation of change in catalyst resting state upon addition of HOBt. Sub., 
ammonium salt substrate, Int., acyl ammonium intermediate, Prod., 4-nitrophenyl ester product. 
 
3.8 Reaction Kinetics 
Having successfully identified all the species present in the reaction mixture by 19F NMR, a full kinetic 
analysis was undertaken to determine the rate order of each of the components of the reaction. In the 
initial period of the reaction there is a significant drop in concentration of substrate, whilst the reaction 
slowly enters a pseudo-steady state section at ~3000 s. Once in the pseudo steady state, the substrate 
309 decays with good pseudo-first order kinetics, which can be shown by plotting a first order log plot 
(Scheme 79). Under the standard conditions ((+)-BTM 197 (6.8 mM), HOBt 216 (6.8 mM), iPr2NH (47 
mM), substrate (34 mM)) a kobs of 1.37 × 10-4 s-1 was observed for the pseudo-steady section of the 
catalysis. The observed rate (kobs) is determined from the gradient of the first order log plot discarding 
the data points within the induction period (the first five data points) (Scheme 79).  
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Scheme 79: Kinetic reaction profile and first-order log-plot for the [2,3]-rearrangement of 309, initial 
concentrations; 309 (34 mM), (+)-BTM 197 (6.8 mM, 20 mol%), HOBt 216 (6.8 mM, 20 mol%), 
iPr2NH (47.6 mM, 1.4 equiv.), d3-MeCN/d6-DMSO (9:1), −20 °C, 4 h. 
Firstly, the order of the catalyst (+)-BTM 197 was examined across a range of concentrations (1.7-13.6 
mM) whilst maintaining the initial concentrations of all other components constant. The observed rate 
kobs, determined by first-order log-plots for the decay of ammonium salt 309, from each of the kinetic 
runs was plotted as a function of concentration. This process was repeated for the other components of 
the reaction, iPr2NH (23.8-95.2 mM) and HOBt 216 (0-34 mM), revealing a first-order rate dependency 
upon both (+)-BTM 197 and iPr2NH, and a zero-order rate dependency upon co-catalyst HOBt. 
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Scheme 79: A) First-order rate dependency on (+)-BTM 197, B) First-order rate dependency on 
iPr2NH, C) Zero-order rate dependency on HOBt . 
3.9 Non-Linear Effect of Catalyst Enantiopurity 
To probe confirm the first-order rate dependency of (+)-BTM 197, the effect of the enantiopurity of 
(+)-BTM 197 on enantiopurity of rearrangement product 310 was probed. Non-linear effects in 
asymmetric catalysis originate from interactions of chiral catalysts or ligands on or off the catalytic 
cycle to generate diastereomeric species which result in non-linear correlation between catalyst and 
product enantiopurity.[49] A good linear relationship was found between the two, further confirming the 
first-order rate dependency and monomeric nature of the active catalyst (+)-BTM 197 (Scheme 81). 
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Scheme 81: Probing non-linear effects of catalyst enantiopurity.  
Based upon order analysis it is thought that HOBt is not involved in any pre-equilibria with or in the 
turnover-rate limiting step of the process. Order analysis indicates that deprotonation of dication 318, 
[2,3]-rearrangement of 319 or product release from 320 maybe turnover-rate limiting. 
3.10 Deuterium kinetic isotope effects 
To probe the turnover-limiting step of the process, deuterium kinetic isotope effects were employed. 
Firstly, the kinetic relevance of the deprotonation of dication 318 into the reactive ammonium ylide 319 
was probed. α-Dideuterio ammonium salt d2-351 was synthesised from d4-malonic acid, starting with 
bromination and decarboxylation to give d3-bromoacetic acid d3-349. Subsequent DCC mediated 
coupling with 4-nitrophenol gave d2-4-nitrophenyl bromoacetate d2-350 (95% D), and addition of N,N-
dimethyl 4-fluorocinnamyl amine 332 gave d2-ammonium salt d2-351 (Scheme 82). Unfortunately, 
ammonium salt formation led to H/D exchange and d2-351 was obtained with 75% D incorporation as 
judged by 1H NMR. A range of alternative solvents was trailed for the ammonium salt formation step, 
including d3-MeCN and d2-dichloromethane, however a higher deuterium incorporation could not be 
achieved. Notably, d2-ammonium salt d2-351 undergoes facile H/D exchange in NMR solvent (d3-
MeCN/d6-DMSO (9:1)), losing ~10% D over 4 h at rt. Consequently, d2-351 was deemed unsuitable 
for precise kinetic analysis. 
Chapter 3: Mechanistic and Stereochemical Studies 
 
 
70 
 
Scheme 82: Synthesis of d2-ammonium salt d2-351 
As a result, efforts were switched to the measurement of a secondary kinetic isotope effect at the C(3) 
position to assess the kinetic significance of the [2,3]-rearrangement step. To achieve this, C(3)-D- d1-
357 was synthesised in six steps from 4-fluoro-1-bromobenzene 352, starting with lithium-halogen 
exchange and quenching with d7-DMF to give d-4-fluorobenzaldehyde d1-353. Wittig olefination 
between d1-353 and ethyl 2-(triphenyl-λ5-phosphanylidene)acetate gave α,β-unsaturated ester d1-355, 
DIBAL-H reduction, followed by bromination and amination with N,N-dimethylamine gave C(3)-D 
amine d1-356. Reaction of d1-356 with 4-nitrophenyl bromoacetate 213 gave C(3)-D ammonium salt 
d1-357 with excellent deuterium incorporation (>99% D).  
 
Scheme 83: Synthesis of C(3)-D ammonium salt d1-357. 
Firstly, the impact of C(3)-deuteration on the yield and stereoselectivity of the [2,3]-rearrangement was 
probed. Pleasingly, C(3)-D ammonium salt d1-357 underwent [2,3]-rearrangement with comparable 
yield and stereocontrol (91%, >95:5 dr, 94% ee, >99% D) with that of C(3)-H isotopologue 309, 
importantly no H/D exchange was observed under the reaction conditions (Scheme 84).  
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Scheme 84: [2,3]-Rearrangement of C(3)-D allylic ammonium salt d1-357.† 
Measurement of a secondary kinetic isotope effect (SKIE) was first attempted through independent rate 
measurement of C(3)-D d1-357 vs C(3)-H 309. The rate of decay of either isotopologue (kobs) was 
determined from first-order log-plots within the pseudo-steady state period of the reaction (>3000 s). 
This analysis was performed in triplicate and an average kobs was calculated for both isotopologues. A 
kH/kD = 1.11 (SKIE) could be calculated, however the variation in kobs for each kinetic run of the C(3)-
D isotopologue d1-357 was larger than the calculated SKIE so therefore measurement by independent 
rate measurement was deemed to be inconclusive.†  
 
                                                     
† A genuine authentic sample of C(3)-D PNP ester was synthesised and characterised see chapter 6. 
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Run C(3)H kobs s-1 C(3)D kobs s-1 
1 1.42 × 10-4 1.26 × 10-4 
2 1.37 × 10-4 1.35 × 10-4 
3 1.37 × 10-4 1.13 × 10-4 
Average 1.39 × 10-4 1.25 × 10-4 
 kH/kD 1.11 
Scheme 85: Attempted measurement of C(3)-SKIE by independent rate measurement. Initial 
concentrations: 360 (34 mM), (+)-BTM 197 (6.8 mM), iPr2NH (47 mM), HOBt 216 (6.8 mM), d3-
MeCN/d6-DMSO (9:1), −20 °C, 4 h. 
3.10.1 Competition SKIE 
As measurement of a small SKIE at the C(3)-position via independent rate measurement was 
inconclusive, attention was switched to a competition SKIE strategy. In order to measure a competition 
KIE by in situ 19F NMR the δF signals of the C(3)-D d1-357 and C(3)-H 309 isotopologues must be 
distinct. To achieve this distinction, a deutero-substituent was installed ortho to the fluorine on the aryl 
ring in the C(3)-H isotopologue 309. Deuteration ortho to an aryl fluoride is known to have a dramatic 
effect upon the δF signal, whilst having minimal effect upon the electronic character of the aromatic 
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ring.[50] A similar double labelling strategy has previously been employed by Lloyd-Jones and co-
workers to measure small 11B/10B, 12C/13C and 14/15N KIEs via competition in the hydrolysis of MIDA-
boronates.[51] The ArC(3)-deutero substituent was installed via lithium-halogen exchange methodology, 
with the starting allylic amine 362 synthesised from the corresponding benzaldehyde in an analogous 
method to that described in chapter 2. Lithium-halogen exchange of 362 followed by quenching with 
D2SO4/D2O provided ArD1-C(3)-H amine d1-363. Subsequent reaction with 4-nitrophenyl bromoacetate 
213 yielded the desired ArD1-C(3)-H ammonium salt d1-364 in 49% yield with high deuterium 
incorporation (97% D).  
 
Scheme 86: Synthesis of ArD1-C(3)-H ammonium salt d1-364. 
The installation of a deutero-substituent ortho to the fluorine resulted in a ΔδF = 0.28 ppm (ArD1-ArD0), 
meaning that ArD1-C(3)-H d1-364 and ArD0-C(3)-D d1-357 are distinct by 19F NMR and therefore a 
competition experiment can be performed. First, the KIE resulting from the installation of the deutero-
substituent was assessed as a control experiment.[52] A equimolar mixture of ArD1-C(3)-H d1-364 (17 
mM) and ArD0-C(3)-H 309 (17 mM) were reacted with (+)-BTM 197 (6.8 mM) and iPr2NH (47.6 mM) 
and monitored by in situ 19F NMR over 4 h (Scheme 87). The ratio of ArD1-C(3)-H d1-364 and ArD0-
C(3)-H 309 was plotted as a function of fractional conversion and the data was fitted to a first-order 
exponential equation. From this, the KIE resulting from ortho-deuteration could be calculated as kC(3)-
H(ArD1)/kC(3)-H(ArD0) = 0.963 (Scheme 88).  
 
Scheme 87: Competition experiment to calculate the KIE of ortho-dueteration. 
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Having determined the KIE of ortho-deuteration, the competition C(3) KIE experiment could be 
performed. An equimolar mixture of ArD1-C(3)-H d1-364 (17 mM) and ArD0-C(3)-D d1-357 (17 mM) 
were reacted with (+)-BTM (6.8 mM) and iPr2NH (47.6 mM) and monitored by in situ 19F NMR over 4 
h (Scheme 88). The ratio of ArD1-C(3)-H d1-364 and ArD0-C(3)-D d1-357 was plotted as a function of 
fractional conversion and the data was fitted to a first-order exponential equations (1) and (2), allowing 
the calculation of kC(3)-H(ArD1)/kC(3)-D(ArD0) = 0.995. Taking into account the effect of the ortho-
deuterium, the C(3) SKIE could be calculated. kC(3)-H/kC(3)-D: (kC(3)-H(ArD1)/ kC(3)-H (ArD0)) / (kC(3)-
H(ArD1)/ kC(3)-D (ArD0)) = kC(3)-H/kC(3)-D = 0.968 (Scheme 88). The magnitude of this inverse SKIE is 
consistent with the [2,3]-rearrangement proceeding though an early exogenic transition state.  
 
(1) [C(3)-D-D0]t = [C(3)-D-D0]0e
((kD/kH)*t) (2) [C(3)-H-D1]t = [C(3)-H-D1]0e
((kD/kH)*t) 
 
Scheme 88: C(3) competition SKIE, graph showing plots of control and experiment, Ratio of 
ArD1/ArD0 as a function of fractional conversion, fitted to first order exponential functions, using 
equations 1 & 2. Fitting performed by Prof. Guy C. Lloyd-Jones.  
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As the observed SKIE was measured by competition, for the SKIE to be “expressed” the substrates d1-
364 and d1-357 must be in full equilibrium with the intermediate prior to the first irreversible step and 
that the irreversible step must involve reaction at the C(3)-position. This competition SKIE does not 
necessarily indicate that the [2,3]-rearrangement step is turnover-rate limiting. 
3.11 Effect of additives on reaction rate 
The effect of additives upon both reaction rate and acyl ammonium turnover was next probed through 
kinetic analysis (Scheme 89). Addition of n-Bu4N 4-nitrophenoxide (27.2 mM, 0.8 equiv.) to the 
rearrangement of 309, resulted in a rapid increase in rate (kobs = 2.42 × 10-4 s-1) compared to standard 
(kobs = 1.37 × 10-4 s-1). This was coupled with a significant reduction in the concentration of acyl 
ammonium intermediate 342 (maximum concentration 2mM). A control experiment using n-Bu4NBr 
(27.2 mM, 0.8 equiv.) as an additive resulted in a similar reaction rate enhancement (kobs = 2.35 × 10-4 
s-1), however acyl ammonium 342 was readily observed in higher concentrations (maximum 
concentration 5 mM). Consistent with these studies, it is postulated that n-Bu4N 4-nitrophenoxide 
promotes esterification of acyl ammonium 342 into product 311. The increase in observed reaction rate 
(kobs) can be accounted for due to the increase in ionic strength of the reaction medium in both cases.  
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Scheme 89: A) Kinetic profile with additional nBu4N 4-nitrophenoxide (27.2 mM, 0.8 equiv.) B) 
Kinetic profile with additional nBu4NBr (27.2 mM, 0.8 equiv.). Standard initial conditions: 309 (34 
mM), (+)-BTM 197 (6.8 mM), HOBt (6.8 mM), iPr2NH (47.6 mM), d3-MeCN/d6-DMSO (9:1), −20 °C, 
4 h. 
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Addition of varying concentrations (0-34 mM) of 4-nitrophenol showed a decrease in observed rate 
(kobs) with a negative first-order rate-dependency. Significant concentrations of acyl ammonium 
intermediate 342 were observed when 4-nitrophenol is added, consistent with 4-nitrophenol itself being 
unable to effect product release (Scheme 90). In contrast, when high concentrations of iPr2NH (>47 
mM) are employed, acyl ammonium intermediate 342 decays much more readily into rearranged 
product 311. This suggests that either 4-nitrophenoxide or benzotriazololate are required to mediate 
product release from observable acyl ammonium intermediate 342.  
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Scheme 90: Effect of additional 4-nitrophenol, A) Effect on reaction profile, 309 (34 mM), (+)-BTM 
197 (6.8 mM), HOBt (6.8 mM), iPr2NH (47.6 mM), d3-MeCN/d6-DMSO (9:1), 4-nitrophenol (27.2 
mM), −20 °C, 4 h. B) Negative first-order dependency on 4-nitrophenol.  
The kinetic significance of deprotonation was further confirmed by the use of (+)-BTM·HCl as a pre-
catalyst. In this case rearrangement of 309 proceeded smoothly (performed as an NMR experiment, 
>95:5 dr, ee not determined), but again with a significant decrease in observed rate (kobs = 8.5 × 10-5 s-
1).  
3.11.1 Influence of HOBt 
HOBt is used in the optimal synthetic reaction conditions as it results in increased diastereo- and 
enantiocontrol, however how it affects the stereocontrol is unclear. Kinetic analysis has shown a zero-
order rate dependency upon HOBt across a wide range of concentrations (0-34 mM), which implies that 
HOBt effects the mechanism after the turnover-limiting step. To probe if HOBt enhances the 
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stereocontrol via suppression of any base mediated background reaction, the iPr2NH-mediated 
rearrangement of 309 was examined with and without HOBt. Treating ammonium salt 309 with iPr2NH 
(47 mM) resulted in slow formation of rearrangement product (±)-311 with low diastereocontrol (79:21 
dr, syn:anti) and an observed rate of kobs = 2.74 × 10-5 s-1. Addition of a catalytic amount of HOBt (0.2 
equiv., 6.8 mM) resulted in a similar observed rate (kobs = 2.70 ×10-5 s-1), however a significant 
improvement in diastereocontrol was observed (88:12 dr, syn:anti) (Scheme 91). This suggests that 
HOBt does not enhance the stereocontrol of the reaction through suppression of iPr2NH-mediated 
background reaction. Although the diastereocontrol of the catalytic process may be enhanced by 
improvement of the diastereoselectivity of the base-mediated background reaction in the presence of 
HOBt, this does not account for the increased enantiocontrol. Attempts to analyse the enantiocontrol 
the [2,3]-rearrangement of 309 as a function of time unfortunately proved impractical, due to the need 
to derivatise 311 for HPLC analysis. Hence the role of HOBt in enhancing stereocontrol remains 
unclear.  
 
Scheme 91: Effect of added HOBt (0.2 equiv, 6.8 mM) on rate and stereocontrol of base mediated 
background rate. 
3.12 Crossover and Reversibility Studies 
Kinetic analysis has given mechanistic insight into the overall process, however the finer details 
regarding each of the key steps of the catalytic cycle are unclear. Firstly, the reversibility of the initial 
acylation step was probed through a crossover-experiment using two ammonium salts 211 and 366 
bearing distinct activated esters and C(3)-aryl units. An equimolar amount of 211 and 366 was reacted 
under previously optimised conditions ((+)-BTM 197 (20 mol %), HOBt (20 mol %), iPr2NH (1.4 
equiv.), MeCN, −20 °C, 16 h), and the crude reaction was analysed after aqueous work-up. The 19F{1H} 
NMR in the aryl-F region revealed the presence of two distinct rearrangement products. The identity of 
the rearrangement products was confirmed through spiking the same NMR sample with authentic 
samples of the possible fluorinated products 311, 367 and 368 and re-analysing the NMR sample by 
19F{1H} NMR (Scheme 92). The presence of 311, 367 and 368 confirms that the activated esters in 
ammonium salt 366 and 211 readily crossover under the reaction conditions. 
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Scheme 92: Crossover experiment of ammonium salts 211 and 366. 19F{1H} NMR (471 MHz, 
CDCl3) analysis of crude material and spiking experiments, showing Ar-CF3 region (−62 - −63 ppm) 
and Ar-F region (−115 - −116 ppm) A) Crude reaction mixture B) A spiked with 218. C) B spiked 
with 367. D) C spiked with 368.  
Whilst it is known that the activated esters in 211 and 366 readily crossover under the reaction 
conditions, it is not known whether the generated phenoxides crossover during the initial acylation step 
or later on in the catalytic cycle. To probe when the phenoxides crossover, the reaction between 211 
and 366 was monitored by in situ 19F{1H} NMR. This revealed the rapid formation of four distinct 
ammonium salts, which subsequently rearrange to form the four crossover products. This is consistent 
with the initial acylation step with (+)-BTM 197 being highly reversible (Scheme 93).  
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Scheme 93: Crossover of 211 and 366 monitored by in situ 19F{1H} NMR. 
The deprotonation step of the catalytic cycle was probed using previously prepared α-dideuterio 
ammonium salt d2-351 (75% D). In situ monitoring of the rearrangement of d2-351 by 19F{1H} NMR 
revealed incomplete deuterium transfer from α-dideuterio ammonium salt d2-351 to rearrangement 
product d1-369, with the α-deutero and α-proto-isotopologues distinguishable by 19F{1H} NMR. 
Exposure of isolated PNP ester 218 to the reaction conditions resulted in no change in dr and so hence 
no epimerisation. This indicates the highly reversible nature of the deprotonation step of the process, 
and also the high acidity of the α-protons on ammonium salt 309.  
 
Scheme 94: Incomplete deuterium transfer from α-dideutero ammonium salt d2-351. 
To probe if the [2,3]-rearrangement step of the process is an intramolecular [2,3]-rearrangement or an 
intermolecular allylic transfer process, two ammonium salts 258 and 259 bearing distinct N-substituents 
and C(3)-aryl units were reacted together under optimal reaction conditions, followed by addition of 
benzylamine. Analysis of the crude reaction mixture by 1H NMR demonstrated only two rearrangement 
products 273 and 265, consistent with the [2,3]-rearrangement being intramolecular with no competitive 
intermolecular allylic transfer. Subsequent spiking of the crude reaction mixture and re-analysis of the 
NMR sample by 1H NMR confirmed the identity of the observed rearrangement products 273 and 265.  
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Scheme 95: Crossover experiment between 258 and 259 demonstrating the intramolecular nature of 
[2,3]-rearrangement. Crossover and spiking experiments performed by Dr. David S. B. Daniels. 
To examine the reversibility of product release from acyl ammonium 342, a crossover of rearrangement 
product 218 and ammonium salt 366 bearing distinct C(3)-aryl units and activated esters was performed. 
The process by monitored by in situ 19F{1H} NMR and only one fluorinated rearrangement product 367 
was observed. This is consistent with product release from acyl ammonium 342 being irreversible 
(Scheme 96).  
 
Scheme 96: Crossover of 211 and 366 
3.13 Hammett Plot 
Next, to gain experimental insight into the electronic influence of substituents on the C(3)-position in 
transition state of the turnover rate-limiting step, a Hammett analysis was performed. To kinetically 
analyse the reactions by in situ 19F{1H} NMR, a fluoro-substituent was retained in each of the substrates. 
Variation of the para-substituent typically has the largest electronic effect,[53] hence the to allow facile 
monitoring of the process a fluorine substituent was installed in the meta-position of the aryl ring 
(Scheme 97). This allowed facile variation of the para-substituent, which has the largest electronic 
substituent effect on the C(3) position of ammonium salt 370. The substrates examined were synthesised 
using previously developed route from the requisite meta-fluoro-substituted benzaldehyde and 
authentic racemic samples of the rearranged products were prepared.  
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Scheme 97: Ammonium salts and rearrangement for Hammett analysis. 
Hammett analysis was first performed using independent rate measurements, with the observed rate, 
(kobs) for each substrate determined by examination of the first-order log-plot of the decay of the 
substrate. The plots of log10(kx/kH) against standard σ and σ+ values showed poor correlation (Scheme 
98).[53]  
X = kobs × 10-4 s-1 log10(kx/kH) σ σ+ 
H 1.01 0 0 0 
OMe 0.99 −0.087 −0.12 −0.78 
Br 2.19 0.336 0.26 0.15 
I 1.71 0.229 −0.14 −0.31 
Me 1.22 0.082 0.18 0.13 
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Scheme 98: Hammett plot via independent rate measurement. 
Due to the ambiguous outcome of the Hammett analysis through independent rate measurement, a 
competition strategy was employed. As ammonium salts 372-376 had significantly different chemical 
shifts (δF = −96.0 - −136.5 ppm), a five-way competition could be carried out where all five reactions 
were monitored concurrently in a single NMR tube, minimising the error between each experiment.  
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X = kobs × 10-4 s-1 log10(kx/kH) σ 
H 0.52 0 0 
OMe 1.09 −0.087 −0.27 
Br 1.23 0.336 0.23 
I 1.43 0.229 0.18 
Me 1.15 0.082 −0.17 
-0.3 -0.2 -0.1 0.0 0.1 0.2 0.3
0.0
0.1
0.2
0.3
0.4
0.5
lo
g
1
0
(k
x
/k
H
)

P
y = 0.17X + 0.37
R
2
 = 0.65
 
Graph 1: Hammett Plot, via five-way competition experiment. Data analysis performed without X = 
H.  
The plot of log10(kx/kH) against standard σ values from the competition experiment displays good 
correlation (Graph 1). The observed ρ value (gradient of the fitted line) 0.17, is very small, indicating 
there is a minimal substituent effect at the C(3)-position of the ammonium salt, in the absence of HOBt. 
This small observed ρ value indicates that in the absence of HOBt there is no charge redistribution 
around the C(3)-aryl position in the turnover-rate limiting events. 
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3.14 Computational Studies 
3.14.1 Reaction Coordinate Modelling 
In collaboration with Daniel M. Walden and Prof. Paul Ha-Yeon Cheong at Oregon State University 
all intermediates, transitions structures (TSs), and possible salt complexes involved in the mechanism 
were computed. Exhaustive conformational searches located all pertinent conformations. Geometries 
and thermodynamic corrections were computed at the M06-2X[54]/6-31G(d) level of theory.[55] Further 
energy refinement was completed using M06-2X/6-311+G(2df,p).[56] Implicit solvation corrections 
were applied using the polarized continuum model (PCM)[57] with UFF radii for acetonitrile in both the 
geometry optimizations and the single-point energy refinements. The hybrid meta-GGA functional 
M06-2X is more robust than B3LYP at accounting for dispersion interactions, i.e. non-bonding 
interactions routinely found in organocatalytic systems[58]  
Kinetic isotope effects were calculated using the theory of Bigeleisen and Mayer[59] along with the rigid-
rotor harmonic oscillator approach (∆H∆S).[60] Quantum-mechanical tunnelling effects were also 
computed for both methods using the one-dimensional parabolic approximation.[61] Vibrational 
frequencies and thermal corrections to the Gibbs free energy were completed using M06-2X/6-31G(d) 
at –20 °C and 1 atm, matching the experimental conditions. Our collaborators have developed in-house 
software for automating and expediting the calculation of the KIE, rendering this analysis routine (See 
SI for more details). The Bigeleisen-Mayer equation gave theoretical KIE values in slightly better 
agreement with experimental data, and are therefore reported herein as the computed KIE. 
To examine the mechanism computationally and probe the origins of stereochemical control, the 
rearrangement of N,N-dimethyl cinnamyl ammonium salt 211 was chosen as standard (Scheme 99). 
Computational reaction coordinate modelling was performed in the absence of the HOBt additive to 
simplify calculations.  
 
Scheme 99: Model system chosen for computational analysis. 
The reaction coordinate begins with direct acylation of (+)-BTM 197 with the substrate 211 to form to 
tetrahedral intermediate 379 (TS-378, ∆G‡ = 14.4 kcal/mol). Release of 4-nitrophenoxide forms 
dication 318 (TS-380, ∆G‡ = 15.5 kcal/mol). The significant energy barrier (∆G = 2.4 kcal/mol) between 
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substrate 211 and dication 318 is consistent with experimentally observed reversible nature of the 
acylation step, and with the greater population of the substrate 211 and free (+)-BTM 197. Dication 318 
is reversibly deprotonated at the α-position by 4-nitrophenoxide (∆G‡ = 10.5 kcal/mol, kinetically 
favoured over deprotonation by iPr2NH), released upon acylation, to give ammonium ylide 319 (∆G = 
0.7 kcal/mol). NBO analysis of ylide intermediate 319 shows it to have significant enolate character. 
Formation of ammonium ylide 319 via ammonium ketene 290 was ruled out computationally due to it 
being thermodynamically unstable (∆G = 21.1 kcal/mol). Ammonium ylide 319 subsequently 
undergoes stereodetermining [2,3]-rearrangement (TS-377-(2S,3S)-Major, ∆G‡ = 16.4 kcal/mol) to 
give acyl ammonium 320. The computed KIE for [2,3]-rearrangement, kH/kD = 0.966, matches 
excellently with experiment, kH/kD = 0.968, further corroborating the transition state of the 
stereodetermining [2,3]-rearrangement. After which turnover-rate limiting (∆G‡ = 16.9 kcal/mol) 
product release occurs directing mediated by 4-nitrophenoxide via tetrahedral intermediate 383, which 
can release (+)-BTM 197 to give PNP ester 218 (Scheme 102). 
3.14.2 Effect of Counterions on the Theoretical Kinetic Isotope Effect and Energy Barriers 
The inclusion of counterions poses a significant challenge to accuracy of the DFT calculations, and 
exponentially increases the complexity of the conformational search and number of relevant structures 
to consider.[62] As all proposed reaction intermediate bear a positive charge, the stabilising nature of the 
counterion is thought to play a role on the energy of relevant intermediates. 
The kinetic isotope effect is computed using vibrational frequencies of the catalyst resting state 211 and 
the highest energy transition state of the catalytic cycle TS-377. These two structures compose the free-
energy span (FES) of the catalytic cycle, their difference giviong the barrier of the reaction (∆G‡FES).[63] 
Given the charged nature of the species present in the reaction,  for identification of the structures that 
compose the free energy span ((∆G‡FES) all possible counterion coordination combinations were 
considered. Since the computed KIE depends upon the vibrational frequencies of the most stable 
reaction intermediate and the TS of the turnover-limiting step, it can be utilised independently of any 
computed thermodynamics and barriers and the error associated therein.[64] In a reaction with highly 
charged intermediate, leveraging the calculated KIE allows a route to determine the structures which 
make up the FES and which counterion are associated with them.[65]  
In order to identify the counterion and coordination state of TS-377-(2S,3S)-Major calculated energy 
barriers and KIEs were compared for all possible counterion combinations, in the absence of HOBt. 
After deprotonation of dication 318 to form ylide 319 three possible counterions exist PNPO-, iPr2NH2+ 
and Br-; the equilibrium between these couterions effects drastically affects the barrier going from 
substrate 211 to TS-377-(2S,3S)-Major. With no counterion coordination to TS-377-(2S,3S)-Major, 
the computed KIE = 0.966, a 0.3% error compared to experiment. Within this coordination motif eight 
combinations of resulting counterions were identified; the lowest in energy is when 4-nitrophenol 
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hydrogen bonds to iPr2NH (PNPOH●●●iPr2NH), leaving Br- free to act as a non-coordinating anion, 
giving an overall ∆G‡FES = 16.4 kcal/mol. Coordination of Br- and PNPO- to TS-377-(2S,3S)-Major 
resulted in ∆G‡FES = 17.9 kcal/mol and ∆G‡FES = 21.0 kcal/mol respectively and result in calculated KIEs 
of 0.976 and 0.930, which are in poor agreement with experiment (Scheme 100).  
 
Scheme 100: Effect of counterion coordination on computed KIEs and energy barriers. 
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3.14.3 Turnover-Rate Limiting Step 
Collaborative reaction coordinate modelling (Scheme 102) suggests that in the absence of HOBt once 
the system has reached pseudo-steady-state the resting-state should be acyl ammonium 320 which is 
readily observed by 19F and 13C NMR spectroscopy, the formation of which has been shown to be 
irreversible. The energy barrier to product release from acyl ammonium 320 is thought to be turnover-
rate limiting (∆G = 16.9 kcal/mol), in the absence of HOBt. Addition of HOBt to the reaction been 
shown to change the resting-state of the system, previously two-catalyst derived species were observed, 
and shown not to be in equilibrium, by 13C isotopic labelling. When significant concentrations of HOBt 
are added only one catalyst derived species is observed, thus the distribution of rate governance must 
have changed. Acyl ammonium 320 is no longer a catalyst resting state and its accelerated breakdown 
is not significantly turnover-rate limiting. In this case the turnover-rate limiting step is now prior to acyl 
ammonium 320, and likely involves a species generated in equilibrium with the catalyst and substrate. 
This is further corroborated by zero-order rate dependence in HOBt concentration, suggesting that 
HOBt is not involved in any pre-equilibrium or in the turnover-rate limiting step.  
3.13.4 Proposed Mechanism 
The data presented above allows for a more detailed catalytic cycle to be proposed (Scheme 101). Initial 
reversible acylation of (+)-BTM 197 forms dication 318 directly and not via ketene 290, as shown by 
computation. Subsequent deprotonation of 318 into ylide 319 is reversible and is likely to occur using 
the 4-nitrophenoxide liberated in the acylation step. Stereodetermining [2,3]-rearrangement of 319 
proceeds in an intramolecular fashion and irreversibly to give acyl ammonium 320. Competition kinetic 
isotope analysis showed there is an inverse SKIE at the C(3) position and is thought to be stereo- and 
product determining step of the process. Acyl ammonium 320 is an observed genuine intermediate 
which is on the catalytic pathway, and is the catalyst resting-state when a low concentration of HOBt is 
employed. At high concentrations of HOBt the resting state of the catalyst change to free (+)-BTM 197. 
Product release from 320 can proceed either directly through 4-nitrophenoxide to form 218 and release 
(+)-BTM 197, product release is postulated as the turnover-rate limiting step step in the absence of 
HOBt by computational analysis. Alternatively, 320 can be esterified by HOBt, which can be slowly 
transesterified by 4-nitrophenoxide to give 218.  
3.14.5 Stereochemical Studies 
There are four major factors that impact upon the stereochemical control of the reaction, E vs. Z 
configuration of the ylide and its enolate character, n0 to σ* C-s catalyst-substrate interaction, endo versus 
exo allyl [2,3]-rearrangement, and the facial selectivity of [2,3]-rearrangement. The four lowest energy 
calculated transition states of the eight possible are detailed in figure 11. In these four transition states 
the rearrangement occurs anti to the stereodirecting phenyl substituent upon the acyl ammonium; 
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rearrangement syn to the phenyl substituent was considered too high in energy to be considered 
significant in accounting for stereocontrol. All stereodetermining transition states proceed with the 
highly preferred Z configuration of the ylide, with phenyl on the cinnamyl group participating in a 
variety of aromatic interactions as a function of its resulting placement in a given TS. Of the two 
transition states that lead to the formation of the anti-diastereoisomer, TS-392-(2R,3S) (ΔG† = 23.9 
kcal/mol) is significantly higher in energy than TS-390-(2S,3R). In TS-377-(2S,3S)-Major (ΔG† = 16.4 
kcal/mol) the rearrangement occurs in an endo fashion with the carbonyl oxygen in a syn orientation to 
the sulfur atom of the acyl ammonium (S•••O distance = 2.79 Å). In TS-390-(2S,3R) (ΔG† = 18.4 
kcal/mol), the same sulfur-oxygen orientation is observed (S•••O distance = 2.77 Å), however 
rearrangement occurs in an exo fashion, whereas TS-391-(2R,3R) (ΔG† = 22.8 kcal/mol) rearrangement 
occurs in an endo fashion with sulfur-oxygen in an anti-orientation. The computed diastereoselectivity 
(ΔΔG† = 2.0 kcal/mol) of 95:5 dr (syn:anti) and enantioselectivity (>99% ee) are in excellent agreement 
with experimental results. 
 
Figure 11: Four lowest calculated transition states for rearrangement of 319. All energies in kcal/mol 
and distances in Å. Shaded grey lines represent forming/breaking bonds. Solid orange lines represent 
non-bonding S•••O interactions. Dashed blue lines represent aromatic interactions. 
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NBO analysis indicates that both the ylide 319 and TS-377-(2S,3S)-Major have significant enolate 
character, with ylide 319 displaying C=O bond order of 1.39 and a C-C bond order of 1.52. Early 
exogenic TS-377-(2S,3S)-Major displays a C=O bond order of 1.54 and C-C bond order of 1.21. The 
diastereocontrol of the process can be rationalised due to differences in electrostatic interactions found 
in TS-377-(2S,3S)-Major and TS-390-(2S,3R). To further probe these differences simplified model 
systems were examined (Figure 12). In these model systems there is a clear preference for C(3)-aryl 
unit to sit above the cation (π-cation) versus the adjacent C-H (π-C-H) bond, ΔΔG† = 0.9 kcal/mol, 
(Figure 12).[66] Interestingly there is no energy difference between endo and exo rearrangement, which 
is how many related [2,3]-rearrangement processes are rationalised. As a result, it is postulated that the 
observed diastereocontrol can be rationalised the stabilising π-cation interaction of the C(3)-aryl unit 
with the positively charged acyl ammonium cation.[67] Such an interaction is not possible in the 
transition state for the anti-diastereomer TS-390-(2S,3R).  
 
Figure 12: Computed simplified model systems, probing key interactions. 
The excellent enantiocontrol of the rearrangement process can be rationalised by a strong non-covalent 
interaction between the sulfur atom on the acyl ammonium and oxygen atom of the carbonyl unit in the 
substrate.[68] Calculated model systems show that the syn orientation between the sulfur and oxygen is 
completely selective (ΔΔG† =4.6 kcal/mol). The transition state leading to the minor enantiomer TS-
391-(2R,3R) undergoes endo rearrangement while maintaining a strong π-cation interaction, the energy 
differece between that and the major transition state TS-377-(2S,3S)-Major (ΔΔG† = 7.2 kcal/mol) is 
a direct result of the loss of the S•••O interaction. The conformational preference for the syn-sulfur-
oxygen orientation is thought to arise from n0 to σ*C-S delocalisation in conjunction with an electrostatic 
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interaction between the partially positively charged sulfur and the partially negatively charged oxygen 
atom.[69] The S•••O distance in the major transition state TS-377-(2S,3S)-Major is 2.79 Å significantly 
below that of the sum of the van der Waals radii of sulfur and oxygen (3.4 Å), consistent with a strong 
non-bonding interaction between sulfur and oxygen in the transition state. 
To further experimentally probe the effect of the π-cation interaction crotyl ammonium salt 401 was 
synthesised. After treatment of 4-1 under the previously optimised reaction conditions rearranged PNP 
ester 402 was isolated in modest yield (31%) with modest stereocontrol (82:18 dr, 83% ee). This system 
was also examined computationally; the competed diastereoselectivity of the reaction matches very well 
with experiment (89:11 dr). The loss of diastereocontrol relative to the cinnamyl model system, is likely 
a result of the favourable π-cation interaction. The enantioselectivity of the reaction is over estimated 
computationally (99% ee), but the energy difference between the enantiomeric transition states TS-
Crotyl-(2S,3S) 403 and TS-Crotyl (2R,3R) 405 is small making calculation of enantioselectivity 
computationally difficult. Notably the calculated transition state for the minor enantiomer TS-Crotyl 
(2R,3R) 404, shows rearrangement occurring syn to the stereodirecting phenyl unit of the acyl 
ammonium. This suggests the C(3)-aryl unit also has a part to play in controlling the enantiocontrol of 
the reaction, stabilising facial selectivity.  
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Scheme 103: Rearrangement of crotyl ammonium salt 401 and calculated transition states. a 
Enantiopurity determined after derivatisation to the corresponding benzylamide. 
3.15 Conclusions 
The joint mechanistic and computational study reported in this chapter has provided mechanistic and 
stereochemical insight into the enantioselective isothiourea-catalysed [2,3]-rearrangement of allylic 
ammonium ylides. Kinetic analysis using 19F NMR has built up reaction profiles and has identified an 
intermediate species. Isotopic labelling of catalyst (15N) and of the substrate (13C) has elucidated the 
constitution of the catalytic intermediate as 320 by in situ 13C NMR. Isotopic entrainment studies have 
shown 320 to be a genuine intermediate which is on the productive pathway towards catalysis. The 
effect of co-catalytic HOBt has been investigated and it has found to change the resting-state of the 
catalyst and deviation away from the turnover-rate limiting step proposed by computation, when 
employed in high concentrations. A number of detailed crossover experiments have provided insight 
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into the reversibility of the key steps of the mechanism. Product release was found to be the turnover-
limiting step of the process in the absence of HOBt through computation, the turnover limiting step of 
the process was found to switch to [2,3]-rearrangement when HOBt was employed. Computational 
calculation has validated experimental mechanistic experiments through reaction coordinate modelling. 
Transition state modelling has provided insight into the key interaction which govern the stereochemical 
outcome of the reaction. 
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Chapter 4: Application of Removable N-Substituents 
4.1 Summary 
This chapter describes the design and development of an enantioselective synthesis of free α-amino 
esters via [2,3]-rearrangement of N,N-diallyl allylic ammonium ylides. Isothiourea-catalysed 
enantioselective [2,3]-rearrangement of N,N-diallyl quaternary ammonium salts 406 gave a range of 
N,N-diallyl-α-amino acid derivatives in excellent yield with excellent levels of diastereo- and 
enantiocontrol (to >95:5 dr, 97% ee). N,N-diallyl esters 407 could be readily selectively mono- or bis-
N-deprotected to give free α-amino esters using literature reported Pd-catalysed methodology. 
 
Scheme 104: Enantioselective synthesis of free α-amino esters via [2,3]-rearrangement of N,N-diallyl 
allylic ammonium ylides. 
4.2 Concept and Aims 
The isothiourea-catalysed [2,3]-rearrangement of allylic ammonium ylides previously described in 
chapter 2 allows access to a range of α-amino acid derivatives bearing N-alkyl substituents. Whilst this 
allows for the synthesis of various pharmacological motifs, such as morpholine, the preparation of free 
α-amino esters was not possible. The removal of these N-alkyl substituents is by no means a trivial 
exercise, often requiring harsh conditions. For example, Olofson and Senet reported the development 
of 1-chloroethyl chloroformate (ACE-Cl) as an N-dealkylating reagent. N-Me tetrahydropyridine 409 
could be readily demethylated, through treatment was ACE-Cl in refluxing DCE, followed by treatment 
with methanol, to give guvacoline·HCl 410 in 95% yield (Scheme 105).[70]  
 
Scheme 105: Deprotection of N-Me group using ACE-Cl 411.[70]  
  
Chapter 4: Application of Removable N-Substituents 
 
 
97 
As highlighted in chapter 1 Sweeney and co-workers[71] have demonstrated the asymmetric [2,3]-
rearrangement of triallyl ammonium salts bearing a camphorsultam auxiliary to give N,N-diallyl α-
amino acid derivatives in excellent yield and stereocontrol. It was found that the N,N-diallyl substituents 
could be readily removed, utilising Pd-catalysed methodology developed by Guibe (Scheme 106).[72]  
 
Scheme 106: [2,3]-Rearrangement of triallyl ammonium salts, and subsequent N,N-diallyl 
deprotection.[71] 
Building on this work, in 2011 Tambar and co-workers[73] demonstrated an elegant Pd-catalysed allylic 
substitution methodology towards the in situ synthesis of allylic ammonium salts. Treatment of N-
methyl-N-allyl amine 412 with cinnamyl carbonate 413 in the presence of Pd2(dba)3·CHCl3, P(2-furyl)3 
and Cs2CO3 gave ammonium ylide 414, bearing a stereogenic nitrogen. [2,3]-Rearrangement of 
ammonium ylide 414 can proceed through the N-cinnamyl unit or the N-allyl unit; this resulted in non-
chemoselective [2,3]-rearrangement to give a 4:1 mixture of N-cinnamyl rearranged product 415 and 
N-allyl rearranged product 416 in a combined 78% yield (Scheme 107).  
 
Scheme 107: Non-chemoselective Pd-Catalysed ammonium salt formation, and [2,3]-rearrangement 
of N-methyl-N-allyl amino ester 412.[73] 
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4.3 Initial Studies 
To avoid any potential chemoselectivity issues the first removable N-substituents trialled in the 
isothiourea-catalysed [2,3]-rearrangement methodology were N,N-dibenzyl. Treatment of N,N-dibenzyl 
cinnamyl amine 417, synthesised from cinnamyl bromide 210 in quantitative yield, with 4-nitrophenyl 
bromoacetate 213 resulted in no ammonium salt formation. This reaction was further monitored by in 
situ 1H NMR, using d3-MeCN and no ammonium salt formation was observed over 16 h at rt, indicating 
that the N,N-dibenzyl substituent may be too sterically hindered to allow ammonium salt formation 
(Scheme 108). 
 
Scheme 108: Attempted synthesis of N,N-dibenzyl ammonium salt 418.  
To reduce the steric bulk around the N-substituent, an N-methyl-N-benzyl substituent was employed. 
The corresponding ammonium salt 420 could not be readily isolated, but pleasingly it was found that 
N-methyl-N-benzyl cinnamyl amine 419 could be quaternised using the in situ ammonium salt 
formation and [2,3]-rearrangement methodology outlined in chapter 2. Treatment of 419 with 4-
nitrophenyl bromoacetate in MeCN followed by (+)-BTM (20 mol %), HOBt (20 mol %) and iPr2NH 
(1.4 equiv.) at −20 °C, then sodium methoxide gave rearranged N-methyl-N-benzyl-α-amino ester in 
good yield (76%), albeit with modest stereocontrol (80:20 dr, 76% ee). The modest diastereocontrol is 
likely to be due to the formation of a stereogenic nitrogen within the ammonium salt 420 and (+)-BTM 
bound-diastereomeric ammonium ylides within the [2,3]-rearrangement step. However, it is not 
currently possible to fully discount the possibility of epimerisation through treatment with sodium 
methoxide or competing base-mediated background [2,3]-rearrangement. We have previously 
demonstrated that all steps prior to [2,3]-rearrangement within the mechanism are thought to be readily 
reversible. As there is some level of diastereocontrol it is likely that the energy barrier for the formation 
of, and [2,3]-rearrangement of each of the diastereomeric ylides is slightly different. 
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Scheme 109: A) In situ N-methyl-N-benzyl ammonium salt 420 formation and isothiourea-catalysed 
[2,3]-rearrangement. B) Diastereomeric ammonium ylide intermediates 422 and 423.  
4.3.1 [2,3]-Rearrangement of N,N-Diallyl Ammonium Salts  
Due to the low diastereocontrol achieved when two different N-substituents were employed, a 
systemetrical N,N-subsitutent was desired and N,N-diallyl was postulated. N,N-diallyl cinnamyl amine 
was subsequently examined. It was found N,N-diallyl cinnamyl amine 424 could be readily synthesised 
from cinnamyl bromide 210; subsequent treatment with 4-nitrophenyl bromoacetate gave the 
corresponding quaternary ammonium salt 425 which could be readily isolated in 50% yield (Scheme 
110. Treatment of 425 under the reaction conditions previously developed in chapter 2 followed by the 
addition of sodium ethoxide gratifyingly resulted in chemoselective [2,3]-rearrangement to give N,N-
diallyl-α-amino ester 426 in excellent yield (91%) and good stereocontrol (92:8 dr, 87% ee) (Scheme 
110).  
 
Scheme 110: Chemoselective [2,3]-rearrangement of N,N-diallyl ammonium salt 425. 
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4.4 Reaction Optimisation  
With this initial hit in hand reaction optimisation was performed to attempt to improve the stereocontrol 
of the process. The requirement for the co-catalyst was examined, removal of HOBt resulted in a 
reduced yield and stereocontrol (81%, 89:11 dr, 76% ee, entry 3, Table 3). The use of a stoichiometric 
amount of NBu4OPNP as an additive also resulted in a loss in both diastereo- and enantiocontrol (88:12 
dr, 74% ee, entry 4, Table 3). However, pleasingly the use of a stoichiometric quantity of HOBt as an 
additive resulted in a dramatic enhancement in enantiocontrol (82%, 94:6 dr, 97% ee, entry 2, Table 3). 
These conditions were hence taken forward to examine the substrate scope of the reaction. Notably it 
was demonstrated that this process could be readily performed on a multi-gram scale without erosion 
of stereocontrol, with 479 mg (1.60 mmol) of ethyl ester 426 being generated from 1.0 g of N,N-diallyl 
ammonium salt 425. 
 
Entrya Additive (mol %) Yield (%)b drc ee (%)d 
1 HOBt (20) 91 92:8 87 
2 HOBt (100) 82 94:6 97 
3 - 81 89:11 76 
4 NBu4OPNP (100) 77 88:12 74 
5e HOBt (100) 76 >95:5 97 
aReactions performed on 0.24 mmol scale, bIsolated yield after flash column chromatography, 
combined yield of mixture of diastereomers cDetermined by 1H NMR of crude material, dDetermined 
by HPLC analysis of chiral stationary phase, ePerformed on 2.11 mmol scale. 
Table 3: Reaction optimization 
4.5 Scope of in situ Nucleophilic Derivatisation 
Next the scope of in situ nucleophilic derivatization was examined under previously optimized 
conditions. The [2,3]-rearrangement product of N,N-diallyl ammonium salt 425 could be in situ 
derivatised using pyyrolidine or LiAlH4 to give amide 429 and amino-alcohol 430 respectively in 
excellent yield and stereocontrol (Scheme 111). However, derivatization with benzylamine to give 431, 
produced inseparable unidentified allyl-derived side products, under the optimal reaction conditions. 
Chapter 4: Application of Removable N-Substituents 
 
 
101 
The use of a catalytic amount of HOBt (20 mol %) allowed the isolation of benzyl amide 431 in 
excellent yield with good levels of stereocontrol (92:8 dr, 84% ee). 
 
Scheme 111: Scope of in situ nucleophilic derivatisation aHOBt, 20 mol % used instead of 1.0 equiv.. 
4.6 Synthesis of N,N-Diallyl Ammonium Salts 
To examine the reaction scope with respect to the C(3)-aryl unit a range of electronically and sterically 
diverse ammonium salts were synthesised, utilising the method previously developed in chapter 2. 
Allylic alcohols 432 were readily converted to the corresponding N,N-diallyl cinnamyl amines 433, 
which upon treatment with p-nitrophenyl bromoacetate 213 gave the desired N,N-diallyl ammonium 
salts 434 in modest yields (28-60%) (Scheme 112).  
 
Scheme 112: Synthesis of N,N-diallyl ammonium salts. 
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4.7 Substrate Scope: Variation of the C(3) Aryl Unit 
Variation of the C(3)-substituent within the N,N-diallyl ammonium salt 434 was next investigated. It 
was shown that electron-neutral and electron-withdrawing aromatic substituents could be well tolerated 
giving ethyl esters 440, 441 and 443 in excellent yield and good to excellent stereocontrol. Incorporation 
of a sterically demanding ortho-substituent in the C(3)-aryl group was well tolerated giving 442 in good 
yield and stereocontrol (Scheme 113). 
 
Scheme 113: Substrate scope of C(3)-aryl unit within N,N-diallyl ammonium salt, aEnantiopurity 
determined after bis-N-deallylation and N-Boc protection. 
4.8 Deprotection of N,N-diallyl rearrangement products 
With a range of N,N-diallyl ethyl esters in hand, efforts were turned to removal of the N,N-diallyl groups 
to synthesise a range of α-amino esters. Utilising the Pd-catalysed bis-N-deallylation chemistry 
developed by Bernard and co-workers[74] treatment of 426 with Pd(dba)2 (10 mol %), dppb (10 mol %) 
and thiosalicylic acid (5.0 equiv.) in THF at 60 °C followed by aq. 1 M HCl allowed facile isolation of 
the desired free amine 444 as its hydrochloride salt,[75], without the need for flash column 
chromatography. This was applied to a small range of N,N-diallyl rearrangement products 407 giving 
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the desired bis-N-deallylation products 408 in good to excellent yield without erosion of diastereo- or 
enantiopurity (Scheme 114). 
 
Scheme 114: N,N-deallylation of [2,3]-rearrangement products, aenantiopurity determined after N-
Boc protection. 
4.9 Application to the Synthesis of Functionalised Piperidines 
It was postulated that if one N-allyl could be selectively removed, this could allow access to a highly 
functionalised piperidine architecture, through ring-closing metathesis followed by hydrogenation. 
Piperidine core structures are ubiquitous among bioactive molecules;[76] analysis of launched drugs 
within the integrity database shows 320 registered drugs contain saturated piperidines.[77] However, the 
synthesis of stereodefined functionalised saturated piperdines is often non-trivial.  
 
Scheme 115: Retrosynthetic analysis of piperidine core to N,N-diallyl ester. 
Bernard and co-workers[74] have previously demonstrated that it is possible to selectively mono- or bis-
deallylate N,N-diallyl amines, through simple tuning of equivalents of thiosalicylic acid utilised in the 
Pd-catalysed deallylation reaction. For example, treatment of 454 with thiosalicylic (2.1 equiv.) in the 
presence of Pd(dba)2 (5 mol %) and dppb (5 mol %) resulted in bis-N-deallylation, whereas treatment 
of 452 with thiosalicylic acid (1.1 equiv.) in the presence of Pd(dba)2 (5 mol %) and dppb (5 mol %) 
resulted in selective mono-N-deallylation (Scheme 116).[74]  
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Scheme 116: Bernard’s selective mono- or bis-N-deallylation of N,N-diallylamines.[74] 
Utilisng Bernard’s methodology 426 was mono-N-deallylated, through treatment with Pd(dba)2 (10 mol 
%), dppb (10 mol %), thiosalicylic acid (1.2 equiv.) in THF at 60 °C, to give 456 in modest yield (46%) 
but with retention of diastereomeric purity. Subsequent N-benzyl protection gave 457 in excellent yield; 
subsequent treatment of 457 with Hoveyda-Grubbs 2nd generation catalyst 102 (5 mol %) in the presence 
of p-toluenesulfonic acid (1.5 equiv.) in toluene at 80 °C gave ring-closed product 458 in good yield 
and as a single diastereoisomer after purification by flash column chromatography. Finally, Pd/C 
catalysed hydrogenation of 458 resulted in reduction of the alkene bond and concomitant N-benzyl 
deprotection to give functionalised piperidine 459 in good yield and with excellent levels of 
stereocontrol (>95:5 dr, 94% ee). It is thought that piperidine core 459 could be further diversified to 
form a library of bioactive compounds such as Merck’s factor XIa inhibitor 460[78] (Scheme 117). 
. 
Scheme 117: Further manipulation of [2,3]-rearrangement product 426. 
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4.10 Conclusions 
The previously developed isothiourea-catalysed enantioselective [2,3]-rearrangement of allylic 
ammonium ylides has been further developed to allow removable N,N-diallyl substituents to be 
incorporated. Excellent chemoselectivity was observed for [2,3]-rearrangement through the N-cinnamyl 
unit over the N-allyl unit. The use of stoichiometric HOBt allowed excellent levels of diastereo- and 
enantiocontrol to be achieved (up to >95:5 dr, up to 98% ee). The substrate scope of this process has 
been examined across a number of different aryl and nucleophilic variations. It has been shown the N,N-
diallyl substituents can be readily mono- or bis-N-deprotected and this methodology has been applied 
to the synthesis of a functionalised piperdine motif. 
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Chapter 5: Conclusions and Outlook 
This thesis has described the design and development of an isothiourea-catalysed enantioselective [2,3]-
rearrangement of allylic ammonium ylides. Initially a proof of concept methodology was developed 
and fully investigated. Subsequent experimental mechanistic work has given great insight into complex 
mechanism of this process. Collaborative computational studies have provided understanding of the 
origins of stereocontrol in the reaction and has validated experimental mechanistic proposals. The 
synthetic utility of this process has been demonstrated through the removal of N-substituents, which has 
allowed application of this methodology to the synthesis of free α-amino esters. 
Firstly, the use of isothioureas to facilitate an enantioselective [2,3]-rearrangement was demonstrated. 
Optimisation and development found that catalytic (+)-BTM in combination with co-catalytic HOBt 
was optimal for the [2,3]-rearrangement of quaternary ammonium salts bearing 4-nitrophenyl esters 
(isolated or generated in situ) to give a range of syn-α-amino acid derivatives in good to excellent yield 
(33-89%) and with excellent levels of stereocontrol (up to >95:5 dr and >99% ee) (Scheme 118).  
 
Scheme 118: Summary of isothiourea-catalysed enantioselective [2,3]-rearrangement of allylic 
ammonium ylides. 
Mechanistic studies into the isothiourea-catalysed enantioselective [2,3]-rearrangement of allylic 
ammonium ylides were undertaken allowing a detailed catalytic cycle to be proposed. Reaction kinetic 
analysis using 19F NMR spectroscopy proved to be a powerful tool in the elucidation of a detailed 
reaction profile including the reaction order of each component and the resting-state of the catalyst. A 
catalytically productive acyl ammonium intermediate has been observed, with isotopic labelling of both 
catalyst (15N) and substrate (13C) allowing unambiguous identification of the observed intermediate 
using in situ 13C NMR spectroscopy. Isotopic entrainment has shown the acyl ammonium intermediate 
to be on-cycle and productive towards catalysis. Kinetic isotope effect analysis has shown [2,3]-
rearrangement to be the turnover-limiting step of the process. The effect of the HOBt additive on the 
reaction and catalyst resting-state has been probed, through in situ 19F NMR spectroscopic analysis. 
Crossover experiments have allowed the reversibility of each step of the proposed catalytic cycle to be 
examined. Collaborative computational analysis has found key transition state stabilising cation-π and 
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1,5-S●●●O interactions to be the origins of the excellent observed stereocontrol. Computational 
reaction coordinate modelling has ruled out alternative mechanistic possibilities and has further 
validated the experimentally proposed catalytic cycle (Scheme 119). 
 
Scheme 119: Summary of mechanistic and computational investigations. 
Finally, this methodology was extended to substrates bearing N-substituents which could be readily 
removed under mild conditions. Evaluation of a small range of removable N-substituents, showed that 
isolated N,N-diallyl ammonium salts underwent chemoselective [2,3]-rearrangement in excellent yields 
and stereocontrol (up to >95:5 dr and 97% ee). The resulting N,N-diallyl α-amino esters could undergo 
Pd-catalysed selective mono- or bis-N-allyl deprotection. Bis-N-allyl deprotection has allowed the 
synthesis of a range of stereodefined free α-amino esters, whilst mono-N-allyl deprotection has allowed 
this methodology to be applied to the synthesis of a target functionalised piperidine motif. 
 
Scheme 120: Summary of isothiourea-catalysed enantioselective [2,3]-rearrangement of N,N-diallyl 
ammonium ylides and subsequent selective N-deprotection strategies  
Future work will likely focus on the extension of this methodology to other develop [2,3]-“onium” 
ylides rearrangements, such as oxonium or sulfonium ylides (Scheme 121). Whilst catalytic 
enantioselective variants have previously been developed, organocatalytic variants still remain a 
significant challenge within the area. Such [2,3]-rearrangements would provide access to a range of 
stereodefined homoallylic ethers and sulfides.  
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Scheme 121: Proposed isothiourea catalysed [2,3]-rearrangements of oxonium and sulfonium ylides. 
At the out-set on this work in 2012 there were no examples of C(1)-acyl ammonium intermediates 
undergoing turnover from an external nucleophile after α-functionalisation with an electrophile. The 
work is thesis has demonstrated that electron poor phenoxides can act as suitable C(1)-acyl ammonium 
turnover agents. Further work could focus on the reaction of C(1)-ammonium enolates with a variety 
electrophilic partners which do not contain an intramolecular turnover mechanism. For example, it is 
envisaged that aryl acetic activated esters could react with an isothiourea to generate a C(1)-ammonium 
enolates; such ammonium enolates could react with a range of electrophiles to form a stereodefined 
C(1)-acyl ammonium intermediates. Product release from such intermediates could generate a range of 
enantioenriched carboxylic acid derivatives (Scheme 122).  
 
Scheme 122: Potential isothiourea-catalysed enantioselective α-functionalisation of aryl acetic 
activated esters. 
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Chapter 6: Experimental Details 
 
General Experimental  
Reactions were performed in flame-dried glassware under an N2 atmosphere unless otherwise stated. 
Anhydrous CH2Cl2 and Et2O were obtained from an MBraun SPS-800 system, MeCN was HPLC grade 
stored over 4 Å MS. All other solvents and commercial reagents were used as received without further 
purification unless otherwise stated. d3-MeCN and d6-DMSO for kinetic experiments were used as 
received. Room temperature (rt) refers to 20-25 °C. Temperatures of 0 °C, −20 °C and −78 °C were 
obtained using ice/water bath, an immersion cooler and CO2(s)/acetone bath, respectively.  
 
Analytical thin layer chromatography was performed on pre-coated aluminium plates (Kieselgel 60 F254 
silica). Plates were visualised under UV light (254 nm) or by staining with either phosphomolybdic acid 
or KMnO4 followed by heating. Flash column chromatography was performed on Kieselgel 60 silica in 
the solvent system stated.  
 
Melting points were recorded on an Electrothermal 9100 melting point apparatus, dec refers to 
decomposition.  
 
Optical rotations were measured on a Perkin Elmer Precisely/Model-341 polarimeter operating at the 
sodium D line with a 100 mm path cell at 20 °C.  
 
HPLC analyses were obtained on a Shimadzu HPLC consisting of a DGU-20A5 degasser, LC-20AT 
liquid chromatography SIL-20AHT autosampler, CMB-20A communications bus module, SPD-M20A 
diode array detector and a CTO-20A column oven that allows the temperature to be set from 25-40 °C. 
Separation was achieved using a Chiralcel OJ-H, or Chiralpak AD-H, AS-H, IA, IB, and ID columns. 
The columns were flushed with 40% IPA/hexane for 15 mins before switching to the indicated solvent 
mixtures, as this ensured reproducibility of chromatograms. 
 
Infrared spectra (νmax) were recorded on a Shimadzu IRAffinity-1 Fourier transform IR 
spectrophotometer using either thin film or solid using Pike MIRacle ATR accessory. Analysis was 
carried out using Shimadzu IRsolution v1.50 and only characteristic peaks are reported. 
 
1H, 13C{1H}, 19F{1H} and 19F NMR spectra were acquired on either a Bruker Avance 300 {δH: (300 
MHz), δC: (75 MHz), δF: (282 MHz)}, a Bruker Avance II 400 {δH: (400 MHz), δC: (101 MHz), δF: 
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(376 MHz)}, a Bruker Ultrashield 500 {δH: (500 MHz), δC: (126 MHz), δF: (471 MHz)}, a Bruker 
Ascend 400 {δH: 400 MHz, δC: (101 MHz), δF: (471 MHz)} or a Bruker Avace III 700 {δH: (700 
MHz), δC: (179 MHz), δF: (659 MHz)} spectrometer at ambient temperature (unless otherwise stated) 
in the deuterated solvent stated. Chemical shifts, δ, are quoted in parts per million (ppm) and are 
referenced to the residual solvent peak. Coupling constants, J, are quoted in Hertz (Hz) to the nearest 
0.1 Hz. The following abbreviations are used: s, singlet; d, doublet; t, triplet; q, quartet; dd, doublet of 
doublets; ddd, doublet of doublet of doublets; dt, doublet of triplets; ddt, doublet of doublets of triplets; 
dtt, doublet of triplets of triplets; dq, doublet of quartets; td, triplet of doublets; tdd, triplet of doublets 
of doublets; tt, triplet of triplets; m, multiplet; br, broad; and apt, apparent. 
 
Mass spectrometry (HRMS) data were acquired by electrospray ionisation (ESI), electron impact (EI), 
chemical ionisation (CI), atmospheric pressure chemical ionisation (APCI) or nanospray ionisation 
(NSI) at the EPSRC UK National Mass Spectrometry Facility at Swansea University. 
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Synthesis of (+)-BTM 
(R)-2-(Benzo[d]thiazol-2-ylamino)-2-phenylethan-1-ol 461 [79]  
 
Following the procedure of Daniels et. al.[79] a solution of 2-Chlorobenzothiazole (8.6 mL, 69.43mmol, 
1.0 equiv.), (R)-phenylglycinol (10.0 g, 72.8 mmol, 1.05 equiv.) and iPr2NEt (31.0 mL, 173.6 mmol, 
2.5 equiv.) in o-dichlorobenzene (34.5 mL, 2.0 M) were heated to 195 °C for 24 h. After cooling to rt, 
the mixture was treated with H2O (100 mL) and toluene (75 mL) and vigorously stirred for 30 mins, the 
resulting precipitate filtered and dried in vacuo. The resulting solid was recrystallized from toluene to 
give the title product as a white solid (11.2 g, 60%); 
[α]D
20 −98.3 (c 1.0 MeOH); {lit. [80][α]D
20 −98.7 (c 1.0 MeOH)}; m.p 156-158 °C (PhMe), {lit. 159-160 
°C};1H NMR (500 MHz, d4-MeOH) δH: 3.77-3.89 (2H, m, C(1)H2), 5.00 (1H, dd, J 7.5, 5.0, C(2)H), 
7.03 (1H, td, J 7.5, 1.2, Ar(4)H), 7.19-7.29 (2H, m, ArH), 7.31-7.40 (3H, m, ArH), 7.44 (2H, dd, J 8.1, 
1.2, Ar(6,7)H), 7.55 (1H, dd, J 8.1, 1.2, Ar(8)H); Data in accordance with the literature.[79]  
(R)-2-Phenyl-2,3-dihydrobenzo[d]imidazo[2,1-b]thiazole ((+)-Benzotetramisole), (+)-BTM 197 [79]  
 
(2R)-2-Phenyl-2-(1-thia-3-aza-2-indanylamino) ethanol 461 (11.2 g, 41.5 mmol, 1.0 equiv.) was 
dissolved in CH2Cl2 (415 mL) and cooled to 0 °C and treated with NEt3 (23.1 ml, 166 mmol, 4.0 equiv.) 
followed by MsCl (4.19 mL, 54.0 mmol, 1.3 equiv.). The mixture was then warmed to rt and stirred for 
15 mins. After which iPrOH (9.0 mL) was added and the mixture heated to reflux for 16 h. The reaction 
mixture was allowed to cool to rt, then quenched by the addition of aq. 1 M NaOH (200 mL) and stirred 
for 30 min. The layers separated and the aqueous layer extracted with CH2Cl2 (100 mL). The combined 
organic layers were washed with brine (100 mL) dried over MgSO4 and concentrated in vacuo. The 
crude residue was azeotroped with PhMe (3 × 50 mL). The residue was triturated with Et2O (200 mL) 
and filtered this was repeated twice. The combined filtrates were extracted with aq. 1 M HCl (5 × 50 
mL) and the combined aqueous layers were basified with aq. 2 M NaOH to ca. pH>14. The aqueous 
was extracted with Et2O (3 × 100 mL) and the combined organic layers washed with brine (100 mL). 
The organic layer was then treated with activated charcoal (~5 g) and MgSO4 and filtered through 
Celite® (eluent 200 mL Et2O), the resulting filtrate was concentrated in vacuo. The resulting solid 
residue was recrystallized from Et2O/PE to give the title product as a white solid (5.34 g, 51%); 
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[α]D
20 +257.9 (c 1.0, MeOH); {lit.[80] [α]D
20 +256.7 (c 1.0, MeOH)}; m.p 89-90 °C (Et2O:PE), {lit. 94.5-
95.0 °C (Et2O:hexanes)}; 1H NMR (500 MHz, CDCl3) δH: 3.72 (1H, dd, J 8.9, 8.1, C(3)HAHB), 4.28 
(1H, dd, J 10.2, 8.9, C(3)HAHB), 5.67 (1H, dd, J 10.2, 8.1, C(2)H), 6.67 (1H, dd, J 7.7, 1.2, Ar(3)H), 
6.97 (1H, td, J 7.7, 1.2, Ar(4)H), 7.19 (1H, td, J 7.7, 1.2, Ar(2)H), 7.27-7.33 (2H, m, ArH), 7.34-7.41 
(4H, m, ArH); Data in accordance with the literature.[79] 
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Experimental Details for Chapter 2 
Amine Synthesis General Scheme: 
 
General Procedure A: Synthesis of α,β-Unsaturated Esters from Aldehydes: 
To a stirred solution of the aldehyde (1.0 equiv.) in CH2Cl2 (10 mL / g aldehyde) was added ethyl 2-
(triphenylphosphoranylidene)acetate (1.05 equiv.). The reaction was stirred overnight at rt, 
concentrated in vacuo, the residue triturated with PE/Et2O (9:1), and the solids removed by filtration. 
The solvent was removed in vacuo and the crude residue purified by flash chromatography on silica gel 
to give the pure α,β-unsaturated esters. 
General Procedure B: Synthesis of α,β-Unsaturated Esters from Acids: 
To a stirred solution of the α,β-unsaturated acid (1.0 equiv.) in ethanol (10 mL / g acid) was added conc. 
H2SO4 (0.1 mL / g acid). The reaction was heated at reflux for 3 h, allowed to cool, and concentrated in 
vacuo. The residue was neutralised with sat aq NaHCO3, extracted with EtOAc (3  equal volume) and 
the combined organics washed with brine (equal volume). The organic layer was dried over MgSO4, 
filtered, and concentrated in vacuo to give the pure α,β-unsaturated esters. 
General Procedure C: Synthesis of Allylic Alcohols: 
To a stirred solution of the α,β-unsaturated ester (1.0 equiv.) in anhydrous CH2Cl2 (0.2 M) at −78 °C 
under N2 was added DIBAL-H (1.0-1.2 M in toluene or hexane, 2.2 equiv.) dropwise. The reaction was 
stirred for 1.5 h at −78 °C, and quenched with 10% aq NaOH (equal volume). The resultant mixture 
was allowed to warm to rt and stirred for 1 h. The layers were separated and the aqueous layer extracted 
with CH2Cl2 (2  equal volume). The combined organics were washed with brine (equal volume), dried 
over MgSO4, filtered, and concentrated in vacuo to give the pure allylic alcohols. 
General Procedure D: Synthesis of Allylic Bromides: 
To a stirred solution of the allylic alcohol (1.0 equiv.) in anhydrous Et2O (0.33 M) at 0 °C was added 
PBr3 (0.4 equiv.). The reaction was stirred until complete by TLC analysis (typically 0.25-1 h), and 
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poured into sat aq NaHCO3 (equal volume). The layers were separated and the aqueous layer extracted 
with Et2O (2  equal volume). The combined organics were washed with sat aq Na2S2O3 and brine (1:1, 
equal volume), dried over MgSO4, filtered and concentrated in vacuo to give the pure allylic bromides. 
General Procedure E: Synthesis of N,N-Dimethyl Allylic Amines: 
A solution of the allylic bromide (1.0 equiv.) in THF (0.5 M) was added dropwise to a solution of 
dimethylamine in water (40% wt., 5.0 equiv.) via a dropping funnel at rt. After addition was complete, 
the funnel was rinsed with a small portion of THF and the reaction stirred for 10 mins. 1 M aq NaOH 
(2 equiv.) was then added in one portion, and the reaction stirred for a further 10 mins. The reaction 
was diluted with Et2O (equal volume), the layers separated and the aqueous layer extracted with Et2O 
(2  equal volume). The combined organics were washed with brine (equal volume), dried over MgSO4, 
filtered, and concentrated in vacuo. The residue was triturated with Et2O, any solids removed by 
filtration, and the solution concentrated in vacuo to afford the dimethyl allylic amines that were used as 
isolated, or purified further by flash chromatography on silica gel or distillation (as indicated). 
General Procedure F: Synthesis of Other Tertiary Allylic Amines: 
A solution of the allylic bromide (1.0 equiv.) in THF (0.5 M) was added dropwise to a solution of the 
secondary amine (2.5 equiv.) in THF (2.5 M) via a dropping funnel at rt. After addition was complete, 
the funnel was rinsed with a small portion of THF and the reaction stirred for 10 mins. 1 M aq NaOH 
(2 equiv.) was then added in one portion, and the reaction stirred for a further 10 mins. The reaction 
was diluted with Et2O (equal volume), the layers separated and the aqueous layer extracted with Et2O 
(2  equal volume). The combined organics were washed with brine (equal volume), dried over MgSO4, 
filtered, and concentrated in vacuo. The residue was triturated with Et2O, any solids removed by 
filtration, and the solution concentrated in vacuo to afford the tertiary allylic amines that were used as 
isolated, or purified further by flash chromatography on silica gel (as indicated). 
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(E)-N,N-Dimethyl-3-phenylprop-2-en-1-amine[81] 212 
 
Following general procedure E, the reaction of cinnamyl bromide (25.0 g, 126.9 mmol, 1.0 equiv.) in 
THF (250 mL) and dimethylamine (80.2 mL, 634.5 mmol, 5.0 equiv.) gave the title compound (15.7 g, 
77%, 97:3 E/Z by 1H NMR) after distillation under vacuum to give a colourless oil. 
bp 80-82 °C at 1 mmHg {Lit.[82] 120 °C at 10 mmHg} 1H NMR (300 MHz, CDCl3) δH: 2.28 (6H, s, 
N(CH3)2), 3.08 (2H, dd, J 6.7, 1.4, C(1)H2), 6.27 (1H, dt, J 15.8, 6.7, C(2)H), 6.52 (1H, dt, J 15.8, 1.4, 
C(3)H), 7.19-7.25 (1H, m, ArC(4)H), 7.28-7.34 (2H, m, ArC(3,5)H), 7.36-7.41 (2H, m, ArC(2,6)H); 
Data consistent with literature.[81] 
1-Cinnamylpiperidine[83]† 239 
 
Following general procedure F, the reaction of cinnamyl bromide (1.00 g, 5.1 mmol, 1.0 equiv.) in THF 
(10 mL) with piperidine (1.25 mL, 12.7 mmol, 2.5 equiv.) in THF (5 mL) gave the title compound (1.01 
g, 99%, >98:2 E/Z by 1H NMR) as an orange oil that was used without further purification. 
1H NMR (300 MHz, CDCl3) δH: 1.41-1.49 (2H, m, C(4)H2), 1.57-1.65 (4H, m, C(3,5)H2), 2.44 (4H, br 
s, C(2,6)H2), 3.12 (2H, dd, J 6.7, 1.3, C(1’)H), 6.31 (1H, dt, J 15.9, 6.7, C(2’)H), 6.50 (1H, dt, J 15.9, 
1.3, C(3’)H), 7.18-7.24 (1H, m, Ar(4)H), 7.27-7.33 (2H, m, Ar(3,5)H), 7.35-7.39 (2H, m, Ar(2,6)H); 
13C{1H} NMR (75 MHz, CDCl3) δC: 24.5, 26.1, 54.7, 62.0, 126.4, 127.4 (2 × C), 128.6, 132.7, 137.2. 
Data consistent with literature.[83] 
4-Cinnamylmorpholine[84]† 240 
 
Following general procedure F, the reaction of cinnamyl bromide (1.00 g, 5.1 mmol, 1.0 equiv.) in THF 
(10 mL) with morpholine (1.11 mL, 12.7 mmol, 2.5 equiv.) in THF (5 mL) gave the title compound 
(1.02 g, 99%, >98:2 E/Z by 1H NMR) as an orange oil that was used without further purification. 
1H NMR (300 MHz, CDCl3) δH: 2.49-2.54 (4H, m, C(3,5)H2), 3.17 (2H, dd, J 6.8, 1.3, C(1’)H), 3.73-
3.77 (4H, m, C(2,6)H2), 6.27 (1H, dt, J 15.9, 6.8, C(2’)H), 6.55 (1H, dt, J 15.9, 1.3, C(3’)H), 7.21-7.27 
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(1H, m, Ar(4)H), 7.29-7.35 (2H, m, Ar(3,5)H), 7.36-7.41 (2H, m, Ar(2,6)H); 13C{1H} NMR (75 MHz, 
CDCl3) δC: 53.8, 61.6, 67.1, 126.1, 126.4, 127.7, 128.7, 133.5, 136.9. Data consistent with literature.[84] 
tert-Butyl 4-cinnamylpiperazine-1-carboxylate[85]† 241 
 
Following general procedure F, the reaction of cinnamyl bromide (1.00 g, 5.1 mmol, 1.0 equiv.) in THF 
(10 mL) with 1-Boc-piperazine (2.36 g, 12.7 mmol, 2.5 equiv.) in THF (5 mL) gave the title compound 
(1.47 g, 4.86 mmol, 96%, >96:4 E/Z by 1H NMR) as a white solid after purification by flash 
chromatography on silica gel (3:1→1:1 PE/EtOAc). 
mp 58-60 °C; 1H NMR (300 MHz, CDCl3) δH: 1.46 (9H, s, C(CH3)3), 2.42-2.47 (4H, m, C(3,5)H2), 3.16 
(2H, dd, J 6.8, 1.3, C(1’)H), 3.42-3.48 (4H, m, C(2,6)H2), 6.26 (1H, dt, J 15.9, 6.8, C(2’)H), 6.52 (1H, 
dt, J 15.9, 1.3, C(3’)H), 7.20-7.25 (1H, m, Ar(4)H), 7.28-7.34 (2H, m, Ar(3,5)H), 7.35-7.39 (2H, m, 
Ar(2,6)H); 13C{1H} NMR (75 MHz, CDCl3) δC: 28.6, 43.6, 53.1, 61.3, 79.8, 126.3, 126.5, 127.7, 128.7, 
133.5, 136.9, 154.9. Data consistent with literature.[85] 
5-Cinnamyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine† 242 
 
To a stirred solution of 4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride (1.0 g, 5.69 mmol, 1.2 
equiv.) in water (10 mL) at 0 °C was added a solution of NaOH (209 mg, 5.22 mmol, 1.1 equiv.) in 
water (10 mL). The resulting solution was stirred for 10 min at rt, and to it added THF (5 mL) and Et3N 
(1.39 mL, 9.95 mmol, 2.1 equiv.). A solution of cinnamyl bromide (934 mg, 4.74 mmol, 1.0 equiv.) in 
THF (10 mL) was added dropwise via dropping funnel over ca. 10 min. The funnel was rinsed with 
THF (2 mL), the reaction stirred for a further 10 min, and quenched with aq. 1 M NaOH (10 mL). The 
reaction was diluted with Et2O (20 mL), the layers separated, and the aqueous layer extracted with Et2O 
(2 × 20 mL). The combined organics were washed with brine (50 mL), dried over MgSO4, filtered and 
the solvent removed in vacuo. The crude product was purified by flash chromatography on silica gel 
(9:1→2:1 PE/EtOAc) to the title compound as a viscous orange oil (925 mg, 76%, >98:2 E/Z by 1H 
NMR). 
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νmax (film, cm−1): 2905, 2772, 1597, 1495, 1449, 1356, 1329, 1167, 1107, 1013, 966, 903; 1H NMR (300 
MHz, CDCl3) δH: 2.85-2.97 (4H, m, C(6 and 7)H2), 3.38 (2H, dd, J 6.7, 1.3, C(1’)H2), 3.63 (2H, t, J 1.6, 
C(4)H2), 6.36 (1H, dt, J 15.9, 6.7, C(2’)H), 6.60 (1H, dt, J 15.9, 1.3, C(3’)H), 6.73 (1H, d, J 5.1, C(3)H), 
7.08 (1H, d, J 5.1, C(2)H), 7.22-7.27 (1H, m, Ar(4)H), 7.30-7.36 (2H, m, Ar(3,5)H), 7.39-7.43 (2H, m, 
Ar(2,6)H); 13C{1H} NMR (75 MHz, CDCl3) δC: 25.6, 50.8, 53.2, 60.3, 122.9, 125.4, 126.5, 126.9, 127.7, 
128.7, 133.2, 133.5, 133.8, 137.0; HRMS (NSI+): C16H18NS [M+H]+ found 256.1156, requires 256.1154 
(+0.6 ppm). 
(E)-Methyl 3-(4-bromophenyl)acrylate[86] 462 
 
Following the procedure of Jørgenson and co-workers,[87] (E)-3-(4-bromophenyl)acrylic acid (10.0 g, 
44.1 mmol, 1.0 equiv.) was suspended in anhydrous methanol (100 mL) and cooled to 0 °C. The 
suspension was treated with thionyl chloride (4.8 mL, 66.1 mmol, 1.5 equiv.) dropwise, and heated to 
reflux for 2 h. The reaction was allowed to cool to rt and concentrated in vacuo to give the title 
compound (9.58 g, 90%) as a white crystalline solid that was used without further purification. 
mp 86-88 °C, {Lit. 88 °C}; 1H NMR (500 MHz, CDCl3) δH: 3.80 (3H, s, OCH3), 6.42 (1H, d, J 16.0, 
C(2)H), 7.38 (2H, d, J 8.2, ArC(2,6)H), 7.51 (2H, d, J 8.2, ArC(3,5)H), 7.62 (1H, d, J 16.0, C(3)H). 
Data consistent with literature.[86] 
(E)-3-(4-Bromophenyl)prop-2-en-1-ol[88] 463 
 
Following general procedure C, the reaction of (E)-methyl 3-(4-bromophenyl)acrylate 462 (3.00 g, 12.5 
mmol, 1.0 equiv.) in anhydrous CH2Cl2 (60 mL) with DIBAL-H (1.0 M in hexane, 22.8 mL, 27.4 mmol, 
2.2 equiv.) gave the title compound (2.60 g, 98%) as a white solid that was used without further 
purification. 
mp 65-67 °C {Lit. 63-65 °C}; 1H NMR (500 MHz, CDCl3) δH: 1.59 (1H, br s, OH), 4.32 (2H, d, J 5.6, 
C(1)H), 6.35 (1H, dt, J 15.9, 5.6, C(2)H), 6.56 (1H, d, J 15.9, C(3)H), 7.24 (2H, d, J 8.6, ArC(2,6)H), 
7.44 (2H, d, J 8.6, ArC(3,5)H). Data consistent with literature.[88] 
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(E)-1-Bromo-4-(3-bromoprop-1-en-1-yl)benzene[89]† 464 
 
Following general procedure D, the reaction of (E)-3-(4-bromophenyl)prop-2-en-1-ol 463 (2.60 g, 12.1 
mmol, 1.0 equiv.) in anhydrous Et2O (36 mL) with PBr3 (0.46 mL, 4.85 mmol, 0.4 equiv.) gave the title 
compound (3.00 g, 90%) as an off-white solid that was used without further purification. 
mp 70-73 °C {Lit. 72-76 °C}; 1H NMR (500 MHz, CDCl3) δH: 4.14 (2H, d, J 7.8, C(3)H), 6.39 (1H, dt, 
J 15.5, 7.8, C(2)H), 6.58 (1H, d, J 15.5, C(1)H), 7.25 (2H, d, J 8.5, ArC(2,6)H), 7.45 (2H, d, J 8.5, 
ArC(3,5)H). Data consistent with literature.[89] 
(E)-1-(3-(4-Bromophenyl)allyl)piperidine† 243 
 
Following general procedure F, the reaction of (E)-1-bromo-4-(3-bromoprop-1-en-1-yl)benzene 464 
(1.00 g, 3.62 mmol, 1.0 equiv.) in THF (7 mL) with piperidine (0.89 mL, 9.06 mmol, 2.5 equiv.) in 
THF (4 mL) gave the title compound (910 mg, 90%, >98:2 E/Z by 1H NMR) as a colourless oil after 
purification by flash chromatography on silica gel (2:1 PE/EtOAc→EtOAc). 
 νmax (film, cm−1): 2932, 2795, 2752, 1487, 1344, 1153, 1109, 1072, 1040, 1009, 966; 1H NMR (300 
MHz, CDCl3) δH: 1.40-1.49 (2H, m, C(4)H2), 1.56-1.65 (4H, m, C(3,5)H2), 2.37-2.47 (4H, m, C(2,6)H2), 
3.10 (2H, dd, J 6.6, 1.1, C(1’)H), 6.29 (1H, dt, J 15.8, 6.6, C(2’)H), 6.43 (1H, dd, J 15.8, 1.1, C(3’)H), 
7.22 (2H, d, J 8.5, ArC(2,6)H), 7.41 (2H, d, J 8.5, ArC(3,5)H); 13C{1H} NMR (75 MHz, CDCl3) δC: 
24.4, 26.1, 54.8, 61.9, 121.2, 127.9, 128.3, 131.5, 131.7, 136.2; HRMS (ESI+): C14H19N79Br [M+H]+ 
found 280.0691, requires 280.0695 (−1.6 ppm). 
(E)-Ethyl 3-(4-methoxyphenyl)acrylate[90]† 465 
 
Following general procedure A, the reaction of p-anisaldehyde (2.0 g, 14.7 mmol, 1.0 equiv.) in CH2Cl2 
(20 mL) with the phosphorane (5.37 g, 15.4 mmol, 1.05 equiv.) gave the title compound (2.91 g, 96%) 
as a white solid after purification by flash chromatography on silica gel (19:1→4:1 PE/Et2O). 
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mp 47-48 °C {lit. 47-49 °C}; 1H NMR (300 MHz, CDCl3) δH: 1.33 (3H, t, J 7.1, OCH2CH3), 3.84 (3H, 
s, OCH3), 4.25 (2H, q, J 7.1, OCH2CH3), 6.31 (1H, d, J 16.0, C(2)H), 6.90 (2H, d, J 8.9, ArC(3)H), 7.48 
(2H, d, J 8.9, ArC(2)H), 7.64 (1H, d, J 16.0, C(3)H); 13C{1H} NMR (75 MHz, CDCl3) δC: 14.5, 55.5, 
60.5, 114.5, 115.9, 127.4, 129.8, 144.4, 161.5, 167.5. Data consistent with literature.[90] 
(E)-3-(4-Methoxyphenyl)prop-2-en-1-ol[91]† 466 
 
Following general procedure C, the reaction of (E)-ethyl 3-(4-methoxyphenyl)acrylate (1.0 g, 4.85 
mmol, 1.0 equiv.) in anhydrous CH2Cl2 (25 ml) with DIBAL-H (1.2 M in toluene, 8.89 mL, 10.67 mmol, 
2.2 equiv.) gave the title compound (790 mg, 4.81 mmol, 99%) as a white solid that was used without 
further purification. 
mp 77-78 °C {lit. 78-80 °C}; 1H NMR (300 MHz, CDCl3) δH: 1.43 (1H, br s, OH), 3.81 (3H, s, OCH3), 
4.28-4.32 (2H, m, C(1)H2), 6.56 (1H, d, J 15.9, C(3)H), 6.24 (1H, dt, J 15.9, 5.9, C(2)H), 6.86 (2H, d, 
J 8.5, ArC(3)H), 7.33 (2H, d, J 8.5, ArC(2)H); 13C{1H} NMR (75 MHz, CDCl3) δC: 55.4, 64.1, 114.2, 
126.4, 127.8, 129.6 131.1, 159.5. Data consistent with literature.[91] 
(E)-1-(3-Bromoprop-1-en-1-yl)-4-methoxybenzene[92]† 467 
 
Following general procedure D with slight modification, the reaction of (E)-3-(4-methoxyphenyl)prop-
2-en-1-ol 466 (1.0 g, 6.09 mmol, 1.0 equiv.) in anhydrous Et2O (18 mL) with PBr3 (0.24 mL, 2.44 
mmol, 0.4 equiv.), with CH2Cl2 replacing Et2O in the work up, gave the title compound (890 mg, 60%) 
as a white solid that was used without further purification. 
mp 76-78 °C; 1H NMR (500 MHz, CDCl3) δH: 3.82 (3H, s, OCH3), 4.17 (2H, dd, J 7.9, 1.0, C(3)H), 
6.27 (1H, dt, J 15.6, 7.9, C(2)H), 6.60 (1H, dt, J 7.9, 1.0, C(1)H), 6.86 (2H, d, J 8.7, ArC(3)H), 7.33 
(2H, d, J 8.7, ArC(2)H); 13C{1H} NMR (75 MHz, CDCl3) δC: 34.4, 55.5, 114.2, 123.1, 128.2, 128.7, 
134.4, 160.0. Data consistent with literature.[92] 
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(E)-3-(4-Methoxyphenyl)-N,N-dimethylprop-2-en-1-amine[93]† 245 
 
Following general procedure E, the reaction of (E)-1-(3-bromoprop-1-en-1-yl)-4-methoxybenzene 467 
(880 mg, 3.87 mmol, 1.0 equiv.) in THF (8 mL) with dimethylamine (2.46 mL, 19.4 mmol, 5.0 equiv.) 
gave the title compound (170 mg, 0.89 mmol, 23%) as a colourless oil after purification by flash 
chromatography on silica gel (CH2Cl2→1:9 MeOH/CH2Cl2). 
1H NMR (500 MHz, CDCl3) δH: 2.27 (6H, s, N(CH3)2), 3.05 (2H, dd, J 6.6, 1.3, C(1)H), 3.80 (3H, s, 
OCH3), 6.12 (1H, dt, J 15.8, 6.6, C(2)H), 6.45 (1H, dt, J 15.8, 1.3, C(3)H), 6.85 (2H, d, J 8.7, ArC(3)H), 
7.31 (2H, d, J 8.7, ArC(2)H); 13C{1H} NMR (126 MHz, CDCl3) δC: 45.4, 55.4, 62.3, 114.1, 125.4, 
127.6, 130.0, 132.1, 159.2. Data consistent with literature.[93] 
(E)-Ethyl 3-(4-nitrophenyl)acrylate[94]† 468 
 
Following general procedure A with slight modification, the reaction of 4-nitrobenzaldehyde (2.0 g, 
13.23 mmol, 1.0 equiv.) in anhydrous CH2Cl2 (20 mL) with the phosphorane (4.84 g, 13.90 mmol, 1.05 
equiv.) gave the title compound (2.47 g, 11.17 mmol, 84%) as a yellow crystalline solid after 
recrystallisation of the crude residue from hot EtOH. 
mp 129-131 °C {Lit. 130-132 °C}; 1H NMR (300 MHz, CDCl3) δH: 1.35 (3H, t, J 7.1, OCH2CH3), 4.29 
(2H, q, J 7.1, OCH2CH3), 6.56 (1H, d, J 16.1, C(2)H), 7.67 (2H, d, J 8.7, ArC(2)H), 7.71 (1H, d, J 16.1, 
C(3)H), 8.25 (2H, d, J 8.7, ArC(3)H). Data consistent with literature.[94] 
(E)-3-(4-Nitrophenyl)prop-2-en-1-ol[92]† 469 
 
Following general procedure C, the reaction of (E)-ethyl 3-(4-nitrophenyl)acrylate 468 (2.0 g, 9.04 
mmol, 1.0 equiv.) in anhydrous CH2Cl2 (45 mL) with DIBAL-H (1.2 M in toluene, 16.6 mL, 19.89 
mmol, 2.2 equiv.) gave the title compound (1.53 g, 94%) as a yellow solid that was used without further 
purification. 
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mp 106-107 °C {Lit.15 107 °C}; 1H NMR (300 MHz, CDCl3) δH: 1.55 (1H, t, J 5.8, OH), 4.41 (2H, ddd, 
J 5.8, 5.0, 1.7, C(1)H), 6.54 (1H, dt, J 16.0, 5.0, C(2)H), 6.72 (1H, dt, J 16.0, 1.7, C(3)H), 7.52 (2H, d, 
J 8.7, ArC(2)H), 8.19 (2H, d, J 8.7, ArC(3)H). Data consistent with literature.[92] 
(E)-1-(3-Bromoprop-1-en-1-yl)-4-nitrobenzene[95]† 470 
 
Following general procedure D with slight modification, the reaction of (E)-3-(4-nitrophenyl)prop-2-
en-1-ol 469 (1.25 g, 6.98 mmol, 1.0 equiv.) in anhydrous Et2O (20 mL) with PBr3 (0.26 mL, 2.79 mmol, 
0.4 equiv.), with CH2Cl2 replacing Et2O in the work up, gave the title compound (1.06 g, 63%) as an 
orange solid that was used without further purification. 
mp 55-56 °C {Lit.19 58-62 °C}; 1H NMR (300 MHz, CDCl3) δH: 4.16 (2H, dd, J 7.4, 0.8, C(3)H), 6.56 
(1H, dt, J 15.6, 7.4, C(2)H), 6.71 (1H, dt, J 15.6, 0.8, C(1)H), 7.52 (2H, d, J 8.8, ArC(2)H), 8.20 (2H, 
d, J 8.8, ArC(3)H); 13C{1H} NMR (75 MHz, CDCl3) δC: 32.0, 124.2, 127.4, 130.0, 132.2, 142.3, 147.5. 
Data consistent with literature.[95] 
(E)-N,N-Dimethyl-3-(4-nitrophenyl)prop-2-en-1-amine† 249 
 
Following general procedure E, the reaction of (E)-1-(3-bromoprop-1-en-1-yl)-4-nitrobenzene 470 
(1.05 g, 4.34 mmol, 1.0 equiv.) in THF (9 mL) with dimethylamine (2.74 mL, 21.7 mmol, 5.0 equiv.) 
gave the title compound (830 mg, 93%, >98:2 E/Z by 1H NMR) as an orange oil that was used without 
further purification. 
νmax (film, cm−1): 2941, 2768, 1595, 1512, 1454, 1337, 1107, 1022, 974, 851; 1H NMR (300 MHz, 
CDCl3) δH: 2.29 (6H, s, N(CH3)2), 3.12 (2H, dd, J 6.3, 1.2, C(1)H), 6.45 (1H, dt, J 15.9, 6.3, C(2)H), 
6.59 (1H, dt, J 15.9, 1.2, C(3)H), 7.49 (2H, d, J 8.8, ArC(2)H), 8.17 (2H, d, J 8.8, ArC(3)H); 13C{1H} 
NMR (75 MHz, CDCl3) δC: 45.6, 62.0, 124.2, 126.9, 130.4, 133.1, 143.7, 147.0. HRMS (NSI+): 
C11H15N2O2 [M+H]+ found 207.1127, requires 207.1128 (−0.5 ppm). 
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(E)-3-(4-Bromophenyl)-N,N-dimethylprop-2-en-1-amine† 244 
 
Following general procedure E, the reaction of (E)-1-bromo-4-(3-bromoprop-1-en-1-yl)benzene 464 
(500 mg, 1.81 mmol, 1.0 equiv.) in THF (4 mL) with dimethylamine (1.15 mL, 9.06 mmol, 5.0 equiv.) 
gave the title compound (403 mg, 93%, >98:2 E/Z by 1H NMR) as a waxy yellow solid that was used 
without further purification. 
mp <30 °C; νmax (film, cm−1): 2940, 2766, 1587, 1485, 1452, 1400, 1360, 1173, 1070, 1007, 968, 835; 
1H NMR (500 MHz, CDCl3) δH: 2.27 (6H, s, N(CH3)2), 3.06 (2H, dd, J 6.6, 1.2, C(1)H2), 6.25 (1H, dt, 
J 15.9, 6.6, C(2)H), 6.45 (1H, d, J 15.9, C(3)H), 7.23 (2H, d, J 8.3, ArC(2,6)H), 7.42 (2H, d, J 8.3, 
ArC(3,5)H); 13C{1H} NMR (126 MHz, CDCl3) δC: 45.5, 62.1, 121.3, 128.0, 128.5, 131.5, 131.8, 136.1; 
HRMS (ESI+): C11H15N79Br [M+H]+ found 240.0378, requires 240.0382 (−1.8 ppm). 
(E)-Ethyl 3-(2-bromophenyl)acrylate[96]† 471 
 
Following general procedure B, the reaction of (E)-3-(2-bromophenyl)acrylic acid (2.85 g, 12.55 mmol, 
1.0 equiv.) with conc. H2SO4 (0.30 mL) in EtOH (30 mL) gave the title compound (3.04 g, 95%) as a 
colourless oil that was used without further purification. 
1H NMR (300 MHz, CDCl3) δH: 1.35 (3H, t, J 7.1, OCH2CH3), 4.28 (2H, q, J 7.1, OCH2CH3), 6.38 (1H, 
d, J 16.0, C(2)H), 7.22 (1H, t, J 7.7, ArCH), 7.32 (1H, t, J 7.7, ArCH), 7.57-7.63 (2H, m, ArCH), 8.04 
(1H, d, J 16.0, C(3)H); 13C{1H} NMR (75 MHz, CDCl3) δC: 14.4, 60.8, 121.3, 124.5, 127.8, 127.9, 
131.3, 133.6, 134.7, 143.0, 166.5. Data consistent with literature.[96] 
(E)-3-(2-Bromophenyl)prop-2-en-1-ol[97]† 472 
 
Following general procedure C, the reaction of (E)-ethyl 3-(2-bromophenyl)acrylate 471 (3.00 g, 11.76 
mmol, 1.0 equiv.) in anhydrous CH2Cl2 (60 mL) with DIBAL-H (1.2 M in toluene, 21.6 mL, 25.87 
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mmol, 2.2 equiv.) gave the title compound (2.37 g, 95%) as a colourless oil that was used without 
further purification. 
1H NMR (300 MHz, CDCl3) δH: 1.68 (1H, br s, OH), 4.36 (2H, dd, J 5.6, 1.7, C(1)H2), 6.31 (1H, dt, J 
15.8, 5.6, C(2)H), 6.96 (1H, dt, J 15.8, 1.7, C(3)H), 7.10 (1H, td, J 7.7, 1.7, ArCH), 7.27 (1H, J 7.8, 1.3, 
0.6, ArCH), 7.49-7.57 (2H, m, ArCH); 13C{1H} NMR (75 MHz, CDCl3) δC: 63.7, 123.8, 127.3, 127.6, 
129.1, 129.9, 131.8, 133.1, 136.7. Data consistent with literature.[97] 
(E)-1-Bromo-2-(3-bromoprop-1-en-1-yl)benzene[89]† 473 
 
Following general procedure D, the reaction of (E)-3-(2-bromophenyl)prop-2-en-1-ol 472 (1.0 g, 4.69 
mmol, 1.0 equiv.) in anhydrous Et2O (15 mL) with PBr3 (0.18 mL, 1.88 mmol, 0.4 equiv.) gave the title 
compound (850 mg, 66%) as a pale yellow oil that was used without further purification. 
1H NMR (500 MHz, CDCl3) δH: 4.18 (2H, dd, J 7.7, 1.1, C(3)H), 6.35 (1H, dt, J 15.5, 7.8, C(2)H), 7.00 
(1H, dt, J 15.5, 1.1, C(1)H), 7.13 (1H, td, J 7.7, 1.7, ArCH), 7.27-7.30 (1H, m, ArCH), 7.52-7.57 (2H, 
m, ArCH); 13C{1H} NMR (126 MHz, CDCl3) δC: 32.9, 124.0, 127.4, 127.7, 128.1, 129.7, 133.1, 133.2, 
135.7. Data consistent with literature.[89] 
(E)-3-(2-Bromophenyl)-N,N-dimethylprop-2-en-1-amine† 248 
 
Following general procedure E, the reaction of (E)-1-bromo-2-(3-bromoprop-1-en-1-yl)benzene (830 
mg, 3.01 mmol, 1.0 equiv.) in THF (6 mL) with dimethylamine (1.90 mL, 15.0 mmol, 5.0 equiv.) gave 
the title compound (616 mg, 85%, >98:2 E/Z by 1H NMR) as a yellow oil that was used without further 
purification. 
νmax (film, cm−1): 2940, 2768, 1464, 1452, 1435, 1360, 1172, 1042, 1020, 961, 868; 1H NMR (500 MHz, 
CDCl3) δH: 2.30 (6H, s, N(CH3)2), 3.13 (2H, dd, J 6.7, 1.5, C(1)H2), 6.20 (1H, dt, J 15.7, 6.7, C(2)H), 
6.85 (1H, dt, J 15.7, 1.5, C(3)H), 7.07-7.11 (1H, m, ArCH), 7.24-7.28 (1H, m, ArCH), 7.51-7.55 (2H, 
m, ArCH); 13C{1H} NMR (126 MHz, CDCl3) δC: 45.4, 62.1, 123.6, 127.2, 127.6, 128.9, 130.6, 131.6, 
133.0, 137.0; HRMS (ESI+): C11H15N79Br [M+H]+ found 240.0377, requires 240.0382 (−2.2 ppm). 
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(E)-Ethyl 3-(2-methoxyphenyl)acrylate[98]† 474 
 
Following general procedure B, the reaction of (E)-3-(2-methoxyphenyl)acrylic acid (2.50 g, 14.03 
mmol, 1.0 equiv.) with conc. H2SO4 (0.25 mL) in EtOH (25 mL) gave the title compound (2.85 g, 98%) 
as a white solid that was used without further purification. 
mp 31-32 °C {Lit. 35 °C}; 1H NMR (300 MHz, CDCl3) δH: 1.34 (3H, t, J 7.1, OCH2CH3), 3.89 (3H, s, 
OCH3), 4.26 (2H, q, J 7.1, OCH2CH3), 6.53 (1H, d, J 16.2, C(2)H), 6.89-6.99 (2H, m, ArCH), 7.35 (1H, 
ddd, J 8.2, 7.4, 1.7, ArCH), 7.48-7.53 (1H, m, ArCH), 7.99 (1H, d, J 16.2, C(3)H); 13C{1H} NMR (75 
MHz, CDCl3) δC: 14.5, 55.6, 60.5, 111.3, 119.0, 120.8, 123.6, 129.1, 131.5, 140.1, 158.5, 167.7. Data 
consistent with literature.[98] 
(E)-3-(2-Methoxyphenyl)prop-2-en-1-ol[99]† 475 
 
Following general procedure C, the reaction of (E)-ethyl 3-(2-methoxyphenyl)acrylate 474 (2.50 g, 
12.12 mmol, 1.0 equiv.) with DIBAL-H (1.2 M in toluene, 22.2 mL, 26.67 mmol, 2.2 equiv.) in 
anhydrous CH2Cl2 (60 mL) gave the title compound (1.97 g, 12.00 mmol, 99%) as a white solid that 
was used without further purification. 
mp 33-34 °C {Lit. 36-37 °C}; 1H NMR (500 MHz, CDCl3) δH: 1.54 (1H, br s, OH), 3.85 (3H, s, OCH3), 
4.33 (2H, dd, J 6.1, 1.5, C(1)H2), 6.39 (1H, dt, J 16.1, 6.1, C(2)H), 6.88 (1H, d, J 8.2, ArCH), 6.91-6.96 
(2H, m, 1 × ArCH and C(3)H), 7.21-7.26 (1H, m, ArCH), 7.44 (1H, dd, J 7.7, 1.7, ArCH). Data 
consistent with literature.[99] 
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(E)-1-(3-Bromoprop-1-en-1-yl)-2-methoxybenzene[92]† 476 
 
Following general procedure D, the reaction of (E)-3-(2-methoxyphenyl)prop-2-en-1-ol 475 (1.0 g, 6.09 
mmol, 1.0 equiv.) in anhydrous Et2O (18 mL) with PBr3 (0.23 mL, 2.44 mmol, 0.4 equiv.) gave the title 
compound (1.29 g, 95%) as a yellow oil that was used without further purification. 
1H NMR (300 MHz, CDCl3) δH: 3.86 (3H, s, OCH3), 4.19 (2H, dd, J 7.8, 1.0, C(3)H2), 6.44 (1H, dt, J 
15.7, 7.8, C(2)H), 6.88 (1H, dd, J 8.3, 1.1, ArCH), 6.94 (1H, tdd, J 7.5, 1.0, 0.5, ArCH), 6.98 (1H, dt, J 
15.7, 1.0, C(1)H), 7.26 (1H, ddd, J 8.2, 7.4, 1.7, ArCH), 7.44 (1H, dd, J 7.7, 1.7, ArCH); 13C{1H} NMR 
(75 MHz, CDCl3) δC: 34.6, 55.6, 111.0, 120.8, 124.8, 125.9, 127.4, 129.6, 129.7, 157.1. Data consistent 
with literature.[92] 
(E)-3-(2-Methoxyphenyl)-N,N-dimethylprop-2-en-1-amine† 247 
 
Following general procedure E, the reaction of (E)-1-(3-bromoprop-1-en-1-yl)-2-methoxybenzene 476 
(1.28 g, 5.64 mmol, 1.0 equiv.) in THF (11 mL) with dimethylamine (3.57 mL, 28.2 mmol, 5.0 equiv.) 
gave the title compound (910 mg, 84%, >98:2 E/Z by 1H NMR) as a yellow oil that was used without 
further purification. 
νmax (film, cm−1): 2940, 2770, 1597, 1580, 1489, 1462, 1437, 1360, 1288, 1238, 1175, 1111, 1028, 974; 
1H NMR (300 MHz, CDCl3) δH: 2.28 (6H, s, N(CH3)2), 3.09 (2H, dd, J 6.8, 1.4, C(1)H2), 3.84 (3H, s, 
OCH3), 6.28 (1H, dt, J 16.0, 6.8, C(2)H), 6.83 (1H, dt, J 16.0, 1.4, C(3)H), 6.86 (1H, d, J 8.0, ArCH), 
6.92 (1H, tdd, J 7.5, 1.1, 0.5, ArCH), 7.21 (1H, ddd, J 8.0, 7.4, 1.7, ArCH), 7.45 (1H, dd, J 7.6, 1.7, 
ArCH); 13C{1H} NMR (75 MHz, CDCl3) δC: 45.4, 55.6, 62.7, 111.0, 120.8, 126.2, 126.9, 127.3, 128.3, 
128.5, 156.7; HRMS (NSI+): C12H18NO [M+H]+ found 192.1378, requires 192.1383 (−2.6 ppm). 
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(2E,4E)-Ethyl 5-phenylpenta-2,4-dienoate[100]† 477 
 
Following general procedure A, the reaction of (E)-cinnamaldehyde (2.0 g, 15.13 mmol, 1.0 equiv.) in 
CH2Cl2 (20 mL) with the phosphorane (5.54 g, 15.89 mmol, 1.05 equiv.) gave the title compound (2.52 
g, 82%) as a colourless oil after purification by flash chromatography on silica gel (19:1→4:1 PE/Et2O). 
1H NMR (300 MHz, CDCl3) δH: 1.32 (3H, t, J 7.1, OCH2CH3), 4.23 (2H, q, J 7.1, OCH2CH3), 5.99 (1H, 
d, J 15.3, C(2)H), 6.82-6.94 (2H, m, C(4 and 5)H), 7.27-7.49 (6H, m, ArH and C(3)H); 13C{1H} NMR 
(75 MHz, CDCl3) δC: 14.5, 60.5, 121.5, 126.4, 127.3, 128.9, 129.2, 136.2, 140.5, 144.7, 167.2. Data 
consistent with literature.[100] 
(2E,4E)-5-Phenylpenta-2,4-dien-1-ol[101]† 478 
 
Following general procedure C, the reaction of (2E,4E)-ethyl 5-phenylpenta-2,4-dienoate 477 (1.50 g, 
7.41 mmol, 1.0 equiv.) in anhydrous CH2Cl2 (40 mL) with DIBAL-H (1.2 M in toluene, 13.6 mL, 16.3 
mmol, 2.2 equiv.) gave the title compound (1.19 g, 7.40 mmol, 99%) as an off-white solid that was used 
without further purification. 
mp 74-76 °C {Lit. 76-77 °C}; 1H NMR (300 MHz, CDCl3) δH: 1.46 (1H, br s, OH), 4.23-4.29 (2H, m, 
C(1)H2), 5.97 (1H, dt, J 15.2, 5.9, C(2)H), 6.43 (1H, ddt, J 15.2, 10.4, 1.5, C(3)H), 6.56 (1H, d, J 15.6, 
C(5)H), 6.80 (1H, dd, J 15.6, 10.4, C(4)H), 7.23 (1H, t, J 7.2, ArC(4)H), 7.32 (2H, t, J 7.2, ArC(3,5)H), 
7.38-7.42 (2H, m, ArC(2,6)H); 13C{1H} NMR (75 MHz, CDCl3) δC: 63.6, 126.5, 127.8, 128.3, 128.8, 
131.8, 132.6, 132.9, 137.3. Data consistent with literature.[101] 
((1E,3E)-5-Bromopenta-1,3-dien-1-yl)benzene[102]† 479 
 
Following general procedure D, the reaction of (2E,4E)-5-phenylpenta-2,4-dien-1-ol 478 (1.2 g, 7.49 
mmol, 1.0 equiv.) in anhydrous Et2O (25 mL) with PBr3 (0.28 mL, 2.99 mmol, 0.4 equiv.) gave the title 
compound as an off-white solid (1.46 g, 6.54 mmol, 87%) that was used without further purification. 
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mp 58-59 °C; 1H NMR (300 MHz, CDCl3) δH: 4.11 (2H, dd, J 8.0, 0.9, C(5)H), 6.00 (1H, dtt, J 14.9, 
8.0, 0.7, C(4)H), 6.46 (1H, ddt, J 14.9, 10.4, 0.9, C(3)H), 6.60 (1H, d, J 15.7, C(1)H2), 6.77 (1H, ddd, J 
15.7, 10.4, 0.7, C(2)H), 7.22-7.28 (1H, m, Ar(4)H), 7.30-7.36 (2H, m, Ar(3)H), 7.38-7.42 (2H, m, 
Ar(2)H); 13C{1H} NMR (75 MHz, CDCl3) δC: 33.6, 126.7, 127.4, 128.2, 128.8, 129.1, 134.6, 135.3, 
138.9. Data consistent with literature.[102] 
(2E,4E)-N,N-Dimethyl-5-phenylpenta-2,4-dien-1-amine[81]† 251 
 
Following general procedure E, the reaction of ((1E,3E)-5-bromopenta-1,3-dien-1-yl)benzene 479 
(1.20 g, 5.38 mmol, 1.0 equiv.) in THF (11 mL) with dimethylamine (3.41 mL, 9.06 mmol, 5.0 equiv.) 
gave the title compound (760 mg, 75%, >98:2 E,E/other isomers by 1H NMR) as a yellow oil after 
purification by flash chromatography on silica gel (CH2Cl2→1:9 MeOH/CH2Cl2). 
1H NMR (300 MHz, CDCl3) δH: 2.25 (6H, s, N(CH3)2), 3.01 (2H, dd, J 6.8, 0.7, C(1)H2), 5.84 (1H, dtt, 
J 15.2, 6.8, 0.7, C(2)H), 6.33 (1H, ddtd, J 15.2, 10.4, 1.4, 0.7, C(3)H), 6.51 (1H, d, J 15.8, C(5)H), 6.79 
(1H, ddd, J 15.8, 10.4, 0.8, C(4)H), 7.21 (1H, t, J 7.0, Ar(4)H), 7.28-7.34 (2H, m, Ar(3)H), 7.37-7.41 
(2H, m, Ar(2)H); 13C{1H} NMR (75 MHz, CDCl3) δC: 45.5, 62.0, 126.4, 127.6, 128.7, 128.8, 131.9, 
132.0, 133.2, 137.4. Data consistent with literature.[81] 
1-Tosyl-1H-indole-3-carbaldehyde[103] 480 
 
1H-Indole-3-carbaldehyde (2.5 g, 17.2 mmol, 1.0 equiv.) was suspended in CH2Cl2 (34 mL) and cooled 
to 0 °C, Et3N (4.8 mL, 34.4 mmol, 2.0 equiv.) was then added and the resulting solution stirred for 10 
min. 4-toluenesulfonyl chloride (3.6 g, 19.0 mmol, 1.1 equiv.) was added and the reaction mixture 
stirred at rt for 16 h. The reaction mixture was washed with 10% aq critic acid (20 mL), sat NaHCO3 
(20 mL) and brine (20 mL), then dried over MgSO4 and concentrated in vacuo to give the title compound 
(5.1 g, 99%) as a purple solid that was used without further purification. 
mp 138-139 °C {Lit.142 °C}; 1H NMR (300 MHz, CDCl3) δH: 2.37 (3H, s, TsCH3), 7.29 (2H, d, J 8.2, 
TsAr(3,5)H), 7.33-7.45 (2H, m, IndArH), 7.85 (2H, d, J 8.2, TsArC(2,6)H), 7.95 (1H, dd, J 7.2, 1.2, 
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IndArH), 8.21-8.28 (2H, m, IndArH and C(2)H), 10.09 (1H, s, CHO). Data in consistent with 
literature.[103] 
(E)-Ethyl 3-(1-tosyl-1H-indol-3-yl)acrylate[104] 481 
 
Following general procedure A, the reaction of 1-tosyl-1H-indole-3-carbaldehyde 480 (2.5 g, 8.36 
mmol, 1.0 equiv.) in CH2Cl2 (25 mL) with the phosphorane (3.06 g, 8.78 mmol, 1.05 equiv.) gave the 
title compound (2.61 g, 85%) as a white solid after purification by flash chromatography on silica gel 
(1:4 Et2O/PE).  
mp 136-138 °C {Lit. 144-146 °C}; 1H NMR (300 MHz, CDCl3) δH: 1.34 (3H, t, J 7.1, OCH2CH3), 2.33 
(3H, s, TsCH3), 4.28 (2H, q, J 7.1, OCH2CH3), 6.52 (1H, d, J 16.1, C(2)H), 7.24 (2H, d, J 8.1, 
TsArC(3,5)H), 7.27-7.42 (2H, m, IndArCH), 7.70-7.89 (5H, m, 2 × IndArCH, 2 × TsArC(2,6)H and 
C(3)H), 8.00 (1H, d, J 7.7, IndArC(4)H). Data consistent with literature.[104] 
(E)-3-(1-Tosyl-1H-indol-3-yl)prop-2-en-1-ol[105] 482 
 
Following general procedure C, the reaction of (E)-ethyl 3-(1-tosyl-1H-indol-3-yl)acrylate 481 (2.60 g, 
7.05 mmol, 1.0 equiv.) in CH2Cl2 (30 mL) with DIBAL-H (1.2 M in toluene, 12.9 mL, 15.5 mmol, 2.2 
equiv.) gave the title compound (2.11 g, 91%) as a white solid that was used without further purification. 
1H NMR (300 MHz, CDCl3) δH: 2.30 (3H, s, TsCH3), 4.34 (2H, t, J 5.5, C(1)H2), 6.43 (1H, dt, J 16.0, 
5.5, C(2)H), 6.67 (1H, d, J 16.0, C(3)H), 7.14-7.38 (4H, m, 2 × TsArC(3,5)H and 2 × IndArCH), 7.58 
(1H, s, IndArC(2)H), 7.70-7.76 (3H, m, 2 × TsArC(2,6)H and 1 × IndArCH), 7.99 (1H, d, J 8.1, 
IndArC(4)H). Data consistent with literature.[105] 
(E)-N,N-Dimethyl-3-(1-tosyl-1H-indol-3-yl)prop-2-en-1-amine 252 
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Following general procedure D, the reaction of (E)-3-(1-tosyl-1H-indol-3-yl)prop-2-en-1-ol 482 (2.1 g, 
6.42 mmol, 1.0 equiv.) in CH2Cl2 (20 mL) with PBr3 (0.24 mL, 2.57 mmol, 0.4 equiv.) gave the title 
compound as a waxy green solid that was used crude (ca. 70% pure by 1H NMR) directly in the next 
step. 
Following general procedure E, the reaction of the above crude material in THF (10 mL) with 
dimethylamine (2.92 mL, 23.1 mmol, 5.0 equiv.) gave the title compound (477 mg, 21%, 2 steps, >95:5 
E/Z by 1H NMR) as a yellow oil after purification by flash chromatography on silica gel (1:9 
MeOH/CH2Cl2).  
νmax (film, cm−1): 2945, 1444, 1364, 1169, 1122, 1088, 978; 1H NMR (500 MHz, CDCl3) δH: 2.31 (6H, 
s, N(CH3)2), 2.32 (3H, s, TsCH3), 3.12 (2H, d, J 6.7, C(1)H2), 6.34 (1H, dt, J 16.0, 6.7, C(2)H), 6.58 
(1H, d, J 16.0, C(3)H), 7.20 (2H, d, J 7.6, TsArC(3,5)H), 7.25 (1H, t, J 7.7, IndArC(5)H), 7.32 (1H, t, 
J 7.7, IndArC(6)H), 7.56 (1H, s, IndArC(2)H), 7.74-7.77 (3H, m, IndArC(7)H and 2 × TsArC(2,6)H), 
7.99 (1H, d, J 8.3, IndArC(4)H); 13C{1H} NMR (126 MHz, CDCl3) δC: 21.7 (ArCH3), 45.3 (N(CH3)2), 
62.6 (C(1)H2), 113.8 (Ind. C(4)H), 120.3 (Ind. C(3)), 120.6 (Ind. C(7)H), 123.6 (C(3)H), 123.6 (Ind. 
C(5)H), 124.0 (Ind. C(2)H), 125.0 (Ind. C(6)H), 127.0 (Ts-ArC(2,6)H), 128.6 (Ind. C(9)), 129.1 
(C(2)H), 130.2 (Ts-ArC(3,5)H), 135.2 (Ts-ArC(1)), 135.6 (Ind. C(8)), 145.1 (Ts-ArC(4)); HRMS (CI+): 
C20H22N2O2S+ [M]+ found 354.1415, requires 354.1402 (+3.7 ppm). 
(E)-Ethyl 3-(3-bromophenyl)acrylate[106]† 483 
 
Following general procedure A, the reaction of 3-bromobenzaldehyde (2.0 g, 10.81 mmol, 1.0 equiv.) 
in CH2Cl2 (20 mL) with the phosphorane (3.95 g, 11.35 mmol, 1.05 equiv.) gave the title compound 
(2.44 g, 88%, 96:4 E/Z by 1H NMR) as a colourless oil after purification by flash chromatography on 
silica gel (24:1→9:1 PE/Et2O). 
1H NMR (300 MHz, CDCl3) δH: 1.34 (3H, t, J 7.1, OCH2CH3), 4.27 (2H, q, J 7.1, OCH2CH3), 6.43 (1H, 
d, J 16.0, C(2)H), 7.25 (1H, t, J 7.8, ArCH), 7.43 (1H, ddd, J 7.8, 2.0, 1.2, ArCH), 7.50 (1H, ddd, J 7.8, 
2.0, 1.0, ArCH), 7.60 (1H, d, J 16.0, C(3)H), 7.65-7.67 (1H, m, ArCH). Data consistent with 
literature.[106] 
(E)-3-(3-Bromophenyl)prop-2-en-1-ol[97]† 484 
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Following general procedure C, the reaction of (E)-ethyl 3-(3-bromophenyl)acrylate 483 (1.5 g, 5.88 
mmol, 1.0 equiv.) in anhydrous CH2Cl2 (30 mL) with DIBAL-H (1.2 M in toluene, 10.8 mL, 12.9 mmol, 
2.2 equiv.) gave the title compound (1.22 g, 5.72 mmol, 97%) as a colourless oil that was used without 
further purification. 
1H NMR (300 MHz, CDCl3) δH: 1.62 (1H, t, J 5.8, OH), 4.33-4.39 (2H, m, C(1)H2), 6.39 (1H, dt, J 
15.9, 5.4, C(2)H), 6.58 (1H, dt, J 15.9, 1.5, C(3)H), 7.21 (1H, t, J 7.8, ArCH), 7.30-7.34 (1H, m, ArCH), 
7.39 (1H, ddd, J 7.8, 2.0, 1.2, ArCH), 7.56 (1H, t, J 1.8, ArCH); 13C{1H} NMR (75 MHz, CDCl3) δC: 
63.5, 122.9, 125.2, 129.5, 129.5, 130.2, 130.2, 130.6, 139.0. Data consistent with literature.[97] 
(E)-1-Bromo-3-(3-bromoprop-1-en-1-yl)benzene† 485 
 
Following general procedure D, the reaction of (E)-3-(3-bromophenyl)prop-2-en-1-ol 484 (1.10 g, 5.16 
mmol, 1.0 equiv.) in anhydrous Et2O (15 mL) with PBr3 (0.19 mL, 2.07 mmol, 0.4 equiv.) gave the title 
compound (1.15 g, 4.17 mmol, 81%) as an off-white solid that was used without further purification. 
νmax (film, cm−1): 3034, 1591, 1560, 1472, 1422, 1202, 1072, 995, 961; 1H NMR (300 MHz, CDCl3) δH: 
4.14 (2H, dd, J 7.6, 0.9, C(3)H2), 6.41 (1H, dt, J 15.6, 7.6, C(2)H), 6.57 (1H, dt, J 15.6, 0.9, C(1)H), 
7.20 (1H, t, J 7.8, ArCH), 7.27-7.31 (1H, m, ArCH), 7.39 (1H, ddd, J 7.8, 2.0, 1.2, ArCH), 7.54 (1H, t, 
J, 1.8, ArCH); 13C{1H} NMR (75 MHz, CDCl3) δC: 32.8, 123.0, 125.5, 126.9, 129.7, 130.3, 131.3, 
133.1, 138.1; HRMS (EI+): C9H879Br2 [M]+ found 273.8997, requires 273.8998 (−0.5 ppm). 
(E)-3-(3-Bromophenyl)-N,N-dimethylprop-2-en-1-amine† 246 
 
Following general procedure E, the reaction of (E)-1-bromo-3-(3-bromoprop-1-en-1-yl)benzene 485 
(1.15 g, 4.17 mmol, 1.0 equiv.) in THF (8 mL) with dimethylamine (2.64 mL, 20.8 mmol, 5.0 equiv.) 
gave the title compound (850 mg 85%, 96:4 E/Z by 1H NMR) as a yellow oil that was used without 
further purification. 
νmax (film, cm−1): 2941, 2768, 1589, 1560, 1468, 1452, 1358, 1240, 1172, 1070, 1042, 1020, 993, 961, 
845; 1H NMR (300 MHz, CDCl3) δH: 2.27 (6H, s, N(CH3)2), 3.06 (2H, dd, J 6.6, 1.0, C(1)H2), 6.26 (1H, 
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dt, J 15.9, 6.6, C(2)H), 6.44 (1H, dt, J 15.9, 1.0, C(3)H), 7.16 (1H, t, J 7.8, ArCH), 7.28 (1H, dd, J 7.8, 
1.3, ArCH), 7.34 (1H, ddd, J 7.8, 2.0, 1.3, ArCH), 7.51 (1H, t, J 1.8, ArCH); 13C{1H} NMR (75 MHz, 
CDCl3) δC: 45.5, 62.0, 122.9, 125.0, 129.4, 129.4, 130.2, 130.4, 131.1, 139.4; HRMS (NSI+): 
C11H1579BrN [M+H]+ found 240.0382, requires 240.0382 (−0.2 ppm). 
(E)-Ethyl 3-(4-(trifluoromethyl)phenyl)acrylate[94]† 486 
 
Following general procedure B, the reaction of (E)-3-(4-(trifluoromethyl)phenyl)acrylic acid (2.50 g, 
11.57 mmol, 1.0 equiv.) with conc. H2SO4 (0.25 mL) in EtOH (25 mL) gave the title compound (2.75 
g, 97%) as a white solid that was used without further purification. 
mp 33-35 °C {Lit.17 31-33 °C}; 1H NMR (300 MHz, CDCl3) δH: 1.34 (3H, t, J 7.1, OCH2CH3), 4.28 
(2H, q, J 7.1, OCH2CH3), 6.50 (1H, d, J 16.0, C(2)H), 7.60-7.65 (4H, m, ArCH), 7.69 (1H, d, J 16.0, 
C(3)H); 13C{1H} NMR (75 MHz, CDCl3) δC: 14.4, 61.0, 121.0, 124.0 (q, 1JCF 272), 126.0 (q, 3JCF 4), 
128.3, 131.8 (q, 2JCF 33), 138.0, 142.8, 166.5; 19F{1H} NMR (282 MHz, CDCl3) δF: −63.4. Data 
consistent with literature.[94] 
(E)-3-(4-(Trifluoromethyl)phenyl)prop-2-en-1-ol[107]† 487 
 
Following general procedure C, the reaction of (E)-ethyl 3-(4-(trifluoromethyl)phenyl)acrylate 486 
(2.50.g, 10.23 mmol, 1.0 equiv.) and DIBAL-H (1.2 M in toluene, 18.8 mL, 22.52 mmol, 2.2 equiv.) in 
anhydrous CH2Cl2 (50 mL) gave the title compound (2.03 g, 98%) as a white solid that was used without 
further purification. 
mp 48-49 °C {Lit. 53-55 °C}; 1H NMR (300 MHz, CDCl3) δH: 1.83 (1H, br s, OH), 4.36 (2H, dd, J 5.3, 
1.6, C(1)H2), 6.45 (1H, dt, J 16.0, 5.3, C(2)H), 6.66 (1H, dt, J 16.0, 1.6, C(3)H), 7.46 (2H, d, J 8.2, 
ArC(2,6)H), 7.56 (2H, d, J 8.2, ArC(3,5)H); 13C{1H} NMR (75 MHz, CDCl3) δC: 63.4, 124.3 (q, 1JCF 
272), 125.7, (q, 3JCF 4), 126.7, 129.4, 129.6 (q, 2JCF 32), 131.4, 140.3; 19F{1H} NMR (282 MHz, CDCl3) 
δF: −63.0. Data consistent with literature.[107] 
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(E)-1-(3-Bromoprop-1-en-1-yl)-4-(trifluoromethyl)benzene[95]† 488 
 
Following general procedure D, the reaction of (E)-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-ol 487 
(1.0 g, 4.95 mmol, 1.0 equiv.) in anhydrous Et2O (15 mL) with PBr3 (0.19 mL, 1.98 mmol, 0.4 equiv.) 
gave the title compound (910 mg, 69%) as a white solid that was used without further purification. 
mp 29-30 °C {Lit. 35.9-36.8 °C}; 1H NMR (300 MHz, CDCl3) δH: 4.15 (2H, dd, J 7.6, 0.9, C(3)H2), 
6.48 (1H, dt, J 15.5, 7.6, C(2)H), 6.67 (1H, dt, J 15.5, 0.9, C(1)H), 7.48 (2H, d, J 8.3, ArC(2,6)H), 7.58 
(2H, d, J 8.3, ArC(3,5)H); 13C{1H} NMR (75 MHz, CDCl3) δC: 32.6, 124.2 (q, 1JCF 272), 125.8 (q, 3JCF 
4), 127.0, 128.0, 130.2 (q, 2JCF 32), 131.4, 140.3; 19F{1H} NMR (282 MHz, CDCl3) δF: −63.1. Data 
consistent with literature.[95] 
(E)-N,N-Dimethyl-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-amine† 250 
 
Following general procedure E, the reaction of (E)-1-(3-bromoprop-1-en-1-yl)-4-
(trifluoromethyl)benzene 488 (890 mg, 3.36 mmol, 1.0 equiv.) in THF (7 mL) with dimethylamine 
(2.13 mL, 16.8 mmol, 5.0 equiv.) gave the title compound (691 mg, 90%, >98:2 E/Z by 1H NMR) as a 
pale yellow oil that was used without further purification. 
νmax (film, cm−1): 2945, 2772, 1614, 1321, 1163, 1119, 1107, 1065, 1015, 972, 845; 1H NMR (300 MHz, 
CDCl3) δH: 2.29 (6H, s, N(CH3)2), 3.10 (2H, dd, J 6.5, 1.6, C(1)H2), 6.36 (1H, dt, J 15.9, 6.5, C(2)H), 
6.55 (1H, dt, J 15.9, 1.6, C(3)H), 7.46 (2H, d, J 8.3, ArC(2,6)H), 7.56 (2H, d, J 8.3, ArC(3,5)H); 13C{1H} 
NMR (75 MHz, CDCl3) δC: 45.5, 62.0, 124.3 (q, 1JCF 272), 125.7 (q, 3JCF 4), 126.7, 129.4 (q, 2JCF 33), 
130.5, 131.3, 140.7; 19F{1H} NMR (282 MHz, CDCl3) δF: −63.0; HRMS (ESI+): C12H15NF3 [M+H]+ 
found 2330.1145, requires 230.1151 (−2.7 ppm). 
N,N-Dimethyl-3-phenylprop-2-yn-1-amine[108]† 489 
 
Following the procedure of Consorti et al.,[108] dimethylamine (40% wt. in water, 18.6 mL, 146.9 mmol, 
1.5 equiv.) was added to a stirred solution of phenylacetylene (10.75 mL, 97.9 mmol, 1.0 equiv.), 
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paraformaldehyde (3.23 g, 107.7 mmol, 1.1 equiv.) and CuI (93 mg, 0.5 mol%) in 1,4-dioxane (50 mL). 
The reaction was heated to reflux for 4 h, cooled and the solvent removed in vacuo. The residue was 
diluted with water (20 mL) and extracted with Et2O (3 x 20 mL). The combined organic layers were 
washed with brine, dried over MgSO4, filtered, and concentrated in vacuo. The crude product was 
purified by vacuum distillation to give the title compound as a colourless oil (8.40 g, 52.8 mmol, 54%). 
bp 106-108 °C at 4 mmHg {Lit. 114 °C at 5 mmHg}; 1H NMR (400 MHz, CDCl3) δH: 2.37 (6H, s, 
N(CH3)2), 3.47 (2H, s, NCH2), 7.28-7.32 (3H, m, ArH), 7.42-7.46 (2H, m, ArH); 13C{1H} NMR (101 
MHz, CDCl3) δC: 44.4, 48.7, 84.7, 85.4, 123.4, 128.2, 128.4, 131.8. Data consistent with literature.[108] 
(Z)-N,N-dimethyl-3-phenylprop-2-en-1-amine[109]† (Z)-283 
 
Following the procedure of Jemison et al.,[109] H2 (balloon) was bubbled through a stirred suspension of 
N,N-dimethyl-3-phenylprop-2-yn-1-amine 489 (1.00 g, 6.28 mmol, 1.0 equiv.) and Lindlar’s catalyst 
(5% wt. Pd/CaCO3 poisoned with 3.5% Pb, 670 mg, 5 mol %) in EtOH (12.5 mL). Careful bubbling of 
hydrogen was maintained until full consumption of the starting material was indicated by analytical 
GC, so as to prevent over-reduction. The reaction mixture was passed through a plug of Celite® (EtOH 
eluent), and the solvent removed in vacuo to give the title compoun as a yellow oil (970 mg, 96%, 97:3 
Z/E by GC) that was used without further purification. 
GC: Column: Agilent DB-5 (30 m, 0.25 mm ID, 0.5 μm film). Method: (Injector 250 °C, FID 305 °C, 
linear velocity 40 cm/s (He), oven ramps (Initial 60 °C (2 min hold) → 300 °C (40 °C/min, 2 min hold)). 
tR over-reduced product (6.32 min), (Z)-283 (6.41 min), (E)-212 (6.62 min), 489 (6.66 min). 
1H NMR (300 MHz, CDCl3) δH: 2.25 (6H, s, N(CH3)2), 3.21 (2H, dd, J 6.5, 2.0, C(1)H2), 5.78 (1H, dt, 
J 11.8, 6.4, C(2)H), 6.57 (1H, dt, J 11.8, 2.0, C(3)H), 7.20-7.37 (5H, m, ArH). Data consistent with 
literature.[109] 
tert-Butyl 4-allylpiperazine-1-carboxylate† 287 
 
Following general procedure F, the reaction of allyl bromide (1.00 g, 8.27 mmol, 1.0 equiv.) in THF 
(16 mL) with 1-Boc-piperazine (3.85 g, 20.66 mmol, 2.5 equiv.) in THF (8 mL) gave the title compound 
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(1.29 g, 69%) as a colourless oil after purification by flash chromatography on silica gel (4:1→1:1 
PE/EtOAc). 
νmax (film, cm−1): 2976, 2797, 1694, 1643, 1456, 1418, 1364, 1238, 1169, 1115, 1003, 918, 866; 1H 
NMR (300 MHz, CDCl3) δH: 1.44 (9H, s, OC(CH3)3), 2.37 (4H, apt t, J 5.25, C(3)H2), 2.99 (2H, dq, J 
6.6, 1.2, C(1’)H2), 3.40-3.45 (4H, m, C(2)H2), 5.12-5.21 (2H, m, C(3’)H), 5.77-5.91 (1H, m, C(2’)H); 
13C{1H} NMR (75 MHz, CDCl3) δC: 28.6, 43.7, 53.0, 61.9, 79.7, 118.4, 134.7, 154.9; HRMS (NSI+): 
C12H23N2O2 [M+H]+ found 227.1752, requires 227.1754 (−0.9 ppm). 
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Bromoacetate Synthesis 
General procedure G: Synthesis of Bromoacetates from Bromoacetic acids 
DCC (1.0 equiv.) was added to a solution of requisite bromoacetic acid (1.0 equiv.), 4-DMAP (0.1 
equiv.) and the corresponding phenol (1.0 equiv.) in EtOAc (0.2 M) at 0 °C. The reaction was allowed 
to warm to rt after 10 min and was stirred for a further 4 h. AcOH (200 µL/g of bromoacetic acid) was 
added and the reaction mixture cooled to −20 °C for 30 min. The cold suspension was filtered through 
a pad of Celite® (EtOAc eluent), and the filtrate concentrated in vacuo. The residue was dissolved in 
hot Et2O, filtered, and the filtrate concentrated in vacuo. The resulting solid was recrystallized from 
Et2O/hexane to give bromoacetates.  
4-Nitrophenyl 2-bromoacetate 213 
 
Following general procedure G, bromoacetic acid (30.0 g, 216 mmol, 1.0 equiv.), p-nitrophenol (30.0 
g, 216 mmol, 1.0 equiv.), DCC (44.5 g, 216 mmol, 1.0 equiv.) and 4-DMAP (2.64 g, 21.6 mmol, 0.1 
equiv.) were reacted in EtOAc (1080 mL) to give the title compound (44.1 g, 79%) as a white solid 
after recrystallization (Et2O/hexanes). 
mp 88-90 °C {Lit 86-87 °C}; 1H NMR (400 MHz, CDCl3) δH: 4.09 (2H, s, CH2Br), 7.34 (2H, d, J 8.8, 
ArC(2,6)H), 8.30 (2H, d, J 8.8, ArC(3,5)H); Data consistent with literature.[110] 
Phenyl 2-bromoacetate[111] 490 
 
Following general procedure G, bromoacetic acid (2.50 g, 18.0 mmol, 1.0 equiv.), phenol (1.69 g, 18.0 
mmol, 1.0 equiv.), DCC (3.71 g, 18.0 mmol, 1.0 equiv.) and 4-DMAP (220 mg, 1.8 mmol, 0.1 equiv.) 
were reacted in EtOAc (90 mL) to give the title product (3.31 g, 86%) as a low metling colourless solid, 
which was used without further purification 
mp <30 °C; 1H NMR (500 MHz, CDCl3) δH: 4.06 (2H, s, CH2), 7.12-7.14 (2H, m, ArH), 7.27 (1H, t, J 
7.8, ArH), 7.36-7.44 (2H, m, ArH); Data consistent with the literature[111] 
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4-Fluorophenyl 2-bromoacetate† 491 
 
Following general procedure G, bromoacetic acid (2.50 g, 18.0 mmol, 1.0 equiv.), 4-fluorophenol (2.02 
g, 18.0 mmol, 1.0 equiv.), DCC (3.71 g, 18.0 mmol, 1.0 equiv.) and DMAP (220 mg, 1.8 mmol, 0.1 
equiv.) in EtOAc (90 mL). to give the title product (4.10 g, 98%) as a low metling yellow solid, which 
was used without further purification 
mp <30 °C; νmax (film, cm−1) 2964, 1755, 1499, 1178, 943; 1H NMR (500 MHz, CDCl3) δH: 4.05 (2H, 
s, CH2), 7.06-7.12 (4H, m, ArH); 19F{1H} NMR (471 MHz, CDCl3) δF: −116.0 (ArCF); 13C{1H} NMR 
(126 MHz, CDCl3) δC: 25.5 (CH2), 116.4 (d, 2JCF 23.6, ArC(3,5)H), 122.7 (d, 3JCF 8.5, ArC(2,6)H), 
146.3 (d, 4JCF 2.7, ArC(1)), 160.6 (d, 1JCF 245, ArC-F), 166.0 (C=O); HRMS (APCI+): C8H779BrFO2 
[M+H]+ found 232.9608, requires 232.9608 (+0.0 ppm). 
3,4,5-Trifluorophenyl 2-bromoacetate† 492 
 
Following general procedure G, bromoacetic acid (1.25 g, 9.0 mmol, 1.0 equiv.), 3,4,5-trifluorophenol 
(1.33 g, 9.0 mmol, 1.0 equiv.), DCC (1.86 g, 9.0 mmol, 1.0 equiv.) and 4-DMAP (110 mg, 0.9 mmol, 
0.1 equiv.) were reacted in EtOAc (45 mL) to give the title product (2.26 g, 93%) as pale orange solid 
after recrystallisation from Et2O. 
mp 46-48 °C; νmax (film, cm−1) 3078, 2955, 1769, 1628, 1522, 1452, 1233, 1126, 1043, 991; 1H NMR 
(500 MHz, CDCl3) δH: 4.03 (2H, s, CH2), 6.86 (2H, dd, J 7.7, 5.8, ArH); 19F{1H} NMR (470 MHz, 
CDCl3) δF: −162.3 (1F, t, JFF 20.7, ArC(4)-F), −132.0 (2F, d, JFF 20.7, ArC(3,5)-F); 13C{1H} NMR (101 
MHz, CDCl3) δC: 24.9 (CH2), 106.8 (dd, 2JCF 17.2, 3JCF 6.2, ArC(2,6)H), 138.6 (dt, 1JCF 250, 2JCF 15.2, 
ArC(4)F), 145.0 (dt, 3JCF 11.5, 4JCF 5.8, ArC(1)O), 151.2 (ddd, 1JCF 250, 2JCF 11.5, 3JCF 5.8, ArC(3,5)F), 
165.2 (C=O);HRMS (APCI+): C8H579BrF3O2 [M+H]+ found 268.9420, requires 268.9420 (+0.0 ppm). 
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3,5-Bis(trifluoromethyl)phenyl 2-bromoacetate 493 
 
Following general procedure G, bromoacetic acid (5.0 g, 36.0 mmol, 1.0 equiv.) was reacted with DCC 
(7.41 g, 36.0 mmol, 1.0 equiv.), 3,5 bis-trifluoromethyl phenol (5.47 mL, 36.0 mmol, 1.0 equiv.) and 
DMAP (439 mg, 3.6 mmol, 0.1 equiv.) in EtOAc (180 mL) to give the title product (12.34 g, 98%) as 
pale orange solid after recrystallization from Et2O/hexane. 
mp 50-51 °C; νmax (film, cm−1) 2963, 1773, 1364, 1273, 1171, 1103, 991; 1H NMR (500 MHz, CDCl3) 
δH: 4.09 (2H, s, CH2), 7.64 (2H, s, Ar(2,6)H), 7.81 (1H, s, Ar(4)H); 19F{1H} NMR (471 MHz, CDCl3) 
δF: −62.9 (CF3); 13C{1H} NMR (126 MHz, CDCl3) δC: 24.8 (CH2), 120.4-120.5 (m, ArC(4)H), 122.2-
122.3 (m, ArC(2,6)H), 122.8 (q, 1JCF 273, CF3), 133.3 (q, 2JCF 34, ArCCF3), 150.9 (ArC(1)O), 165.2 
(C=O); HRMS (APCI+): C10H679BrF6O2 [M+H]+ found 350.9450, requires 350.9450 (+0.0 ppm). 
2,4,6-Trichlorophenyl 2-bromoacetate 494 
 
A solution of bromoacetic acid (2.5 g, 18 mmol, 1.0 equiv.), 2,4,6-trichlorophenol (3.55 g, 18 mmol, 
1.0 equiv.) and 4-DMAP (0.22 g, 1.8 mmol, 01 equiv.) in EtOAc (90 mL) was treated with DCC (3.71 
g, 18 mmol, 1.0 equiv.) and stirred at rt for 16 h. The resulting mixture was filtered through celite®, 
washed with aq. 1 M HCl (20 mL) then sat. aq. NaHCO3 (20 mL), dried over MgSO4 and concentrated 
in vacuo. The crude residue was dissolved in Et2O (20 mL) and filtered then concentrated in vacuo, the 
residue was recrystallized from Et2O/petanes to give the title product (0.69 g, 12%)as an off white solid  
mp 37-39 °C; νmax (film, cm−1) 3082, 1767, 1560, 1447, 1387, 1234, 1204, 1090, 922; 1H NMR (500 
MHz, CDCl3) δH: 4.14 (2H, s, CH2), 7.39 (2H, s, ArH);13C{1H} NMR (126 MHz, CDCl3) δC: 24.2 
(CH2), 128.9 (ArC(3,5)H), 129.5 (ArC(2,6)Cl), 132.7 (ArC(4)Cl), 142.4 (ArC(1)), 163.6 (C=O); HRMS 
(APCI+): C8H579Br35Cl3O2 [M+H]+ found 316.8536, requires 316.8533 (+0.9 ppm). 
  
Chapter 6: Experimental Details 
 
 
139 
Perfluorophenyl 2-bromoacetate[112] 495 
 
A solution of bromoacteyl bromide (474 μL, 5.44 mmol, 1.0 equiv.) in CH2Cl2 (9 mL) was treated with 
a solution of iPr2NEt (946 μL, 5.44 mmol, 1.0 equiv.) and pentafluorophenol (1.0 g, 5.44 mmol, 1.0 
equiv.) over 15 min. The reaction mixture was then allowed to warm to rt and stirred for a further 1 h, 
the reaction was quenched with water and the layers separated, the organic layer was washed with brine 
(15 mL) dried over MgSO4 and concentrated in vacuo to give the title product (1.49 g, 90%) as a 
colourless liquid. 
1H NMR (300 MHz, CDCl3) δH: 4.14 (2H, s, CH2); 19F NMR (282 MHz, CDCl3) δF: −162.09 (2F, dd, J 
21.7, 17.2, ArC(3,5)F), −157.18 (1F, t, 21.7, ArC(4)F), −152.88 (2F, d, J 17.2, ArC(2,6)F); Data 
consistent with the literature.[112] 
 
  
Chapter 6: Experimental Details 
 
 
140 
Ammonium Salt Synthesis 
General Procedure H: Synthesis of activated ammonium salts: 
A flame-dried flask was charged with 4-nitrophenyl 2-bromoacetate (1.1-3.0 equiv.) under N2 and the 
indicated solvent added. A solution of amine (1.0 equiv.) in the indicated solvent was then added and 
the reaction mixture stirred at rt for 1-24 h. The resulting precipitate was filtered and washed with Et2O 
( 3) and dried in vacuo to give the ammonium salts that were used as isolated, or recrystallised from 
the stated solvent if necessary.  
(E)-N,N-Dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)-3-phenylprop-2-en-1-ammonium bromide 
211 
 
Following general procedure H, the reaction of 4-nitrophenyl 2-bromoacetate 213 (4.44 g, 17.1 mmol, 
1.1 equiv.) in MeCN (10.0 mL) with (E)-N,N-dimethyl-3-phenylprop-2-en-1-amine 212 (2.50 g, 15.5 
mmol, 1.0 equiv.) in MeCN (5.5 mL) for 1 h gave the title compound (5.90 g, 90%) as a white solid. 
mp 122 °C (dec); νmax (film, cm−1): 2957, 1765, 1530, 1483, 1352, 1179, 1148, 1035, 982; 1H NMR 
(300 MHz, DMSO-d6) δH: 3.34 (6H, s, N+(CH3)2), 4.40 (2H, d, J 7.5, C(1)H2), 4.82 (2H, s, COCH2), 
6.60 (1H, dt, J 15.6, 7.5, C(2)H), 6.97 (1H, d, J 15.6, C(3)H), 7.32-7.47 (3H, m, ArCH), 7.50-7.59 (2H, 
m, p-NO2ArC(2,6)H), 7.64 (2H, dd, J 8.1, 1.6, ArCH), 8.28-8.45 (2H, m, p-NO2ArC(3,5)H); 13C{1H} 
NMR (75 MHz, DMSO-d6) δC: 50.1 (N+(CH3)2), 60.5 (COCH2), 67.2 (C(1)H2), 116.1 (C(2)H), 123.1 
(ArC(3,5)H), 125.5 (ArC(2,6)H), 127.4 (C(3)ArC(4)H), 128.8 (C(3)ArC(2,6)H), 129.2 
(C(3)ArC(3,5)H), 135.1 (C(3)ArC(1)), 141.7 (C(3)H), 145.6 (ArC(4)-NO2), 154.0 (ArC(1)-O), 163.2 
(C=O); HRMS (ESI+): C19H21O4N2+ [M]+ found 341.1489, requires 341.1496 (−2.0 ppm). 
(E)-N-(2-(tert-Butoxy)-2-oxoethyl)-N,N-Dimethyl-3-phenylprop-2-en-1-ammonium bromide 221 
 
Following general procedure H, the reaction of tert-butyl 2-bromoacetate (1.1 mL, 7.45 mmol, 1.2 
equiv.) with (E)-N,N-dimethyl-3-phenylprop-2-en-1-amine 212 (1.0 g, 6.21 mmol, 1.0 equiv.) in MeCN 
(6.21 mL) for 1 h gave the title compound (1.58 g, 71%) as a white solid. 
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m.p 138-140 °C; νmax (film, cm−1) 2940, 1732, 1250, 1167, 1150, 968, 895; 1H NMR (300 MHz, CDCl3) 
δH: 1.45 (9H, s, C(CH3)3), 3.63 (6H, s, N+(CH3)2), 4.57 (2H, s, COCH2), 4.82 (2H, d, J 7.7, C(1)H2), 
6.28 (1H, dt, J 15.7, 7.7, C(2)H), 7.03 (1H, d, J 15.7, C(3)H), 7.39-7.29 (3H, m, ArH), 7.40-7.49 (2H, 
m, ArH); 13C{1H} NMR (75 MHz, CDCl3) δC: 28.1 (C(CH3)3), 50.9 (N+(CH3)2), 61.0 (COCH2), 66.9 
(C(1)H2), 85.5 (C(CH3)3), 113.7 (C(2)H), 127.4 (ArCH), 129.0 (ArCH), 129.8 (ArCH), 134.5 
(C(3)ArC(1)), 144.6 (C(3)H), 163.8 (C=O); HRMS (NSI+) C17H26O2N+ [M+] found: 276.1955, requires: 
276.1958 (−1.1 ppm).  
(E)-N,N-Dimethyl-N-(2-oxo-2-phenoxyethyl)-3-phenylprop-2-en-1-ammonium bromide 222 
 
Following general procedure H, the reaction of phenyl 2-bromoacetate 490 (1.0 g, 4.65 mmol, 1.2 
equiv.) with (E)-N,N-dimethyl-3-phenylprop-2-en-1-amine 212 (624 mg, 3.88 mmol, 1.0 equiv.) in 
MeCN (4 mL) for 1 h gave the title compound (1.22 g, 84%) as a white solid. 
mp 141°C (dec.); νmax (film, cm−1) 2997, 1757, 1483, 1386, 1184, 983; 1H NMR (300 MHz, DMSO-d6) 
δH: 3.34 (6H, s, N+(CH3)2), 4.41 (2H, d, J 7.4, C(1)H2), 4.81 (2H, s, COCH2), 6.60 (1H, dt, J 15.5, 7.4, 
C(2)H), 6.96 (1H, d, J 15.5, C(3)H), 7.09-7.28 (2H, m, ArH), 7.29-7.53 (6H, m, ArH), 7.64 (2H, d, J 
6.7, ArH);13C{1H} NMR (75 MHz, DMSO-d6) δC: 50.8 (N+(CH3)2), 60.4 (COCH2), 67.0 (C(1)H2), 
116.2 (C(2)H), 121.5 (ArCH), 126.7 (ArCH), 127.4 (ArCH), 128.7 (ArCH), 129.1 (ArCH), 129.7 
(ArCH), 135.1 (C(3)ArC(1)), 141.5 (C(3)H), 149.3 (ArC(1)O), 163.9 (C=O); HRMS (NSI+) 
C19H22NO2+ [M]+ found 296.1644, requires 296.1645 (−0.4 ppm). 
(E)-N-(2-(4-Fluorophenoxy)-2-oxoethyl)-N,N-dimethyl-3-phenylprop-2-en-1-ammonium 
bromide 223 
 
Following general procedure H, (E)-N,N-dimethyl-3-phenylprop-2-en-1-amine 212 (250 mg, 1.55 
mmol, 1 equiv.) was reacted with 4-fluorophenyl 2-bromoacetate 491 (434 mg, 1.86 mmol, 1.2 equiv.) 
in MeCN (1.5 mL), to give the title coumpound (543 mg, 89%) as a white solid. 
mp 156-158 °C; νmax (film, cm−1) 2955, 1762, 1501, 1396, 1172, 1036, 982; 1H NMR (300 MHz, 
DMSO-d6) δH: 3.34 (6H, s, N+(CH3)2), 4.41 (2H, br. s, C(1)H2), 4.80 (2H, br. s, COCH2), 6.60 (1H, dt, 
J 15.5, 7.3, C(2)H), 6.96 (1H, d, J 15.5, C(3)H), 7.15-7.52 (7H, m, ArH), 7.63 (2H, d, J 7.0, ArH); 
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19F{1H} NMR (282 MHz, CDCl3) δF: −116.5 (ArC-F); 13C{1H} NMR (75 MHz, DMSO-d6) δC: 50.8 
(N+(CH3)2), 60.4 (COCH2), 67.0 (C(1)H2), 116.2 (C(2)H), 116.4 (d, 2JCF 23.7, ArC(3,5)H), 123.5 (d, 
3JCF 8.8, ArC(2,6)H), 127.4 (ArCH), 128.8 (ArCH), 129.1 (ArCH), 135.1 (C(3)ArC(1)), 141.6 (C(3)H), 
145.3 (ArC(1)O), 160.0 (d, 1JCF 243, ArC-F), 163.9 (C=O); HRMS (NSI+) C19H21FNO2+ [M]+ found 
314.1549, requires 314.1551 (−0.6 ppm). 
(E)-N,N-Dimethyl-N-(2-oxo-2-(3,4,5-trifluorophenoxy)ethyl)-3-phenylprop-2-en-1-ammonium 
bromide 224 
 
Following general procedure H, (E)-N,N-dimethyl-3-phenylprop-2-en-1-amine 212 (250 mg, 1.55 
mmol, 1.0 equiv.) and 3,4,5-trifluorophenyl 2-bromoacetate 492 (500 mg, 1.86 mmol, 1.2 equiv.) were 
reacted in MeCN (1.5 mL) to give the title compound (528 mg, 79%) as a white solid  
m.p 156-158 °C; νmax (film, cm−1) 2972, 1769, 1634, 1520, 1452, 1177, 1144, 1047, 982; 1H NMR (500 
MHz, DMSO-d6) δH: 3.31 (6H, s, N+(CH3)2), 4.37 (2H, d, J 6.6, C(1)H2), 4.73 (2H, s, COCH2), 6.58 
(1H, dt, J 15.6, 7.6, C(2)H), 6.96 (1H, d, J 15.6, C(3)H), 7.27-7.47 (5H, m, ArH), 7.63 (2H, d, J 7.1, 
ArH); 19F{1H} NMR (470 MHz, DMSO-d6) δF: −163.0 (1F, td, J 22.1, 7.2, Ar(4)F), −133.5 (2F, dd, J 
22.1, 5.5, Ar(3,5)F); 13C{1H} NMR (101 MHz, DMSO-d6) δC: 50.8 (N+(CH3)2), 60.4 (COCH2), 67.1 
(C(1)H2), 108.1 (d, 2JCF 23.9, ArC(2,6)H), 116.1 (C(2)H), 127.4 (C(3)ArCH), 128.8 (C(3)ArCH), 129.1 
(C(3)ArCH), 135.1 (C(3)ArC(1)), 137.7 (dt, 1JCF 250, 2JCF 15.3, ArC(4)F), 141.7 (C(3)H), 144.2 (td, 
3JCF 12.1, 4JCF 3.6, ArC(1)O), 150.1 (ddd, 1JCF 250, 2JCF 10.5, 3JCF 4.9, ArC(3,5)F), 163.2 (C=O); HRMS 
(NSI+) C19H19F3NO2+ [M]+ found 350.1361, requires 350.1362 (−0.4 ppm). 
(E)-N,N-Dimethyl-N-(2-oxo-2-(2,4,6-trichlorophenoxy)ethyl)-3-phenylprop-2-en-1-ammonium 
bromide 226 
 
Following general prodcedure H, E)-N,N-dimethyl-3-phenylprop-2-en-1-amine 212 (135 mg, 0.84 
mmol, 1.0 equiv.) and 2,4,6-trichlorophenyl 2-bromoacetate 494 (400 mg, 1.26 mmol, 1.5 equiv.) were 
reacted in MeCN (1.0 mL) to give the title compound (217 mg, 54%) as a white solid  
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mp 154 °C (dec.);νmax (film, cm−1) 2940, 1776, 1445, 1165, 1120, 974; 1H NMR (500 MHz, DMSO-d6) 
δH: 3.41 (6H, s, N+(CH3)2), 4.49 (2H, d, J 7.5, C(1)H2), 5.27 (2H, s, COCH2), 6.58 (1H, dt, J 15.5, 7.5, 
C(2)H), 6.90 (1H, d, J 15.5, C(3)H), 7.34-7.42 (3H, m, ArH), 7.59-7.62 (2H, m, ArH), 7.92 (2H, s, 
Ar(3,5)H); 13C{1H} NMR (126 MHz, DMSO-d6) δC: 51.4 (N+(CH3)2), 59.6 (COCH2), 67.0 (C(1)H2), 
116.4 (C(2)H), 127.8 (C(3)ArCH), 128.9 (C(3)ArCH), 129.1 (C(3)ArCH), 129.6 (OArC(4)Cl), 129.6 
(OArC(3,5)H), 133.1 (OArC(2,6)Cl), 135.5 (C(3)ArC(1)), 141.5 (ArC(1)O), 141.9 (C(3)H), 162.9 
(C=O); HRMS (NSI+): C19H1935Cl3NO2+ [M]+ found: 398.0476, requires 398.0476 (+0.0 ppm). 
(E)-N,N-Dimethyl-N-(2-oxo-2-(perfluorophenoxy)ethyl)-3-phenylprop-2-en-1-ammonium 
bromide 225 
 
Following general prodcedure H, E)-N,N-dimethyl-3-phenylprop-2-en-1-amine 212 (0.52 g, 3.25 
mmol, 1.0 equiv.) and perfluorophenyl 2-bromoacetate 495 (1.48 g, 4.88 mmol, 1.5 equiv.) were reacted 
in MeCN (7.0 mL) to give the title compound (0.60 g, 39%) as a white solid  
mp 161 °C (dec.); νmax (film, cm−1) 2762, 1788, 1520, 1139, 1122, 1030, 1002, 977, 885; 1H NMR (300 
MHz, CD3CN) δH: 3.42 (6H, s, N+(CH3)2), 4.48 (2H, d, J 7.7, C(1)H2), 5.09 (2H, s, COCH2), 6.45 (1H, 
dt, J 15.6, 7.7, C(2)H), 7.02 (1H, d, J 15.6, C(3)H), 7.28-7.49 (3H, m, ArH), 7.56-7.60 (2H, m, ArH); 
19F{1H} NMR (282 MHz, CD3CN) δF: −153.7 (2F, d, J 16.8, Ar(2,6)F), −159.0 (1F, t, J 21.0, Ar(4)F), 
−164.2 (2F, dd, J 21.0, 16.8, Ar(3,5)F); HRMS (NSI+): C19H17F5NO2+ [M]+ found: 386.1164, requires 
386.1174 (−2.6 ppm); A good quality 13C{1H} NMR spectrum could not be readily obtained. 
(E)-N-(2-(3,5-Bis(trifluoromethyl)phenoxy)-2-oxoethyl)-N,N-dimethyl-3-phenylprop-2-en-1-
ammonium bromide 227 
 
Following general procedure H, (E)-N,N-dimethyl-3-phenylprop-2-en-1-amine 212 (250 mg, 1.55 
mmol, 1.0 equiv.) was reacted with 3,5-bis(trifluoromethyl)phenyl 2-bromoacetate 493 (653 mg, 1.86 
mmol, 1.2 equiv.) in MeCN (1.5 mL) to give the title product (598 mg, 75%) as a white solid. 
mp 160 °C (dec.); νmax (film, cm−1): 2928, 1780, 1458, 1364, 1275, 1130, 1016, 896; 1H NMR (500 
MHz, DMSO-d6) δH: 3.34 (6H, s, N+(CH3)2), 4.39 (2H, d, J 7.4, C(1)H2), 4.74 (2H, s, COCH2), 6.60 
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(1H, dt, J 15.6, 7.4, C(2)H), 6.97 (1H, d, J 15.6, C(3)H), 7.32-7.44 (3H, m, ArH), 7.63 (2H, d, J 7.1, 
ArH), 8.09 (2H, s, OAr(2,5)H), 8.19 (1H, s, OAr(4)H); 19F NMR (470 MHz, DMSO-d6) δF: -61.3 (CF3); 
13C{1H} NMR (101 MHz, DMSO-d6) δC: 50.9 (N+(CH3)2), 60.6 (COCH2), 67.1 (C(1)H2), 116.1 
(C(2)H), 120.5-121.1 (m, OArC(4)H), 122.7 (q, 1JCF 273.0, CF3), 123.7 (OArC(2,6)H), 127.3 
(C(3)ArC(3,5)H), 128.7 (C(3)ArC(2,6)H), 129.1 C(3)ArC(4)H), 131.6 (q, 2JCF 33.7, ArC(3,5)CF3), 
135.1 (C(3)ArC(1)), 141.8 (C(3)H), 150.0 (ArC(1)O), 163.3 (C=O); HRMS (NSI+): C21H20F6NO2+ [M-
Br]+ found 432.1386, requires 432.1393 (−1.6 ppm).  
1-Cinnamyl-1-(2-(4-nitrophenoxy)-2-oxoethyl)piperidin-1-ium bromide 259 
 
Following general procedure H, the reaction of 4-nitrophenyl 2-bromoacetate 213 (1.94 g, 7.46 mmol, 
3.0 equiv.) in MeCN (5.0 mL) with 1-cinnamylpiperidine 239 (0.50 g, 2.49 mmol, 1.0 equiv.) in MeCN 
(5.0 mL) for 24 h gave the title compound (0.80 g, 69%) as a white solid. 
mp 168 °C (dec); νmax (film, cm−1): 2957, 1763, 1522, 1346, 1196, 1150, 974; 1H NMR (500 MHz, 
DMSO-d6) δH: 1.56-1.68 (2H, m, C(4)H2), 1.88-2.02 (4H, m, C(3,5)H2), 3.61 (2H, dt, J 12.3, 5.5, 
C(2,6)HAHB), 3.79 (2H, dt, J 11.4, 5.5, C(2,6)HAHB), 4.45 (2H, d, J 7.4, C(1’)H2), 4.83 (2H, s, COCH2), 
6.53-6.65 (1H, m, C(2’)H), 6.96 (1H, d, J 15. 6, C(3’)H), 7.33-7.51 (5H, m, 2 × OArC(2,6)H and 3 × 
ArH), 7.59-7.65 (2H, m, ArH), 8.36 (2H, d, J 9.1, OAr(3,5)H); 13C{1H} NMR (126 MHz, DMSO-d6) 
δC: 19.2 (C(4)H2), 20.6 (C(3,5)H2), 56.0 (COCH2), 59.5 (C(2,6)H2), 62.4 (C(1’)H2), 115.8 (C(2’)H), 
123.1 (OArC(3,5)H), 125.5 (OArC(2,6)H), 127.4 (C(3)ArC(2,6)H), 128.8 (C(3)ArC(3,5)H), 129.2 
(C(3)ArC(4)H), 135.2 (C(3)ArC(1)), 141.1 (C(3)H), 145.6 (ArC(4)-NO2), 153.8 (ArC(1)-O), 163.3 
(C=O); HRMS (NSI+): C22H25O4N2+ [M]+ found 381.1803, requires 381.1809 (−1.5 ppm). 
4-Cinnamyl-4-(2-(4-nitrophenoxy)-2-oxoethyl)morpholin-4-ium bromide 260 
 
Following general procedure H, the reaction of 4-nitrophenyl 2-bromoacetate 213 (1.92 g, 7.40 mmol, 
3.0 equiv.) in MeCN (5 mL) with 4-cinnamylmorpholine 240 (0.50 g, 2.46 mmol, 1.0 equiv.) in MeCN 
(5 mL) gave the title compound (0.80 g, 70%) as a white solid. 
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mp 151 °C (dec); νmax (film, cm−1): 2959, 1767, 1524, 1348, 1169, 880; 1H NMR (300 MHz, DMSO-
d6) δH: 3.75 (2H, d, J 13.5, C(2,6)H
AHB), 3.88 (2H, d, J 13.5, C(2,6)HAHB), 4.04-4.13 (4H, m, C(3,5)H), 
4.63 (2H, d, J 7.4, C(1’)H), 5.02 (2H, s, COCH2), 6.61 (1H, dt, J 15.5, 7.4, C(2’)H), 7.00 (1H, d, J 15.5, 
C(3’)H), 7.46-7.33 (3H, m, ArH), 7.49 (2H, d, J 9.1, p-NO2ArC(2)H), 7.58-7.69 (2H, m, ArH), 8.36 
(2H, d, J 9.1, OArC(3,5)H); 13C{1H} NMR (126 MHz, DMSO-d6) δC: 56.2 (COCH2), 58.3 (C(2,6)H2), 
59.7 (C(3,5)H2), 62.4 (C(1’)H2), 115.4 (C(2’)H2), 123.0 (OArC(2,6)H), 125.5 (OArC(3,5)H), 127.4 
(C(3)ArC(2,6)-H), 128.8 (C(3)ArC(3,5)H), 129.2 (C(3)ArC(4)H), 135.1 (C(3)ArC(1)), 141.6 (C(3’)H), 
145.6 (ArC(4)-NO2), 153.7 (ArC(1)-O), 163.1 (C=O); HRMS (NSI+): C21H23O5N2+ [M]+ found 
383.1592, requires 383.1601 (−2.5 ppm). 
4-(tert-Butoxycarbonyl)-1-cinnamyl-1-(2-(4-nitrophenoxy)-2-oxoethyl)piperazin-1-ium bromide 
261 
 
Following general procedure H, the reaction of 4-nitrophenyl 2-bromoacetate 213 (1.29 g, 4.97 mmol, 
3.0 equiv.) in MeCN (3 mL) with tert-butyl 4-cinnamylpiperazine-1-carboxylate 241 (0.50 g, 1.66 
mmol, 1.0 equiv.) in MeCN (3.75 mL) for 24 h gave the title compound (0.60 g, 64%) as a white solid. 
 
mp 153 °C (dec); νmax (film, cm−1): 2953, 1767, 1711, 1528, 1416, 1167, 1142, 852; 1H NMR (500 MHz, 
DMSO-d6) δH: 1.44 (9H, s, OC(CH3)3), 3.69-3.93 (8H, m, C(2,6 and 3,5)H2), 4.58 (2H, d, J 7.4, C(1’)H) 
4.99 (2H, s, COCH2), 6.61 (1H, dt, J 15.4, 7.4, C(2’)H), 7.00 (1H, d, J 15.6, C(3’)H), 7.44-7.36 (3H, 
m, ArH), 7.50 (2H, d, J 9.1, p-NO2ArC(2,6)H), 7.63 (2H, d, J 7.2, ArH), 8.36 (2H, d, J 9.1, p-
NO2ArC(3,5)H); 13C{1H} NMR (126 MHz, DMSO-d6) δC: 28.0 ((CH3)3), 36.6 and 37.7 (rotameric 
C(3,5)H2), 55.9 (COCH2), 58.0 (C(2,6)H2), 61.8 (C(1’)H2), 80.1 (C(CH3)3), 115.4 (C(2’)H), 123.1 
(ArC(2,6)H), 125.5 (ArC(3,5)H), 127.4 (C(3)ArC(2,6)H), 128.8 (C(3)ArC(3,5)H), 129.2 
C(3)ArC(4)H), 135.1 (C(3)ArC(1)), 141.6 (C(3’)H), 145.6 (ArC(4)-NO2), 153.5 (ArC(1)-O), 153.7 
(NC=O), 163.1 (C=O); HRMS (NSI+): C26H32O6N3+ [M]+ found 482.2276, requires 482.2286 (−2.0 
ppm). 
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5-Cinnamyl-5-(2-(4-nitrophenoxy)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-ium 
bromide† 262 
 
Following general procedure H, the reaction of 4-nitrophenyl 2-bromoacetate 213 (764 mg, 2.94 mmol, 
3.0 equiv.) in MeCN (0.5 mL) with 5-cinnamyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 242 (250 mg, 
0.98 mmol, 1.0 equiv.) in MeCN (0.5 mL) for 2 h gave the title product (355 mg, 70%) as an off-white 
solid. 
mp 169-170 °C (dec); νmax (film, cm−1): 2945, 2926, 1767, 1649, 1614, 1592, 1528, 1487, 1443, 1350, 
1192, 1153, 1059, 980, 866, 856; 1H NMR (500 MHz, DMSO-d6) δH: 3.36-3.38 (2H, m, C(7)H), 3.96-
4.03 (1H, m, C(6)HAHB), 4.25-4.30 (1H, m, C(6)HAHB), 4.48-4.53 (2H, m, C(1’)H), 4.76-4.87 (2H, m, 
COCH2), 4.87-4.96 (2H, m, C(4)H), 6.69 (1H, dt, J 15.5, 7.6, C(2’)H), 7.00 (1H, d, J 15.5, C(3’)H), 
7.00 (1H, d, J 5.2, C(3)H), 7.37-7.41 (1H, m, Ar(4)H), 7.42-7.45 (2H, m, Ar(3)H), 7.48 (2H, d, J 9.1, 
OArC(2,6)H), 7.61 (1H, d, J 5.2, C(2)H), 7.63-7.65 (2H, m, C(3)Ar(2,6)H), 8.35 (2H, d, J 9.1, 
OArC(3,5)H); 13C{1H} NMR (126 MHz, DMSO-d6) δC: 20.5, 55.7, 56.9, 59.5, 63.4, 115.8, 123.1, 125.5 
(2 × C), 126.3, 126.5, 127.4, 128.8, 129.2, 130.6, 135.1, 141.6, 145.6, 153.8, 163.4; HRMS (ESI+): 
C24H23N2O4S [M]+ found 435.1367, requires 435.1373 (−1.4 ppm). 
(E)-1-(3-(4-Bromophenyl)allyl)-1-(2-(4-nitrophenoxy)-2-oxoethyl)piperidin-1-ium bromide† 263 
 
Following general procedure H, the reaction of 4-nitrophenyl 2-bromoacetate 213 (1.39 g, 5.35 mmol, 
3.0 equiv.) in MeCN (6.0 mL) with (E)-1-(3-(4-bromophenyl)allyl)piperidine 243 (500 mg, 1.78 mmol, 
1.0 equiv.) in MeCN (6.0 mL) for 16 h gave the title compound (330 mg, 34%) as a white solid after 
purification by trituration with hot CHCl3 (5.0 mL), washing with cold CHCl3 (5.0 mL) and drying in 
vacuo. 
mp 166-168 °C (dec); νmax (film, cm−1): 2957, 1763, 1616, 1589, 1518, 1489, 1350, 1196, 1152, 1011, 
978, 856; 1H NMR (500 MHz, DMSO-d6) δH: 1.59-1.65 (2H, m, C(4)H2), 1.91-1.98 (4H, m, C(3,5)H2), 
3.56-3.59 (2H, m, C(2,6)HAHB), 3.76-3.83 (2H, m, C(2,6)HAHB), 4.45 (2H, d, J 7.2, C(1’)H), 4.87 (2H, 
                                                     
† Synthesised and characterised by Dr David S. B. Daniels 
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s, COCH2), 6.65 (1H, dt, J 15.5, 7.2, C(2’)H), 6.94 (1H, d, J 15.5, C(3’)H), 7.49 (2H, d, J 8.6, p-
NO2ArC(2)H), 7.57-7.64 (4H, m, C(3)ArC(2,6 and 3,5)H), 8.36 (2H, d, J 8.6, OArC(3,5)H); 13C{1H} 
NMR (126 MHz, DMSO-d6) δC: 19.1, 20.6, 56.1, 59.6, 62.2, 117.0, 122.3, 123.0, 125.5, 129.3, 131.7, 
134.5, 139.7, 145.6, 153.8, 163.3; HRMS (ESI+): C22H24O4N279Br [M]+ found 459.0906, requires 
459.0914 (−1.7 ppm). 
(E)-3-(4-Methoxyphenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)prop-2-en-1-
ammonium bromide 256 
 
Following general procedure H, the reaction of 4-nitrophenyl 2-bromoacetate 213 (260 mg, 1.00 mmol, 
1.2 equiv.) in CH2Cl2/Et2O (1:4 v:v, 0.85 mL) with (E)-3-(4-Methoxyphenyl)-N,N-dimethylprop-2-en-
1-amine 245 (158 mg, 0.830 mmol, 1.0 equiv.) in CH2Cl2/Et2O (1:4 v:v, 0.85 mL) for 16 h gave the 
title compound (239 mg, 64%) as a pale yellow solid. 
mp 114 °C (dec); νmax (film, cm−1): 2958, 1765, 1609, 1530, 1514, 1348, 1251, 1177, 980; 1H NMR 
(500 MHz, CD3CN) δH: 3.37 (6H, s, N+(CH3)2), 3.81 (3H, s, OCH3), 4.41 (2H, d, J 7.7, C(1)H2), 4.81 
(2H, s, COCH2), 6.32 (1H, dt, J 15.5, 7.7, C(2)H), 6.94-6.99 (3H, m, C(3)Ar(3,5)H and C(3)H), 7.47 
(2H, d, J 9.1, OArC(2,6)H), 7.54 (2H, d, J 8.8, C(3)ArC(2,6)H), 8.30 (2H, d, J 9.1, OAr(3,5)H); 13C{1H} 
NMR (126 MHz, CD3CN) δC: 51.8 (N+(CH3)2), 56.0 (OCH3), 61.5 (COCH2), 68.8 (C(1)H2), 113.2 
(C(2)H), 115.0 (C(3)ArC(3,5)H), 123.8 (OArC(2,6)H), 126.3 (OArC(3,5)H), 128.7 (C(3)ArC(1)), 
129.9 (C(3)ArC(2,6)H), 143.8 (C(3)H), 147.0 (ArC(4)-NO2), 154.9 (ArC(1)-O), 161.5 (C(3)ArC(4)-
OCH3), 164.3 (C=O); HRMS (NSI+): C20H23N2O5+ [M]+ found 371.1591, requires 371.1601 (−2.8 ppm). 
(E)-N,N-Dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)-3-(4-nitrophenyl)prop-2-en-1-ammonium 
bromide 257 
  
Following general procedure H, the reaction of 4-nitrophenyl bromoacetate 213 (617 mg, 2.37 mmol, 
1.2 equiv.) in CH2Cl2 / Et2O (1:4 v:v, 1.6 mL) with (E)-N,N-dimethyl-3-(4-nitrophenyl)prop-2-en-1-
amine 249 (405 mg, 1.98 mmol, 1.0 equiv.) in CH2Cl2 / Et2O (1:4 v:v, 1.6 mL) for 3 h gave the title 
compound (331 mg, 36%) as a pale brown solid after recrystallisation from CHCl3 / CH3CN / Et2O. 
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mp 101 °C (dec); νmax (film, cm−1): 2930, 1775, 1539, 1516, 1483, 1344, 1202, 1161, 860; 1H NMR 
(300 MHz, DMSO-d6) δH: 3.37 (6H, s, N+(CH3)2), 4.51 (2H, d, J 7.3, C(1)H2), 4.93 (2H, s, COCH2), 
6.97-6.80 (1H, m, C(2)H), 7.12 (1H, d, J 15.7, C(3)H), 7.58 (2H, d, J 9.1, OArC(2,6)H), 7.93 (2H, d, J 
8.8, C(3)ArC(2,6)H), 8.26 (2H, d, J 8.8, C(3)ArC(3,5)H), 8.37 (2H, d, J 9.1, OArC(3,5)H); 13C{1H} 
NMR (126 MHz, DMSO-d6) δC: 51.1 (N+(CH3)2), 60.7 (COCH2), 66.6 (C(1)H2), 121.4 (C(2)H), 123.1 
(OArC(2,6)H), 123.9 (C(3)ArC(3,5)H), 125.5 (OArC(3,5)H), 128.5 (C(3)ArC(2,6)H), 139.1 (C(3)H), 
141.7 (C(3)ArC(1)), 145.6 (ArC(4)-NO2), 147.3 (C(3)ArC(4)-NO2), 153.9 (ArC(1)-O), 163.2 (C=O); 
HRMS (NSI+): C19H20N3O6+ [M]+ found 386.1336, requires 386.1347 (−2.7 ppm). 
(E)-3-(4-Bromophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)prop-2-en-1-
ammonium bromide 258 
 
Following general procedure H, the reaction of 4-nitrophenyl 2-bromoacetate 213 (406 mg, 1.56 mmol, 
1.5 equiv.) in MeCN (0.5 mL) with (E)-3-(4-bromophenyl)-N,N-dimethyl-prop-2-en-1-amine 244 (250 
mg, 1.04 mmol, 1.0 equiv.) in MeCN (0.5 mL) for 1 h gave the title compound (435 mg, 0.87 mmol, 
84%) as a white solid. 
mp 160 °C (dec); νmax (film, cm−1): 2936, 1771, 1616, 1591, 1526, 1485, 1385, 1204, 1157, 1070, 959, 
899; 1H NMR (500 MHz, DMSO-d6) δH: 3.32 (6H, s, N+(CH3)2), 4.37 (2H, d, J 7.6, C(1)H), 4.79 (2H, 
s, COCH2), 6.64 (1H, dt, J 15.3, 7.6, C(2)H), 6.94 (1H, d, J 15.3, C(3)H), 7.56 (2H, d, J 9.1, 
OArC(2,6)H), 7.58-7.64 (4H, m, C(3)ArCH), 8.38 (2H, d, J 9.1, OArC(3,5)H); 13C{1H} NMR (101 
MHz, DMSO-d6) δC: 50.9 (N+(CH3)2), 60.5 (COCH2), 67.0 (C(1)H2), 117.2 (C(2)H), 122.3 
(C(3)ArC(4)-Br), 123.1 (OArC(2,6)H), 125.5 (OArC(3,5)H), 129.4 C(3)ArC(2,6)H), 131.7 
(C(3)ArC(3,5)H), 134.4 (C(3)ArC(1)), 140.3 (C(3)H), 145.6 (ArC(4)-NO2), 153.8 (ArC(1)-O), 163.2 
(C=O); HRMS (NSI+): C19H2079BrN2O4 [M]+ found 419.0592, requires 419.0601 (−2.1 ppm). 
(E)-3-(2-Bromophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)prop-2-en-1-
ammonium bromide 254 
 
Following general procedure H, the reaction of 4-nitrophenyl 2-bromoacetate 213 (260 mg, 1.00 mmol, 
1.2 equiv.) in CH2Cl2 / Et2O (1:4 v:v, 0.8 mL) with (E)-3-(2-bromophenyl)-N,N-dimethyl-prop-2-en-1-
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amine 248 (200 mg, 0.83 mmol, 1.0 equiv.) in CH2Cl2 / Et2O (1:4 v:v, 0.8 mL) for 1 h gave the title 
compound (310 mg, 75%) as a white solid. 
mp 112 °C (dec); νmax (film, cm−1): 2938, 1767, 1520, 1346, 1195, 1150, 1024, 950; 1H NMR (300 MHz, 
DMSO-d6) δH: 3.37 (6H, s, N+(CH3)2), 4.50 (2H, d, J 6.0, C(1)H), 4.88 (2H, s, COCH2), 6.62 (1H, ddt, 
J 15.4, 6.0, C(2)H), 7.20 (1H, d, J 15.4, C(3)H), 7.32 (1H, td, J 7.8, 1.5, C(3)ArC(4)H), 7.46 (1H, t, J 
7.3, C(3)ArC(5)H), 7.58 (2H, d, J 9.1, OArC(2,6)H), 7.64-7.73 (1H, m, C(3)ArC(6)H), 7.95 (1H, d, J 
7.8, C(3)ArC(3)H), 8.38 (2H, d, J 9.1, OArC(3,5)H); 13C{1H} NMR (75 MHz, DMSO-d6) δC: 50.9 
(N+(CH3)2), 60.5 (COCH2), 66.7 (C(1)H2), 119.9 (C(2)H), 123.1 (ArC(2,6)H), 123.2 (C(3)ArC(2)-Br), 
125.5 (ArC(3,5)H), 128.1 (C(3)ArC(4)H), 128.4 (C(3)ArC(6)H), 130.9 (C(3)ArC(5)H), 132.9 
(C(3)ArC(3)H), 134.7 (C(3)ArC(1)), 139.5 (C(3)H), 145.6 (ArC(4)-NO2), 153.9 (ArC(1)-O), 163.2 
(C=O); HRMS (APCI+): C19H20O4N279Br+ [M]+ found 419.0598, requires 419.0601 (−0.7 ppm). 
(E)-3-(2-Methoxyphenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)prop-2-en-1-
ammonium bromide 255 
 
Following general procedure H, the reaction of 4-nitrophenyl 2-bromoacetate 213 (445 mg, 1.71 mmol, 
1.5 equiv.) in MeCN (2.3 mL) with (E)-3-(2-methoxyphenyl)-N,N-dimethylprop-2-en-1-amine 247 
(217 mg, 1.14 mmol, 1.0 equiv.) for 24 h gave the title compound (402 mg, 78%) as an off-white solid. 
mp 141 °C (dec); νmax (film, cm−1): 2936, 1765, 1518, 1489, 1344, 1244, 1148, 1026, 986; 1H NMR 
(500 MHz, DMSO-d6) δH: 3.34 (6H, s, N+(CH3)2), 3.83 (3H, s, OCH3), 4.43 (2H, d, J 7.5, C(1)H), 4.83 
(2H, s, COCH2), 6.53 (1H, dt, J 15.5, 7.5, C(2)H), 7.00 (1H, t, J 7.5, C(3)ArC(5)H), 7.07 (1H, d, J 7.9, 
C(3)ArC(3)H), 7.21 (1H, d, J 15.8, C(3)H), 7.31-7.45 (1H, m, C(3)ArC(4)H), 7.56 (2H, d, J 9.2, 
OAr(2,6)H), 7.75 (1H, dd, J 7.7, 1.5, C(3)ArC(6)H), 8.38 (2H, d, J 9.2, OAr(3,5)H); 13C{1H} NMR 
(125 MHz, DMSO-d6) δC: 50.8 (N+(CH3)2), 55.6 (OCH3), 60.4 (COCH2), 67.5 (C(1)H2), 111.5 
(C(3)ArC(3)H), 116.0 (C(2)H), 120.6 (C(3)ArC(4)H), 123.1 (OArC(2,6)H), 123.4 (C(3)ArC(1)), 125.5 
(OArC(3,5)H), 127.3 (C(3)ArC(6)H), 130.6 (C(3)ArC(4)H), 136.1 (C(3)H), 145.6 (ArC(4)NO2), 153.9 
(ArC(1)-O), 156.6 (C(3)ArC(2)-OMe), 163.3 (C=O); HRMS (NSI+): C20H23O5N2+ [M]+ found 
371.1597, requires 371.1601 (1.2 ppm). 
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1-Allyl-4-(tert-butoxycarbonyl)-1-(2-(4-nitrophenoxy)-2-oxoethyl)piperazin-1-ium bromide 288 
  
Following general procedure H, the reaction of 4-nitrophenyl 2-bromoacetate 213 (1.03 g, 3.96 mmol, 
3.0 equiv.) in MeCN (0.65 mL) with tert-butyl 4-allylpiperazine-1-carboxylate 288 (300 mg, 1.33 
mmol, 1.0 equiv.) in MeCN (0.65 mL) for 2 h gave title compound (416 mg, 65%) as an off-white solid. 
 
mp 138 °C (dec); νmax (film, cm−1): 2951, 1773, 1709, 1532, 1448, 1144, 858; 1H NMR (500 MHz, 
DMSO-d6) δH: 1.43 (9H, s, OC(CH3)3), 3.63-3.85 (8H, m, C(2 and 3)H2), 4.42 (2H, d, J 7.2, C(1’)H), 
4.94 (2H, s, COCH2), 5.68-5.76 (2H, m, C(3’)H), 6.11-6.24 (1H, m, C(2’)H), 7.58 (2H, d, J 9.1, 
ArC(2,6)H), 8.38 (2H, d, J 9.1, ArC(3,5)H); 13C{1H} NMR (125 MHz, DMSO-d6) δC: 27.9 (C(CH3)3), 
36.5 and 37.6 (rotameric C(3,5)H2), 55.9 (COCH2), 58.1 (C(2,6)H2), 61.9 (C(1’)H2), 80.1 (C(CH3)3), 
123.1 (ArC(2,6)H), 124.9 (C(2’)H), 125.6 (ArC(3,5)H), 128.7 (C(3’)H), 145.7 (ArC(4)-NO2), 153.5 
(NC=O), 153.8 (ArC(4)-NO2), 163.0 (C=O); HRMS (ESI+): C20H28O6N3+ [M]+ found 406.1966, 
requires 406.1973 (−1.6 ppm). 
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Rearrangement Products 
General procedure I: Asymmetric [2,3]-Rearrangement and Sequential Nucleophilic Quench: 
A flame-dried flask under N2 was charged with (+)-BTM (0.2 equiv.) and HOBt (0.2 equiv.) followed 
by MeCN (0.07 M with respect to ammonium salt). i-Pr2NH (1.4 equiv.) was added and the resulting 
solution cooled to −20 °C and stirred for five mins. The corresponding ammonium salt (1.0 equiv.) was 
added and the reaction stirred for 24 h. The corresponding nucleophile (2.0-15.0 equiv.) was added and 
the reaction allowed to warm to rt and stirred for the time stated. The reaction was quenched with aq. 1 
M NaOH (equal volume) and extracted with CH2Cl2 (3  equal volume). The organic layers were 
washed with aq. 1 M NaOH (2  equal volume), brine (equal volume), dried over MgSO4 and 
concentrated in vacuo. The residue was analysed by 1H NMR to determine dr, then purified by flash 
column chromatography to yield the rearranged product. 
Racemic samples were prepared using (±)-tetramisole∙HCl (0.2 equiv.) or (±)-BTM (0.2 equiv.) as 
catalyst, stirring the rearrangement for 1 h at rt before quenching with the required nucleophile. 
General Procedure J: In situ Ammonium Salt Formation, Asymmetric [2,3]-rearrangement and 
Subsequent Nucleophilic Quench: 
A flame-dried flask under N2 was charged with 4-nitrophenyl 2-bromoacetate (1.0 equiv.) and a solution 
of the corresponding allylic amine (1.05 equiv.) in MeCN (0.14 M with respect to bromoacetate) and 
the resulting solution was stirred at rt for 24 h. The reaction mixture was cooled to 20 °C, stirred for 5 
min, and a pre-cooled solution of (+)-BTM (0.2 equiv.), HOBt (0.2 equiv.) and i-Pr2NH (1.4 equiv.) in 
MeCN (0.14 M with respect to bromoacetate) was added via cannula, and the reaction stirred for 24 h. 
The corresponding nucleophile (3.0-5.0 equiv.) was added and the reaction allowed to warm to rt and 
stir (1-16 h). The reaction was quenched with aq. 1 M NaOH (equal volume) and extracted with CH2Cl2 
(3  equal volume). The organic layers were washed with aq. 1 M NaOH (2  equal volume), brine 
(equal volume), dried over MgSO4 and concentrated in vacuo. The residue was analysed by 1H NMR 
to determine dr, then purified by flash column chromatography to yield the rearranged product. 
Racemic samples were prepared using (±)-tetramisole∙HCl (0.2 equiv.) or (±)-BTM (0.2 equiv.) as 
catalyst, stirring the rearrangement for 1 h at rt before quenching with the required nucleophile. 
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(±)-syn-Ethyl 2-(dimethylamino)-3-phenylpent-4-enoate[113] 233 
 
Following general procedure I, (E)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)-3-phenylprop-2-
en-1-ammonium bromide 211 (100 mg, 0.240 mmol, 1.0 equiv.), (±)-BTM (12.0 mg, 0.048 mmol, 0.2 
equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.), iPr2NH (47 µL, 0.19 mmol, 1.4 equiv.) in MeCN (3.5 
mL) were stirred for 1 h, quenched with NaOEt (1 M in EtOH, 720 µL, 0.72 mmol, 3.0 equiv.) and 
stirred for a further 1 h. Crude dr 92:8. The residue was purified by flash chromatography on silica gel 
(10% EtOAc/PE) to give the title compound (41 mg, 0.166 mmol, 69%, 92:8 dr isolated) as a colourless 
oil. 
νmax (film, cm−1): 2938, 1726, 1452, 1257, 1162, 1031, 926; 1H NMR (500 MHz, CDCl3) δH: 1.29 (3H, 
t, J 7.1, OCH2CH3) , 2.26 (6H, s, N(CH3)2), 3.58 (1H, d, J 11.2, C(2)H), 3.76 (1H, dd, J 11.2, 8.4, 
C(3)H), 4.18 (2H, q, J 7.1, OCH2CH3), 5.01 (1H, d, J 10.1, C(5)H
cis), 5.07 (1H, d, J 17.1, C(5)Htrans), 
5.87 (1H, ddd, J 17.1, 10.1, 8.4, C(4)H), 7.37-7.18 (5H, m, ArH); 13C{1H} NMR (126 MHz, CDCl3) 
δC: 14.7 (OCH2CH3), 41.5 (N(CH3)2), 50.2 (C(3)H), 60.0 (OCH2CH3), 71.0 (C(2)H), 116.7 (C(5)H2), 
126.7 (ArC(4)H), 128.0 (ArC(3,5)H), 128.6 (ArC(2,6)H), 138.7 (C(4)H), 141.0 (ArC(1)), 170.7 (C=O); 
HRMS (NSI+): C15H22O2N+ [M+H]+ found 248.1638, requires 248.1651 (−2.8 ppm). 
1H NMR spectrum of 233 consistent with that given by Doyle et al.[113] for the syn-diastereomer. Along 
with the X-Ray crystal structure of 274 (vide infra), we assign our major diastereomer in all cases as 
syn by analogy. 
(±)-syn-4-Nitrophenyl 2-(dimethylamino)-3-phenylpent-4-enoate 218 
 
Following general procedure I, (E)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)-3-phenylprop-2-
en-1-ammonium bromide 211 (200 mg, 0.480 mmol, 1.0 equiv.), (±)-tetramisole∙HCl (23.2 mg, 0.096 
mmol, 0.2 equiv.), HOBt (14.4 mg, 0.096 mmol, 0.2 equiv.), iPr2NH (108 µL, 0.768 mmol, 1.6 equiv.) 
in MeCN (7.0 mL) were stirred for 1 h. Crude dr 92:8. The residue was purified by flash 
chromatography on silica gel (10→15% EtOAc/PE) to give the title compound (68 mg, 0.200 mmol, 
42%, >95:5 dr isolated) as a yellow solid. 
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m.p 103-105 °C; νmax (film, cm−1): 2927, 1755, 1613, 1589, 1518, 1487, 1344, 1204, 1117, 1090; 1H 
NMR (500 MHz, CD2Cl2) δH: 2.39 (6H, s, N(CH3)2) 3.93-3.82 (2H, m, C(2)H and C(3)H), 5.26-5.12 
(2H, m, C(5)H), 6.00 (1H, ddd, J 17.0, 10.1, 7.9, C(4)H), 7.31-7.23 (5H, m, ArH), 7.38-7.33 (2H, m, 
Ar(2,6)H), 8.28 (2H, d, J 9.1, Ar(3,5)H); 13C{1H} NMR (126 MHz, CD2Cl2) δC: 41.6, 50.8, 71.3, 117.7, 
123.3, 125.7, 127.4, 128.4, 129.2, 139.0, 141.1, 155.8, 168.8; HRMS (NSI+) C19H21N2O4+ [M+H]+ 
found: 341.1496, requires: 341.1496 (±0.0 ppm). 
(2S,3S)-N-Benzyl-2-(dimethylamino)-3-phenylpent-4-enamide 215 
 
Following general procedure I, (E)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)-3-phenylprop-2-
en-1-ammonium bromide 211 (100 mg, 0.240 mmol, 1.0 equiv.), (+)-BTM (12.0 mg, 0.048 mmol, 0.2 
equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.), iPr2NH (47 µL, 0.19 mmol, 1.4 equiv.) in MeCN (3.5 
mL) were stirred for 24 h, quenched with BnNH2 (131 µL, 1.20 mmol, 5.0 equiv.) and stirred for a 
further 24 h. Crude dr >95:5. The residue was purified by flash chromatography on silica gel 
(50→100% EtOAc/PE) to give the title compound (56 mg, 76%, >95:5 dr isolated) as a yellow solid. 
HPLC: Chiralcel OJ-H (5% IPA:hexane, flow rate 1.5 mL min-1, 211 nm, 40 °C) tR minor: 11.6 min, tR 
major: 13.7 min, 99% ee. 
[α]D
20 +86.9 (c 1.0, CHCl3); mp 110 °C (dec); νmax (film, cm−1): 3293, 2922, 1636, 1541, 1452, 1265, 
1030, 916; 1H NMR (300 MHz, CDCl3) δH: 2.30 (6H, s, NCH3)2), 3.22 (1H, d, J 8.4, C(2)H), 3.81-3.89 
(1H, m, C(3)H), 4.44 (2H, d, J 5.7, PhCH2), 5.02-5.12 (2H, m, C(5)H), 6.11 (1H, dt, J 17.9, 8.6, C(4)H), 
6.34 (1H, br s, NH), 7.18-7.37 (10H, m, ArH); 13C{1H} NMR (126 MHz, CDCl3) δC: 42.6 (N(CH3)2), 
43.4 (PhCH2), 50.2 (C(3)H), 73.8 (C(2)H), 116.8 (C(5)H2), 126.6 (ArCH), 127.6 (ArCH), 128.2 
(ArCH), 128.3 (ArCH), 128.6 (ArCH), 128.8 (ArCH), 138.3 (ArC(1)), 138.7 (C(4)H), 141.9 
(C(3)ArC(1)), 170.3 (C=O); HRMS (NSI+): C20H25ON2+ [M+H]+ found 309.1960, requires 309.1961 
(−0.5 ppm). 
215 was also synthesized by the in situ protocol: 
Following general procedure J, the reaction of (E)-N,N-dimethyl-3-phenylprop-2-en-1-amine 212 (41 
mg, 0.250 mmol, 1.05 equiv.) and 4-nitrophenyl 2-bromoacetate (62 mg, 0.24 mmol, 1.0 equiv.) in 
MeCN (1.75 mL) were stirred for 24 h, followed by addition of (+)-BTM (12.0 mg, 0.048 mmol, 0.2 
equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and iPr2NH (47 µL, 0.19 mmol, 1.4 equiv.) in MeCN 
(1.75 mL) and stirred for a further 24 h. Quenched with BnNH2 (131 µL, 1.20 mmol, 5.0 equiv.) and 
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stirred for a further 24 h. Crude dr >95:5. The residue was purified by flash chromatography on silica 
gel (50→100% EtOAc/PE) to give the title compound (44 mg, 0.144 mmol, 60%, >95:5 dr isolated, 
92% ee) as an off white solid. Spectral data and HPLC analysis identical to that above. 
215 was also synthesized from (Z)-amine (Z)-283 by the in situ protocol: 
Following general procedure J, the reaction of (Z)-N,N-dimethyl-3-phenylprop-2-en-1-amine (Z)-283 
(41 mg, 0.250 mmol, 1.05 equiv.) and 4-nitrophenyl 2-bromoacetate 213 (62 mg, 0.24 mmol, 1.0 equiv.) 
in MeCN (1.75 mL) were stirred for 24 h, followed by addition of (+)-BTM (12.0 mg, 0.048 mmol, 0.2 
equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and iPr2NH (47 µL, 0.19 mmol, 1.4 equiv.) in MeCN 
(1.75 mL) and stirred for a further 24 h. Quenched with BnNH2 (131 µL, 1.20 mmol, 5.0 equiv.) and 
stirred for a further 24 h. Crude dr 87:13. The residue was purified by flash chromatography on silica 
gel (50→100% EtOAc/PE) to give the title compound (4.0 mg, 5%, >95:5 dr isolated, 92% ee) as an 
off white solid. Spectral data and HPLC analysis identical to that above. 
(2S,3S)-2-(Dimethylamino)-N-methoxy-N-methyl-3-phenylpent-4-enamide 229 
 
Following general procedure I, (E)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)-3-phenylprop-2-
en-1-ammonium bromide 211 (100 mg, 0.240 mmol, 1.0 equiv.), (+)-BTM (12.0 mg, 0.048 mmol, 0.2 
equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.), iPr2NH (47 µL, 0.19 mmol, 1.4 equiv.) in MeCN (3.5 
mL) were stirred for 24 h, quenched with N,O-dimethylhydroxylamine (264 µL, 3.60 mmol, 15.0 
equiv.) and stirred for a further 24 h. Crude dr 95:5. The residue was purified by flash chromatography 
on silica gel (10→20% Et2O/CH2Cl2, then 10% MeOH/CH2Cl2) to give the title compound (41 mg, 
65%, >95:5 dr isolated) as a yellow oil. 
HPLC: Chiralpak AD-H (1% IPA:hexane, flow rate 1.5 ml min-1, 220 nm, 40 °C) tR minor: 9.4 min, tR 
major: 10.5 min, >99% ee. 
[α]D
20 +118.2 (c 1.0, CHCl3); νmax (film, cm−1): 2935, 1624, 1454, 1392, 1134, 1024, 987, 918; 1H NMR 
(500 MHz, CDCl3) δH: 2.26 (6H, s, N(CH3)2), 2.94 (3H, s, MeONCH3), 2.99 (3H, s, MeNOCH3), 3.92-
3.97 (2H, m, C(2 and 3)H), 4.95-5.05 (2H, m, C(5)H), 5.93-6.02 (1H, m, C(4)H), 7.15-7.38 (5H, m, 
ArH); 13C{1H} NMR (126 MHz, CDCl3) δC: 35.6 (NCH3), 37.8 (OCH3), 41.7 (N(CH3)2), 50.3 (C(3)H), 
65.5 (C(2)H), 116.8 (C(5)H2), 126.7 (ArC(4)H), 128.5 (ArC(2,6)H), 128.6 (ArC(3,5)H), 138.7 (C(4)H), 
141.5 (ArC(1)), 170.7 (C=O); HRMS (NSI+): C15H23O2N2 [M+H]+ found 263.1755, requires 263.1754 
(+0.4 ppm). 
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(2S,3S)-2-(Dimethylamino)-3-phenyl-1-(pyrrolidin-1-yl)pent-4-en-1-one 230 
 
Following general procedure I, (E)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)-3-phenylprop-2-
en-1-ammonium bromide 211 (100 mg, 0.240 mmol, 1.0 equiv.), (+)-BTM (12.0 mg, 0.048 mmol, 0.2 
equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.), iPr2NH (47 µL, 0.19 mmol, 1.4 equiv.) in MeCN (3.5 
mL) were stirred for 24 h, quenched with pyrrolidine (100 µL, 1.20 mmol, 5.0 equiv.) and stirred for a 
further 24 h. Crude dr 95:5. The residue was purified by flash chromatography on silica gel (50→100% 
EtOAc/PE) to give the title compound (40 mg, 61%, >95:5 dr isolated) as an off white solid. 
HPLC: Chiralcel OJ-H (5% IPA:hexane, flow rate 1.5 ml min-1, 200 nm, 40 °C) tR minor: 4.8 min, tR 
major: 5.7 min, 99% ee. 
[α]D
20 +114.0 (c 1.0, CHCl3); mp 87-90 °C; νmax (film, cm−1): 2874, 1618, 1421, 1227, 1040, 993 921; 
1H NMR (500 MHz, CDCl3) δH: 1.69-1.94 (4H, m, C(3’ and 4’)H2), 2.29 (6H, s, N(CH3)2), 3.19-3.25 
(1H, m, C(2’)HAHB), 3.39-3.53 (3H, m, 2  C(5’)H and C(2’)HAHB), 3.63 (1H, d, J 9.4, C(2)H), 3.92 
(1H, t, J 9.4, C(3)H), 4.97-5.04 (2H, m, C(5)H2), 6.08 (1H, ddd, J 16.9, 9.4, 8.1, C(4)H), 7.18-7.34 (5H, 
m, ArH); 13C{1H} NMR (126 MHz, CDCl3) δC: 24.3 (C(4’)H2), 26.3 (C(3’)H2), 42.0 (N(CH3)2), 45.4 
(C(5’)H2), 46.9 (C(2’)H2), 50.4 (C(3)H), 68.8 (C(2)H), 116.9 (C(5)H2), 126.7 (ArC(4)H), 128.5 
(ArC(2,6)H), 128.6 (ArC(3,5)H), 138.6 (C(4)H), 141.5 (ArC(1)), 169.3 (C=O); HRMS (NSI+): 
C17H25ON2 [M+H]+ found 273.1963, requires 273.1691 (+0.6 ppm). 
(2S,3S)-Methyl 2-(dimethylamino)-3-phenylpent-4-enoate 231 
 
Following general procedure I, (E)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)-3-phenylprop-2-
en-1-ammonium bromide 211 (4.00 g, 9.60 mmol, 1.0 equiv.), (+)-BTM (480 mg, 1.92 mmol, 0.2 
equiv.), HOBt (256 mg, 1.92 mmol, 0.2 equiv.), iPr2NH (1.88 mL, 13.44 mmol, 1.4 equiv.) in MeCN 
(140 mL) were stirred for 24 h, quenched with NaOMe (1 M in MeOH, 28.8 mL, 28.8 mmol, 3.0 equiv.) 
and stirred for a further 1 h. Crude dr 95:5. The residue was purified by flash chromatography on silica 
gel (10→20% EtOAc/PE) to give the title compound (1.95 g, 8.36 mmol, 87%, 95:5 dr isolated) as a 
colourless oil. 
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HPLC: Chiralcel OJ-H (1% IPA:hexane, flow rate 1.5 mL min-1, 211 nm, 40 °C) tR minor: 4.3 min, tR 
major: 5.4 min, 95% ee. 
[α]D
20 +67.8 (c 1.0, CHCl3); νmax (film, cm−1): 2947, 1730, 1454, 1256, 1190, 1143, 982, 918; 1H NMR 
(500 MHz, CDCl3) δH: 2.29 (6H, s, N(CH3)2), 3.65 (1H, d, J 11.3, C(2)H), 3.73 (3H, s, OCH3), 3.80 
(1H, dd, J 11.3, 8.3, C(3)H), 5.02-5.15 (2H, m, C(5)H2), 5.91 (1H, ddd, J 16.8, 10.1, 8.3, C(4)H), 7.23-
7.28 (3H, m, ArH), 7.36 (2H, t, J 7.6, ArH); 13C{1H} NMR (126 MHz, CDCl3) δC: 41.5 (N(CH3)2), 50.2 
(C(3)H), 50.8 (OCH3), 71.0 (C(2)H), 116.6 (C(5)H2), 126.7 (ArC(4)H), 128.0 (ArC(2,6)H), 128.6 
(ArC(3,5)H), 138.7 (C(4)H), 140.8 (ArC(1)), 171.1 (C=O); HRMS (NSI+): C14H20NO2 [M+H]+ found 
234.1482, requires 234.1489 (−2.8 ppm). 
The 0.240 mmol scale reaction of (E)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)-3-phenylprop-
2-en-1-ammonium bromide 211 gave 231 (36 mg, 64%, 95:5 dr isolated, 98% ee) as a colourless oil. 
Spectral data and HPLC analysis identical to the above. 
231 was also synthesized by the in situ protocol:  
Following general procedure J, the reaction of (E)-N,N-dimethyl-3-phenylprop-2-en-1-amine 212 (41 
mg, 0.250 mmol, 1.05 equiv.) and 4-nitrophenyl 2-bromoacetate (62 mg, 0.24 mmol, 1.0 equiv.) in 
MeCN (1.75 mL) were stirred for 24 h, followed by addition of (+)-BTM (12.0 mg, 0.048 mmol, 0.2 
equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and iPr2NH (47 µL, 0.19 mmol, 1.4 equiv.) in MeCN 
(1.75 mL) and stirred for a further 24 h. Quenched with NaOMe (1 M in MeOH, 720 μL, 0.72 mmol, 
3.0 equiv.) and stirred for a further 24 h. Crude dr >95:5. The residue was purified by flash 
chromatography on silica gel (10→20% EtOAc/PE) to give the title compound (35 mg, 0.150 mmol, 
63%, 95:5 dr isolated, 94% ee) as a colourless oil. Spectral data and HPLC analysis identical to that 
above. 
(2S,3S)-2-(Dimethylamino)-3-phenylpent-4-en-1-ol 232 
 
Following general procedure I with slight modification, (E)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-
oxoethyl)-3-phenylprop-2-en-1-ammonium bromide 211 (100 mg, 0.240 mmol, 1.0 equiv.), (+)-BTM 
(12.0 mg, 0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.), iPr2NH (47 µL, 0.19 mmol, 
1.4 equiv.) in MeCN (3.5 mL) were stirred for 24 h, concentrated in vacuo and the solvent switched to 
THF (3.5 mL, 2 cycles). The solution was cooled to 0 °C, and LiAlH4 (1.0 M in THF, 0.48 mL, 0.48 
mmol, 2.0 equiv.) was added dropwise. The reaction was stirred for 1 h, quenched with aq. 1 M KOH 
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(10 mL), extracted with EtOAc (3 × 20 mL). The combined organic layers were washed with aq. 1 M 
KOH (2 × 10 mL), brine (1 × 10 mL), dried over MgSO4, filtered, and concentrated in vacuo. Crude dr 
>95:5. The residue was purified by flash chromatography on silica gel (10→20% Et2O/CH2Cl2, then 
10% MeOH/CH2Cl2) to give the title compound (29 mg, 59%, >95:5 dr isolated) as a pale yellow oil. 
HPLC: Chiralpak AD-H (2% IPA:hexane, flow rate 1.5 ml min-1, 211 nm, 40 °C) tR minor: 6.1 min, tR 
major: 8.2 min, 96% ee. 
[α]D
20 +95.4 (c 1.0, CHCl3); νmax (film, cm−1): 3363, 2928, 1452, 1411, 1176, 1059, 1032, 914; 1H NMR 
(500 MHz, CDCl3) δH: 2.14 (6H, s, N(CH3)2), 3.14 (1H, td, J 10.6, 5.0, C(2)H), 3.28 (1H, t, J 10.7, 
C(1)HAHB), 3.45 (1H, t, J 9.6, C(3)H), 3.63 (1H, dd, J 10.7, 5.0, C(1)HAHB), 4.89-5.04 (2H, m, C(5)H), 
5.86 (1H, dt, J 16.9, 9.6, C(4)H), 7.19-7.32 (5H, m, ArH); 13C{1H} NMR (126 MHz, CDCl3) δC: 40.7 
(N(CH3)2), 50.5 (C(3)H), 60.1 (C(1)H2), 67.7 (C(2)H), 115.7 (C(5)H2), 126.8 (ArC(4)H), 128.1 
(ArC(3,5)H), 128.8 (ArC(2,6)H), 138.8 (C(4)H), 143.1 (ArC(1)); HRMS (NSI+): C13H20ON [M+H]+ 
found 206.1539, requires 206.1539 (0.2 ppm). 
(2S,3S)-N-Benzyl-3-phenyl-2-(piperidin-1-yl)pent-4-enamide 265 
 
Following general procedure I, 1-cinnamyl-1-(2-(4-nitrophenoxy)-2-oxoethyl)piperidin-1-ium bromide 
259 (111 mg, 0.240 mmol, 1.0 equiv.), (+)-BTM (12.0 mg, 0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 
0.048 mmol, 0.2 equiv.), iPr2NH (47 µL, 0.19 mmol, 1.4 equiv.) in MeCN (3.5 mL) were stirred for 24 
h, quenched with BnNH2 (131 µL, 1.20 mmol, 5.0 equiv.) and stirred for a further 24 h. Crude dr >95:5. 
The residue was purified by flash chromatography on silica gel (2→5% Et2O/CH2Cl2), and the resulting 
solid triturated with Et2O (2 × 2.0 mL) to give the title compound 21 (70 mg, 0.201 mmol, 84%, >95:5 
dr isolated) as an off white solid. 
HPLC: Chiralcel OJ-H (1% IPA:hexane, flow rate 1.5 ml min-1, 211 nm, 40 °C), tR minor: 23.3 min 
(not observed), tR major: 29.2 min >99% ee. 
[α]D
20 +71.8 (c 1.0, CHCl3); mp 142-145 °C; νmax (film, cm−1): 3281, 2929, 1636, 1557, 1452, 1426, 
1360, 1257, 1221, 926; 1H NMR (500 MHz, CDCl3) δH: 1.28-1.42 (6H, m, C(3’,5’ and 4’)H), 2.45-2.56 
(4H, br s, C(2’,6’)H), 3.29 (1H, d, J 7.8, C(2)H), 3.88 (1H, t, J 7.8, C(3)H), 4.46 (2H, d, J 5.5, PhCH2), 
4.95-5.14 (2H, m, C(5)H), 6.12 (1H, dt, J 17.1, 8.6, C(4)H), 6.61 (1H, br s, NH), 7.11-7.55 (10H, m, 10 
× ArH); 13C{1H} NMR (126 MHz, CDCl3) δC: 24.4 (C(4’)H2), 26.5 (C(3’,5’)H2), 43.3 (PhCH2), 49.4 
Chapter 6: Experimental Details 
 
 
158 
(C(3)H), 51.8 (C(2’,6’)H2), 74.1 (C(2)H), 116.4 (C(5)H2), 126.3 (ArCH), 127.6 (ArCH), 128.0 (ArCH), 
128.4 (ArCH), 128.5 (ArCH), 128.8 (ArCH), 138.6 (ArC(1)), 139.3 (C(4)H), 142.6 (C(3)ArC(1)), 170.7 
(C=O); HRMS (NSI+): C23H29ON2 [M+H]+ found 349.2276, requires 349.2274 (+0.2 ppm). 
(2S,3S)-N-Benzyl-2-morpholino-3-phenylpent-4-enamide 266 
 
Following general procedure I, 4-cinnamyl-4-(2-(4-nitrophenoxy)-2-oxoethyl)morpholin-4-ium 
bromide 260 (111 mg, 0.240 mmol, 1.0 equiv.), (+)-BTM (12.0 mg, 0.048 mmol, 0.2 equiv.), HOBt 
(6.4 mg, 0.048 mmol, 0.2 equiv.), iPr2NH (47 µL, 0.19 mmol, 1.4 equiv.) in MeCN (3.5 mL) were 
stirred for 24 h, quenched with BnNH2 (131 µL, 1.20 mmol, 5.0 equiv.) and stirred for a further 24 h. 
Crude dr 94:6. The residue was purified by flash chromatography on silica gel (2→5% Et2O/CH2Cl2), 
and the resulting solid triturated with Et2O (2 × 2.0 mL) to give the title compound 22 (70 mg, 83%, 
>95:5 dr isolated) as an off white solid. 
HPLC: Chiralpak AD-H (3% IPA:hexane, flow rate 1.5 ml min-1, 211 nm, 40 °C) tR minor: 32.5 min, 
tR major: 37.7 min, 86% ee. 
[α]D
20 +58.2 (c 1.0, CHCl3); mp 180-182 °C; νmax (film, cm−1): 3267, 2853, 1635, 1558, 1448, 1418, 
1248, 1111, 999; 1H NMR (500 MHz, CDCl3) δH: 2.52-2.62 (4H, m, C(2’,6’)H2), 3.23 (1H, d, J 8.6, 
C(2)H), 3.40-3.54 (4H, m, C(3’,5’)H2), 3.87 (1H, t, J 8.6, C(3)H), 4.44 (2H, d, J 5.6, PhCH2), 5.03-5.09 
(2H, m, C(5)H), 6.06 (1H, ddd, J 17.9, 9.7, 8.6, C(4)H), 6.24 (1H, br s, NH), 7.16-7.38 (10H, m, ArH); 
13C{1H} NMR (126 MHz, CDCl3) δC: 43.5 (PhCH2), 49.5 (C(3)H), 50.9 (C(2’,6’)H2), 67.3 (C(3’,5’)H2), 
73.8 (C(2)H), 116.9 (C(5)H2), 126.6 (ArCH), 127.7 (ArCH), 128.1 (ArCH), 128.3 (ArCH), 128.5 
(ArCH), 128.9 (ArCH), 138.3 (ArC(1)), 138.5 (C(4)H), 141.6 (C(3)ArC(1)), 169.8 (C=O); HRMS 
(NSI+): C22H27O2N2 [M+H]+ found 351.2070, requires 351.2067 (+0.8 ppm). 
  
Chapter 6: Experimental Details 
 
 
159 
tert-Butyl 4-((2S,3S)-1-(benzylamino)-1-oxo-3-phenylpent-4-en-2-yl)piperazine-1-carboxylate 
267 
 
Following general procedure I, 4-(tert-butoxycarbonyl)-1-cinnamyl-1-(2-(4-nitrophenoxy)-2-
oxoethyl)piperazin-1-ium bromide 261 (135 mg, 0.240 mmol, 1.0 equiv.), (+)-BTM (12.0 mg, 0.048 
mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.), iPr2NH (47 µL, 0.19 mmol, 1.4 equiv.) in 
MeCN (3.5 mL) were stirred for 24 h, quenched with BnNH2 (131 µL, 1.20 mmol, 5.0 equiv.) and 
stirred for a further 24 h. Crude dr 93:7. The residue was purified by flash chromatography on silica gel 
(2→5% Et2O/CH2Cl2), and the resulting solid triturated with Et2O (2 × 2.0 mL) to give the title 
compound (96 mg, 89%, >95:5 dr isolated) as an off white solid. 
HPLC: Chiralcel OJ-H (5% IPA:hexane, flow rate 1.5 ml min-1, 220 nm, 40 °C) tR major: 7.8 min, tR 
minor: 17.8 min, 96% ee. 
[α]D
20 +51.4 (c 1.0, CHCl3); mp 155-157 °C; νmax (film, cm−1): 3279, 2970, 1681, 1635, 1558, 1456, 
1364, 1248, 1163, 1001, 920; 1H NMR (500 MHz, toluene-d8, 351 K) δH: 1.37 (9H, s, OC(CH3)3), 2.29 
(2H, dt, J 10.5, 5.0, C(3,5)HAHB), 2.46 (2H, dt, J 10.5, 5.0, C(3,5)HAHB), 2.89 (1H, d, J 9.6, C(2’)H), 
3.01-3.16 (4H, m, C(2,6)H2), 3.88 (1H, t, J 8.6, C(3’)H), 4.19 (1H, dd, J 14.7, 5.9, PhCH
AHB), 4.28 (1H, 
dd, J 14.7, 5.9, PhCHAHB), 4.91-5.01 (2H, m, C(5’)H), 5.41 (1H, br s, NH), 5.96 (1H, ddd, J 17.5, 10.2, 
7.7, C(4’)H), 6.95-7.17 (10H, m, ArH); 13C{1H} NMR (126 MHz, toluene-d6, 351 K) δC: 28.6 
(C(CH3)3), 43.6 (PhCH2), 44.8 (C(3,5)H2), 49.8 (C(3’)H), 50.3 (C(2,6)H2), 73.2 (C(2’)H), 79.0 
(C(CH3)3), 116.5 (C(5’)H), 126.6 (ArCH), 127.6 (ArCH), 128.3 (ArCH), 128.5 (ArCH), 128.8 (ArCH), 
129.1 (ArCH), 139.6 (ArC(1)), 139.8 (C(4’)H), 142.2 (C(3’)ArC(1)), 154.7 (Boc,C=O), 168.9 (C=O); 
HRMS (NSI+): C27H36O3N3 [M+H]+ found 450.2749, requires 450.2751 (0.5 ppm). 
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(2S,3S)-N-Benzyl-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-3-phenylpent-4-enamide 268 
 
Following general procedure I, 5-cinnamyl-5-(2-(4-nitrophenoxy)-2-oxoethyl)-4,5,6,7-
tetrahydrothieno[3,2-c]pyridin-5-ium bromide 262 (124 mg, 0.240 mmol, 1.0 equiv.), (+)-BTM (12.0 
mg, 0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.), iPr2NH (47 µL, 0.19 mmol, 1.4 
equiv.) in MeCN (3.5 mL) were stirred for 24 h, quenched with BnNH2 (131 µL, 1.20 mmol, 5.0 equiv.) 
and stirred for a further 24 h. Crude dr >95:5. The residue was purified by flash chromatography on 
silica gel (0→10% Et2O/CH2Cl2) to give the title compound (77 mg, 80%, >95:5 dr isolated) as an off 
white solid. 
HPLC: Chiralpak AD-H (4% IPA:hexane, flow rate 1.5 ml min-1, 211 nm, 40 °C) tR minor: 30.3 min, 
tR major: 36.7 min, >99% ee. 
[α]D
20 +70.6 (c 1.0, CHCl3); mp 50-52 °C; νmax (film, cm−1): 3273, 2918, 1638, 1559, 1454, 1265, 1039, 
912; 1H NMR (500 MHz, CDCl3) δH: 2.47-2.57 (1H, m, C(7’)HAH
B), 2.58-2.67 (1H, m, C(7ʹ)HAHB), 
2.74-2.83 (1H, m, C(6’)HAHB), 3.00 (1H, dt, J 11.0, 5.1, C(6’)HAHB), 3.53 (1H, d, J 8.1, C(2)H), 3.64 
(1H, d, J 14.1, C(4’)HAHB), 3.76 (1H, d, J 14.1, C(4’)HAHB), 3.98 (1H, t, J 8.1, C(3)H), 4.44 (2H, apt 
quintet, J 8.9, PhCH2), 4.99-5.12 (2H, m, C(5)H), 6.16 (1H, dt, J 18.3, 9.3, C(4)H), 6.54 (1H, br s, NH), 
6.62 (1H, d, J 5.0, C(3’)H), 7.00 (1H, d, J 5.0, C(2’)H), 7.36-7.13 (10H, m, 10 × ArH); 13C{1H} NMR 
(126 MHz, CDCl3) δC: 26.1 (C(7’)H2), 43.4 (PhCH2), 47.8 (C(6’)H2), 50.0 (C(3)H), 50.7 (C(4’)H2), 
72.8 (C(2)H), 116.8 (C(5)H2), 122.6 (C(3’)H), 125.2 (C(2’)H), 126.6 (ArCH), 127.7 (ArCH), 128.1 
(ArCH), 128.4 (ArCH), 128.6 (ArCH), 128.8 (ArCH), 133.5 (C(9’)), 133.8 (C(8’),) 138.4 (ArC(1)), 
138.9 (C(4)H), 142.0 (C(3)ArC(1)), 170.5 (C=O); HRMS (ESI+): C25H27ON2S [M+H]+ found 403.1833, 
requires 403.1844 (1.4 ppm). 
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(2S,3S)-N-Benzyl-3-(4-bromophenyl)-2-(piperidin-1-yl)pent-4-enamide† 269 
 
Following general procedure I, (E)-1-(3-(4-bromophenyl)allyl)-1-(2-(4-nitrophenoxy)-2-
oxoethyl)piperidin-1-ium bromide 263 (130 mg, 0.240 mmol, 1.0 equiv.), (+)-BTM (12.0 mg, 0.048 
mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.), iPr2NH (47 µL, 0.19 mmol, 1.4 equiv.) in 
MeCN (3.5 mL) were stirred for 24 h, quenched with BnNH2 (131 µL, 1.20 mmol, 5.0 equiv.) and 
stirred for a further 24 h. Crude dr >95:5. The residue was purified by flash chromatography on silica 
gel (0→4% Et2O/CH2Cl2) to give the title compound (89 mg, 87%, >95:5 dr isolated) as a white solid. 
HPLC: Chiralpak AD-H (5% IPA:hexane, flow rate 1.5 ml min-1, 220 nm, 40 °C) tR major: 10.6 min, 
tR minor: 18.0 min, 98% ee. 
[α]D
20 +69.3 (c 1.0, CHCl3); mp 170-172 °C; νmax (film, cm−1): 3271, 2930, 2812, 1659, 1635, 1558, 
1487, 1454, 1221, 1103, 1070, 1009, 991, 918, 814; 1H NMR (300 MHz, CDCl3) δH: 1.28-1.43 (6H, m, 
C(3’,5’ and 4’)H2), 2.40-2.57 (4H, m, C(2’)H), 3.16-3.27 (1H, m, C(2)H), 3.83-3.93 (1H, m, C(3)H), 
4.39-4.51 (2H, m, PhCH2), 5.00-5.08 (2H, m, C(5)H), 6.06 (1H, ddd, J 16.7, 10.5, 8.2, C(4)H), 6.51 
(1H, br s, NH), 7.13 (2H, d, J 8.4, C(3)ArC(2,6)H), 7.25-7.37 (5H, m, ArH), 7.40 (2H, d, J 8.4, 
C(3)ArC(3,5)H); 13C{1H} NMR (126 MHz, CDCl3) δC: 24.4, 26.5, 43.4, 48.5, 51.7, 73.8, 117.0, 120.1, 
127.6, 128.0, 128.8, 130.3, 131.4, 138.4, 138.7, 141.5, 170.1; HRMS (ESI+): C23H28ON279Br [M+H]+ 
found 427.1365, requires 427.1380 (−3.4 ppm). 
(2S,3S)-N-Benzyl-2-(dimethylamino)-3-(4-methoxyphenyl)pent-4-enamide 271 
 
Following general procedure I, (E)-3-(4-methoxyphenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-
oxoethyl)prop-2-en-1-ammonium bromide 256 (108 mg, 0.240 mmol, 1.0 equiv.), (+)-BTM (12.0 mg, 
0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.), iPr2NH (47 µL, 0.19 mmol, 1.4 
                                                     
† Synthesised and characterised by Dr David S. B. Daniels 
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equiv.) in MeCN (3.5 mL) were stirred for 24 h, quenched with BnNH2 (131 µL, 1.20 mmol, 5.0 equiv.) 
and stirred for a further 24 h. Crude dr 88:12. The residue was purified by flash chromatography on 
silica gel (50→100% EtOAc/PE) to give the title compound (49 mg, 60%, 93:7 dr isolated) as an off 
white solid. 
HPLC: Chiralcel OJ-H (3% IPA:hexane, flow rate 1.5 mL min-1, 211 nm, 40 °C) tR major: 31.0 min, tR 
minor: 36.9 min (not observed), >99% ee. 
[α]D
20 +89.7 (c 1.0, CHCl3); mp 94 °C (dec); νmax (film, cm−1): 3304, 2932, 2862, 1640, 1545, 1510, 
1452, 1248, 1217, 1030, 908; 1H NMR (400 MHz, CDCl3) δH: 2.29 (6H, s, N(CH3)2), 3.14 (1H, d, J 8.3, 
C(2)H), 3.77-3.80 (4H, m, C(3)H and OCH3), 4.43 (2H, d, J 5.7, PhCH2), 5.01-5.07 (2H, m, C(5)H), 
6.08 (1H, ddd, J 17.8, 9.7, 8.5, C(4)H), 6.26 (1H, br s, NH), 6.84 (2H, d, J 8.7, C(3)ArC(3,5)H), 7.15 
(2H, d, J 8.7, C(3)ArC(2,6)H), 7.37-7.23 (5H, m, ArH); 13C{1H} NMR (101 MHz, CDCl3) δC: 42.7 
(N(CH3)2), 43.4 (PhCH2), 49.3 (C(3)H), 55.3 (OCH3), 74.0 (C(2)H), 114.0 (C(3)ArC(3,5)H), 116.5 
(C(5)H2), 127.6 (ArC(4)H), 128.2 (ArC(2,6)H), 128.8 (ArC(3,5)H), 129.2 (C(3)ArC(2,6)H), 133.9 
(C(3)ArC(1)), 138.4 (ArC(1)), 138.9 (C(4)H), 158.2 (C(3)ArC(4)-OMe), 170.4 (C=O); HRMS (NSI+): 
C21H27N2O2 [M+H]+ found 339.2069, requires 339.2067 (+0.6 ppm). 
(2S,3S)-N-Benzyl-2-(dimethylamino)-3-(4-nitrophenyl)pent-4-enamide 272 
 
Following general procedure I, (E)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)-3-(4-
nitrophenyl)prop-2-en-1-ammonium bromide 257 (112 mg, 0.240 mmol, 1.0 equiv.), (+)-BTM (12.0 
mg, 0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.), iPr2NH (47 µL, 0.19 mmol, 1.4 
equiv.) in MeCN (3.5 mL) were stirred for 24 h, quenched with BnNH2 (131 µL, 1.20 mmol, 5.0 equiv.) 
and stirred for a further 24 h. Crude dr >95:5. The residue was purified by flash chromatography on 
silica gel (50→100% EtOAc/PE) to give the title compound (60 mg, 71%, >95:5 dr isolated) as an off 
white solid. 
HPLC: Chiralpak AD-H (5% IPA:hexane, flow rate 1.5 mL min-1, 200 nm, 40 °C) tR major: 20.1 min, 
tR minor: 22.4 min, 96% ee. 
[α]D
20 +94.4 (c 1.0, CHCl3); mp 128-130 °C; νmax (film, cm−1): 3285, 2922, 1640, 1556, 1510, 1344, 
1224, 1180, 1006, 934; 1H NMR (500 MHz, CDCl3) δH: 2.31 (6H, s, N(CH3)2), 3.27 (1H, d, J 8.4, 
C(2)H), 4.04 (1H, t, J 8.4, C(3)H), 4.42-4.56 (2H, m, PhCH2), 5.08-5.19 (2H, m, C(5)H), 6.05 (1H, dt, 
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J 17.8, 9.8, C(4)H), 6.37 (1H, br s, NH), 7.27-7.40 (5H, m, ArH), 7.42 (2H, d, J 8.6, C(3)ArC(2,6)H), 
8.18 (2H, d, J 8.6, C(3)ArC(3,5)H); 13C{1H} NMR (126 MHz, CDCl3) δC: 42.3 (N(CH3)2), 43.5 
(PhCH2), 49.4 (C(3)H), 73.0 (C(2)H), 118.5 (C(5)H2), 123.8 (C(3)ArC(3,5)H), 127.8 (ArCH), 128.2 
(ArCH), 128.9 (ArCH), 129.3 (C(3)ArC(2,6)H), 137.2 (C(4)H), 138.2 (ArC(1)), 146.6 (C(3)ArC(4)-
NO2), 149.9 (C(3)ArC(1)), 169.1 (C=O); HRMS (NSI+): C20H24N3O3 [M+H]+ found 354.1816, requires 
354.1812 (+1.1 ppm). 
(2S,3S)-N-Benzyl-3-(4-bromophenyl)-2-(dimethylamino)pent-4-enamide 273 
 
Following general procedure I, (E)-3-(4-bromophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-
oxoethyl)prop-2-en-1-ammonium bromide 258 (120 mg, 0.240 mmol, 1.0 equiv.), (+)-BTM (12.0 mg, 
0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.), iPr2NH (47 µL, 0.19 mmol, 1.4 
equiv.) in MeCN (3.5 mL) were stirred for 24 h, quenched with BnNH2 (131 µL, 1.20 mmol, 5.0 equiv.) 
and stirred for a further 24 h. Crude dr 95:5. The residue was purified by flash chromatography on silica 
gel (50→100% EtOAc/PE) to give the title compound (71 mg, 76%, >95:5 dr isolated) as an off white 
solid. 
HPLC: Chiralcel OJ-H (2% IPA:hexane, flow rate 1.5 mL min-1, 220 nm, 40 °C) tR major: 25.4 min, tR 
minor: 29.4 min, >99% ee. 
[𝛼]D
20 +93.3 (c 1.0, CHCl3); mp 115-117 °C; νmax (film, cm−1): 3291, 2918, 1641, 1552, 1487, 1009, 
928; 1H NMR (300 MHz, CDCl3) δH: 2.31 (6H, s, N(CH3)2), 3.17 (1H, d, J 8.4, C(2)H), 3.85 (1H, t, J 
8.3, C(3)H), 4.33-4.57 (2H, m, PhCH2), 5.02-5.13 (2H, m, C(5)H2), 6.06 (1H, ddd, J 16.9, 10.3, 8.3, 
C(4)H), 6.29 (1H, br s, NH), 7.14 (2H, d, J 8.4, C(3)ArC(2,6)H), 7.24-7.41 (5H, m, ArH), 7.44 (2H, d, 
J 8.4, C(3)ArC(3,5)H); 13C{1H} NMR (126 MHz, CDCl3) δC: 42.5 (N(CH3)2), 43.4 (PhCH2), 49.3 
(C(3)H), 73.5 (C(2)H), 117.4 (C(5)H2), 120.4 (C(3)ArC(4)-Br), 127.7 (ArCH), 128.2 (ArCH), 128.8 
(ArCH), 130.1 (C(3)ArC(2,6)H), 131.7 (C(3)ArC(3,5)H), 138.2 (C(4)H), 138.3 (ArC(1)), 141.0 
(C(3)ArC(1)), 169.8 (C=O); HRMS (NSI+): C20H24ON279Br [M+H]+ found 387.1069, requires 387.1067 
(+0.6 ppm). 
  
Chapter 6: Experimental Details 
 
 
164 
(2S,3S)-N-Benzyl-3-(2-bromophenyl)-2-(dimethylamino)pent-4-enamide 274 
 
Following general procedure I, (E)-3-(2-bromophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-
oxoethyl)prop-2-en-1-ammonium bromide 254 (120 mg, 0.240 mmol, 1.0 equiv.), (+)-BTM (12.0 mg, 
0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.), iPr2NH (47 µL, 0.19 mmol, 1.4 
equiv.) in MeCN (3.5 mL) were stirred for 24 h, quenched with BnNH2 (131 µL, 1.20 mmol, 5.0 equiv.) 
and stirred for a further 24 h. Crude dr >95:5. The residue was purified by flash chromatography on 
silica gel (50→100% EtOAc/PE) to give the title compound (51 mg, 55%, >95:5 dr isolated) as an off 
white solid. 
HPLC: Chiralpak AD-H (2.5% IPA:hexane, flow rate 1.5 mL min-1, 200 nm, 40 °C) tR major: 13.8 min, 
tR minor: 19.0 min, 86% ee. 
[α]D
20 +42.0 (c 1.0, CHCl3); mp 122-126 °C; νmax (film, cm−1): 3293, 2924, 1638, 1553, 1454, 1267, 
1222, 1020, 918; 1H NMR (500 MHz, CDCl3) δH: 2.33 (6H, s, N(CH3)2), 3.27 (1H, d, J 7.1, C(2)H), 
4.40 (1H, t, J 8.2, C(3)H), 4.46 (2H, d, J 5.2, PhCH2), 5.08-5.19 (2H, m, C(5)H2), 6.11 (1H, dt, J 17.5, 
9.3, C(4)H), 6.43 (1H, br s, NH), 7.07-7.13 (1H, m, o-BrAr(4)CH), 7.25-7.39 (7H, m, 2 × C(3)ArCH 
and 5 × ArH), 7.57 (1H, dd, J 8.0, 1.1, C(3)ArC(3)H); 13C{1H} NMR (126 MHz, CDCl3) δC: 42.8 
(N(CH3)2), 43.4 (PhCH2), 48.7 (C(3)H), 72.8 (C(2)H), 117.8 (C(5)H2), 124.7 (ArC(2)-Br), 127.5 
(ArCH), 127.6 (ArCH), 128.1 (C(3)ArC(5)H), 128.2 (ArCH), 128.8 (ArCH), 130.0 (ArCH), 133.2 
(C(3)ArC(3)H), 137.0 (C(4)H), 138.3 (C(3)ArC(1)), 140.7 (ArC(1)), 170.2 (C=O); HRMS (NSI+): 
C20H24ON279Br [M+H]+ found 387.1070, requires 387.1067 (+0.9 ppm). 
Crystal data for 274: C20H23BrN2O, M = 378.32, colourless prism, orthorhombic space group P 21 21 
21; a = 8.039(2) Å, b = 9.628(2) Å, c = 24.585(5) Å, α = β = γ = 90°, V = 1902.7(7) Å3, Z = 4, Dc = 
1.352 g cm−3, flack parameter = 0.046(5), R = 0.0257, RW = 0.0623 for 3464 data with I> 2σ(I) and 255 
parameters. Data were recorded at 93 K on Saturn 70 diffractometer using multi-layer mirror 
monochromated MoKa (I = 0.71075 Å) radiation and the structures were solved by direct methods and 
refined using full-matrix least square analysis. 
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(2S,3S)-N-Benzyl-2-(dimethylamino)-3-(2-methoxyphenyl)pent-4-enamide 275 
 
Following general procedure I, (E)-3-(2-methoxyphenyl)-N,N-Dimethyl-N-(2-(4-nitrophenoxy)-2-
oxoethyl)prop-2-en-1-ammonium bromide 256 (108 mg, 0.240 mmol, 1.0 equiv.), (+)-BTM (12.0 mg, 
0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.), iPr2NH (47 µL, 0.19 mmol, 1.4 
equiv.) in MeCN (3.5 mL) were stirred for 24 h, quenched with BnNH2 (131 µL, 1.20 mmol, 5.0 equiv.) 
and stirred for a further 24 h. Crude dr 94:6. The residue was purified by flash chromatography on silica 
gel (50→100% EtOAc/PE) to give the title compound (27 mg, 33%, >95:5 dr isolated) as a pale yellow 
solid. 
HPLC: Chiralpak AD-H (1% IPA:hexane, flow rate 1.5 mL min-1, 220 nm, 40 °C) tR major: 41.6 min, 
tR minor: 64.0 min, 95% ee. 
[α]D
20 +61.6 (c 0.18, CHCl3); mp 147-149 °C; νmax (film, cm−1): 3933, 2934, 1641, 1492, 1242, 1029, 
916; 1H NMR (500 MHz, CDCl3) δH: 2.28 (6H, s, N(CH3)2), 3.32 (1H, d, J 7.8, C(2)H), 3.83 (3H, s, 
OCH3), 4.25 (1H, t, J 8.3, C(3)H), 4.43 (2H, d, J 5.6, PhCH2), 5.01-5.14 (2H, m, C(5)H), 6.14-6.25 (1H, 
m, C(4)H), 6.39 (1H, br s, NH), 6.85 (1H, d, J 8.2, C(3)Ar(3)H), 6.92 (1H, t, J 7.4, C(3)ArC(4)H), 7.13-
7.37 (7H, m, C(3)Ar(5 & 6)H and 5 × ArH); 13C{1H} NMR (126 MHz, CDCl3) δC: 42.7 (N(CH3)2), 
43.3 (PhCH2), 43.7 (C(3)H), 55.5 (OCH3), 72.5 (C(2)H), 110.8 (ArCH), 116.8 (C(5)H2), 120.8 (ArCH), 
127.6 (2 × ArCH), 128.2 (ArCH), 128.7 (ArCH), 129.4 (ArCH), 130.4 (C(3)ArC(1)), 138.1 (C(4)H), 
138.5 (ArC(1)), 156.6 (ArC(2)-OMe), 170.9 (C=O); HRMS (NSI+): C21H27O2N2 [M+H]+ found 
339.2070, requires 339.2067 (+0.9 ppm). 
(2S,3S,E)-N-Benzyl-2-(dimethylamino)-5-phenyl-3-vinylpent-4-enamide 279 
 
Following general procedure J, (2E,4E)-N,N-dimethyl-5-phenylpenta-2,4-dien-1-amine 251 (47 mg, 
0.250 mmol, 1.05 equiv.) and 4-nitrophenyl 2-bromoacetate 213 (62 mg, 0.24 mmol, 1.0 equiv.) in 
MeCN (1.75 mL) were stirred for 24 h, followed by addition of (+)-BTM (12.0 mg, 0.048 mmol, 0.2 
equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and iPr2NH (47 µL, 0.19 mmol, 1.4 equiv.) in MeCN 
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(1.75 mL) and stirred for a further 24 h. Quenched with BnNH2 (131 µL, 1.20 mmol, 5.0 equiv.) and 
stirred for a further 24 h. Crude dr 88:12. The residue was purified by flash chromatography on silica 
gel (30% EtOAc/PE) to give the title compound (42 mg, 51%, >95:5 dr isolated) as an off white solid. 
HPLC: Chiralcel OJ-H (4% IPA:hexane, flow rate 1.5 mL min-1, 254 nm, 40 °C) tR major: 12.8 min, tR 
minor: 16.0 min, 96% ee. 
[α]D
20 +89.5 (c 1.0, CHCl3); mp 133-136 °C; νmax (film, cm−1): 3292, 2934, 1641, 1545, 1454, 1213, 
1028, 962; 1H NMR (500 MHz, CDCl3) δH: 2.34 (6H, s, N(CH3)2), 2.93 (1H, d, J 5.7, C(2)H), 3.51 (1H, 
q, J 6.8, C(3)H), 4.45 (2H, d, J 5.1, PhCH2), 5.05-5.20 (2H, m, C(5’)H), 5.97 (1H, ddd, J 17.3, 10.3, 
7.1, C(4’)H), 6.33 (1H, dd, J 15.9, 7.7, C(4)H), 6.42 (1H, d, J 15.9, C(5)H), 6.73 (1H, br s, NH), 7.18-
7.36 (10H, m, ArH); 13C{1H} NMR (126 MHz, CDCl3) δC: 43.3 (PhCH2), 43.4 (N(CH3)2), 47.3 (C(3)H), 
74.5 (C(2)H), 117.1 (C(5’)H2), 126.5 (ArCH), 127.4 (ArCH), 127.6 (ArCH), 128.1 (ArCH), 128.6 
(ArCH), 128.8 (ArCH), 129.5 (C(4)H), 131.6 (C(5)H), 137.5 (ArC(1’)), 137.7 (C(4’)H), 138.4 
(ArC(1)), 170.9 (C=O); HRMS (ESI+): C22H27ON2 [M+H]+ found 335.2114, requires 335.2123 (1.2 
ppm). 
(2S,3S)-N-Benzyl-2-(dimethylamino)-3-(1-tosyl-1H-indol-3-yl)pent-4-enamide 280 
 
Following general procedure J, (E)-N,N-dimethyl-3-(1-tosyl-1H-indol-3-yl)prop-2-en-1-amine 252 (89 
mg, 0.250 mmol, 1.05 equiv.) and 4-nitrophenyl 2-bromoacetate 213 (62 mg, 0.24 mmol, 1.0 equiv.) in 
MeCN (1.75 mL) were stirred for 24 h, followed by addition of (+)-BTM (12.0 mg, 0.048 mmol, 0.2 
equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and iPr2NH (47 µL, 0.19 mmol, 1.4 equiv.) in MeCN 
(1.75 mL) and stirred for a further 24 h. Quenched with BnNH2 (131 µL, 1.20 mmol, 5.0 equiv.) and 
stirred for a further 24 h. Crude dr >95:5. The residue was purified by flash chromatography on silica 
gel (0→5% Et2O/CH2Cl2) to give the title compound (67 mg, 56%, >95:5 dr isolated) as an off white 
solid. 
HPLC: Chiralpak AD-H (10% IPA:hexane, flow rate 1.5 mL min-1, 220 nm, 40 °C) tR major: 15.5 min, 
tR minor: 21.8 min, 92% ee. 
[α]D
20 +39.1 (c 1.0, CHCl3); mp 62-64 °C; νmax (film, cm−1): 3290, 2926, 1643, 1447, 1362, 1169, 1120, 
1070, 978; 1H NMR (500 MHz, CDCl3) δH: 2.30 (6H, N(CH3)2), 2.30 (3H, s, TsCH3), 3.27-3.37 (1H, 
m, C(2)H), 4.10 (1H, t, J 7.8, C(3)H), 4.40 (2H, d, J 5.1, PhCH2), 4.98-5.14 (2H, m, C(5)H), 6.04 (1H, 
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dt, J 17.6, 8.9, C(4)H), 6.39 (1H, br s, NH), 7.16 (2H, d, J 8.2, TsArC(3,5)H), 7.18-7.23 (2H, m, 
IndArC(5 and 6)H), 7.27-7.34 (5H, m, ArH), 7.49 (1H, d, J 7.8, IndArC(4)H), 7.54 (1H, s, IndArC(2)H), 
7.71 (2H, d, J 8.2, TsArC(2,6)H), 7.95 (1H, d, J 8.3, IndArC(7)H); 13C{1H} NMR (126 MHz, CDCl3) 
δC: 21.7, 40.9, 42.7, 43.4, 72.6, 114.0, 117.6, 119.7, 122.1, 123.3, 124.7 (2 × C), 126.9, 127.6, 128.1, 
128.8, 129.9, 130.6, 135.3, 135.3, 137.0, 138.2, 144.8, 170.0; HRMS (ESI+): C29H32O3N3S [M+H]+ 
found 502.2155, requires 502.2164 (0.7 ppm). 
(2S,3S)-N-Benzyl-3-(3-bromophenyl)-2-(dimethylamino)pent-4-enamide 281 
 
Following general procedure J, (E)-3-(3-bromophenyl)-N,N-dimethylprop-2-en-1-amine 246 (61 mg, 
0.250 mmol, 1.05 equiv.) and 4-nitrophenyl 2-bromoacetate 213 (62 mg, 0.24 mmol, 1.0 equiv.) in 
MeCN (1.75 mL) were stirred for 24 h, followed by addition of (+)-BTM (12.0 mg, 0.048 mmol, 0.2 
equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and iPr2NH (47 µL, 0.19 mmol, 1.4 equiv.) in MeCN 
(1.75 mL) and stirred for a further 24 h. Quenched with BnNH2 (131 µL, 1.20 mmol, 5.0 equiv.) and 
stirred for a further 24 h. Crude dr >95:5. The residue was purified by flash chromatography on silica 
gel (30→70% EtOAc/PE) to give the title compound (65 mg, 70%, >95:5 dr isolated) as a pale yellow 
solid. 
HPLC: Chiralcel OJ-H (2% IPA:hexane, flow rate 1.5 mL min-1, 211 nm, 40 °C) tR major: 20.9 min, tR 
minor: 28.8 min, 91% ee. 
[α]D
20 +73.0 (c 1.0, CHCl3); mp 113-116 °C; νmax (film, cm−1): 3298, 2922, 1645, 1537, 1474, 1452, 
1354, 1255, 918; 1H NMR (500 MHz, CDCl3) δH: 2.32 (6H, s, N(CH3)2), 3.22 (1H, d, J 7.9, C(2)H), 
3.85 (1H, t, J 8.4, C(3)H), 4.46 (2H, d, J 5.6, PhCH2), 5.04-5.10 (2H, m, C(5)H), 6.04 (1H, ddd, J 16.8, 
10.4, 8.4, C(4)H), 6.35 (1H, br s, NH), 7.15-7.20 (2H, m, C(3)ArH), 7.25-7.31 (3H, m, ArH), 7.31-7.36 
(3H, m, 1 × C(3)ArH and 2 × ArH), 7.39 (1H, s, C(3)Ar(2)H); 13C{1H} NMR (126 MHz, CDCl3) δC: 
42.5 (N(CH3)2), 43.4 (PhCH2), 49.6 (C(3)H), 73.3 (C(2)H), 117.6 (C(5)H2), 122.6 (ArC(2)-Br), 127.1 
(ArCH), 127.7 (ArCH), 128.2 (ArCH), 128.8 (ArCH), 129.8 (ArCH), 130.2 (ArCH), 131.4 (ArCH), 
137.9 (C(4)H), 138.3 (ArC(1)), 144.3 (C(3)ArC(1)), 169.6 (C=O); HRMS (NSI+): C20H24ON279Br 
[M+H]+ found 387.1071, requires 387.1067 (+1.2 ppm). 
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(2S,3S)-N-Benzyl-2-(dimethylamino)-3-(4-(trifluoromethyl)phenyl)pent-4-enamide 282 
 
Following general procedure J, (E)-N,N-dimethyl-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-amine 
250 (58 mg, 0.250 mmol, 1.05 equiv.) and 4-nitrophenyl 2-bromoacetate 213 (62 mg, 0.24 mmol, 1.0 
equiv.) in MeCN (1.75 mL) were stirred for 24 h, followed by addition of (+)-BTM (12.0 mg, 0.048 
mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and iPr2NH (47 µL, 0.19 mmol, 1.4 equiv.) 
in MeCN (1.75 mL) and stirred for a further 24 h. Quenched with BnNH2 (131 µL, 1.20 mmol, 5.0 
equiv.) and stirred for a further 24 h. Crude dr >95:5. The residue was purified by flash chromatography 
on silica gel (5→20% Et2O/CH2Cl2) to give the title compound (47 mg, 52%, >95:5 dr isolated) as an 
off white solid. 
HPLC: Chiralpak AD-H (1% IPA:hexane, flow rate 1.5 mL min-1, 211 nm, 40 °C) tR major: 37.0 min, 
tR minor: 44.7 min, 85% ee. 
[α]D
20 +70.6 (c 0.5, CHCl3); mp 160-163 °C; νmax (film, cm−1): 3284, 2917, 1641, 1557, 1322, 1152, 
1119, 1067, 927; 1H NMR (500 MHz, CDCl3) δH: 2.31 (6H, s, N(CH3)2), 3.26 (1H, d, J 8.4, C(2)H), 
3.96 (1H, t, J 8.4, C(3)H), 4.47 (2H, apt t, J 5.7, PhCH2), 5.16-5.03 (2H, m, C(5)H), 6.07 (1H, ddd, J 
18.4, 10.1, 8.5, C(4)H), 6.39 (1H, br s, NH), 7.19-7.44 (7H, m, C(3)ArC(2,6)H and 5 × ArH), 7.57 (2H, 
d, J 8.1, C(3)ArC(3,5)H); 13C{1H} NMR (126 MHz, CDCl3) δC: 42.4 (N(CH3)2), 43.4 (PhCH2), 49.6 
(C(3)H), 73.2 (C(2)H), 117.8 (C(5)H2), 124.4 (q, 1JCF 272, CF3), 125.5 (q, 3JCF 4, C(3)ArC(3,5)H), 127.7 
(ArCH), 128.2 (ArCH), 128.7 (ArCH), 128.7 (q, 2JCF 32, C(3)ArC(4)), 128.9 (ArCH), 137.9 (C(4)H), 
138.2 (ArC(1)), 146.1 (C(3)ArC(1)), 169.6 (C=O); 19F{1H} NMR (470 MHz, CDCl3) δF: 62.3 (CF3); 
HRMS (NSI+): C21H24ON2F3 [M+H]+ found 377.1837, requires 377.1835 (+0.5 ppm). 
(S)-tert-Butyl 4-(1-(benzylamino)-1-oxopent-4-en-2-yl)piperazine-1-carboxylate 289 
 
Following general procedure J, 1-allyl-4-(tert-butoxycarbonyl)-1-(2-(4-nitrophenoxy)-2-
oxoethyl)piperazin-1-ium bromide 288 (117 mg, 0.240 mmol, 1.0 equiv.), (+)-BTM (12.0 mg, 0.048 
mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.), iPr2NH (47 µL, 0.19 mmol, 1.4 equiv.) in 
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MeCN (3.5 mL) were stirred for 24 h, quenched with BnNH2 (131 µL, 1.20 mmol, 5.0 equiv.) and 
stirred for a further 24 h. The residue was purified by flash chromatography on silica gel (0→10% 
Et2O/CH2Cl2) to give the title compound (68 mg, 76%, >95:5 dr isolated) as an off white solid. 
HPLC: Chiralpak AD-H (5% IPA:hexane, flow rate 1.5 ml min-1, 211 nm, 40 °C) tR major: 13.3 min, 
tR minor: 16.5 min, 56% ee. 
[α]D
20 +8.7 (c 1.0, CHCl3); mp 77-79 °C; νmax (film, cm−1): 3261, 2970, 1695, 1643, 1415, 1244, 1120, 
995; 1H NMR (500 MHz, CDCl3) δH: 1.44 (9H, s, OC(CH3)3), 2.43-2.50 (3H, m, 2 × C(2,6)HAHB and 
C(3’,5’)HAHB), 2.56-2.65 (3H, m, 2 × C(2,6)HAHB and C(3’,5’)HAHB), 3.07 (1H, t, J 6.3, C(2’)H), 3.30-
3.44 (4H, m, C(3,5)H), 4.37-4.51 (2H, m, PhCH2), 5.05 (1H, dd, J 10.2, 1.5, C(5’)H
cis), 5.11 (1H, dd, J 
17.0, 1.5, C(5’)Htrans), 5.86 (1H, ddd, J 17.0, 10.2, 1.5, C(4’)H), 7.23-7.36 (5H, m, ArH); 13C{1H} NMR 
(126 MHz, CDCl3) δC: 28.5 (C(CH3)3), 32.4 (C(2’)H), 43.3 (C(2,6)H2), 43.4 (PhCH2), 50.3 (C(3,5)H2), 
69.1 (C(3)H), 80.0 (C(CH3)3), 117.5 (C(5’)H2), 127.7 (ArCH), 127.8 (ArCH), 128.9 (ArCH), 135.5 
(C(4’)H), 138.5 (ArC(1)), 154.8 (Boc-C=O), 172.0 (C=O); HRMS (ESI+): C21H32O3N3 [M+H]+ found 
374.2427, requires 374.2444 (3.0 ppm). 
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Experimental Details for Chapter 3 
Standard Kinetic Procedure 
 
Typical Experiment: (E)-3-(4-fluorophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)prop-2-
en-1-ammonium bromide 309 (10.5 mg, 0.024 mmol) was added to a NMR tube and dissolved in d3-
MeCN (540 µL, spiked with PhCF3 25 µL/10 mL) and d6-DMSO (60 µL) with sonication. The NMR 
tube was loaded into a NMR spectrometer that had been pre-cooled to −20 °C, the sampled locked to 
d3-MeCN, shimmed and an initial 19F {1H} spectrum acquired (ns = 1 or ns = 32, d1 = 15 s, sweep width 
80 ppm (spectral centre −90 ppm). The sample was then removed from the spectrometer and placed in 
a −20 °C bath (CO2 (s)/acetone) before a sample (100 µL) of a 2 mL stock solution containing (+)-BTM 
(24 mg, 0.96 mmol) and iPr2NH (94 µL, 0.67 mmol) in d3-MeCN/d6-DMSO (9:1) was added. The 
sample was returned to the NMR spectrometer and the kinetic experiment initiated.  
General Considerations: Stock solutions were prepared by adding reagents directly to volumetric 
glassware. The required stock solution volume was measured using a gas-tight 100 µL syringe. Kinetic 
experiments were collected at 471 MHz, kinetic experiments (arrays of spectra) were implemented 
using Bruker Topspin software. Typical experiment 1 scan per spectrum, 598 s delay between the start 
of each spectrum or 32 scans (15 s delay between scans) per spectrum with 91 s between the start of 
each spectrum. For typical kinetic runs 24 spectra were collected and processed using MestRe Nova 9.0 
software. Time points were taken from NMR spectra timestamps from Bruker Topspin, the time at 
which the stock solution was added was recorded from Bruker Topspin software. 
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Typical Kinetic Profile and Analysis 
Typical 19F {1H} NMR of Kinetic Run 
 
Scheme 123: Typical 19F{1H} NMR (471 MHz) (d3-MeCN/d6-DMSO (9:1), 253 K) in the ArF region 
at ~10000 s, (+)-BTM (6.8 mM), HOBt (13.6 mM), iPr2NH (47.6 mM), Ammonium Salt (34 mM) 
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Component δF: (ppm) (d3-MeCN/d6-DMSO, 471 MHz) 
 
−113.12 
 
−113.69 
 
−116.47 
 
−117.02  
 
−117.21 
 
−117.59 
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−117.63 
Table 4: Reaction species and corresponding chemical shifts. 
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Intermediate Identification 
Catalyst Resting State Studies 
To identify the unknown intermediate species δF: = −117.0 ppm, F-BTM 315 was employed with 309 
and the process monitored by 19F {1H} NMR.  
 
Scheme 124: Rearrangement of 309 using (+)-F-BTM 
Following the standard kinetic procedure with slight modification, except using (+)-F-BTM in place of 
(+)-BTM. Two fluorinated catalyst derived species were observed throughout the reaction a signal at 
δF: −123.35 ppm which corresponds to (+)-F-BTM and a signal at δF: −113.44 ppm. Simplified model 
compounds are synthesised to attempt to identify the signal at δF: −113.44 ppm. Based upon the shift 
of benzoylated F-BTM 317 the unknown species was identified as an acyl ammonium intermediate.  
 
Figure 13: 19F{1H} NMR (471 MHz) (d3-MeCN/d6-DMSO (9:1), 253 K) in the ArF region, (+)-F-
BTM (6.8 mM), iPr2NH (47.6 mM), Ammonium Salt (34 mM) 
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Figure 14: Fluorinated isothiourea derivatives 315, 316 and 317 and δF 
Isotopic Labelling 
13C2-322 with 15N-F-BTM 15N-321 
To unambiguously identify the acyl ammonium species, an isotopic labelling strategy was used. Firstly, 
13C2 substrate 13C2-322 and 15N catalyst 15N-321 were employed. 
 
Scheme 125: Isotopic labelling studies of catalyst and substrate 
A solution of 13C2 ammonium salt 13C2-322 (10.5 mg, 0.024 mmol, 34 mM) in d3-MeCN/d6-DMSO 
(9:1) (600 µL) was prepared in an NMR tube. The NMR tube was loaded into a pre-cooled spectrometer 
(273 K) and an initial 13C {1H} (101 MHz) spectrum was taken. The solution was treated with a 100 µL 
sample of a 1 mL stock solution (15N-F-BTM 15N-321 (13 mg, 0.048 mmol) and iPr2NH (23.5 µL, 0.168 
mmol) in d3-MeCN/d6-DMSO (9:1)) at 0 °C. The sample returned to the spectrometer a 13C {1H} 
spectrum (ns = 16, d1 = 2 s) were recorded every 10 min for 40 min.  
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13C3-341 with (+)-F-BTM 315 
To unambiguously determine if the intermediate is pre- or post-rearrangement, 13C3 substrate 13C3-341 
was used.  
 
Scheme 126: 13C3-341 with (+)-F-BTM catalyst 315 
A solution of 13C3 ammonium salt 13C3-341 (10 mg, 0.024 mmol, 34 mM) in d3-MeCN/d6-DMSO (9:1) 
(600 µL) was prepared in an NMR tube. The NMR tube was loaded into a pre-cooled spectrometer (273 
K) and an initial 13C {1H} (101 MHz) spectrum was taken. The solution was then treated with a 100 µL 
sample of a 1 mL stock solution ((+)-F-BTM 315 (13 mg, 0.048 mmol) and iPr2NH (23.5 µL, 0.168 
mmol) in d3-MeCN/d6-DMSO (9:1)) at 0 °C. The sample returned to the spectrometer amd 13C{1H} 
spectra (ns = 16, d1 = 2 s) were recorded every 10 min for 40 min.  
Reversibility of [2,3]-Rearrangement 
A solution of (E)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl-1,2-13C2)-3-phenylprop-2-en-1-
ammonium-3-13C bromide 13C3-341 (10.0 mg, 0.024 mmol, 1.0 equiv.) in d3-MeCN/d6-DMSO (9:1) 
(600 µL) in an NMR tube was treated with 100 µL of a 1 mL stock solution ((+)-F-BTM (65 mg, 0.24 
mmol) and iPr2NH (24 µL, 0.17 mmol) at rt. The reaction was monitored by 19F and 13C NMR until full 
conversion 13C3-341 substrate was observed. Once 13C3-341 was fully consumed (E)-3-(4-
fluorophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl-2-13C)prop-2-en-1-ammonium 
bromide 13C1-344 (10 .5 mg, 0.024 mmol, 1.0 equiv.) was added, the resulting solution was monitored 
by in situ 13C NMR, for 1 h and no reversal of 13C3 material into the substrate was observed. iPr2NH 
(2.3 µL, 0.017 mmol, 0.7 equiv.) was added and the reaction monitored for a further 30 mins, again no 
reversal of 13C3 material into the substrate was observed. Further iPr2NH (4.7 µL, 0.034 mmol, 1.4 
equiv.) was added and the reaction was monitored for a further 30 mins and no reversal of 13C3 material 
was observed in the substrate. This indicates that the [2,3]-rearrangement step is highly irreversible.  
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Scheme 127: Reversibility studies of the [2,3]-rearrangement step 
Entrainment Study 
13C2-333 entrained into 13C1-344 reaction within the pseudo-steady state 
In order to determine if the observed intermediate is on or off the catalytic cycle an isotopic entrainment 
experiment was undertaken. A 13C1 catalytic cycle was set up and once it has reached pseudo-steady-
state 13C2 substrate was entrained into the catalytic cycle and the rate of growth of the 13C2 intermediate 
and 13C2 product was monitored.  
 
Scheme 128: Isotopic entrainment of 13C2 substrate 13C2-333 (17 mM) into 13C1 catalytic cycle (13C1 
substrate 13C1-344 (17 mM), (+)-BTM (6.8 mM), iPr2NH (47.6 mM)) within the pseudo-steady-state 
A solution of 13C1 ammonium salt 13C1-344 (5.25 mg, 0.012 mmol, 17 mM) in d3-MeCN/d6-DMSO 
(9:1) (600 µL) was prepared in an NMR tube. The NMR tube was loaded into a pre-cooled spectrometer 
(253 K) and an initial inverse gated quantitative 13C {1H} (ns = 16, d1 = 30 s) (126 MHz) spectrum was 
taken. The solution was then treated with a 100 µL sample of a 2 mL stock solution ((+)-BTM (24 mg, 
0.096 mmol) and iPr2NH (94 µL, 0.67 mmol) in d3-MeCN/d6-DMSO (9:1)) at −20 °C and the sample 
returned to the spectrometer. The reaction was monitored for ~2000 s taking a 13C {1H} every 606 s, 
until the reaction reached the pseudo-steady-state, at which point the NMR tube was removed from the 
spectrometer and 13C2 ammonium salt 13C2-333 (5.25 mg, 0.012 mmol, 17 mM) was added at −20 °C, 
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the NMR tube was then returned to the spectrometer and a kinetic run initiated (ns = 16, d1 = 30 s, 606 
s between the start of each spectrum, 25 spectra).  
Non-Linear Effects  
To probe the relationship between the enantiopurity of the (+)-BTM 197 catalyst the enantiomeric 
excess of the product, 310 was treated under standard catalytic conditions, using five different samples 
of catalyst with different enantiopurities. Stock solutions of (+)-BTM 197 with different enantiopurities 
were prepared by mixing the appropriate quantities of (+)-BTM and (−)-BTM in MeCN (4 mL, 0.055 
mmol total of BTM). The enantiopurity of the catalyst stock solutions was measured via chiral HPLC 
analysis.  
 
General Procedure 
Stock solution of (+)-BTM (3.5 mL, 0.048 mmol) was treated with HOBt (6.4 mg, 0.048 mmol, 0.2 
equiv.) and iPr2NH (47 µL, 0.34 mmol, 1.4 equiv.) and cooled to −20 °C. The resulting solution was 
treated with (E)-3-(4-fluorophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)prop-2-en-1-
ammonium bromide (105 mg, 0.24 mmol, 1.0 equiv.) and stirred for 16 h. Once complete the mixture 
was treated with NaOMe (1 M in MeOH, 0.72 mL, 0.72 mmol, 3.0 equiv.) and the stirred at rt for 1 h, 
diluted with CH2Cl2 (20 mL) and aq. 1 M NaOH (10 mL), the layers separated and the aqueous extracted 
with CH2Cl2 (2 × 20 mL). The combined organic layers were washed with aq. 1 M NaOH (10 mL) and 
brine (10 mL) dried over MgSO4 then concentrated in vacuo. The crude residue (>95:5 dr) was purified 
by flash column chromatography on silica gel (10-15% EtOAc/hexanes) to give the product as a 
colourless oil (>95:5 dr), ee measured by chiral HPLC analysis.  
Entry (+)-BTM ee (%) Product ee (%) 
1 0 0 
2 19 16 
3 54 59 
4 65 61 
5 100 98 
a Determined by HPLC analysis on a chiral stationary phase 
Chapter 6: Experimental Details 
 
 
179 
0 50 100
0
50
100
P
ro
d
u
c
t 
e
e
 (
%
)
(+)-BTM ee (%)
y = 0.99x -0.37
 
Figure 14: Probing non-linear effects of catalyst enantiopurity 
 
Kinetic Isotope Effects 
α-Deuterium Primary Kinetic Isotope Effect 
To probe if α-deprotonation is kinetically significant, α-D2 ammonium salt d2-351 was prepared, 
however only 75% D incorporation was achieved. It was found that significant H/D exchange occurs in 
d3-MeCN/d6-DMSO (9:1). Treating α-D2 ammonium salt d2-351 under the standrard reaction conditions 
(Scheme 129), further H/D exchange was achieved, 29% D incorporation by 19F{1H} NMR, isolated of 
the α-D product d1-358, lead to further H/D exchange. 
 
Scheme 129: H/D exchange under reaction conditions of α-D2 ammonium salt d2-351 
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4-Nitrophenyl (2S,3S)-2-(dimethylamino)-3-(4-fluorophenyl)pent-4-enoate-2-d d1-358 
 
Following general procedure L, (E)-3-(4-fluorophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-
oxoethyl)prop-2-en-1-ammonium-3-d bromide d2-351 (105 mg, 0.24 mmol, 1.0 equiv.) was reacted 
with (+)-BTM (12 mg, 0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and iPr2NH 
(47 μL, 0.34 mmol, 1.4 equiv.) in MeCN (3.5 mL). Direct purification via flash column chromatography 
(15% EtOAc/hexanes) gave the title product as a pale yellow solid (35 mg, 41%, 10% D) 
1H NMR (500 MHz, CDCl3) δH: 2.41 (6H, s, N(CH3)2), 3.81-3.93 (1.8 H, m, C(2)H + C(3)H), 5.13-5.30 
(2H, m,C(5)H2), 5.98 (1H, ddd, J 17.6, 10.1, 7.9, C(4)H), 7.08 (2H, t, J 8.6, C(3)Ar(3,5)H), 7.21-7.32 
(4H, m, C(3)Ar(2,6)H + OAr(2,6)H), 8.31 (2H, d, J 9.0, OAr(3,5)H); 19F{1H} NMR (376 MHz, CDCl3) 
δF: −115.8 (ArF); 13C{1H} NMR (101 MHz, CDCl3) δC: 41.4 (N(CH3)2 (C(2)D)), 41.4 (N(CH3)2 
(C(2)H)), 49.4 (C(3)H (C(2)D)), 49.5 (C(3)H (C(2)H), 70.4 (t, 1JCD 22, C(2)D), 70.8 (C(2)H), 115.7 (d, 
2JCF 21, C(3)ArC(3,5)H), 117.6 (C(5)H2), 122.8 (OArC(2,6)H), 125.4 (OArC(3,5)H), 129.4 (d, 3JCF 8, 
C(3)ArC(2,6,)H), 135.8 (d, 4JCF 3, C(3)ArC(1)), 138.3 (C(4)H), 145.6 (ArC(1)-O), 155.2 (ArC(4)-NO2), 
161.8 (d, 1JCF 245, ArC-F), 168.4 (C=O); HRMS: Due to low deuterium incorporation an accurate high 
resolution mass spectrum could not be obtained.  
  
Chapter 6: Experimental Details 
 
 
181 
Hammett Plot 
 
Scheme 130: Ammonium salts and rearrangement for Hammett analysis. 
Hammett analysis by indepent rate measurement 
Following the standard kinetic procedure, the requiste ammonium salt (0.024 mmol, 1.0 equiv.) was 
treated with a 100 µL aliquot of a 2 mL stock solution, containing (+)-BTM, and iPr2NH, in d3-
MeCN/d6-DMSO (9:1). First order rate constants were extracted within the pseudo-steady state and 
compared.  
Hammett analysis by five-way competition 
Following the standard kinetic procedure with slight modification, all five ammonium salts 372-376 
(0.0048 mmol, 6.8 mM) were weiged into an NMR tube then solvated with d3-MeCN/d6-DMSO (9:1, 
600 µL total volume) and loaded into a pre-cooled spectrometer (471 MHz, 253 K), and a t=0 19F{1H} 
NMR spectrum (80 ppm sweep width, spectral centre −100 ppm, ns = 32, d1 = 15 s, expt 8 min 29 s) 
was taken. The sample was removed from the spectrometer and placed in a −20 °C cooling bath (CO2 
(s), acetone) a 100 µL aliquot of a 2 mL stock solution, containing (+)-BTM (0.096 mmol), and iPr2NH 
(0.672 mmol), in d3-MeCN/d6-DMSO (9:1). The sample returned to the spectrometer and the kinetic 
run initated (24 spectra, 91 s delay between spectra). First-order rate constants were extracted from the 
decay of each of the substrates.  
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Figure 15: 19F{1H} NMR spectrum containg internal standrard PhCF3 (−62.9 ppm) and five 
ammonium salts 
Ammonium salt δF: (ppm) (d3-MeCN/d6-DMSO, 471 MHz) 
 
−96.0 
 
−109.1 
 
−114.4 
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−118.6 
 
−136.5 
Table 5: Ammonium salts and δF: chemical shift, used in Hammett analysis. 
Crossover Experiments 
Phenol Crossovers 
A flamed dried Schlenk under Ar was charged with (+)-BTM (12 mg, 0.24 mmol, 0.2 equiv.) and HOBt 
(6.4 mg, 0.24 mmol, 0.2 equiv.) in MeCN (3.5 mL) the resulting solution was cooled to −20 °C and 
stirred for 5 min. (E)-N-(2-(3,5-bis(trifluoromethyl)phenoxy)-2-oxoethyl)-3-(4-fluorophenyl)-N,N-
dimethylprop-2-en-1-ammonium bromide 366 (64 mg, 0.12 mmol, 0.5 equiv.) and (E)-N,N-dimethyl-
N-(2-(4-nitrophenoxy)-2-oxoethyl)-3-phenylprop-2-en-1-ammonium bromide 211 (50 mg, 0.12 mmol, 
0.5 equiv.) were added together and the reaction was stirred for 16 h. The reaction was quenched by the 
addition of aq. 1 M NaOH (10 mL) and extracted with CH2Cl2 (3 × 20 mL), the combined organic layers 
were washed with brine (20 mL), dried over MgSO4 and concentrated in vacuo. The crude residue was 
analysed by 19F{1H} NMR, genuine samples of the potential crossover products were individually 
added to the crude residue and then re-analysed by 19F{1H} NMR.  
 
Scheme 131. Crossover experiment between activated esters 211 and 366 
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Phenol Crossovers following by in situ 19F{1H} NMR 
Following the standard kinetic procedure, (E)-N-(2-(3,5-bis(trifluoromethyl)phenoxy)-2-oxoethyl)-3-
(4-fluorophenyl)-N,N-dimethylprop-2-en-1-ammonium bromide 366 (6.4 mg, 0.012 mmol, 0.5 equiv.) 
and (E)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)-3-phenylprop-2-en-1-ammonium bromide 
211 (5.0 mg, 0.012 mmol, 0.5 equiv.) were weighed into an NMR tube and solvated with d3-MeCN/d6-
DMSO (9:1, total volume 600 µL). The NMR tube was then loaded into a pre-cooled spectrometer (500 
MHz, 253 K) and a t=0 spectra taken. The NMR tube was removed from the spectrometer and added 
to a −20 °C (CO2 (s) acetone) bath and a 100 µL aliquot of a 2 mL stock solution containing (+)-BTM, 
HOBt, and iPr2NH in d3-MeCN/d6-DMSO (9:1) was added and the NMR tube returned to the 
spectrometer an kinetic run initiated (24 spectra, 598 s delay between spectra).  
 
Scheme 132: Crossover experiment followed by 19F{1H} NMR 
Reversibility of Product Release 
Following standard kinetic procedure A solution of (E)-N-(2-(3,5-bis(trifluoromethyl)phenoxy)-2-
oxoethyl)-3-(4-fluorophenyl)-N,N-dimethylprop-2-en-1-ammonium bromide 366 (6.4 mg, 0.012 
mmol, 0.5 equiv.) and 4-nitrophenyl syn-2-(dimethylamino)-3-phenylpent-4-enoate 218 (4.1 mg, 0.012 
mmol, 0.5 equiv.) in d3-MeCN/d6-DMSO (9:1) (600 µL) was prepared and 100 µL of a 2 mL stock 
solution ((+)-BTM (24 mg, 0.48 mmol), HOBt (12.8 mg, 0.48 mmol) and iPr2NH (94 µL, 0.68 mmol)) 
was added at −20 °C and a 19F{1H} NMR spectrum taken every 10 min. only a single fluorinated 
rearranged product was observed throughout the reaction.  
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Scheme 133: Crossover experiment a p-nitrophenyl ester product and a bis-trifluoromethyl 
ammonium salt, showing no crossover, following by 19F {1H} NMR only one fluorinated rearranged 
product observed 
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General Procedure K: Synthesis of N, N-Dimethyl Amines from Allylic Alcohols 
A solution of allylic alcohol (1.0 equiv.) in Et2O (0.33 M) was cooled to 0 °C and treated with PBr3 (0.4 
equiv.) and stirred for 1 h, the reaction was quenched by the dropwise addition of aq. sat. NaHCO3 
(equal volume), the mixture was allowed to warm to rt. The layers were then separated, the aqueous 
layer extracted with Et2O (2 × equal volume), the combined organic layers washed with brine, dried 
over MgSO4 and concentrated in vacuo. The residue was dissolved in THF (0.5 M) and added to aq. 
dimethylamine (40% wt., 5.0 equiv.) via dropping funnel, upon completion the dropping funnel was 
rinsed with THF (half volume) and the reaction was stirred at rt for 15 min. The reaction was treated 
with aq. 1 M NaOH (equal volume) and stirred for 15 min, then Et2O (equal volume) was added, the 
layers separated and the aqueous layer extracted with Et2O (2 × equal volume). The combined organic 
layers were washed with brine, dried over MgSO4 then concentrated in vacuo, the crude residue was 
purified by high vacuum distillation to give N, N-dimethyl allylic amines.  
Amine Synthesis 
Ethyl (E)-3-(4-fluorophenyl)acrylate[114] 496 
 
Following general procedure A, 4-fluorobenzaldhyde (4.7 mL, 43.6 mmol, 1.0 equiv.) was reacted with 
ethyl 2-(triphenyl-λ5-phosphanylidene)acetate (16.0 g, 46.0 mmol, 1.05 equiv.) in CH2Cl2 (50 mL) to 
give the title product (8.46 g, quant.) as a pale yellow oil after flash chromatography on silica gel 
(0→20% EtOAc/hexanes). 
1H NMR (400 MHz, CDCl3) δH: 1.33 (3H, t, J 7.1, CH2CH3), 4.26 (2H, q, J 7.1, CH2CH3), 6.35 (1H, d, 
J 16.0, C(2)H), 7.07 (2H, t, J 8.7, Ar(3,5)H), 7.50 (2H, dd, J 8.7, 5.4, Ar(2,6)H), 7.64 (1H, d, J 16.0, 
C(3)H) ; Data consistent with literature.[114] 
(E)-3-(4-Fluorophenyl)prop-2-en-1-ol[115] 497 
 
Following general procedure C, ethyl (E)-3-(4-fluorophenyl)acrylate 496 (5.0 g, 25.8 mmol, 1.0 equiv.) 
was reacted with DIBAL-H (56.7 mL, 1.0 M in hexane, 56.7 mmol, 2.2 equiv.) in CH2Cl2 (125 mL) to 
give the title product (3.92 g, quant.) as a white solid, which was used without further purification. 
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mp 54-56 °C {lit. mp 58-60 °C}; 1H NMR (400 MHz, CDCl3) δH: 4.26-4.36 (2H, m, C(1)H2), 6.29 (1H, 
dt, J 15.9, 5.7, C(2)H), 6.58 (1H, d, J 15.9, C(3)H), 7.02 (2H, t, J 8.7, Ar(3,5)H), 7.30-7.40 (2H, m, 
Ar(2,6)H); 19F{1H} NMR (376 MHz, CDCl3) δF: −114.4 (ArF); Data consistent with literature.[115] 
(E)-3-(4-Fluorophenyl)-N,N-dimethylprop-2-en-1-amine 498 
 
Following general procedure K, (E)-3-(4-fluorophenyl)prop-2-en-1-ol 497 (6.83 g, 44.9 mmol, 1.0 
equiv.) was reacted with PBr3 (1.70 mL, 18.0 mmol, 0.4 equiv.) in Et2O (135 mL) then with 
dimethylamine (aq. 40% wt., 28.5 mL, 225 mmol, 5.0 equiv.) in THF (90 mL) to give the title product 
(4.54 g, 56% over two steps, 96:4 E:Z) as a colourless oil after high vacuum distillation 
bp 100-102 °C @ 1 mmbar; νmax (film, cm−1): 2943, 2767, 1602, 1508, 1224, 1157, 970; 1H NMR (400 
MHz, CDCl3) 2.26 (6H, s, N(CH3)2), 3.00-3.08 (2H, m, C(1)H2), 6.17 (1H, dt, J 15.8, 6.7, C(2)H), 6.46 
(1H, d, J 15.8, C(3)H), 6.99 (2H, t, J 8.7, Ar(2,6)H), 7.33 (2H, dd, J 8.7, 5.4, Ar(3,5)H); 19F NMR (472 
MHz, CDCl3) δF: −114.8 (ArF); 13C{1H} NMR (126 MHz, CDCl3) δC: 45.4 (N(CH3)2), 62.1 (C(1)H2), 
115.5 (d, 2JCF 21.5, ArC(3,5)H), 127.3 (d, J 1.9, C(2)H), 127.8 (d, 3JCF 7.9, ArC(2,6)H), 131.4 (C(3)H), 
133.3 (ArC(1)), 162.3 (d, 1JCF 246, ArC(4)-F); HRMS (NSI+): C11H15NF+ [M+H]+ found: 180.1181, 
requires: 180.1183 (−1.1 ppm). 
α-Deuterio-4-fluoro-benzaldhyde d1-353 
 
A solution of 4-fluoro-bromobenzene (6.24 mL, 56.8 mmol, 1.0 equiv.) in THF (315 mL) was cooled 
to −78 °C and treated with n-BuLi (32.6 mL, 1.92 M in hexanes, 62.5 mmol, 1.1 equiv.) dropwise. The 
resulting solution was stirred for 30 min at −78 °C and d7-DMF (5.0 g, 62.5 mmol, 1.1 equiv.) was 
added dropwise and stirred for a further 30 min. The reaction was quenched by the addition of sat. 
NH4Cl (20 mL) and aq. 1 M H2SO4 (3 drops) and allowed to warm to rt. The mixture was extracted with 
Et2O (3  200 mL), the combined organic layers washed with brine (100 mL), dried over MgSO4 and 
concentrated in vacuo. The residue was purified by distillation under vacuum to give the product as a 
colourless liquid (3.65 g, 51%); 
bp 40-42 °C @ 1 mmbar; νmax (film, cm−1): 1678 1593, 1504, 1414, 1222, 1149, 881, 810; 1H NMR 
(500 MHz, CDCl3) δH: 7.17 (2H, t, J 8.6, Ar(3,5)H), 7.79-7.93 (2H, m, Ar(2,6)H); 19F NMR (471 MHz, 
CDCl3) δF: −102.3—102.4 (m, ArF); 13C{1H} NMR (126 MHz, CDCl3) δC: 116.4 (d, 2JCF 22, 
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ArC(3,5)H), 132.3 (d, 3JCF 10, ArC(2,6)H), 132.9 (d, 4JCF 3, ArC(1)), 166.5 (d, 1JCF 257, ArC-F), 189.8-
190.5 (m, CDO); HRMS (EI+) C7H5DOF+ [M+H]+ found: 126.0464, requires: 126.0465 (−0.8 ppm). 
Ethyl (E)-3-(4-fluorophenyl)acrylate-3-d, d1-354 
 
Following general procedure A, α-deuterio-4-fluoro-benzaldhyde d1-353 (3.0 g, 24.0 mmol, 1.0 equiv.) 
was reacted with ethyl 2-(triphenyl-λ5-phosphanylidene)acetate (8.8 g, 25.2 mmol, 1.05 equiv.) in 
CH2Cl2 (30 mL) to give the title product (4.42 g, quant., 96:4 E:Z) as a white solid after flash column 
chromatography on silica gel (0→20% EtOAc/hexane). 
mp <30 °C; νmax (film, cm−1) 2991, 1708, 1625, 1586, 1506, 1311, 1230, 1174, 1078, 881; 1H NMR 
(500 MHz, CDCl3) δH: 1.33 (3H, t, J 7.1, CH2CH3), 4.26 (2H, q, J 7.1, CH2CH3), 6.35 (1H, J 2.1, 
C(2)H), 7.07 (2H, t, J 8.7, Ar(3,5)H), 7.51 (2H, dd, J 8.7, 5.4, Ar(2,6)H); 19F NMR (679 MHz, CDCl3) 
δF: −109.7- 13C{1H} NMR (126 MHz, CDCl3) δC: 14.3 (CH3), 60.6 (CH2), 116.0 (d, 2JCF 22, ArC(3,5)H), 
117.9 (C(2)H), 129.9 (d, 3JCF 8.4, ArC(2,6)H), 130.7 (d, 4JCF 3.0, ArC(1)), 142.9 (t, 1JCD 24, C(3)D), 
163.9 (d, 1JCF 251, ArC-F), 166.8 (C=O); HRMS (NSI+) C11H11DFO2+ [M+H]+ found: 196.0876, 
requires: 196.0879 (−1.3 ppm). 
(E)-3-(4-Fluorophenyl)prop-2-en-3-d-1-ol d1-355 
 
Following general procedure C, ethyl (E)-3-(4-fluorophenyl)acrylate-3-d d1-354 (3.0 g, 16.95 mmol, 
1.0 equiv.) was reacted with DIBAL-H (37.3 mL, 1.0 M in hexane, 37.3 mmol, 2.2 equiv.) in CH2Cl2 
(85 mL) to give the title product (1.77 g, 68%, 96:4 E:Z) as a white solid, which was used without 
further purification. 
mp 54-56 °C; νmax (film, cm−1): 3257, 2930, 1598, 1506, 122, 1091, 1019, 977, 837; 1H NMR (500 
MHz, CDCl3) δH: 4.28 (2H, t, J 4.2, CH2), 6.24 (1H, br. s, C(2)H), 6.95-7.00 (2H, m, Ar(3,5)H), 7.27-
7.33 (2H, m, Ar(2,6)H);19F NMR (471 MHz, CDCl3) δF: −114.3—114.4 (m, ArF); 13C{1H} NMR (126 
MHz, CDCl3) δC: 63.4 (C(1)H2), 115.5 (d, 2JCF 22.0, ArC(3,5)H), 128.0 (d, 3JCF 8.0, ArC(2,6)H), 128.2 
(C(2)H), 129.5 (t, 1JCD 24.0, C(3)D), 132.9 (ArC(1)), 162.4 (d, 1JCF 247, ArC-F); HRMS (EI+) C9H8DOF 
[M]+ found: 153.0701, requires: 153.0700 (+0.7 ppm). 
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(E)-1-(3-Bromoprop-1-en-1-yl-1-d)-4-fluorobenzene d1-499 
 
Following general procedure D, (E)-3-(4-fluorophenyl)prop-2-en-3-d-1-ol d1-355 (1.5 g, 9.80 mmol, 
1.0 equiv.) was reacted with PBr3 (418 μL, 4.44 mmol, 0.4 equiv.) in Et2O (33 mL) to give the title 
product (2.02 g, 95%), as a colourless oil, which was used immediately. 
1H NMR (500 MHz, CDCl3) δH: 4.15 (2H, d, J 7.8, C(1)H2), 6.31 (1H, t, J 7.8, C(2)H), 7.02 (2H,t, J 
8.4, Ar(3,5)H), 7.36 (2H, dd, J 8.4, 5.4, Ar(2,6)H). 
(E)-3-(4-Fluorophenyl)-N,N-dimethylprop-2-en-1-amine-3-d, d1-356 
 
Following general procedure E, (E)-1-(3-bromoprop-1-en-1-yl-1-d)-4-fluorobenzene d1-499 (1.80 g, 
8.33 mmol, 1.0 equiv.) was reacted with dimethylamine (aq. 40% wt, 5.3 mL, 41.67 mmol, 5.0 equiv.) 
in THF (18 mL) gave the title product (1.45 g, 96%, 97:3 E:Z) after high vacuum distillation.  
bp 100-102 °C @ 1 mmbar; νmax (film, cm−1): 2770, 1600, 1506, 1225, 1157, 1029, 835; 1H NMR (500 
MHz, CDCl3) δH: 1.89 (6H, s, N(CH3)2), 2.66 (2H, d J 6.8, C(1)H2), 5.81 (1H, t, J 6.8, C(2)H), 6.61 
(2H, t, J 8.7, Ar(3,5)H), 6.92-6.95 (2H, m, Ar(2,6)H); 19F{1H} NMR (282 MHz, CDCl3) δF: −114.8 
(ArF); 13C{1H} NMR (126 MHz, CDCl3) δC: 44.4 (N(CH3)2), 61.1 (C(1)H2), 114.6 (d, 2JCF 22.0, 
ArC(3,5)H), 126.5 (d, 2JCD 2.0, C(2)H), 126.9 (d, 3JCF 7.8, ArC(2,6)H), 129.9 (t, 1JCD 24.0, C(3)D), 
132.5 (d, 4JCF 3.0, ArC(1)), 161.4 (d, 1JCF 246, ArC-F); HRMS (NSI+) C11H14DNF+ [M+H]+ found: 
181.1245, requires: 181.1246 (−0.4 ppm). 
Phenylmethanol-13C[116] 13C1-337 
 
Following the procedure of Blake et.al,[116] a solution of [α-13C]-benzoic acid 13C1-336 (1.0 g, 8.13 
mmol, 1.0 equiv.) in THF (15 mL) was added dropwise to a solution of LiAlH4 (2.4 M in THF, 5.60 
mL, 13.4 mmol, 1.65 equiv.) in THF (15 mL) at 0 °C. The resulting solution was allowed to warm to rt 
and stirred for 16 h, the reaction was quenched by the addition of aq. 1 M KOH (15 mL) dropwise at 0 
°C. Et2O (30 mL) was then added and the mixture stirred for 30 min at rt, the layers separated and the 
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aqueous layer extracted with Et2O (2  30 mL). The combined organic layers were washed with aq. 1 
M HCl (30 mL), then brine (30 mL) dried over MgSO4 and concentrated in vacuo to give the product 
(972 mg, quant.) as a colourless oil which was used without further purification.  
1H NMR (500 MHz, CDCl3) δH: 4.67 (2H, ddd, J 142.4, 6.1, 3.2, Ph13CH2), 7.27-7.41 (5H, m, ArH); 
13C{1H} NMR (101 MHz, CDCl3) δC: 65.2 (13CH2), 127.1 (d, 3JCC 3, ArC(3,5)H), 127.7 (ArC(4)H), 
128.6 (d, 2JCC 4, ArC(2,6)H), 140.9 (d, 1JCC 47, ArC(1)); data consistent with the literature.[116]  
α-13C Benzaldhyde[116] 13C1-338 
 
A solution of phenylmethanol-13C 13C1-337 (972 mg, 8.13 mmol, 1.0 equiv.) in CH2Cl2 (16 mL) was 
cooled to 0 °C and treated with Celite® (2.11 g) and PCC (2.11 g, 9.76 mmol, 1.2 equiv.) and the reaction 
allowed to warm to rt and stirred for 16 h. The mixture was concentrated in vacuo and re-dissolved in 
Et2O (20 mL) and filtered through a pad of silica gel and washed with Et2O (100 mL), the filtrate was 
concentrated in vacuo to give the product as a colourless oil (554 mg, 64%); 
1H NMR (400 MHz, CDCl3) δH: 7.53 (2H, t, J 7.6, Ar(3,5)H), 7.59-7.69 (1H, m, Ar(4)H), 7.79-7.95 
(2H, m, Ar(2,6)H), 10.04 (1H, d, 1JCH 174.0, CHO); 13C{1H} NMR (101 MHz, CDCl3) δC: 129.1 (d, 
2JCC 5.0, ArC(2,6)H), 129.9 (d, 3JCC 4.0, ArC(3,5)H), 134.6 (ArC(4)H), 136.5 (d, 1JCC 54, ArC(1)), 192.5 
(13CHO); data consistent with the literature.[116]  
Ethyl cinnamate-3-13C 13C1-339 
 
Following general procedure A, α-13C benzaldhyde 13C1-338 (554 mg, 5.13 mmol, 1.0 equiv.) was 
reacted with ethyl 2-(triphenyl-λ5-phosphanylidene)acetate (1.87 g, 5.39 mmol, 1.05 equiv.) in CH2Cl2 
(6 mL) to give the title product (760 mg, 84%, 97:3 E:Z) as a yellow oil after purification by flash 
column chromatography on silica gel (10% EtOAc/hexanes), which was used directly. 
1H NMR (500 MHz, CDCl3) δH: 1.30 (3H, t, J 7.2, CH2CH3), 4.23 (2H, q, J 7.2, CH2CH3), 6.41 (1H, 
dd, J 16.0, 1.0, C(2)H), 7.29-7.37 (2H, m, ArH), 7.43-7.49 (3H, m, ArH), 7.66 (1H, dd, 1JCH 156.1, 3JHH 
16.0, C(3)H);  
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(E)-N,N-Dimethyl-3-phenylprop-2-en-1-amine-3-13C 13C1-340 
 
Following general procedure C, ethyl cinnamate-3-13C (760 mg, 4.29 mmol, 1.0 equiv.) was reacted 
with DIBAL-H (1 M in hexane, 9.44 mL, 9.44 mmol, 2.2 equiv.) in CH2Cl2 (22 mL), to give crude 
alcohol (584 mg, 76%, 97:3 E:Z), which was used immediately. Following general procedure K, (E)-3-
phenylprop-2-en-1-ol-3-13C (584 mg, 3.28 mmol, 1.0 equiv.) was reacted with PBr3 (123 μL, 1.31 
mmol, 0.4 equiv.) in Et2O (10 mL), then with dimethylamine (40% wt. in H2O, 2.1 mL, 16.4 mmol, 5.0 
equiv.) in THF (7 mL) to give the title product (297 mg, 56% over two steps, 98:2 E:Z) as a colourless 
oil after Kugerohlor distillation (140 °C @ 2 mmbar). 
νmax (film, cm−1): 2974, 2767, 1495, 1449, 1360, 1127, 1020, 960, 864; 1H NMR (500 MHz, CDCl3) δH: 
2.30 (6H, s, N(CH3)2), 3.10 (2H, t, J 6.4, C(1)H2), 6.29 (1H, dt, J 15.9, 6.4, C(2)H), 6.54 (1H, dd, J 
150.9, 15.9, 13C(3)H), 7.21-7.48 (5H, m, ArH); 13C{1H} NMR (126 MHz, CDCl3) δC: 45.5 (N(CH3)2), 
62.2 (d, 3JCC 1.7, C(1)H2), 126.4 (d, 3JCC 2.0, ArC(3,5)H), 127.6 (d, 1JCC 72, C(2)H), 128.7 (d, 2JCC 4.3, 
ArC(2,6)H), 130.9 (ArC(4)H), 132.6 (13C(3)H), 137.2 (d, 1JCC 56, ArC(1)); HRMS (ESI+) C1013CH16N+ 
[M+H]+ found: 163.1310, requires: 163.1311 (−0.5 ppm). 
Ethyl (E)-3-(3-bromo-4-fluorophenyl)acrylate[117] 500 
 
Following general procedure A, the reaction of 3-bromo-4-fluorobenzaldehyde (3.0 g, 14.78 mmol, 1.0 
equiv.) with ethyl 2-(triphenylphosphoranylidene)acetate (6.17 g, 17.73 mmol, 1.2 equiv.) in CH2Cl2 
(30 mL) gave the title product (3.59 g, 89%, 94:6 E:Z) as a white solid after purification by flash column 
chromatography (10→20% EtOAc/hexanes); 
mp 62-64 °C {lit. 64-65 °C};1H NMR (500 MHz, CDCl3) δH: 1.32 (3H, t, J 7.1, CH2CH3), 4.26 (2H, q, 
J 7.1, CH2CH3), 6.35 (1H,d, J 16.0, C(2)H), 7.12 (1H, t, J 8.4, Ar(5)H), 7.38-7.46 (1H, m, Ar(6)H), 
7.56 (1H, d, J 16.0, C(3)H), 7.71 (1H, dd, J 6.6, 2.2, Ar(2)H); 19F{1H} NMR (471 MHz, CDCl3) δF: 
−104.2 (ArF); Data consistent with the literature.[117]  
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(E)-3-(3-Bromo-4-fluorophenyl)prop-2-en-1-ol 501 
 
Following general procedure C, the reaction of ethyl (E)-3-(3-bromo-4-fluorophenyl)acrylate 500 (1.59 
g, 5.82 mmol, 1.0 equiv.) with DIBAL-H (1.0 M in hexane, 12.8 mL, 12.8 mmol, 2.2 equiv.) in CH2Cl2 
(30 mL) gave the title product (1.18 g, 88%, 94:6 E:Z) as a colourless oil, which was used without 
further purification. 
1H NMR (500 MHz, CDCl3) δH: 4.33 (2H, dd, J 5.5, 1.6, CH2OH), 6.29 (1H, dt, J 15.9, 5.5, C(2)H), 
6.53 (1H, d, J 15.9, C(3)H), 7.06 (1H, t, J 8.4, Ar(5)H), 7.24-7.32 (1H, m, Ar(6)H), 7.57 (1H, dd, J 6.6, 
2.2, Ar(2)H); 19F NMR (471 MHz, CDCl3) δF: −108.8 - −109.0 (m, ArF).  
(E)-3-(3-Bromo-4-fluorophenyl)-N,N-dimethylprop-2-en-1-amine 362 
 
Following general procedure K, the reaction of (E)-3-(3-bromo-4-fluorophenyl)prop-2-en-1-ol 501 (6.0 
g g, 26.0 mmol, 1.0 equiv.) with PBr3 (978 µL, 10.4 mmol, 0.4 equiv.) in Et2O (80 mL), then with aq. 
dimethylamine (40% wt., 16.4 mL, 130 mmol, 5.0 equiv.) in THF (52 mL) gave the title product (3.52 
g, 52%, 95:5 E:Z) as a colourless liquid after high vacuum distillation. 
bp 135-140 °C @ 1mmbar; νmax (film, cm−1): 2770, 1492, 1247, 1043, 962; 1H NMR (500 MHz, CDCl3) 
δH: 2.27 (6H, s, N(CH3)2), 3.05 (2H, dd, J 6.8, 1.4, CH2), 6.18 (1H, dt, J 15.9, 6.6, C(2)H), 6.41 (1H,d, 
J 15.9, C(2)H), 7.05 (1H, t, J 8.4, Ar(5)H), 7.20-7.30 (1H, m, Ar(6)H), 7.54 (1H, dd, J 6.6, 2.2, Ar(2)H); 
19F NMR (471 MHz, CDCl3) δF: −109.3 - −109.4 (m, ArF); 13C{1H} NMR (126 MHz, CDCl3) δC: 45.4 
(N(CH3)2), 61.9 (C(1)H2), 109.2 (d, 2JCF 21.0, ArC-Br), 116.5 (d, 2JCF 23.0, ArC(5)H), 126.7 (d, 3JCF 
7.0, ArC(6)H), 128.9 (d, 3JCF 2.0, ArC(2)H), 130.0 (C(2)H), 131.2 (C(3)H), 134.9 (d, 4JCF 4, ArC(1)), 
158.4 (d, 1JCF 248, ArC(4)-F); HRMS (ESI+) C11H14N79BrF+ [M+H]+ found: 258.0286, 
requires:258.1344 (−0.8 ppm).  
Ethyl (E)-3-(3-fluorophenyl)acrylate[118] 502 
 
Following general procedure A, 3-fluoro-benzaldhyde (2.56 mL, 24.2 mmol, 1.0 equiv.) was reacted 
with ethyl 2-(triphenyl-λ5-phosphanylidene)acetate (10.1 g, 29.0 mmol, 1.2 equiv.) in CH2Cl2 (30 mL) 
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to give the title product (3.99 g, 85%, 97:3 E:Z) as a colourless oil after flash column chromatography 
on silica gel (10→20% EtOAc/hexane). 
1H NMR (500 MHz, CDCl3) δH: 1.34 (3H, t, J 7.2, CH2CH3), 4.27 (2H, q, J 7.2, CH2CH3), 6.42 (1H, d, 
J 16.0, C(2)H), 7.03-7.11 (1H, m, Ar(2)H), 7.21 (1H, dt, J 9.7, 2.0, Ar(4)H), 7.29 (1H, d, J 7.7, Ar(5)H), 
7.35 (1H, td, J 7.9, 5.8, Ar(6)H), 7.63 (1H, d, J 16.0, C(3)H); 19F{1H} NMR (471 MHz, CDCl3) δF: 
−112.6 (ArF); Data consistent with literature.[118]  
(E)-3-(3-Fluorophenyl)prop-2-en-1-ol[119] 503 
 
Following general procedure C, the reaction of ethyl (E)-3-(3-fluorophenyl)acrylate 502 (3.0 g, 15.5 
mmol, 1.0 equiv.) with DIBAL-H (1.0 M in hexane, 34.0 mL, 34.0 mmol, 2.2 equiv.) in CH2Cl2 (78 
mL) gave the title product (2.08 g, 88%, 97:3 E:Z) as a colourless oil and was used without further 
purification. 
1H NMR (500 MHz, CDCl3) δH: 4.35 (2H, d, J 5.5, CH2), 6.39 (1H, dt, J 15.9, 5.5, C(2)H), 6.61 (1H, 
d, J 15.9, C(3)H), 6.96 (1H, td, J 8.4, 2.5, Ar(2)H), 7.10 (1H, dt, J 10.2, 2.1, Ar(4)H), 7.16 (1H, d, J 
7.8, Ar(5)H), 7.26-7.35 (1H, m, Ar(6)H); 19F{1H} NMR (471 MHz, CDCl3) δF: −113.5 (ArF); Data 
consistent with literature.[119] 
(E)-3-(3-Fluorophenyl)-N,N-dimethylprop-2-en-1-amine 504 
 
Following general procedure K, the reaction of (E)-3-(3-fluorophenyl)prop-2-en-1-ol 503 (2.0 g, 13.2 
mmol, 1.0 equiv.) with PBr3 (495 µL, 5.26 mmol, 0.4 equiv.) in Et2O (39 mL), then with aq. 
dimethylamine (40% wt., 8.34 mL, 66 mmol, 5.0 equiv.) in THF (26 mL) gave the title product (1.12 
g, 47%, 98:2 E:Z) as a colourless liquid after high vacuum distillation. 
bp 85-87 °C @ 1mmbar; νmax (film, cm−1): 2943, 1611, 1591, 1485, 1446, 1359, 1256, 1233, 1175, 
1141, 1092, 1022, 964, 872, 856; 1H NMR (500 MHz, CDCl3) δH; 2.29 (6H, s, N(CH3)2), 3.08 (2H, dd, 
J 6.6, 1.3, C(1)H2), 6.29 (1H, dt, J 15.9, 6.6, C(2)H), 6.49 (1H, J 15.9, C(3)H), 6.93 (1H, td, J 8.4, 2.7, 
Ar(2)H), 7.08 (1H, dt, J 10.2, 2.1, Ar(4)H), 7.15 (1H, d, J 7.8, Ar(6)H), 7.27 (1H, td, J 8.0, 6.0, Ar(5)H); 
19F NMR (471 MHz, CDCl3) δF: −113.6 (td, J 9.6, 6.2, ArF); 13C{1H} NMR (126 MHz, CDCl3) δC: 
45.5 (N(CH3)2), 62.0 (C(1)H2), 112.9 (d, 2JCF 22.0, ArC(2)H), 114.3 (d, 2JCF 21, ArC(4)H), 122.2 (d, 
4JCF 2.7, ArC(6)H), 129.1 (C(2)H), 130.1 (d, 3JCF 8.3, ArC(5)H), 131.4 (d, J 2.6, C(3)H), 139.5 (d, 3JCF 
7.8, ArC(1)), 163.2 (d, 1JCF 245, ArC-F); HRMS (NSI+) C11H15NF+ [M+H]+ found: 180.1179, requires: 
180.1183 (−2.2 ppm).  
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Ethyl (E)-3-(3-fluoro-4-methoxyphenyl)acrylate 505 
 
Following general procedure A, 3-fluoro-4-methoxybenzaldehyde (5.0 g, 32.5 mmol, 1.0 equiv.) was 
reacted with ethyl 2-(triphenyl-λ5-phosphanylidene)acetate (13.56 g, 39.0 mmol, 1.2 equiv.) in CH2Cl2 
(50 mL) to give the title product (6.68 g, 92%, 96:4 E:Z) as a white solid after flash column 
chromatography on silica gel (10→20% EtOAc/hexane); 
mp 36-38 °C; 1H NMR (500 MHz, CDCl3) δH: 1.34 (3H, t, J 7.1, CH2CH3), 3.93 (3H, s, OCH3), 4.27 
(2H, q, J 7.1, CH2CH3), 6.30 (1H, d, J 16.0, C(2)H), 6.96 (1H, t, J 8.5, Ar(5)H), 7.22-7.27 (1H, m, 
Ar(2)H), 7.29 (1H, dd, J 12.0, 2.1, Ar(6)H), 7.59 (1H, d, J 16.0, C(3)H); 19F NMR (471 MHz, CDCl3) 
δF: −134.5 (dd, J 11.7, 8.7, ArF). 
(E)-3-(3-Fluoro-4-methoxyphenyl)prop-2-en-1-ol 506 
 
Following general procedure C, the reaction of ethyl (E)-3-(3-fluoro-4-methoxyphenyl)acrylate 505 
(3.0 g, 13.4 mmol, 1.0 equiv.) with DIBAL-H (1.0 M in hexane, 29.5 mL, 29.5 mmol, 2.2 equiv.) in 
CH2Cl2 (67 mL) gave the title product (2.12 g, 87%, 96:4 E:Z) as a white solid and was used without 
further purification. 
mp 54-56 °C;1H NMR (400 MHz, CDCl3) δH: 3.88 (3H, s, O(CH3)), 4.29 (2H, d, J 5.7, C(1)H2), 6.21 
(1H, dt, J 15.8, 5.7, C(2)H), 6.50 (1H, dt, J 15.7, 1.4, C(3)H), 6.88 (1H, t, J 8.5, Ar(5)H), 7.05 (1H, dt, 
J 8.5, 1.5, Ar(6)H), 7.13 (1H, dd, J 12.5, 2.1, Ar(2)H); 19F{1H} NMR (376 MHz, CDCl3) δF: −135.4 
(ArF).  
(E)-3-(3-Fluoro-4-methoxyphenyl)-N,N-dimethylprop-2-en-1-amine 507 
 
Following general procedure K, the reaction of (E)-3-(3-fluoro-4-methoxy-phenyl)prop-2-en-1-ol 506 
(2.12 g, 11.65 mmol, 1.0 equiv.) with PBr3 (438 µL, 4.66 mmol, 0.4 equiv.) in Et2O (36 mL), then with 
aq. dimethylamine (40% wt., 7.58 mL, 60 mmol, 5.0 equiv.) in THF (24 mL) gave the title product 
(1.14 g, 47%, 97:3 E:Z) as a colourless liquid after high vacuum distillation. 
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bp 144-148 °C @ 1mmbar; νmax (film, cm−1): 2940, 1618, 1514, 1441, 1300, 1271, 1219, 1121, 1026, 
996, 858; 1H NMR (500 MHz, CDCl3) δH: 2.26 (6H, s, N(CH3)2), 3.04 (2H, dd, J 6.7, 1.4, C(1)H2), 3.87 
(3H, s, O(CH3)), 6.11 (1H, dt, J 15.8, 6.7, C(2)H), 6.40 (1H, d, J 15.8, C(3)H), 6.88 (1H, t, J 8.5, 
Ar(5)H), 7.05 (1H, d, J 8.5, Ar(6)H), 7.12 (1H, dd, J 12.5, 2.1, Ar(2)H); 19F{1H} NMR (471 MHz, 
CDCl3) δF: −135.5 (ArF); 13C{1H} NMR (126 MHz, CDCl3) δC: 45.3 (N(CH3)2), 56.3 (OCH3), 62.0 
(C(1)H2), 113.3 (d, 4JCF 2.3, ArC(6)H), 113.5 (d, 2JCF 19, ArC(2)H), 122.6 (d, 3JCF 3.2, ArC(5)H), 126.9 
(C(2)H), 130.8 (d, 3JCF 6.6, ArC(1)), 131.2 (d, 4JCF 2.2, C(3)H), 147.1 (d, 2JCF 11.0, ArC(4)-OMe), 152.6 
(d, 1JCF 245, ArC-F); HRMS (NSI+) C12H17FNO [M+H]+ found: 210.1286, requires: 210.1289 (−1.3 
ppm). 
Ethyl (E)-3-(4-bromo-3-fluorophenyl)acrylate 508 
 
Following general procedure A, 3-fluoro-4-bromobenzaldehyde (5.0 g, 24.6 mmol, 1.0 equiv.) was 
reacted with ethyl 2-(triphenyl-λ5-phosphanylidene)acetate (10.3 g, 29.6 mmol, 1.2 equiv.) in CH2Cl2 
(50 mL) to give the title product (7.36 g, quant., 95:5 E:Z) as a white solid after flash column 
chromatography on silica gel (10→20% EtOAc/hexane). 
mp 32-34 °C; 1H NMR (500 MHz, CDCl3) δH: 1.33 (3H, t, J 7.1, CH2CH3), 4.26 (2H, q, J 7.1, CH2CH3), 
6.42 (1H, d, J 15.9, C(2)H), 7.17 (1H, dd, J 8.2, 1.9, Ar(6)H), 7.26 (1H, dd, J 9.3, 1.9, Ar(2)H ), 7.51-
7.62 (2H, m, C(3)H + Ar(5)H); 19F NMR (471 MHz, CDCl3) δF: −106.5 (m, ArF). 
(E)-3-(4-Bromo-3-fluorophenyl)prop-2-en-1-ol 509 
 
Following general procedure C, the reaction of ethyl (E)-3-(4-bromo-3-fluorophenyl)acrylate 508 (3.0 
g, 11.0 mmol, 1.0 equiv.) with DIBAL-H (1.0 M in hexane, 24.2 mL, 24.2 mmol, 2.2 equiv.) in CH2Cl2 
(55 mL) gave the title product (2.12 g, 87%, 94:6 E:Z) as a colourless oil and was used without further 
purification. 
νmax (film, cm−1): 3296, 2920, 1558, 1483, 1419, 1159, 1089, 1039, 962, 869;1H NMR (400 MHz, 
CDCl3) δH: 4.26-4.46 (2H, m, C(1)H2), 6.39 (1H, dt, J 15.9, 5.3, C(2)H), 6.57 (1H, dt, J 15.9, 1.7, 
C(3)H), 7.05 (1H, dd, J 8.3, 2.0, Ar(6)H), 7.16 (1H, dd, J 9.8, 2.0, Ar(2)H), 7.50 (1H, dd, J 8.3, 7.2, 
Ar(5)H); 19F{1H} NMR (376 MHz, CDCl3) δF: −107.7 (ArF); 13C{1H} NMR (126 MHz, CDCl3) δC: 
63.3 (C(1)H2), 107.9 (d, 2JCF 21.0, ArC(4)-Br), 114.0 (d, 2JCF 23.0, ArC(2)H), 123.5 (d, 4JCF 3.6, 
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ArC(6)H), 128.8 (C(3)H), 130.8 (C(2)H), 133.6 (ArC(5)H), 138.4 (d, J ArC(1)), 159.3 (d, 1JCF 247, 
ArC-F); HRMS (ASAP+) C9H7OF79Br− [M−H]− found: 228.9660, requires: 228.9664 (−0.4 ppm). 
(E)-3-(4-Bromo-3-fluorophenyl)-N,N-dimethylprop-2-en-1-amine 510 
 
Following general procedure J, the reaction of (E)-3-(3-fluoro-4-bromo-phenyl)prop-2-en-1-ol 509 (2.5 
g, 10.82 mmol, 1.0 equiv.) with PBr3 (407 µL, 4.33 mmol, 0.4 equiv.) in Et2O (33 mL), then with aq. 
dimethylamine (40% wt., 6.95 mL, 55 mmol, 5.0 equiv.) in THF (22 mL) gave the title product (1.16 
g, 42%, 98:2 E:Z) as a colourless liquid after high vacuum distillation. 
bp 108-110 °C @ 1mmbar; νmax (film, cm−1): 2941, 1570, 1479, 1417, 1358, 1236, 1148, 1040, 966, 
858;1H NMR (500 MHz, CDCl3) δH: 2.26 (6H, s, N(CH3)2), 3.05 (2H, dd, J 6.6, 1.4, C(1)H2), 6.27 (1H, 
dt, J 15.9, 6.6, C(2)H), 6.43 (1H, d, J 15.9, C(3)H), 7.01 (1H, dd, J 8.3, 2.0, Ar(2)H), 7.11 (1H, dd, J 
9.9, 2.0, Ar(5)H), 7.40-7.49 (1H, m, Ar(6)H); 19F{1H} NMR (471 MHz, CDCl3) δF: −107.8 (ArF); 
13C{1H} NMR (126 MHz, CDCl3) δC: 45.5 (N(CH3)2), 61.9 (C(1)H2), 107.6 (d, 2JCF 21.2 ArC-Br), 113.9 
(d, 2JCF 22.7, ArC(2)H), 123.3 (d, 4JCF 3.3, ArC(6)H), 129.9 (C(2)H), 130.5 (d, 3JCF 2.3, ArC(5)H), 
133.6 (C(3)H), 138.8 (d, 3JCF 7.1, ArC(1)), 159.3 (d, 1JCF 247, ArC-F); HRMS (NSI+) C11H14N79BrF+ 
[M+H]+ found: 259.0288 requires: 259.0288 (−0.1 ppm). 
Ethyl (E)-3-(3-fluoro-4-methylphenyl)acrylate[120] 511 
 
Following general procedure A, 3-fluoro-4-methylbenzaldehyde (5.0 g, 36.2 mmol, 1.0 equiv.) was 
reacted with ethyl 2-(triphenyl-λ5-phosphanylidene)acetate (15.1 g, 43.5 mmol, 1.2 equiv.) in CH2Cl2 
(50 mL) to give the title product (7.14 g, 95%, 96:4 E:Z) as a colourless liquid after flash column 
chromatography on silica gel (20% EtOAc/hexane). 
1H NMR (500 MHz, CDCl3) δH: 1.33 (3H, t, J 7.2, CH2CH3), 2.29 (3H, d, J 2.0, ArCH3), 4.26 (2H, q, 
J 7.2, CH2CH3), 6.38 (1H, d, J 15.9, C(2)H), 7.13-7.23 (3H, m, ArH), 7.60 (1H, d, J 15.9, C(3)H); 
19FNMR (471 MHz, CDCl3) δF: −116.83 - −116.97 (m, ArF); Data consistent with literature.[120]  
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(E)-3-(3-fluoro-4-methylphenyl)prop-2-en-1-ol 512 
 
Following general procedure C, the reaction of ethyl (E)-3-(3-fluoro-4-methylphenyl)acrylate 511 (2.0 
g, 9.62 mmol, 1.0 equiv.) with DIBAL-H (1.0 M in hexane, 21.2 mL, 21.2 mmol, 2.2 equiv.) in CH2Cl2 
(50 mL) gave the title product (1.73 g, quant., 97:3 E:Z) as a white solid and was used without further 
purification. 
mp 38-40 °C; νmax (film, cm−1): 3310, 2853, 1572, 1506, 1420, 1259, 1115, 1086, 964, 874; 1H NMR 
(700 MHz, CDCl3) δH: 2.25 (3H, d, J 2.0, CH3), 4.29 (2H, d, J 5.6, C(1)H2), 6.32 (1H, dt, J 15.9, 5.6, 
C(3)H), 6.52 (1H, d, J 15.9, C(3)H), 6.96-7.04 (2H, m, Ar(2 + 6)H), 7.09 (1H, t, J 8.0, Ar(5)H); 19F 
NMR (657 MHz, CDCl3) δF: −117.84 (t, J 9.5, ArF); 13C{1H}NMR (179 MHz, CDCl3) δC: 14.5 (d, 3JCF 
3.4, ArCH3), 63.7 (C(1)H2), 112.6 (d, 2JCF 23.0, ArC(2)H), 122.2 (d, 4JCF 3.7, ArC(6)H), 124.4 (d, 2JCF 
18, ArC(4)-Me), 128.9 (C(2)H), 130.1 (C(3)H), 131.6 (d, 3JCF 5.6, ArC(5)H, 136.6 (d, 3JCF 7.6, ArC(1)), 
161.6 (d, 1JCF 244 ArC-F). HRMS (ASAP+) C10H10OF− [M−H]− found: 165.0712, requires: 165.0716 
(−0.4 ppm). 
(E)-3-(3-fluoro-4-methylphenyl)-N,N-dimethylprop-2-en-1-amine 513 
 
Following general procedure K, the reaction of (E)-3-(3-fluoro-4-methyl-phenyl)prop-2-en-1-ol 512 
(1.70 g, 10.24 mmol, 1.0 equiv.) with PBr3 (385 µL, 4.10 mmol, 0.4 equiv.) in Et2O (30 mL), then with 
aq. dimethylamine (40% wt., 6.47 mL, 51.2 mmol, 5.0 equiv.) in THF (20 mL) gave the title product 
(0.87 g, 44%, 97:3 E:Z) as a colourless liquid after high vacuum distillation. 
bp 85-95 °C @ 1mmbar; νmax (film, cm−1): 2943, 1574, 1508, 1454, 1419, 1256, 1113, 1023, 966, 871; 
1H NMR (700 MHz, CDCl3) δH: 2.24 (3H, d, J 2.0, CH3), 2.26 (6H, s, N(CH3)2), 3.05 (2H, dd, J 6.6, 
1.5, C(1)H2), 6.21 (1H, dt, J 15.8, 6.6, C(2)H), 6.43 (1H d, J 15.8, C(3)H), 6.99-7.04 (2H, m, Ar(5 + 
6)H), 7.09 (1H, t, J 8.0, Ar(2)H); 19F NMR (659 MHz, CDCl3) δF: −117.92 (t, J 9.9, ArF); 13C{1H}NMR 
(179 MHz, CDCl3) δC: 14.5 (d, 3JCF 3.5, ArCH3), 45.4 (N(CH3)2), 62.0 (C(1)H2), 112.5 (d, 2JCF 23.0, 
ArC(2)H), 121.9 (d, 4JCF 3.2, ArC(6)H), 123.9 (d, 2JCF 18, ArC(4)-Me), 127.9 (C(2)H), 131.5-131.5 (m, 
ArC(5)H + C(3)H), 136.9 (d, 3JCF 7.7, ArC(1)), 161.6 (d, 1JCF 245, ArC-F); HRMS (ASAP+) C12H16FN 
[M] found: 193.1262, requires: 193.1267 (−2.6 ppm). 
  
Chapter 6: Experimental Details 
 
 
198 
Ethyl (E)-3-(3-fluoro-4-iodophenyl)acrylate 514 
 
Following general procedure A, 3-fluoro-4-iodobenzaldehyde (1.0 g, 4.0 mmol, 1.0 equiv.) was reacted 
with ethyl 2-(triphenyl-λ5-phosphanylidene)acetate (1.67 g, 4.8 mmol, 1.2 equiv.) in CH2Cl2 (10 mL) 
to give the title product (1.42 g, quant., 94:6 E:Z) as a pale yellow oil after flash column chromatography 
on silica gel (20% EtOAc/hexane). 
νmax (film, cm−1): 2980, 1705, 1637, 1560, 1478, 1416, 1313, 1265, 1177, 1026, 978, 856; 1H NMR (500 
MHz, CDCl3) δH: 1.34 (3H, t, J 7.1, CH2CH3), 4.27 (2H, q, J 7.1, CH2CH3), 6.45 (1H, d, J 16.0, C(2)H), 
7.05 (1H, dd, J 8.2, 2.0, Ar(5)H), 7.20 (1H, dd, J 8.8, 2.0, Ar(2)H), 7.57 (1H, d, J 16.0, C(3)H), 7.76 
(1H, dd, J 8.2, 6.5, Ar(6)H); 19F NMR (471 MHz, CDCl3) δF: −93.2 (dd, J 8.5, 6.8, ArF); 13C{1H}NMR 
(179 MHz, CDCl3) δC:14.3 (CH3), 60.7 (OCH2), 83.3 (d, 2JCF 26, ArC(4)-I), 114.3 (d, 2JCF 25.0, 
ArC(2)H), 120.2 (C(2)H), 125.2 (d, 3JCF 3.6, ArC(5)H), 136.9 (d, 3JCF 7.1, ArC(1)), 139.8 (d, 4JCF 1.9, 
ArC(6)H), 142.1 (d, 4JCF 2.5, C(3)H), 161.9 (d, 1JCF 246, ArC-F), 166.3 (C=O); HRMS (ESI+) 
C11H10O2FINa+ [M+Na]+ found: 342.9593, requires: 342.9596 (−2.5 ppm). 
(E)-3-(3-fluoro-4-iodophenyl)prop-2-en-1-ol 515 
 
Following general procedure C, the reaction of ethyl (E)-3-(3-fluoro-4-iodophenyl)acrylate 514 (1.2 g, 
3.75 mmol, 1.0 equiv.) with DIBAL-H (1.0 M in hexane, 8.25 mL, 8.25 mmol, 2.2 equiv.) in CH2Cl2 
(20 mL) gave the title product (0.81 g, 77%, 97:3 E:Z) as a colourless oil and was used without further 
purification. 
mp 52-54 °C; νmax (film, cm−1): 3225, 2887, 1558, 173, 1406, 1086, 1016, 961, 869;1H NMR (400 MHz, 
CDCl3) δH: 4.33 (2H, s, C(1)H2), 6.39 (1H, dt, J 15.9, 5.3, C(2)H), 6.54 (1H, d, J 15.9, C(3)H), 6.92 
(1H, dd, J 8.2, 2.0, Ar(5)H), 7.08 (1H, dd, J 9.3, 2.0, Ar(2)H), 7.67 (1H, dd, J 8.2, 6.6, Ar(6)H); 19F{1H} 
NMMR (376 MHz, CDCl3) δF: −94.4 (ArF);13C{1H}NMR (179 MHz, CDCl3) δC: 63.3 (C(1)H2), 79.6 
(d, 2JCF 26.0, ArC(4)-I), 113.2 (d, 2JCF 24.0, ArC(2)H), 123.9 (d, 4JCF 3.1, ArC(5)H), 128.7 (d, 4JCF 2.3, 
C(3)H), 130.8 (C(2)H), 139.3 (d, 4JCF 1.6, ArC(6)H), 139.4(d, 3JCF 7.0, ArC(1)), 161.9 (d, 1JCF 245 ArC-
F); HRMS (CI+) C9H9OFI+ [M+H]+ found: 278.9685, requires: 278.9682 (+1.0 ppm). 
  
Chapter 6: Experimental Details 
 
 
199 
(E)-3-(3-Fluoro-4-iodophenyl)-N,N-dimethylprop-2-en-1-amine 516 
 
Following general procedure K, the reaction of (E)-3-(3-fluoro-4-methyl-phenyl)prop-2-en-1-ol 515 
(0.81 g, 2.90 mmol, 1.0 equiv.) with PBr3 (109 µL, 1.16 mmol, 0.4 equiv.) in Et2O (9 mL), then with 
aq. dimethylamine (40% wt., 1.83 mL, 14.5 mmol, 5.0 equiv.) in THF (6 mL) gave the title product 
(0.68 g, 77%, 95:5 E:Z) as a pale yellow solid, which was used without purification. 
mp 49-51 °C; νmax (film, cm−1): 2860, 1555, 1471, 1404, 1257, 1230, 1143, 1038, 1017, 996, 876; 1H 
NMR (500 MHz, CDCl3) δH: 2.25 (6H, s, N(CH3)2), 3.05 (2H, dd, J 6.5, 1.4, C(1)H), 6.28 (1H, dt, J 
15.8, 6.5, C(2)H), 6.41 (1H, d, J 15.8, C(3)H), 6.89 (1H, dd, J 8.2, 2.0, Ar(5)H), 7.05 (1H, dd, J 9.3, 
2.0, Ar(2)H), 7.63 (1H, dd, J 8.2, 6.6, Ar(6)H);19F NMR (471 MHz, CDCl3) δF: −94.5 - −94.6 (m, 
ArF);13C{1H} NMR (126 MHz, CDCl3) δC: 45.5 (N(CH3)2), 61.9 (C(1)H2), 79.4 (d,2JCF 26, ArC(4)-I), 
113.1 (d, 2JCF 24, ArC(2)H), 123.8 (d, 3JCF 3.1, ArC(1)), 130.0 (C(2)H), 130.5 (d, 4JCF 2.1, ArC(6)H), 
139.3 (d, 4JCF 1.8, C(3)H), 139.8 (d, 3JCF 7.1, ArC(5)H), 162.0 (d, 1JCF 245, ArC-F); HRMS (ASAP+) 
C11H14FIN [M + H]+ found: 306.0147, requires: 306.0155 (−0.8 ppm). 
Bromoacetate Synthesis 
4-Nitrophenyl 2-bromoacetate-13C2 13C2-331 
 
Following general procedure G, 13C2-bromoacetic acid (400 mg, 2.84 mmol, 1.0 equiv.) was reacted 
with DCC (585 mg, 2.84 mmol, 1.0 equiv.), 4-nitrophenol (395 mg, 2.84 mmol, 1.0 equiv.) and DMAP 
(34 mg, 0.28 mmol, 0.1 equiv.) in EtOAc (14 mL) to give the title product (379 mg, 51%) as a white 
solid after recrystallization from Et2O/hexane.  
mp 83-84 °C; νmax (film, cm−1): 2957, 1724, 1587, 1516, 1338, 1207, 1009, 923; 1H NMR (500 MHz, 
CDCl3) δH: 4.11 (2H, dd, J 154, 4.8, 13CH2), 7.34 (2H, d, J 9.1, Ar(2,6)H), 8.30 (2H, d, J 9.1, Ar(3,5)H); 
13C{1H} NMR (126 MHz, CDCl3) δC: 25.1 (d, 1JCC 67, 13CH2), 122.2 (ArC(2,6)H), 125.5 (ArC(3,5)H), 
145.9 (ArC(4)-NO2), 155.0 (ArC(1)-O), 165.1 (d, 1JCC 67, 13C=O); HRMS (APCI+) C613C2H7BrNO4+ 
[M+H]+ found: 261.9620, requires 261.9620 (−0.0 ppm). 
  
Chapter 6: Experimental Details 
 
 
200 
4-Nitrophenyl 2-bromoacetate-1-13C 13C1-517 
 
Following general procedure G, 13C1-bromoacetic acid (500 mg, 3.55 mmol, 1.0 equiv.) was reacted 
with DCC (731 mg, 3.55 mmol, 1.0 equiv.), 4-nitrophenol (493 mg, 3.55 mmol, 1.0 equiv.) and DMAP 
(43 mg, 0.36 mmol, 0.1 equiv.) in EtOAc (20 mL) to give the title product (424 mg, 46%) as a white 
solid after recrystallization from Et2O/hexane. 
mp 80-82 °C; νmax (film, cm−1): 2962, 1726, 1587, 1514, 1487, 1335, 1091, 929;1H NMR (500 MHz, 
CDCl3) δH: 4.09 (2H, d, 2JCH 4.8, CH2), 7.32-7.36 (2H, m, Ar(2,6)H), 8.27-8.32 (2H, m, Ar(3,5)H); 
13C{1H} NMR (126 MHz, CDCl3) δC: 25.2 (d, 1JCC 67, CH2), 122.2 (ArC(2,6)H), 125.5 (ArC(3,5)H), 
145.8 (ArC(4)-NO2), 155.0 (d, 2JCC 3.4, ArC(1)), 165.1 (13C=O); HRMS (ASAP+) C713CH7NO4Br 
[M+H]+ found: 260.9598, requires: 260.9502 (+2.3 ppm). 
2-Bromoacetic-d2 acid-d[121] d3-349 
 
A solution of d4-malonic acid d4-348 (4.0 g, 36 mmol, 1.0 equiv.) in Et2O (100 mL) was treated with 
Br2 (1.91 mL, 36 mmol, 1.0 equiv.) dropwise at 0 °C. Once the addition was complete the reaction 
mixture was concentrated in vacuo. The resulting solid was heated at 140 °C until bubbling ceased, the 
residue was purified by distillation to give the product as a colourless liquid (3.90 g, 76%). 
bp 82-84 °C @ 2 mmbar; 13C{1H} (400 MHz, d6-DMSO) δC: 26.7-28.5 (m, CD2), 168.4 (C=O); data 
consistent with the literature.[121]  
4-Nitrophenyl 2-bromoacetate-d2, d2-350 
 
Following general procedure G, 2-bromoacetic-d2 acid-d d3-349 (1.0 g, 7.04 mmol, 1.0 equiv.) was 
reacted with DCC (1.45 g, 7.04 mmol, 1.0 equiv.), 4-nitrophenol (0.98 mg, 7.04 mmol, 1.0 equiv.) and 
DMAP (86 mg, 0.70 mmol, 0.1 equiv.) in EtOAc (35 mL) to give the title product (550 mg, 30%, 95% 
D) as a white solid after recrystallization from Et2O/hexane. 
mp 66-68 °C; νmax (film, cm−1): 2933, 1762, 1589, 1514, 1487, 1336, 1199, 1105, 979;1H NMR (300 
MHz, CDCl3) δH: 4.09-4.11 (0.1H, m, C(2)HD + C(2)H2), 7.34 (2H, d, J 9.1, Ar(2,6)H), 8.30 (2H, d, J 
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9.1, Ar(3,5)H); 13C{1H} NMR (101 MHz, CDCl3) δC: 24.4-25.1 (m, CD2), 122.2 (ArC(2,6)H), 125.5 
(ArC(3,5)H), 145.8 (ArC(1)O), 155.0 (ArC(4)NO2), 165.1 (C=O); HRMS (APCI+) C8H52H2BrNO4+ 
[M+H]+ found: 261.9672, requires: 261.9679 (−2.5 ppm). 
 
Ammonium Salt Synthesis 
(E)-3-(4-Fluorophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)prop-2-en-1-
ammonium bromide 309 
 
Following general procedure H, (E)-3-(4-fluorophenyl)-N,N-dimethylprop-2-en-1-amine 498 (4.0 g, 
22.4 mmol, 1.0 equiv.) was reacted with p-nitrophenyl bromoacetate 213 (6.97 g, 26.8 mmol, 1.2 equiv.) 
in MeCN (23 mL) to give the title product (8.95 g, 91%) as a white solid.  
mp 146 °C (dec.); νmax (film, cm−1): 2918, 1775, 1591, 1510, 1348, 1226, 1205, 1146, 1132, 978, 893;1H 
NMR (300 MHz, CD3CN) δH: 3.40 (6H, s, N+(CH3)2), 4.46 (2H, d, J 7.6, C(1)H2), 4.88 (2H, s, COCH2), 
6.44 (1H, dt, J 15.6, 7.6, C(2)H), 7.02 (1H, d, J 15.6, C(3)H), 7.16 (2H, t, J 8.9, C(3)Ar(3,5)H), 7.48 
(2H, d, J 9.2, OAr(2,6)H), 7.64 (2H, dd, J 8.9, 5.5, C(3)Ar(2,6)H), 8.30 (2H, d, J 9.2, 
OAr(3,5)H);19F{1H} NMR (282 MHz, CD3CN) δF: −113.9 (Ar-F); 13C{1H} NMR (101 MHz, DMSO-
d6) δC: 50.8 (N+(CH3)2), 60.5 (COCH2), 67.0 (C(1)H2), 115.6 (d, 2JCF 22, C(3)ArC(3,5)H), 116.1 
(C(2)H), 123.1 (OArC(3,5)H), 125.5 (OArC(2,6)H), 129.5 (d, 3JCF 7.8, C(3)ArC(2,6)H), 131.8 (d, 4JCF 
2.9, C(3)ArC(1)), 140.3 (C(3)H), 145.6 (OArC(1)O), 153.9 (OArC(4)NO2), 162.5 (d, 1JCF 247, ArC-F), 
163.2 (C=O); HRMS (NSI+): C19H20FN2O4+ [M-Br]+ found: 359.1392, requires 359.1402 (−2.7 ppm). 
(E)-3-(4-Fluorophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl-1,2-13C2)prop-2-en-1-
ammonium bromide 13C2-333 
 
Following general procedure H, (E)-3-(4-fluorophenyl)-N,N-dimethylprop-2-en-1-amine 498 (172 mg, 
0.96 mmol, 1.0 equiv.) was reacted with 4-nitrophenyl 2-bromoacetate-13C2 13C2-331 (300 mg, 1.15 
mmol, 1.2 equiv.) in MeCN (1 mL) to give the title product (348 mg, 79%) as a white solid.  
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mp 129 °C (dec.); νmax (film, cm−1): 2912, 1732, 1508, 1390, 1116, 972;1H NMR (500 MHz, d6-DMSO) 
δH: 3.34 (6H, s, N+(CH3)2), 4.41 (2H, d, J 7.3, C(1)H2), 4.86 (2H, dd, J 147, 6.7, 13CH2), 6.57 (1H, dt, J 
15.6, 7.3, C(2)H), 6.96 (1H, d, J 15.6, C(3)H), 7.26 (2H, t, J 8.8, C(3)Ar(3,5)H), 7.57 (2H, d, J 9.1, 
OAr(2,6)H), 7.70 (2H, dd, J 8.8, 5.6, C(3)Ar(2,6)H), 8.38 (2H, d, J 9.1, OAr(3,5)H); 19F NMR (471 
MHz, d6-DMSO) δF: −112.2 (ArF); 13C{1H} NMR (126 MHz, d6-DMSO) δC: 50.8 (N+(CH3)2), 60.5 (d, 
J 64, 13CH2), 67.1 (C(1)H2), 115.7 (d, 2JCF 21.6, C(3)ArC(3,5)H), 116.1 (C(2)H), 123.1 (OArC(3,5)H), 
125.5 (OArC(2,6)H), 129.5 (d, 3JCF 8.3, C(3)ArC(2,6)H), 131.8 (d, 4JCF 2.9, C(3)ArC(1)), 140.4 
(C(3)H), 145.6 (OArC(1)), 153.9 (OArC(4)NO2), 162.5 (d, 1JCF 247, ArC-F), 163.2 (d, 1JCC 64, 13C=O); 
HRMS (NSI+) C1713C2H20FN2O4+ [M]+ found: 361.1459, requires 361.1469 (−2.7 ppm). 
(E)-3-(4-Fluorophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl-2-13C)prop-2-en-1-
ammonium bromide 13C1-341 
 
Following general procedure H, (E)-3-(4-fluorophenyl)-N,N-dimethylprop-2-en-1-amine 498 (156 mg, 
0.87 mmol, 1.0 equiv.) was reacted with 4-nitrophenyl 2-bromoacetate-13C1 13C1-517 (250 mg, 0.96 
mmol, 1.2 equiv.) in MeCN (2 mL) to give the title product (292 mg, 76%) as a white solid.  
mp 136 °C (dec.); νmax (film, cm−1): 2995, 1730, 1595, 1508, 1350, 1226, 1203, 1132, 1119, 977, 889, 
850;1H NMR (400 MHz, d6-DMSO) δH: 3.34 (6H, s, N+(CH3)2), 4.38 (2H, d, J 7.5, C(1)H2), 4.81 (2H, 
d, J 6.8, 13COCH2), 6.55 (1H, dt, J 15.6, 7.5, C(2)H), 6.96 (1H, d, J 15.6, C(3)H), 7.27 (2H, t, J 8.8, 
C(3)Ar(3,5)H), 7.56 (2H, d, J 9.1, OAr(2,6)H), 7.70 (2H, dd, J 8.8, 5.6, C(3)Ar(2,6)H), 8.38 (2H, d, J 
9.1, OAr(3,5)H); 19F{1H} NMR (471 MHz, d6-DMSO) δF: −112.1 (ArF); 13C{1H} NMR (101 MHz, d6-
DMSO) δC: 50.8 (N+C(H3)2), 60.5 (d, 1JCC 65, 13COCH2), 67.1 (C(1)H2), 115.6 (d, 2JCF 21.7, 
C(3)ArC(3,5)H), 116.0 (C(2)H), 123.1 (OArC(3,5)H), 125.5 (OArC(2,6)H), 129.5 (d, 3JCF 8.4, 
ArC(2,6)H), 131.8 (d, 4JCF 3, ArC(1)), 140.4 (C(3)H), 145.6 (ArC(1)O), 153.8 (ArC(4)NO2), 162.5 (d, 
1JCF 247, ArC-F), 163.2 (13C=O); HRMS (ESI+) C1813CH20FN2O4+ [M]+ found: 360.1425, requires: 
360.1435 (−2.8 ppm).  
  
Chapter 6: Experimental Details 
 
 
203 
(E)-N-(2-(3,5-Bis(trifluoromethyl)phenoxy)-2-oxoethyl)-3-(4-fluorophenyl)-N,N-dimethylprop-2-
en-1-ammonium bromide 366 
 
Following general procedure H, (E)-3-(4-fluorophenyl)-N,N-dimethylprop-2-en-1-amine 498 (1.0 g, 
5.59 mmol, 1 equiv.) was reacted with 3,5-bis(trifluoromethyl)phenyl 2-bromoacetate 493 (2.35 g, 6.70 
mmol, 1.2 equiv.) in MeCN (5.6 mL) to give the title product (739 mg, 25%) as a white solid, after 
recrystallization from MeCN/Et2O. 
mp 160 °C (dec.); νmax (film, cm−1): 2904, 1778, 1510, 1363, 1278, 1130, 974, 847; 1H NMR (400 MHz, 
DMSO-d6) δH: 3.34 (6H, s, N+(CH3)2), 4.41 (2H, d, J 7.5, C(1)H2), 4.78 (2H, s, COCH2), 6.57 (1H, dt, 
J 15.7, 7.5, C(2)H2), 6.98 (1H, d, J 15.7, C(3)H), 7.26 (2H, t, J 8.7, C(3)Ar(3,5)H), 7.70 (2H, dd, J 8.7, 
5.6, C(3)Ar(2,6)H), 8.09 (2H, s, OAr(2,6)H), 8.16 (1H, s, OAr(4)H); 19F NMR (376 MHz, d6-DMSO) 
δF: −112.2 (Ar-F), −61.3 (Ar-CF3); 13C{1H} (126 MHz, d6-DMSO) δC: 50.9 (N+(CH3)2), 60.6 (COCH2), 
67.0 (C(1)H2), 115.7 (d, 2JCF 22, C(3)ArC(3,5)H), 116.1 (C(2)H), 120.8 (br. s, OArC(4)H), 122.7 (q, 
1JCF 273, CF3), 123.7 (d, 3JCF 3, OArC(2,6)H), 129.5 (d, 3JCF 8.3, C(3)ArC(2,6)H), 131.6 (q, 2JCF 34, 
OArC(3,5)-CF3), 131.8 (d, 4JCF 3, C(3)ArC(1)), 140.5 (C(3)H), 150.0 (ArC(1)-O), 162.5 (d, 1JCF 247, 
ArC-F), 163.3 (C=O); HRMS (NSI+) C21H19F7NO2+ [M]+ found: 450.1292, requires: 450.1299 (−1.5 
ppm). 
(E)-3-(4-Fluorophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl-1,1-d2)prop-2-en-1-
ammonium bromide d2-351 
 
Following general procedure H, (E)-3-(4-fluorophenyl)-N,N-dimethylprop-2-en-1-amine 498 (155 mg, 
0.95 mmol, 1.0 equiv.) was reacted with 4-nitrophenyl 2-bromoacetate-d2 d2-350 (300 mg, 1.15 mmol, 
1.2 equiv.) in MeCN (2 mL) to give the title product (307 mg, 76%, 75% D) as a white solid.  
mp 136 °C (dec.); νmax (film, cm−1): 2913, 1780, 1591, 1508, 1487, 1348, 1227, 1203, 1163, 1064, 975, 
852;1H NMR (500 MHz, d6-DMSO) δH: 3.56 (6H, s, N+(CH3)2), 4.39 (2H, d, J 7.5, C(1)H2), 4.81-4.85 
(0.68H, m, COCH2/COCHD), 6.53 (1H, dt, J 15.6, 7.5, C(2)H), 6.97 (1H, d, J 15.6, C(3)H), 7.24 (2H, 
t, J 8.7, C(3)Ar(3,5)H), 7.55 (2H, d, J 9.1, OAr(2,6)H), 7.69 (2H, dd, J 8.7, 5.7, C(3)Ar(2,6)H), 8.36 
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(2H, d, J 9.1, OAr(3,5)H); 13C{1H} NMR (126 MHz, d6-DMSO) δC: 51.0 (d, 3JCD 4.0, N+(CH3)2), 60.1-
60.6 (m, CD2/CHD/CH2), 67.3 (C(1)H2), 115.9 (d, 2JCF 21.5, ArC(3,5)H), 116.0 (C(2)H), 123.3 
(OArC(2,6)H), 125.7 (OArC(3,5)H), 129.7 (d, 3JCF 8.4, C(3)ArC(2,6)H), 131.9 (d, 4JCF 3.1, ArC(1)), 
140.8 (C(3)H), 145.8 (ArC(1)-O), 154.0 (ArC(4)-NO2), 162.7 (d, 1JCF 247, ArC-F), 163.3-163.4 (m, 
C=O); HRMS (NSI+) C19H18D2FN2O4+ [M]+ found:361.1517, requires: 361.1527 (−2.8 ppm).  
(E)-N,N-Dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl-1,2-13C2)-3-phenylprop-2-en-1-ammonium-
3-13C bromide 13C3-341 
 
Following general procedure H, (E)-N,N-dimethyl-3-phenylprop-2-en-1-amine-3-13C 13C1-340 (155 
mg, 0.95 mmol, 1.0 equiv.) was reacted with 4-nitrophenyl 2-bromoacetate-13C2 13C2-331 (300 mg, 1.15 
mmol, 1.2 equiv.) in MeCN (2 mL) to give the title product (307 mg, 76%) as a white solid.  
mp 148 °C (dec.); νmax (film, cm−1): 2943, 1722, 1527, 1350, 1166, 1120, 978, 856; 1H NMR (500 MHz, 
d6-DMSO) δH: 3.34 (6H, s, N+(CH3)2), 4.40 (2H, t, J 5.8, C(1)H2), 4.82 (2H, dd, J 147.3, 6.7, 
13CO13CH2), 6.60 (1H, dt, J 15.4, 7.5, C(2)H), 6.97 (1H, dd, J 154.0, 15.6, C(3)H), 7.36-7.44 (3H, m, 
C(3)ArH), 7.56 (2H, d, J 9.1, OAr(2,6)H), 7.62-7.65 (2H, m, C(3)ArH), 8.38 (2H, d, J 9.1, OAr(3,5)H); 
13C{1H} NMR (126 MHz, d6-DMSO) δC: 50.8 (N+(CH3)2), 60.5 (d, 1JCC 64, 13CH2), 67.2 (C(1)H2), 116.1 
(d, 1JCC 71, C(2)H), 123.1 (OArC(2,6)H), 125.5 (OArC(3,5)H), 127.4 (d, 3JCC 2, C(3)ArC(3,5)H), 128.8 
(d, 2JCC 4, C(3)ArC(2,6)H), 129.2 (ArC(4)H), 135.1 (d,1JCC 55, C(3)ArC(1)), 141.7 (13C(3)H), 145.6 
(ArC(4)-NO2), 153.9 (ArC(1)-O), 163.2 (d, 1JCC 64, 13C=O); HRMS (ESI+) C1613C3H21N2O4+ [M]+ 
found: 344.1586, requires 344.1596 (−3.1 ppm).  
(E)-3-(4-Fluorophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)prop-2-en-1-
ammonium-3-d bromide d1-357 
 
Following general procedure H, (E)-3-(4-fluorophenyl)-N,N-dimethylprop-2-en-1-amine-3-d d1-356 
(407 mg, 2.26 mmol, 1.0 equiv.) was reacted with 4-nitrophenyl 2-bromoacetate 213 (705 mg, 2.71 
mmol, 1.2 equiv.) in MeCN (2.5 mL) to give the title product (580 mg, 58%, >99% D) as a white solid.  
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mp 132 °C (dec.); νmax (film, cm−1): 2897, 1775, 1591, 1510, 1348, 1206, 1147, 1132, 985, 891; 1H 
NMR (500 MHz, d6-DMSO) δH: 3.32 (6H, s, N+(CH3)2), 4.37 (2H, d, J 7.5, C(1)H2), 4.79 (2H, s, 
COCH2), 6.54 (1H, t, J 7.5,C(2)H), 7.27 (2H, t, J 8.9, C(3)Ar(3,5)H), 7.56 (2H, d, J 9.1, OAr(2,6)H), 
7.70 (2H, dd, J 8.9, 5.6, C(3)Ar(2,6)H), 8.38 (2H, d, J 9.1, OAr(3,5)H); 19F{1H} NMR (376 MHz, d6-
DMSO) δF: −112.2 (Ar-F); 13C{1H} NMR (126 MHz, d6-DMSO) δC: 50.8 (N+(CH3)2), 60.5 (COCH2), 
67.0 (C(1)H2), 115.7 (d, 2JCF 22, C(3)ArC(3,5)H), 115.9 (C(2)H), 123.1 (OArC(2,6)H), 125.5 
(OArC(3,5)H), 129.5 (d, 3JCF 9, C(3)ArC(2,6)H), 131.7 (d, 4JCF 2, C(3)ArC(1)), 141.1 (t, 1JCD 21, 
C(3)D), 145.6 (OArC(1)-O), 153.9 (OArC(4)-NO2), 162.5 (d, 1JCF 247, ArC-F), 163.2 (C=O); HRMS 
(NSI+) C19H19DO4N2F+ [M]+ found: 360.1458, requires: 360.1464 (−1.8 ppm).  
(E)-3-(4-Fluorophenyl-3-d)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)prop-2-en-1-
ammonium bromide d1-364 
 
A solution of (E)-3-(3-bromo-4-fluorophenyl)-N,N-dimethylprop-2-en-1-amine 362 (250 mg, 0.97 
mmol, 1.0 equiv.) in anhydrous Et2O (10 mL) was cooled to −78 °C and treated with n-BuLi (2.31 M in 
hexanes, 0.93 mL, 2.13 mmol, 2.2 equiv.) dropwise and the resulting solution stirred for 30 min. D2SO4 
(98% in D2O, 250 µL, 2.43 mmol, 2.5 equiv.) was added dropwise and the reaction was allowed to 
warm to rt, D2O (5 mL) was then added. The mixture was basified with aq. 1 M NaOH (10 mL) to ca. 
pH 14 and extracted with Et2O (3 × 20 mL), the combined organic layers were washed with brine (10 
mL), dried over MgSO4 and concentrated in vacuo. The residue was dissolved in MeCN (2 mL) and p-
nitrophenyl bromoacetate (303 mg, 1.16 mmol, 1.2 equiv.) was added and the reaction stirred for 1 h at 
rt, the resulting precipitate was filtered and dried in vacuo to give the title product as a white solid (209 
mg, 97% D, 49% over two steps). 
mp 143 °C (dec.); νmax (film, cm−1): 2898, 1778, 1591, 1519, 1489, 1348, 1205, 1163, 1143, 977, 854, 
823; 1H NMR (500 MHz, d6-DMSO) δH: 3.34 (6H, s, N+(CH3)2), 4.38 (2H, d, J 7.5, C(1)H2), 4.80 (2H, 
s, COCH2), 6.55 (1H, dt, J 15.5, 7.5, C(2)H), 6.96 (1H, d, J 15.5, C(3)H), 7.27 (1H, t, J 9.1, Ar(5)H), 
7.56 (2H, d, J 9.2, OAr(2,6)H), 7.70 (2H, td, J 5.0, 2.4, C(3)Ar(3,5)H), 8.38 (2H, d, J 9.2, OAr(3,5)H); 
19F{1H} NMR (376 MHz, d6-DMSO) δF: −112.4 (ArF); 13C{1H} NMR (126 MHz, d6-DMSO) δC: 50.8 
(N+(CH3)2), 60.5 (COCH2), 67.1 (C(1)H2), 115.5-116.1 (m, C(3)ArC(5)H + C(3)ArC(3)D), 123.1 
(ArC(3,5)H), 125.5 (ArC(2,6)H), 129.6-129.3 (m, C(3)ArC(2)H + C(3)ArC(6)H), 131.8 (d, 3JCF 3, 
C(3)ArC(1)), 140.5 (C(3)H), 145.6 (OArC(1)O), 153.9 (OArC(4)NO2), 162.5 (d, 1JCF 247, ArC-F), 
163.2 (C=O); HRMS (ESI+) C19H19DO4N2F+ [M]+ found: 360.1455, requires: 360.1464 (−2.61 ppm). 
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(E)-3-(3-Fluorophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)prop-2-en-1-
ammonium bromide 372 
 
Following general procedure H, (E)-3-(3-fluorophenyl)-N,N-dimethylprop-2-en-1-amine 504 (0.5 g, 
2.79 mmol, 1.0 equiv.) was reacted with p-nitrophenyl bromoacetate 213 (0.87 g, 3.35 mmol, 1.2 equiv.) 
in MeCN (3 mL) to give the title product (0.93 g, 76%) as a white solid.  
mp 146 °C (dec.); νmax (film, cm−1): 3011, 1751, 1524, 1489, 1346, 1200, 1169, 1144, 984, 882, 852; 
1H NMR (500 MHz, d6-DMSO) δH: 3.35 (6H, s, N+(CH3)2), 4.43 (2H, d, J 7.5, C(1)H2), 4.87 (2H, s, 
COCH2), 6.70 (1H, dt, J 15.5, 7.5, C(2)H), 6.98 (1H, d, J 15.5, C(3)H), 7.13-7.27 (1H, m, Ar(2)H), 
7.39-7.51 (2H, m, Ar(4)H + Ar(5)H), 7.48-7.65 (3H, m, Ar(6)H + Ar(2,6)H), 8.38 (2H, d, J 9.1, 
Ar(3,5)H); 19F NMR (471 MHz, d6-DMSO) δF: −113.2 (td, J 9.7, 5.5, ArF); 13C{1H} NMR (126 MHz, 
d6-DMSO) δC: 50.9 (N+(CH3)2), 60.6 (COCH2), 66.8 (C(1)H2), 113.4 (d, 2JCF 22.0, ArC(2)H), 115.8 (d, 
2JCF 21.0, ArC(4)H), 118.1 (C(2)H), 123.1 (ArC(3,5)H), 124.0 (d, 3JCF 3, ArC(6)H), 125.5 (ArC(2,6)H), 
130.7 (d, 3JCF 9.0, ArC(5)H), 137.7 (d, 3JCF 8, ArC(1)), 140.1 (d, 4JCF 3, C(3)H), 145.6 (ArC(1)-O), 
153.9 (ArC(4)-NO2), 162.5 (d, 1JCF 243, ArC-F), 163.2 (C=O); HRMS (ASAP+) C19H20FN2O4+ [M]+ 
found: 359.1408, requires: 359.1407 (+0.3 ppm).  
(E)-3-(3-Fluoro-4-methoxyphenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)prop-2-en-1-
ammonium bromide 373 
 
Following general procedure H, (E)-3-(3-fluoro-4-methoxyphenyl)-N,N-dimethylprop-2-en-1-amine 
507 (0.5 g, 2.39 mmol, 1.0 equiv.) was reacted with p-nitrophenyl bromoacetate 213 (0.75 g, 2.87 mmol, 
1.2 equiv.) in MeCN (2.5 mL) to give the title product (1.04 g, 93%) as a white solid.  
mp 147 °C (dec.); νmax (film, cm−1): 3005, 1762, 1520, 1350, 1287, 1223, 1200, 1174, 1150, 980, 887; 
1H NMR (500 MHz, d6-DMSO) δH: 3.32 (6H, s, N+(CH3)2), 3.86 (3H, s, OCH3), 4.37 (2H, d, J 7.5, 
C(1)H2), 4.82 (2H, s, COCH2), 6.51 (1H, dt, J 15.5, 7.5, C(2)H), 6.88 (1H, d, J 15.5, C(3)H), 7.19 (1H, 
t, J 8.7, Ar(5)H), 7.36 (1H, dd, J 8.7, 2.0, Ar(6)H), 7.56 (2H, d, J 9.1, Ar(2,6)H), 7.64 (1H, dd, J 12.8, 
2.1, Ar(2)H), 8.38 (2H, d, J 9.1, Ar(3,5)H); 19F NMR (471 MHz, d6-DMSO) δF: −135.3 (td, J 12.9, 9.0, 
ArF); 13C{1H} NMR (126 MHz, d6-DMSO) δC: 51.2 (N+(CH3)2), 56.6 (OCH3), 60.9 (COCH2), 67.6 
(C(1)H2), 114.1 (ArC(6)H), 114.3 (d, 2JCF 19, ArC(2)H), 115.6 (C(2)H), 123.6 (ArC(2,6)H), 125.3 (d, 
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3JCF 3.1, ArC(5)H), 126.0 (ArC(3,5)H), 128.9 (d, 3JCF 6.7, ArC(1)), 140.7 (C(3)H), 146.1 (ArC(1)-O), 
148.3 (d, 2JCF 11, ArC(4)-OMe), 152.0 (d, 1JCF 244, ArC-F), 154.3 (ArC(4)-NO2), 163.9 (C=O); HRMS 
(ASAP+) C20H22FN2O5+ [M]+ found: 389.1510, requires: 389.1513 (−0.8 ppm). 
(E)-3-(4-Bromo-3-fluorophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)prop-2-en-1-
ammonium bromide 374 
 
Following general procedure H, (E)-3-(3-fluoro-4-bromophenyl)-N,N-dimethylprop-2-en-1-amine 510 
(0.5 g, 1.94 mmol, 1.0 equiv.) was reacted with p-nitrophenyl bromoacetate 213 (0.61 g, 2.33 mmol, 
1.2 equiv.) in MeCN (2.0 mL) to give the title product (0.82 g, 82%) as a white solid.  
mp 148 °C (dec.); νmax (film, cm−1): 3009, 1767, 1522, 1475, 1418, 1342, 1193, 1161, 984, 883; 1H 
NMR (500 MHz, d6-DMSO) δH: 3.34 (6H, s, N+(CH3)2), 4.41 (2H, d, J 7.5, C(1)H2), 4.84 (2H, 
s,COCH2), 6.73 (1H, dt, J 15.5, 7.5, C(2)H), 6.94 (1H, d, J 15.5, C(3)H), 7.41 (1H, dd, J 8.3, 1.9, ArH), 
7.57 (2H, d, J 9.1, Ar(2,6)H), 7.67-7.85 (2H, m, ArH), 8.38 (2H, d, J 9.1, Ar(3,5)H); 19F NMR (471 
MHz, d6-DMSO) δF: −108.45—108.27 (m, ArF); 13C{1H} NMR (179 MHz, d6-DMSO) δC: 50.9 
(N+(CH3)2), 60.6 (COCH2), 66.6 (C(1)H2), 108.4 (d, 2JCF 21, ArC(4)-Br), 114.8 (d, 2JCF 23, ArC(2)H), 
119.0 (C(2)H), 123.1 (ArC(2,6)H), 125.4 (d, 4JCF 2.5, ArC(6)H), 125.5 (ArC(3,5)H), 133.7 (ArC(5)H), 
137.2 (d, 3JCF 7.4, ArC(1)), 139.1 (C(3)H), 145.6 (ArC(1)-O), 153.9 (ArC(4)-NO2), 158.5 (d, 1JCF 244, 
ArC-F), 163.2 (C=O); HRMS (ASAP+) C19H1979BrFN2O4+ [M]+ found: 437.0511, requires: 437.0512 
(−0.2 ppm). 
(E)-3-(3-Fluoro-4-methylphenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)prop-2-en-1-
ammonium bromide 376 
 
Following general procedure H, (E)-3-(3-fluoro-4-methylphenyl)-N,N-dimethylprop-2-en-1-amine 513 
(0.5 g, 2.59 mmol, 1.0 equiv.) was reacted with p-nitrophenyl bromoacetate 213 (0.81 g, 3.11 mmol, 
1.2 equiv.) in MeCN (3.0 mL) to give the title product (0.25 g, 21%) as a white solid.  
mp 138 °C (dec.); νmax (film, cm−1): 2957, 1763, 1532, 1348, 1179, 1150, 1116, 980, 856; 1H NMR (500 
MHz, d6-DMSO) δH: 2.24 (3H, s, CH3), 3.34 (6H, s, N+(CH3)2), 4.41 (2H, s, C(1)H2), 4.86 (2H, s, 
COCH2), 6.63 (1H, br. s, C(2)H), 6.92 (1H, d, J 15.5, C(3)H), 7.33 (2H, s, ArH), 7.43-7.66 (3H, m, 
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ArH), 8.37 (2H, br. s, ArC(3,5)H); 19F (657 MHz, d6-DMSO) δF: −117. 6 (br. s, ArF); 13C{1H} NMR 
(126 MHz, d6-DMSO) δC: 14.1 (CH3), 50.8 (N+(CH3)2), 60.5 (COCH2), 66.9 (C(1)H2), 113.0 (d, 2JCF 
22.9, ArC(2)H), 116.9 (C(2)H), 123.1 (ArC(2,6)H), 123.7 (ArC(6)H), 125.2 (d, 2JCF 17.4, ArC(4)-Me), 
125.5 (ArC(2,6)H), 131.8 (d, 3JCF 5.3, ArC(5)H), 135.2 (d, 3JCF ArC(1)), 140.2 (C(3)H), 145.6 (ArC(1)-
O), 153.9 (ArC(4)-NO2), 160.9 (d, 1JCF 243, ArC-F), 163.2 (C=O); HRMS (ASAP+) C20H22N2O4F+ [M]+ 
found: 373.1563, requires: 373.1564 (−0.3 ppm). 
(E)-3-(3-Fluoro-4-iodophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)prop-2-en-1-
ammonium bromide 375 
 
Following general procedure H, (E)-3-(3-fluoro-4-iodophenyl)-N,N-dimethylprop-2-en-1-amine 516 
(0.4 g, 1.31 mmol, 1.0 equiv.) was reacted with p-nitrophenyl bromoacetate 213 (0.41 g, 1.57 mmol, 
1.2 equiv.) in MeCN (2.0 mL) to give the title product (0.67 g, 90%) as a white solid.  
mp 170 °C (dec.); νmax (film, cm−1); 2930, 1769, 1514, 1481, 1398, 1344, 1221, 1161, 989, 883; 1H 
NMR (500 MHz, d6-DMSO) δH: 3.33 (6H, s, N+(CH3)2), 4.39 (2H, d, J 7.5, C(1)H2), 4.82 (2H, s, 
COCH2), 6.73 (1H, dt, J 15.5, 7.5, C(2)H), 6.92 (1H, d, J 15.5, C(3)H), 7.25 (1H, dd, J 8.2, 1.9, Ar(6)H), 
7.56 (2H, d, J 9.1, Ar(3,5)H), 7.64 (1H, dd, J 9.6, 1.9, Ar(2)H), 7.89 (1H, dd, J 8.2, 6.8, Ar(5)H), 8.38 
(2H, d, J 9.1, Ar(2,6)H); 19F NMR (471 MHz, d6-DMSO) δF: −95.4 (dd, J 9.5, 6.7, ArF); 13C{1H} NMR 
(126 MHz, d6-DMSO) δC: 50.9 (N+(CH3)2), 60.6 (COCH2), 66.7 (C(1)H2), 83.0 (d, 2JCF 26, C(3)ArC(4)-
I), 113.7 (d, 2JCF 25, C(3)ArC(2)H), 118.7 (C(2)H), 123.1 (OArC(2,6)H), 125.5 (OArC(3,5)H), 125.6 
(d, 4JCF 2.9, ArC(6)H), 137.9 (d, 3JCF 7.6, ArC(1)), 139.3 (C(3)H), 139.5 (d, 3JCF 2.0, ArC(5)H), 145.6 
(ArC(1)-O), 153.9 (ArC(4)-NO2), 161.5 (d, 1JCF 242, ArC-F), 163.2 (C=O); HRMS (NSI+) 
C19H19FIN2O2+ [M]+ found: 485.0360, requires: 485.0368 (−1.7 ppm). 
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Catalyst Synthesis  
(R)-2-((6-Fluorobenzo[d]thiazol-2-yl)amino)-2-phenylethan-1-ol 314 
 
A solution of 2-chloro-6-fluoro-benzothiazole 312 (1.50 g, 7.98 mmol, 1.0 equiv.) and (R)-phenyl 
glycinol (1.15 g, 8.37 mmol, 1.05 equiv.) in 1,2 dichlorobenzene (4 mL) was treated with N,N 
diisopropylethylamine (3.48 mL, 19.95 mmol, 2.5 equiv.) and heated at refluxed for 24 h. The reaction 
was cooled to rt and water (12 mL) and toluene (12 mL) were added and the mixture stirred for 30 min, 
the precipitate was filtered and washed with toluene. The resulting solid was recrystallized from toluene 
to give the title product as a white solid (1.01 g, 44%). 
[α]D
20−94.3 (c 1, MeOH); mp 140-142 °C; νmax (film, cm−1): 3209, 3001, 1605, 1562, 1462, 1350, 1194, 
1063, 817; 1H NMR (500 MHz, d4-MeOH) δH: 3.82 (2H, ddt, J 18.8, 11.3, 6.3, C(1)H2), 4.99 (1H, t, J 
6.3, C(2)H), 6.97 (1H, t, J 8.9, Ar(5)H), 7.25 (1H, t, J 7.1, C(2)Ar(4)H), 7.29-7.37 (4H, m, ArH), 7.42 
(2H, d, J 7.6, ArH); 19F{1H} NMR (376 MHz, d4-MeOH) δF: −123.7 (ArF); 13C{1H} NMR (101 MHz, 
d4-MeOH) δC: 62.2 (C(2)H), 66.8 (C(1)H2), 108.4 (d, 2JCF 27.5, ArC(7)H), 114.1 (d, 2JCF 24.1, 
ArC(5)H), 119.6 (d, 3JCF 8.8, ArC(4)H), 128.1 (C(2)ArC(2,6)H), 128.6 (C(2)ArC(4)H), 129.5 
(C(2)ArC(3,5)H), 132.4 (d, 3JCF 10.9, ArC-S), 141.0 (C(2)ArC(1)), 149.7 (d, 4JCF 1.3, ArC-N), 159.6 
(d, 1JCF 239, ArC-F), 168.6 (C=N); HRMS (NSI+): C15H14FN2OS [M+H]+ found: 289.0807, requires 
289.0805 (+0.5 ppm). 
(R)-7-Fluoro-2-phenyl-2,3-dihydrobenzo[d]imidazo[2,1-b]thiazole (F-(+)-BTM) 315 
 
A solution of (R)-2-((6-fluorobenzo[d]thiazol-2-yl)amino)-2-phenylethan-1-ol 314 (500 mg, 1.74 
mmol, 1.0 equiv.) and NEt3 (966 μL, 6.94 mmol, 4.0 equiv.) in CH2Cl2 (17.4 mL) was cooled to 0 °C 
and MsCl (176 μL, 2.26 mmol, 1.3 equiv.) was added dropwise. The reaction mixture was then allowed 
to warm to rt and stirred for 15 min, once (R)-2-((6-fluorobenzo[d]thiazol-2-yl)amino)-2-phenylethan-
1-ol was consumed by TLC, iPrOH (350 μL) was added. The mixture was then heated to reflux and 
stirred for 16 h. Once complete, the reaction was cooled to rt and quenched by the addition of aq. 1 M 
NaOH (15 mL), the layers separated and the aqueous extracted with CH2Cl2 (2  20 mL), the combined 
organic layers washed with brine and dried over MgSO4 then concentrated in vacuo. The residue was 
azeotroped with toluene (3  20 mL), the residue was purified by flash chromatography on silica gel 
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(2→15% EtOAc/CH2Cl2). The residue was recrystallized (Et2O/hexane) to give the product as a white 
solid (281 mg, 60%);  
HPLC analysis, Chiralpak AD-H (10% IPA/hexane, flow rate 1.5 mL/min, 254 nm, 40 °C) tR Major 
11.5 min, Minor 15.8 min, >99% ee;  
[α]D
20 +211.2 (c 1, CHCl3); mp 110-112 °C; νmax (film, cm−1): 2885, 1604, 1595, 1573, 1483, 1465, 
1259, 1179, 960; 1H NMR (500 MHz, CDCl3) δH: 3.71 (1H, t, J 8.5, C(3)HAHB), 4.28 (1H, app. t, J 9.5, 
C(3)HAHB), 5.69 (1H, dd, J 10.1, 8.5, C(2)H), 6.60 (1H, dd, J 8.5, 4.3, ArC(5)H), 6.92 (1H, td, J 8.8, 
2.5, ArC(6)H), 7.10 (1H, dd, J 8.0, 2.5, ArC(8)H), 7.33, (1H, m, ArH), 7.40 (4H, d, J 4.3, ArH); 19F{1H} 
NMR (471 MHz, CDCl3) δF: −121.21 (ArF); 13C{1H} NMR (126 MHz, CDCl3) δC: 53.0 (C(3)H2), 75.7 
(C(2)H), 108.6 (d, 3JCF 8.4, ArC(5)H), 111.0 (d, 2JCF 27.5, ArC(8)H), 113.3 (d, 2JCF 23.7, ArC(6)H), 
126.6 (C(2)ArC(2,6)H), 127.8 (C(2)ArC(4)H), 128.5 (d, 3JCF 9.9, ArC-S), 128.9 (C(2)ArC(3,5)H), 
133.8 (d, 4JCF 1.3, ArC-N), 142.6 (C(2)ArC(1), 158.0 (d, 1JCF 241, ArC-F), 166.8 (C=N); HRMS (NSI+): 
C15H12FN2S [M+H]+ found: 271.0697, requires 271.0700 (−1.0 ppm). 
(R)-7-Fluoro-2-phenyl-2,3-dihydrobenzo[d]imidazo[2,1-b]thiaacupzole hydrochloride (F-(+)-
BTM·HCl) 316 
 
A solution of (+)-F-BTM 315 (100 mg, 0.37 mmol, 1.0 equiv.) in Et2O (3.7 mL) was treated with HCl 
(2 M in Et2O, 0.92 mL, 1.84 mmol, 5.0 equiv.) at rt and stirred for 15 min. The resulting mixture was 
concentrated in vacuo to give the title product as an off white solid (116 mg, quant.)  
[α]D
20+112.2 (c 1, MeCN); mp 128-130 °C; νmax (film, cm−1) 2991, 2858, 1568, 1501, 1470, 1259, 1203, 
1024, 878; 1H NMR (500 MHz, d6-DMSO) δH: 4.39 (1H, dd, J 10.6, 8.5, C(3)HAHB), 4.98 (1H, t, J 
10.6, C(3)HAHB), 5.98 (1H, dd, J C(2)H), 7.41-7.48 (4H, m, ArH), 7.55-7.58 (3H, m, ArH), 8.04 (1H, 
dd, J 8.7, 2.4, ArC(8)H), 11.75 (1H, br. s, NH); 19F{1H} NMR (376 MHz, d6-DMSO) δF: −117.1 (ArF); 
13C{1H} NMR (126 MHz, d6-DMSO) δC: 53.5 (C(3)H2), 66.3 (C(2)H), 112.2 (d, 2JCF 29, ArC(8)H), 
113.8 (d, 3JCF 9, ArC(5)H), 115.5 (d, 2JCF 25, ArC(6)H), 127.1 (C(2)ArC(2,6)H), 129.0 
(C(2)ArC(3,5)H), 129.2 (d, 3JCF 11, ArC-S), 131.7 (C(2)ArC(4)H), 138.7 (C(2)ArC(1)), 158.6 (d, 1JCF 
241, ArC-F), 170.0 (C=N); HRMS (ESI+) C15H12N2FS+ [M]+ found: 271.0692, requires: 271.3329 
(−2.85 ppm). 
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(R)-1-benzoyl-7-fluoro-2-phenyl-2,3-dihydrobenzo[d]imidazo[2,1-b]thiazol-1-ium chloride 317 
 
A solution of (+)- F-BTM 315 (100 mg, 0.37 mmol, 1.0 equiv.) in CH2Cl2 (3.7 mL) was treated with 
benzoyl chloride (52 µL, 0.44 mmol, 1.2 equiv.) and stirred at rt for 15 min. Et2O (4 mL) was added 
and the precipitate was filtered and dried in vacuo to give the title product as a white solid (94 mg, 
62%). 
[α]D
20 −52.0 (c 1, DMSO); mp 174-176 °C; νmax (film, cm−1): 2997, 1674, 1485, 1375, 1338, 1201, 1012, 
881;1H NMR (500 MHz, d6-DMSO) δH: 4.81 (1H, dd, J 11.3, 6.7, C(3)HAHB), 5.45 (1H, t, J 11.3, 
C(2)H), 6.72 (1H, dd, J 10.5, 6.7, C(3)HAHB), 7.18-7.28 (3H, m, ArH), 7.32 (2H, d, J 7.1, ArH), 7.44 
(2H, t, J 7.7, ArH), 7.58 (1H, t, J 7.7, ArH), 7.63 (2H, d, J 7.7, ArH), 7.75 (1H, td, J 9.0, 2.7, ArC(6)H), 
8.08 (1H, dd, J 9.0, 4.3, ArC(8)H), 8.41 (1H, dd, J 8.6, 2.7, ArC(5)H); 19F NMR (471 MHz, d6-DMSO) 
δF: −113.0 (td, J 8.8, 4.4, ArF); 13C{1H}NMR (126 MHz, CDCl3) δC: 55.9 (C(3)H2), 68.0 (C(2)H), 112.5 
(d, 2JCF 29, ArC(8)H), 116.7 (d, 3JCF 9.3, ArC(5)H), 117.4 (d, 2JCF 26, ArC(6)H), 127.4 (PhC(2,6)H), 
127.5 (PhC(2,6)H), 128.7 (PhC(3,5)H), 128.8 (PhC(3,5)H), 129.0 (PhC(4)H), 130.3 (ArCH), 130.8 
(ArCH), 131.6 (d, 3JCF 12, ArC-S), 132.8 (ArCH), 136.9 (ArC), 159.8 (d, 1JCF 245, ArC-F), 167.8 (C=O 
+ C=N); HRMS (ESI+) C22H16ON2FS+ [M]+ found: 375.0951, requires: 375.0962 (−2.90 ppm). 
(R)-2-Phenyl-2,3-dihydrobenzo[d]imidazo[2,1-b]thiazole hydrochloride ((+)-BTM·HCl) 517 
 
A solution of (+)-BTM 197 (100 mg, 0.40 mmol, 1.0 equiv.) in Et2O (4 mL) was treated with HCl (2 M 
in Et2O, 1 mL, 2.00 mmol, 5.0 equiv.) at rt and stirred for 15 min. The resulting mixture was 
concentrated in vacuo to give the title product as an off white solid (114 mg, quant.). 
mp 201-203 °C;[α]D
20+132.5 (c 1, MeCN); νmax (film, cm−1): 3390, 2723, 1589, 1568, 1497, 1440, 1367, 
1271, 1030, 916, 819; 1H NMR (700 MHz, d6-DMSO) δH: 4.40 (1H, dd, J 10.6, 8.3 C(3)HAHB), 4.99 
(1H, t, J 10.6, C(3)HAHB), 5.97 (1H, dd, J 10.6, 8.3, C(2)H), 7.36–7.45 (2H, m, ArH), 7.47 (2H, dd, J 
8.3, 6.6, ArH), 7.53 (1H, dd, J 8.1, 1.2, ArH), 7.57 (3H, dt, J 7.4, 2.7, ArH), 8.07 (1H, dd, J 8.1, 1.0, 
ArH), 11.53 (1H, s, N+H); 13C{1H}NMR (126 MHz, CDCl3) δC: 53.1 (C(3)H2), 66.2 (C(2)H), 112.8 
(ArCH), 124.6 (ArCH), 124.9 (ArCH), 127.1 (ArCH), 127.6 (ArC), 128.0 (ArCH), 129.0 (ArCH), 129.0 
ArCH), 134.8 (ArC), 138.7 (ArC), 169.7 (C=N); HRMS (ESI+) C15H13N2S+ [M]+ found: 253.0784, 
requires: 253.0788 (−3.9 ppm). 
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Synthesis of 15N-F-BTM, 15N-321 
 
2-(Amino-15N)-2-phenylacetonitrile hydrochloride 15N-325 
 
Caution: KCN, potassium cyanide, is a potent poison, which should be handled with gloves in a well-
ventilated fume hood. Contact with acid releases HCN, due care should be taken to avoid contact with 
acid. 
A solution of 15NH4Cl (1.0 g, 18.2 mmol, 1.0 equiv.) and KCN (1.24 g, 19.1 mmol, 1.05 equiv.) in H2O 
(23 mL) was treated with a solution of benzaldehyde (1.85 mL, 18.2 mmol, 1.0 equiv.) in MeOH (23 
mL) and stirred for 16 h at rt. Once complete water (20 ml) was added and the mixture extracted with 
CH2Cl2 (3  50 mL), the organic extracts were washed with brine, dried over MgSO4 and concentrated 
in vacuo. The residue was dissolved in Et2O (30 mL) and treated with HCl (2.5 M in EtOH, 11 mL, 27.3 
mmol, 1.5 equiv.) then stirred for 30 min at rt, the resulting precipitate was filtered and washed with 
Et2O (20 mL) and dried in vacuo to give the product as a white solid (1.28 g, 41%);  
mp 148 °C (dec.); νmax (film, cm−1) 2843, 2573, 2021, 1595, 1467, 1192, 1115, 991; 1H NMR (500 
MHz, d6-DMSO) δH: 5.99 (1H, s, CHCN), 7.49-7.55 (3H, m, ArH), 7.66-7.73 (2H, m, ArH), 9.83 (3H, 
br. s, N+H3); 13C{1H} NMR (126 MHz, d6-DMSO) δC: 43.2 (d, 1JCN 6.7, CHCN), 116.3 (CN), 128.5 
(ArC(2,6)H), 129.2 (ArC(3,5)H), 130.3 (ArC(4)H), 130.4 (ArC(1)); HRMS (APCI+): C8H9N15N+ [M]+ 
found: 134.0734, requires 134.0731 (+2.5 ppm). 
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2-(Amino-15N)-2-phenylacetic acid hydrochloride 15N-326 
 
A solution of 2-(amino-15N)-2-phenylacetonitrile hydrochloride 15N-325 (1.2 g, 7.10 mmol, 1.0 equiv.) 
in aq. 6 M HCl (71 mL) was heated to reflux for 24 h. Once complete the reaction mixture was cooled 
to rt and concentrated in vacuo to give the product as a white solid (1.57 g, quant.). 
mp 228 °C (dec.); νmax (film, cm−1): 3105, 2884, 1728, 1476, 1408, 1209, 1180, 1010, 875; 1H NMR 
(500 MHz, d6-DMSO) δH: 5.04 (1H, s, 15NCH), 7.04-7.63 (5H, m, ArH), 8.95 (1H, br. s, CO2H), 9.09 
(3H, br. s, N+H3); 13C{1H} NMR (126 MHz, d6-DMSO) δC: 55.5 (d, 1JCN 6.7, 15NCH), 128.2 
(ArC(2,6)H), 128.9 (ArC(3,5)H), 129.3 (ArC(4)H), 133.3 (ArC(1)), 169.6 (C=O); HRMS (NSI+): 
C8H10O215N+ [M]+ found: 153.0672, requires 153.0676 (−2.9 ppm). 
Methyl 2-(amino-15N)-2-phenylacetate 15N-327 
 
A solution of 2-(amino-15N)-2-phenylacetic acid hydrochloride 15N-326 (1.2 g, 6.38 mmol, 1.0 equiv.) 
in MeOH (14 mL) was cooled to 0 °C and was treated dropwise with thionyl chloride (931 μL, 12.77 
mmol, 2.0 equiv.) the resulting reaction mixture was allowed to warm to rt and stirred for 16 h. Once 
complete the mixture was concentrated in vacuo, the residue was partitioned between EtOAc (20 mL) 
and aq. 1M NaOH (20 mL), the layers separated the aqueous layer extracted with EtOAc (2  20 mL), 
the combined organic layers were washed with brine, dried over MgSO4 and concentrated in vacuo to 
give the product as a yellow oil (462 mg, 44%). 
νmax (film, cm−1): 3244, 2953, 1737, 1670, 1494, 1215, 1127, 1002, 827; 1H NMR (500 MHz, CDCl3) 
δH: 1.97 (2H, br. s, NH2), 3.68 (3H, s, OCH3), 4.61 (1H, s, PhCH), 7.27-7.40 (5H, m, ArH); 13C{1H} 
NMR (126 MHz, CDCl3) δC: 52.5 (OCH3), 58.8 (d, 1JCN 4.2, 15NCH), 126.9 (ArC(2,6)H), 128.1 
(ArC(4)H), 128.7 (ArC(3,5)H), 140.3 (ArC(1)), 174.5 (C=O); HRMS (NSI+): C9H12O215N+ [M+H]+ 
found: 167.0829, requires 167.0833 (−2.3 ppm). 
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2-(Amino-15N)-2-phenylethan-1-ol 15N-328 
 
A solution of methyl 2-(amino-15N)-2-phenylacetate 15N-327 (755 mg, 4.55 mmol, 1.0 equiv.) in THF 
(46 mL) was cooled to 0 °C and treated dropwise with LiAlH4 (2.4 M in THF, 2.85 mL, 6.82 mmol, 1.5 
equiv.) after stirring for 15 min, the reaction was heated to reflux for 1 h. Once complete the reaction 
was cooled to 0 °C and quenched with aq. 1 M KOH (40 mL) dropwise, EtOAc was then added (30 mL) 
and the mixture stirred at rt for 30 min. The layers separated and the aqueous layer extracted with EtOAc 
(3  30 mL) the combined organic layers were washed with brine, dried over MgSO4 and concentrated 
to give the product as a yellow oil (473 mg, 75%) which was used directly without further purification.  
1H NMR (500 MHz, CDCl3) δH: 2.40 (2H, br. s, NH2), 3.55 (1H, ddd, J 10.7, 8.4, 2.1, C(1)HAHB), 3.70-
3.77 (1H, m, C(1) HAHB), 4.04 (1H, dd, J 8.4, 4.3, C(2)H), 7.27-7.38 (5H, m, ArH), 13C{1H} NMR (126 
MHz, CDCl3) δC: 57.5 (d, 1JCN 4.3, C(2)H), 68.0 (d, 2JCN 2.1, C(1)H), 126.6 (ArC(2,6)H), 127.7 
(ArC(4)H), 128.8 (ArC(3,5)H), 142.7 (ArC(1)). 
2-((6-Fluorobenzo[d]thiazol-2-yl)amino-15N)-2-phenylethan-1-ol 15N-329 
 
A solution of 2-chloro-6-fluoro-benzothiazole 312 (590 mg, 3.15 mmol, 1.0 equiv.) and 2-(amino-15N)-
2-phenylethan-1-ol 15N-328 (457 mg, 3.31 mmol, 1.05 equiv.) in 1,2 dichlorobenzene (1.58 mL) was 
treated with N,N diispropylethylamine (1.37 mL, 7.88 mmol, 2.5 equiv.) and heated at reflux for 24 h. 
The reaction was cooled to rt and concentrated in vacuo, the residue was dissolved in CH2Cl2 (30 ml) 
and washed with brine, dried over MgSO4 and concentrated in vacuo, the residue was recrystallized 
from toluene to give the title product as a white solid (218 mg, 24%). 
mp 164-165°C; νmax (film, cm−1): 3205, 3016, 1600, 1531, 1460, 1209, 1049, 1029, 852; 1H NMR (500 
MHz, MeOH-d4) δH: 3.70-3.91 (2H, m, C(1)H2), 4.99 (1H, br. s, C(2)H), 6.96 (1H, t, J 7.9, Ar(5)H), 
7.22-7.29 (1H, m, C(2)Ar(4)H), 7.29-7.38 (4H, m, ArH), 7.39-7.45 (2H, m, ArH); 19F{1H} NMR (376 
MHz, MeOH-d4) δF: −123.7 (ArF); 13C{1H} NMR (126 MHz, MeOH-d4) δC: 62.1 (d, 1JCN 21.6, C(2)H), 
66.8 (C(1)H2), 108.4 (d, 2JCF 27.4, ArC(7)H), 114.1 (d, 2JCF 24.1, ArC(5)H), 119.5 (d, 3JCF 8.7, 
ArC(4)H), 128.1 (C(2)ArC(2,6)H), 128.6 (C(2)ArC(4)H), 129.5 (C(2)ArC(3,5)H), 132.4 (d, 3JCF 10.8, 
ArC-S), 141.0 (C(2)ArC(1)), 149.6 (ArC-N), 159.6 (d, 1JCF 239, ArC-F), 168.6 (d, 1JCN 21.6, C=N); 
HRMS (NSI+): C15H14FN15NOS+ [M+H]+ found: 290.0776, requires 290.0776 (+0.1 ppm). 
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(±)-7-Fluoro-2-phenyl-2,3-dihydrobenzo[d]imidazo[2,3-b]thiazole-1-15N, 15N-321 
 
A solution of 2-((6-fluorobenzo[d]thiazol-2-yl)amino-15N)-2-phenylethan-1-ol 15N-329 (218 mg, 0.76 
mmol, 1.0 equiv.) in CH2Cl2 (7.6 mL) was cooled to 0 °C and treated with NEt3 (423 μL, 3.04 mmol, 
4.0 equiv.) followed by MsCl (76 μL, 0.98 mmol, 1.3 equiv.) dropwise. The resulting solution was 
allowed to warm to rt and stirred for 15 min, once complete the reaction was treated with iPrOH (220 
μL) and heated to reflux for 16 h. Once complete the reaction was cooled to rt and quenched by the 
addition of aq. 1 M NaOH (10 mL), the layers separated and the aqueous extracted with CH2Cl2 (2  
20 mL), the combined organic layers washed with brine and dried over MgSO4 then concentrated in 
vacuo. The residue was azeotroped with toluene (3  20 mL), the residue was purified by flash 
chromatography on silica gel (5% iPrOH/hexane). The residue was recrystallized (Et2O/hexane) to give 
the product as a yellow solid (87 mg, 42%). 
mp 111-113 °C; νmax (film, cm−1): 3028, 160, 1490, 1188, 871; 1H NMR (500 MHz, CDCl3) δH: 3.69 
(1H, t, J 8.5, C(3)HAHB), 4.13-4.34 (1H, m, C(3)HAHB), 5.57-5.76 (1H, m, C(2)H), 6.58 (1H, dd, J 8.6, 
4.3, Ar(5)H), 6.90 (1H, td, J 8.8, 2.5, Ar(6)H), 7.08 (1H, dd, J 8.0, 2.5, Ar(8)H), 7.27-7.32 (1H, m, 
ArH), 7.35-7.40 (4H, m, ArH); 19F{1H} NMR (376 MHz, CDCl3) δF: −121.2 (ArF); 13C{1H} NMR (101 
MHz, CDCl3) δC: 53.0 (C(3)H2), 75.7 (d, 1JCN 4.6, C(2)H), 108.6 (d, 3JCF 8.4, ArC(5)H), 111.1 (d, 2JCF 
28, ArC(8)H), 113.3 (d, 2JCF 24, ArC(6)H), 126.6 (C(2)ArC(2,6)H), 127.8 (C(2)ArC(4)H), 128.6 (d, 
3JCF 9.9, ArC-S) 128.9 (C(2)ArC(3,5)H), 133.8 (d, 4JCF 1.4, ArC-N), 142.9 (d, 2JCN 1.3, C(2)ArC(1)), 
158.0 (d, 1JCF 241, ArC-F), 166.8 (d, 1JCN 2.3, C=15N); HRMS (NSI+): C15H12FN15NS+ [M+H]+ found: 
272.0669, requires 272.0670 (−0.4 ppm). 
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Catalytic [2,3]-Rearrangements 
General Procedure L: Catalytic [2,3]-Rearrangement of Allylic Ammonium Salts 
A flamed dried Schlenk was charged with (+)-BTM (0.2 equiv.) and HOBt (0.2 equiv.) in MeCN (0.07 
M with respect to the ammonium salt). iPr2NH (1.4 equiv.) was added and the solution was cooled to 
−20 °C ad stirred for five min. The corresponding ammonium salt (1.0 equiv.) was added and the 
reaction stirred for 16 h, after which the reaction was quenched by the addition of aq. 1 M NaOH (equal 
volume) and extracted with CH2Cl2 (3 × equal volume). The combined organic layers were washed with 
brine (equal volume) dried over MgSO4 and concentrated in vacuo, the crude residue was analysed by 
1H and 19F{1H} NMR to determine diastereoselectivity then purified by flash column chromatography 
to give the syn rearranged activated ester.  
General Procedure M: Racemic Catalytic [2,3]-Rearrangement of Allylic Ammonium Salts 
A flamed dried Schlenk was charged with (±)-BTM (0.2 equiv.) and HOBt (0.2 equiv.) in MeCN (0.07 
M with respect to the ammonium salt). iPr2NH (1.4 equiv.) The corresponding ammonium salt (1.0 
equiv.) was added and the reaction stirred for 30 min at rt, after which the reaction was quenched by 
the addition of aq. 1 M NaOH (equal volume) and extracted with CH2Cl2 (3 × equal volume). The 
combined organic layers were washed with brine (equal volume) dried over MgSO4 and concentrated 
in vacuo, the crude residue was analysed by 1H and 19F NMR to determine diastereoselectivity then 
purified by flash column chromatography to give the (±)-syn rearranged activated ester.  
General Procedure N: Catalytic [2,3]-Rearrangement of Allylic Ammonium Salts and sequential 
Sodium Methoxide Quench 
A flamed dried Schlenk was charged with (+)-BTM (0.2 equiv.) and HOBt (0.2 equiv.) in MeCN (0.07 
M with respect to the ammonium salt). iPr2NH (1.4 equiv.) was added and the solution was cooled to 
−20 °C ad stirred for five min. The corresponding ammonium salt (1.0 equiv.) was added and the 
reaction stirred for 16 h, after which the reaction was quenched by the addition of NaOMe (1.0 M, 3.0 
equiv.) and stirred at rt for 1 h. The reaction mixture was quenched with aq. 1 M NaOH (equal volume) 
and extracted with CH2Cl2 (3 × equal volume), the combined organic layers washed with aq. 1 M NaOH 
(2 × equal volume), brine (equal volume), dried over MgSO4 and concentrated in vacuo. The crude 
residue was analysed by 1H and 19F NMR to determine diastereoselectivity then purified by flash 
column chromatography to give the rearranged syn methyl ester. 
1 M NaOMe in MeOH was freshly prepared before use, by dissolving Na metal in anhydrous methanol 
at 0 °C and stirred for 30 min at rt.  
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Methyl (2S,3S)-2-(dimethylamino)-3-(4-fluorophenyl)pent-4-enoate 310 
 
Following general procedure N (E)-3-(4-fluorophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-
oxoethyl)prop-2-en-1-ammonium bromide 309 (105 mg, 0.24 mmol, 1.0 equiv.) was reacted with (+)-
BTM (12 mg, 0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and iPr2NH (47 μL, 
0.34 mmol, 1.4 equiv.) in MeCN (3.5 mL) then NaOMe (1 M in MeOH, 0.72 mL, 0.72 mmol, 3.0 equiv.) 
to give the title product (57 mg, 95%, >95:5 dr) as a white solid after purification by flash column 
chromatography (10% EtOAc/hexanes). 
HPLC analysis, Chiralpak OJ-H (3% IPA/hexane, flow rate 1.5 mL/min, 211 nm, 40 °C) tR Major 4.4 
min, Minor 3.6 min, >99% ee;  
mp 54-56 °C; [α]D
20 +56.8 (c 1, CHCl3); νmax (film, cm−1): 2949, 1728, 1506, 1346, 1217, 1155, 979, 
921; 1H NMR (500 MHz, CDCl3) δH: 2.24 (6H, s, N(CH3)2), 3.54 (1H, d, J 11.3, C(2)H), 3.70 (3H, s, 
OCH3), 3.74 (1H, dd, J 11.3, 8.3, C(3)H), 4.69-5.09 (2H, m, C(5)H2), 5.82 (1H, ddd, J 17.0, 10.2, 8.3, 
C(4)H), 7.01 (2H, t, J 8.7, Ar(3,5)H), 7.17 (2H, dd , J 8.7, 5.4, Ar(2,6)H); 19F NMR (471 MHz, CDCl3) 
δF: −116.4 (ArF); 13C{1H} NMR (126 MHz, CDCl3) δC: 41.5 (N(CH3)2), 49.3 (C(3)H), 50.9 (OCH3), 
71.0 (C(2)H), 115.5 (d, 2JCF 21, ArC(3,5)H), 116.9 (C(5)H2) 129.4 (d, 3JCF 7.9, ArC(2,6)H), 136.5 (d, 
4JCF 3, ArC(1)), 138.6 (C(4)H), 161.7 (d, 1JCF 245, ArC-F), 171.0 (C=O); HRMS (NSI+) C14H19FNO2+ 
[M+H]+ found: 252.1396, requires: 252.1394 (+0.7 ppm).  
Methyl (2S,3S)-2-(dimethylamino)-3-(4-fluorophenyl)pent-4-enoate-3-d d1-359 
 
Following general procedure N, (E)-3-(4-fluorophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-
oxoethyl)prop-2-en-1-ammonium-3-d bromide d1-357 (105 mg, 0.24 mmol, 1.0 equiv.) was reacted 
with (+)-BTM (12 mg, 0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and iPr2NH 
(47 μL, 0.34 mmol, 1.4 equiv.) in MeCN (3.5 mL) then NaOMe (1 M in MeOH, 0.72 mL, 0.72 mmol, 
3.0 equiv.) to give the title product (55 mg, 95%, >95:5 dr, >95% D) as a white solid after purification 
by flash column chromatography (15% EtOAc/hexanes). 
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HPLC analysis, Chiralpak OJ-H (3% IPA/hexane, flow rate 1.5 mL/min, 211 nm, 40 °C) tR Major 4.4 
min, Minor 3.6 min, 94% ee;  
mp 55-57 °C; [α]D
20 +51.0 (c 1, CHCl3); νmax (film, cm−1): 2978, 2949, 1726, 1506, 1425, 1215, 1155, 
922; 1H NMR (400 MHz, CDCl3) δH: 2.24 (6H, s, N(CH3)2), 3.54 (1H, s, C(2)H), 3.70 (3H, s, OCH3), 
4.86-5.20 (2H, m, C(5)H2), 5.82 (1H, dd, J 17.0, 10.2, C(4)H), 7.00 (2H, t, J 8.8, Ar(3,5)H), 7.17 (2H, 
dd, J 8.8, 5.4, Ar(2,6)H); 19F NMR (471 MHz, CDCl3) δF: −116.4 (Ar-F); 13C{1H} NMR (101 MHz, 
CDCl3) δC: 41.4 (N(CH3)2), 48.9 (t, 1JCD 20, C(3)D), 50.9 (OCH3), 71.0 (C(2)H), 115.5 (d, 2JCF 21, 
ArC(3,5)H), 116.8 (C(5)H2), 129.4 (d, 3JCF 7.8, ArC(2,6)H), 136.5 (ArC(1)), 138.5 (C(4)H), 161.7 (d, 
1JCF 245, ArC-F), 171.0 (C=O); HRMS (NSI+) C14H18DFNO2+ [M+H]+ found: 253.1460, requires: 
253.1457 (+1.1 ppm).  
(±)-3,5-Bis(trifluoromethyl)phenyl syn-2-(dimethylamino)-3-phenylpent-4-enoate 368 
 
Following general procedure M, (E)-N-(2-(3,5-bis(trifluoromethyl)phenoxy)-2-oxoethyl)-N,N-
dimethyl-3-phenylprop-2-en-1-ammonium bromide 227 (123 mg, 0.24 mmol, 1.0 equiv.) was reacted 
with (±)-BTM (12 mg, 0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and iPr2NH 
(47 μL, 0.34 mmol, 1.4 equiv.) in MeCN (3.5 mL). to give the title product (73 mg, 71%) as a white 
solid after flash column chromatography (10→15% EtOAc/hexanes). 
mp 88-90 °C; νmax (film, cm−1): 2937, 1755, 1456, 1369, 1275, 1171, 1119, 1105, 902; 1H NMR (500 
MHz, CDCl3) δH: 2.41 (6H, s, N(CH3)2), 3.88-3.90 (2H, m, C(2)H + C(3)H), 5.12-5.32 (2H, m, C(5)H2), 
5.91-6.12 (1H, m, C(4)H), 7.26-7.30 (3H, m, ArH), 7.32-7.42 (2H, m, ArH), 7.53 (2H, s, Ar(2,6)H), 
7.78 (1H, s, ArC(4)H); 19F{1H} NMR (376 MHz, CDCl3) δF: −62.9 (CF3); 13C{1H} NMR (126 MHz, 
CDCl3) δC: 41.6 (N(CH3)2), 50.5 (C(3)H), 70.9 (C(2)H), 117.6 (C(5)H2), 119.9-120.0 (m, OArC(4)H), 
121.7-123.0 (m, OArC(2,6)H), 122.8 (q, 1JCF 273, CF3), 127.2 (C(3)ArC(4)H), 128.0 (C(3)ArC(2,6)H), 
128.9 (C(3)ArC(3,5)H), 133.1 (q, 2JCF 34.0, ArC-CF3), 138.3 (C(4)H), 140.1 (C(3)ArC(1)), 151.0 
(ArC(1)), 168.8 (C=O); HRMS (NSI+) C21H20F6NO2+ [M+H]+ found: 432.1387, requires: 432.1393 
(−1.3 ppm).  
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(±)-3,5-Bis(trifluoromethyl)phenyl syn-2-(dimethylamino)-3-(4-fluorophenyl)pent-4-enoate 367 
 
Following general procedure M, (E)-N-(2-(3,5-bis(trifluoromethyl)phenoxy)-2-oxoethyl)-3-(4-
fluorophenyl)-N,N-dimethylprop-2-en-1-ammonium bromide 366 (127 mg, 0.24 mmol, 1.0 equiv.) was 
reacted with (±)-BTM (12 mg, 0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and 
iPr2NH (47 μL, 0.34 mmol, 1.4 equiv.) in MeCN (3.5 mL). to give the title product (51 mg, 40%) as a 
white solid after flash column chromatography (10→15% EtOAc/hexanes). 
mp 58-60 °C; νmax (film, cm−1): 2941, 1761, 1512, 1460, 1366, 1276, 1167, 1119, 933, 891; 1H NMR 
(500 MHz, CDCl3) δH: 2.42 (6H, s, N(CH3)2), 3.83-3.94 (2H, m, C(2)H + C(3)H), 5.14-5.22 (2H, m, 
C(5)H), 5.99 (1H, ddd, J 17.5, 10.0, 7.9, C(4)H), 7.08 (2H, t, J 8.6, Ar(3,5)H), 7.22-7.35 (2H, m, 
Ar(2,6)H), 7.56 (2H, s, Ar(2,6)H), 7.80 (1H, s, Ar(4)H); 19F{1H} NMR (376 MHz, CDCl3) δF: −62.9 
(CF3), −115.8 (ArF); 13C{1H} NMR (101 MHz, CDCl3) δH: 41.5 (N(CH3)2), 49.6 (C(3)H), 70.8 (C(2)H), 
115.8 (d, 2JCF 21.3, C(3)ArC(3,5)H), 117.7 (C(5)H2), 119.6-120.3 (m, OArC(4)H), 122.4-122.8 (m, 
OArC(2,6)H), 122.9 (q, 1JCF 273, CF3), 129.4 (d, 2JCF 7.9, ArC(2,6)H), 133.2 (q, 2JCF 34.1, ArCCF3), 
135.8 (d, 4JCF 3.2, C(3)ArC(1)), 138.3 (C(4)H), 151.0 (ArC(1)), 161.9 (d, 1JCF 245.3, C(3)ArC(4)-F), 
168.6 (C=O); HMRS (NSI+) C21H19F7NO2+ [M+H]+ found: 450.1291, requires: 450.1299 (−1.7 ppm). 
4-Nitrophenyl syn-2-(dimethylamino)-3-(4-fluorophenyl)pent-4-enoate 311 
 
Following general procedure L, (E)-3-(4-fluorophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-
oxoethyl)prop-2-en-1-ammonium bromide 309 (105 mg, 0.24 mmol, 1.0 equiv.) was reacted with (+)-
BTM (12 mg, 0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and iPr2NH (47 μL, 
0.34 mmol, 1.4 equiv.) in MeCN (3.5 mL) gave the title product as a pale yellow solid (44 mg, 52%, 
>95:5 dr); after flash column chromatography (10→20% EtOAc/hexanes). 
mp 92-95 °C; [α]D
20 +29.0 (c 1, MeCN); νmax (film, cm−1): 2951, 1745, 1589, 1508, 1342, 1201, 1069, 
921, 846; 1H NMR (400 MHz, CDCl3) δH: 2.39 (6H, s, N(CH3)2), 3.78-3.92 (2H, m, C(2)H+C(3)H), 
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5.02-5.39 (2H, m, C(5)H2), 5.95 (1H, ddd, J 17.4, 10.1, 7.7, C(4)H), 7.05 (2H, t J 8.7, C(3)Ar(3,5)H), 
7.21-7.27 (4H, m, C(3)Ar(2,6)H + OAr(2,6)H), 8.28 (2H, d, J 9.1, OAr(3,5)H); 19F{1H} NMR (282 
MHz, CDCl3) δF: −116.3 (ArF); 13C{1H} NMR (126 MHz, CDCl3) δC: 41.4 (N(CH3)2), 49.5 (C(3)H), 
70.8 (C(2)H), 115.7 (d, 2JCF 21, C(3)ArC(3,5)H), 117.6 (C(5)H2), 122.8 (OArC(2,6)H), 125.4 
(OArC(3,5)H), 129.4 (d, 3JCF 8, C(3)ArC(2,6)H), 135.8 (d, 4JCF 3, C(3)ArC(1)), 138.3 (C(4)H), 145.6 
(ArC(1)-O), 155.2 (ArC(4)-NO2), 161.8 (d, 1JCF 245, ArC-F), 168.4 (C=O). HRMS (NSI+) 
C19H20FN2O4+ [M+H]+ found: 359.1402, requires: 359.1402 (+0.1 ppm).  
(±)-4-Nitrophenyl (syn)-2-(dimethylamino)-3-(4-fluorophenyl)pent-4-enoate-1-13C 13C1-518 
 
Following general procedure M, (E)-3-(4-fluorophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-
oxoethyl-2-13C)prop-2-en-1-ammonium bromide 13C1-344 (105 mg, 0.24 mmol, 1.0 equiv.) was reacted 
with (±)-BTM (12 mg, 0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and iPr2NH 
(47 μL, 0.34 mmol, 1.4 equiv.) in MeCN (3.5 mL) gave the title product as a pale yellow solid (53 mg, 
62%, >95:5 dr); after flash column chromatography (10→20% EtOAc/hexanes). 
mp 99-100 °C; νmax (film, cm−1): 2941, 1713, 1591, 1523, 1508, 1346, 1206, 1159, 1080, 923, 864;1H 
NMR (500 MHz, CDCl3) δH: 2.41 (6H, s, N(CH3)2), 3.62-4.02 (2H, m, C(2)H + C(3)H), 5.03-5.37 (2H, 
m, C(5)H2), 5.98 (1H, ddd, J 16.9, 10.1, 8.0, C(4)H), 7.07 (2H, t, J 8.7, Ar(3,5)H), 7.16-7.38 (4H, m, 
Ar(2,6)H + Ar(2,6)H), 8.31 (2H, d, J 9.0, Ar(3,5)H); 19F NMR (471 MHz, CDCl3) δF: −115.74 - −115.86 
(m, ArF), 13C{1H} NMR (126 MHz, CDCl3) δC: 41.4 (N(CH3)2), 49.5 (C(3)H), 70.8 (d, 1JCC 56, C(2)H), 
115.7 (d, 2JCF 21, C(3)ArC(3,5)H), 117.6 (C(5)H2), 122.8 (OArC(2,6)H), 125.4 (OArC(3,5)H), 129.4 
(d, 3JCF 7.8, C(3)ArC(2,6)H), 135.8 (app. t, J 3.9, ArC(1)), 138.3 (C(4)H), 145.6 (ArC(4)-NO2), 155.2 
(d, 2JCC 3.8, ArC(1)-O), 161.8 (d, 1JCF 245, ArC-F), 168.4 (13C=O); HRMS (ESI+) C1813CH20O4N2F+ 
[M+H]+ found: 360.1482, requires: 360.1435 (−1.99 ppm). 
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(±)-4-Nitrophenyl (syn)-2-(dimethylamino)-3-(4-fluorophenyl)pent-4-enoate-1,2-13C2 13C2-335 
 
Following general procedure M, (E)-3-(4-fluorophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-
oxoethyl-1,2-13C2)prop-2-en-1-ammonium bromide 13C2-333 (105 mg, 0.24 mmol, 1.0 equiv.) was 
reacted with (±)-BTM (12 mg, 0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and 
iPr2NH (47 μL, 0.34 mmol, 1.4 equiv.) in MeCN (3.5 mL) gave the title product as a pale yellow solid 
(51 mg, 59%, >95:5 dr); after flash column chromatography (10→20% EtOAc/hexanes). 
mp 100-102 °C; νmax (film, cm−1): 2939, 1714, 1591, 1524, 1506, 1346, 1205, 1159, 1078, 916, 864;1H 
NMR (500 MHz, CDCl3) δH: 2.41 (6H, d, 2JCH 4.2, N(CH3)2), 3.83-3.94 (1H, m, C(3)H), 3.85 (1H, ddd, 
1JCH 142, 2JCH 11.4, 3JCH 5.2, 13C(2)H), 5.11-5.35 (2H, m, C(5)H2), 5.98 (1H, dddd, J 17.0, 10.1, 8.6, 
2.6, C(4)H), 7.08 (2H, t, J 8.7, Ar(3,5)H), 7.18-7.29 (4H, m, OAr(2,6)H + C(3)Ar(2,6)H), 8.29 (2H, d, 
J 9.1, OAr(3,5)H); 19F (471 MHz, CDCl3) δF: −115.8 (tt, J 9.1, 5.2, ArF); 13C{1H} NMR (126 MHz, 
CDCl3) δC: 41.4 (N(CH3)2), 49.5 (d, 1JCC 38, C(3)H), 70.8 (d, 1JCC 57, 13C(2)H), 115.7 (d, 2JCF 21, 
C(3)ArC(3,5)H), 117.6 (d, 4JCH 3.6, C(5)H2), 122.8 (OArC(2,6)H), 125.4 (OArC(3,5)H), 129.4 (dd, 3JCF 
8.1, 3JCC 1.8, ArC(2,6)H), 135.7-135.9 (m, ArC(1)), 138.3 (C(4)H), 145.6 (ArC(4)-NO2), 155.2 (dd, J 
3.5, 1.7, ArC(1)-O), 161.8 (d, 1JCF 245, ArC-F), 168.4 (d, 1JCC 57, 13C=O); HRMS (ESI+) 
C1713C2H20O4N2F+ [M+H]+ found: 361.1462, requires: 361.1469 (−1.86 ppm). 
(±)-4-Nitrophenyl (syn)-2-(dimethylamino)-3-phenylpent-4-enoate-1,2,3-13C3 13C3-343 
 
Following general procedure M, (E)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl-1,2-13C2)-3-
phenylprop-2-en-1-ammonium-3-13C bromide 13C3-341 (100 mg, 0.24 mmol, 1.0 equiv.) was reacted 
with (±)-BTM (12 mg, 0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and iPr2NH 
(47 μL, 0.34 mmol, 1.4 equiv.) in MeCN (3.5 mL) gave the title product as a pale yellow solid (49 mg, 
60%, >95:5 dr); after flash column chromatography (10→20% EtOAc/hexanes). 
mp 107-109 °C; νmax (film, cm−1): 2984, 1707, 1516, 1487, 1344, 1198, 1155, 1072, 1045, 910, 862; 1H 
NMR (700 MHz, CDCl3) δH: 2.42 (6H, dd, J 4.4, 2.2, N(CH3)2), 3.75-4.04 (2H, m, 13C(2)H + 13C(3)H), 
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5.18 (1H, t, J 10.8, C(5)HcisH), 5.26 (1H, dd, J 17.0, 6.4, C(5)HHtrans), 5.95-6.09 (1H, m, C(4)H), 7.26-
7.32 (5H, m, Ar(2,6)H + ArH), 7.39 (2H, t, J 7.6, ArH), 8.31 (2H, d, J 9.1, Ar(3,5)H);13C{1H} NMR 
(179 MHz, CDCl3) δC: 41.5 (N(CH3)2), 50.4 (d, 1JCC 38, 13C(3)H, 70.9 (dd, 1JCC 57, 1JCC 38, 13C(2)H), 
117.5 (d, 3JCC 3.6, C(5)H2), 122.8 (ArC(2,6)H), 125.4 (ArC(3,5)H), 127.1 (ArC(4)H), 127.9 
(ArC(3,5)H), 128.9 (d, 3JCC 3.5, ArC(2,6)H), 138.4 (d, 1JCC 41, C(4)H), 140.2 (dd, 1JCC 45.4, 2JCC 3.2, 
ArC(1)), 145.6 (ArC(4)NO2), 155.3 (d, 2JCC 2.0, ArC(1)-O), 168.6 (d, 1JCC 57, 13C=O); HRMS (ESI+) 
C1613C3H21O4N2+ [M+H]+ found: 344.1589, requires: 344.1596 (−2.17 ppm). 
(±)-4-Nitrophenyl (syn)-2-(dimethylamino)-3-(4-fluorophenyl-3-d)pent-4-enoate d1-365 
 
Following general procedure M, (E)-3-(4-fluorophenyl-3-d)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-
oxoethyl)prop-2-en-1-ammonium bromide d1-364 (53 mg, 0.12 mmol, 1.0 equiv.) was reacted with (±)-
BTM (6 mg, 0.024 mmol, 0.2 equiv.), HOBt (3.2 mg, 0.024 mmol, 0.2 equiv.) and iPr2NH (24 μL, 0.34 
mmol, 1.4 equiv.) in MeCN (1.75 mL) gave the title product as a pale yellow solid (38 mg, 44%, >95:5 
dr); after flash column chromatography (15% EtOAc/hexanes). 
mp 96-98 °C; νmax (film, cm−1): 2949, 1757, 1589, 1516, 1489, 1342, 1201, 1092, 923, 894;1H NMR 
(500 MHz, CDCl3) δH: 2.41 (6H, s, N(CH3)2), 3.62-4.11 (2H, m, C(2)H + C(3)H), 4.71-5.42 (2H, m, 
C(5)H2), 5.97 (1H, ddd, J 17.6, 10.1, 7.8, C(4)H), 7.07 (1H, t, J 8.9, Ar(5)H), 7.19-7.36 (4H, m, 
Ar(2,6)H + Ar(2)H + Ar(6)H), 8.31 (2H, d, J 9.1, Ar(3,5)H); 19F (471 MHz, CDCl3) δF: −116.08 (dt, J 
10.2, 5.3, ArF); 13C{1H} NMR (126 MHz, CDCl3) δC: 41.4 (N(CH3)2), 49.5 (C(3)H), 70.8 (C(2)H), 
115.8 (d, 2JCF 21, ArC(5)H), 117.6 (C(5)H2), 122.8 (ArC(2,6)H), 125.4 (ArC(3,5)H), 129.3 (app. dd, J 
11, 7.8, ArC(3)-D + ArC(2)H + ArC(6)H), 135.8 (d, 4JCF 3.2, ArC(1)), 138.3 (C(4)H), 145.6 (ArC(4)-
NO2), 155.2 (ArC(1)-O), 161.8 (d, 1JCF 245, ArC-F), 168.4 (C=O); HRMS (ESI+) C19H19DO4N2F 
[M+H]+ found: 360.1458, requires: 360.1464 (−1.77 ppm). 
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(±)-4-Nitrophenyl (syn)-2-(dimethylamino)-3-(4-fluorophenyl)pent-4-enoate-3-d d1-358 
 
Following general procedure M, (E)-3-(4-fluorophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-
oxoethyl)prop-2-en-1-ammonium-3-d bromide d1-357 (15 mg, 0.03 mmol, 1.0 equiv.) was reacted with 
(±)-BTM (1.5 mg, 0.006 mmol, 0.2 equiv.), HOBt (0.8 mg, 0.006 mmol, 0.2 equiv.) and iPr2NH (5.8 
μL, 0.04 mmol, 1.4 equiv.) in MeCN (0.5 mL) gave the title product as a pale yellow solid (3 mg, 28%, 
>95:5 dr); after flash column chromatography (15% EtOAc/hexanes). 
mp 97-98 °C; νmax (film, cm−1): 2940, 1757, 1525, 1510, 1346, 1206, 1159, 1113,1099, 918;1H NMR 
(700 MHz, CDCl3) δH: 2.38 (6H, s, N(CH3)2), 3.82 (1H, s, C(2)H), 5.15 (1H, d, J 10.1, C(5)HAHB), 
5.21 (1H, d, J 17.0, C(5)HAHB), 5.94 (1H, dd, J 17.0, 10.1, C(4)H), 7.05 (2H, t, J 8.4, Ar(3,5)H), 7.17-
7.27 (4H, m, Ar(2,6)H + Ar(2,6)H), 8.28 (2H, d, J 8.9, Ar(3,5)H); 19F (657 MHz, CDCl3) δF: −115.82 
(m, ArF); 13C{1H} NMR (179 MHz, CDCl3) δC: 41.5 (N(CH3)2), 48.8-49.3 (m, C(3)D), 70.8 (C(2)H), 
115.8 (d, 2JCF 21, ArC(3,5)H), 117.6 (C(5)H2), 122.8 (OArC(2,6)H), 125.4 (OArC(3,5)H), 129.3 (d, 
3JCF 7.9, ArC(2,6)H), 135.8 (d, 4JCF 2.9, ArC(1)), 138.3 (C(4)H), 145.6 (ArC(4)-NO2), 155.2 (ArC(1)-
O), 161.8 (d, 1JCF 245, ArC-F), 168.4 (C=O); HRMS (ESI+) C19H19DO4N2F [M+H]+ found: 360.1457, 
requires: 360.1464 (−2.05 ppm). 
(±)-4-Nitrophenyl (anti)-2-(dimethylamino)-3-(4-fluorophenyl)pent-4-enoate 519 
 
A solution of (E)-3-(4-fluorophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)prop-2-en-1-
ammonium bromide 309 (1.0 g, 2.28 mmol, 1.0 equiv.) in MeCN (33 mL) was treated with KOtBu 
(0.31 g, 2.73 mmol, 1.2 equiv.) and the resulting mixture was stirred for 1 h at rt. The reaction mixture 
was then concentrated in vacuo the residue dissolved in CH2Cl2 (100 mL) and water (100 mL) the layers 
separated and the aqueous extracted with CH2Cl2 (2 × 50 mL). The combined organic lyaers were 
washed with brine (50 mL), dried over MgSO4 and concentrated in vacuo The crude residue was 
analysed by 1H NMR (2.6:1 syn:anti). The residue was then purified by flash column chromatography 
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(10→15% EtOAc/hexane) to give the syn diastereoisomer (150 mg, 18%) followed by the anti 
diastereoisomer (49 mg, 6%) as a beige solid; 
Data for anti diastereoisomer; 
mp 99-101 °C; νmax (film, cm−1): 2949, 1747, 1591, 1519, 1346, 1210, 1161, 1093, 908; 1H NMR (500 
MHz, CDCl3) δH: 2.54 (6H, s, N(CH3)2), 3.76-3.88 (2H, m, C(2)H + C(3)H), 5.08-5.25 (2H, m, C(5)H2), 
6.16 (1H, ddd, J 17.6, 10.3, 7.2, C(4)H), 6.75 (2H, d, J 9.1, Ar(2,5)H), 7.05 (2H, t, J 8.6, Ar(3,5)H), 
7.21-7.32 (2H, m, Ar(2,6)H), 8.16 (2H, d, J 9.1, Ar(3,5)H); 13C{1H} NMR (126 MHz, CDCl3) δC: 41.4 
(N(CH3)2), 49.0 (C(3)H), 72.0 (C(2)H), 115.8 (d, 2JCF 21, ArC(3,5)H), 117.1 (C(5)H2), 122.6 
(OArC(2,6)H), 125.3 (OArC(3,5)H), 130.3 (d, 3JCF 8, C(3)ArC(2,6)H), 136.0 (d, 4JCF 3, ArC(1)), 138.0 
(C(4)H), 145.6 (ArC(4)-NO2), 154.9 (ArC(1)-O), 162.1 (d, 1JCF 246, ArC-F), 168.0 (C=O); HRMS 
(ESI+) C19H20FN2O4+ [M+H]+ found: 359.1395, requires: 359.1402 (−1.84 ppm).  
(±)-Syn-2-(dimethylamino)-3-(4-fluorophenyl)pent-4-enoic acid hydrochloride 347 
 
A solution of 4-nitrophenyl syn-2-(dimethylamino)-3-(4-fluorophenyl)pent-4-enoate 311 (1.0 g, 3.00 
mmol, 1.0 equiv.) in aq. 6 M HCl (30 mL) was heated at reflux for 16 h. Once complete the reaction 
mixture was cooled to rt and Et2O (30 mL) added, the layers separated and the aqueous layer washed 
with Et2O (2  30 mL). The aqueous layer was concentrated in vacuo the resulting solid was 
recrystallized (CH2Cl2/EtOAc) to give the product as a white solid (466 mg, 57%, >95:5 dr); 
mp 157-159 °C; νmax (film, cm−1): 2907, 2681, 2507, 1728, 1508, 1361, 1224, 1200, 993, 831; 1H NMR 
(400 MHz, d6-DMSO) δH: 2.80 (6H, s, N(CH3)2), 3.61 (1H, br. s, N+H) 4.24 (1H, t, J 7.4, C(3)H), 4.43 
(1H, br. s, C(2)H), 5.23-5.41 (2H, m, C(5)H2), 6.08 (1H, dt, J 17.0, 9.8, C(4)H), 7.21 (2H, t, J 8.8, 
Ar(3,5)H), 7.41-7.53 (2H, m, Ar(2,6)H); 13C{1H} NMR (126 MHz, d6-DMSO) δC: 41.4 (N(CH3)2), 46.2 
(C(3)H), 69.6 (C(2)H), 115.5 (d, 2JCF 21, ArC(3,5)H), 120.0 (C(5)H2), 130.2 (d, 3JCF 8.1, ArC(2,6)H), 
134.9 (C(4)H), 135.3 (d, 4JCF 2.0, ArC(1)), 161.4 (d, 1JCF 243, ArC-F), 168.0 (C=O); HRMS (NSI+) 
C13H17FNO2+ [M]+ found: 238.1234, requires: 238.1238 (−1.6 ppm).  
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(±)-1H-Benzo[d][1,2,3]triazol-1-yl syn-2-(dimethylamino)-3-(4-fluorophenyl)pent-4-enoate 346 
 
A solution of syn-2-(dimethylamino)-3-(4-fluorophenyl)pent-4-enoic acid hydrochloride 347 (100 mg, 
0.37 mmol, 1.0 equiv.) in CH2Cl2 (3.7 mL) was treated with NEt3 (52 μL, 0.37 mmol, 1.0 equiv.) and 
stirred for 15 min at rt. The mixture was treated with HOBt (75 mg, 0.56 mmol, 1.5 equiv.) and 
EDC·HCl (108 mg, 0.56 mmol, 1.5 equiv.) and the mixture stirred at rt for 16 h. After which CH2Cl2 
(20 mL) and sat. aq. NaHCO3 (10 mL) were added, the layers separated, the organic layer washed with 
brine (10 mL), dried over MgSO4 and concentrated in vacuo. The residue was dissolved in EtOAc (30 
mL) and filtered through a plug of silica gel washing with EtOAc (50 mL). The filtrate was concentrated 
in vacuo to give the product as a beige solid (118 mg, 90%, >95:5 dr); 
mp 51 °C (dec.); νmax (film, cm−1): 2791, 1792, 1602, 1510, 1225, 1037, 894; 1H NMR (500 MHz, 
CDCl3) δH: 2.48 (6H, s, N(CH3)2), 3.93 (1H, dd, J 11.5, 8.8, C(3)H), 4.10 (1H, d, J 11.5, C(2)H), 5.29-
5.37 (2H, m, C(5)H2), 6.05 (1H, dt, J 17.9, 8.8, C(4)H), 7.10 (2H, t, J 8.7, Ar(3,5)H), 7.28 (2H, dd, J 
8.6, 5.2, Ar(2,6)H), 7.41 (d, J 8.3, Ar(4)H), 7.45 (1H, t, J 7.6, (Ar(6)H), 7.57 (1H, t, J 7.6, Ar(5)H), 
8.11 (1H, d, J 8.3, Ar(7)H); 13C{1H} NMR (126 MHz, CDCl3) δC: 41.3 (N(CH3)2), 49.3 (C(3)H), 69.3 
(C(2)H), 108.5 (ArC(4)H), 115.8 (d, 2JCF 21, C(3)ArC(3,5)H), 118.6 (C(5)H2), 120.7 (ArC(7)H), 124.9 
(ArC(6)H), 128.7 (ArC-N), 128.9 (ArC(5)H), 129.4 (d, 3JCF 8, C(3)ArC(2,6)H), 135.1 (d, 4JCF 3, 
C(3)ArC(1)), 137.6 (C(4)H), 143.5 (ArC-N), 161.9 (d, 1JCF 246, ArC-F), 166.0 (C=O); HRMS (NSI+) 
C19H20FN4O2+ [M+H]+ found: 355.1564, requires: 355.1565 (−0.2 ppm).  
(±)-4-Nitrophenyl (syn)-2-(dimethylamino)-3-(3-fluorophenyl)pent-4-enoate 520 
 
Following general procedure M, (E)-3-(3-fluorophenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-2-
oxoethyl)prop-2-en-1-ammonium bromide 372 (105 mg, 0.24 mmol, 1.0 equiv.) was reacted with (±)-
BTM (12 mg, 0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and iPr2NH (47 μL, 
0.34 mmol, 1.4 equiv.) in MeCN (3.5 mL). to give the title product (45 mg, 52%, >95:5 dr) as a white 
solid after flash column chromatography (10→20% EtOAc/hexanes); 
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mp 77-80 °C; νmax (film, cm−1): 2836, 1746, 1614, 1591, 1518, 1487, 1343 1204, 1098, 925;1H NMR 
(700 MHz, CDCl3) δH: 2.39 (6H, s, N(CH3)2), 3.79-3.91 (2H, m, C(2)H+C(2)H), 5.14-5.27 (2H, m, 
C(5)H2), 5.95 (1H, ddd, J 17.0, 10.1, 8.1, C(4)H), 6.91-7.00 (2H, m, Ar(4)H + Ar(6)H), 7.05 (1H, d, J 
7.6, Ar(2)H), 7.26 (2H, d, J 9.1, Ar(2,6)H), 7.32 (1H, td, J 7.9, 5.9, Ar(5)H), 8.29 (2H, d, J 9.1, 
Ar(3,5)H; 19F NMR (659 MHz, CDCl3) δF: −112.9 (q, J 8.6, ArF); 13C{1H} NMR (179 MHz, CDCl3) 
δC: 41.5 (N(CH3)2), 50.0 (C(3)H), 70.7 (C(2)H), 114.0 (d, 2JCF 22, ArC(4)H), 114.9 (d, 2JCF 22, 
ArC(2)H), 118.0 (C(5)H2), 122.8 (ArC(2,6)H), 123.7 (d, 4JCF 2.7, ArC(6)H), 125.4 (ArC(3,5)H), 130.3 
(d, 3JCF 8.3, ArC(5)H), 137.8 (C(4)H), 142.8 (ArC(1)), 145.6 (ArC(1)-O), 155.2 (ArC(4)-NO2), 163.1 
(d, 1JCF 246, ArC-F), 168.2 (C=O); HRMS (ESI+) C19H20O4N2F+ [M+H]+ found: 359.1396, requires: 
359.1402 (−1.56 ppm).  
(±)-4-Nitrophenyl (syn)-2-(dimethylamino)-3-(3-fluoro-4-methoxyphenyl)pent-4-enoate 521 
 
Following general procedure M, (E)-3-(3-fluoro-4-methoxy-phenyl)-N,N-dimethyl-N-(2-(4-
nitrophenoxy)-2-oxoethyl)prop-2-en-1-ammonium bromide 373 (113 mg, 0.24 mmol, 1.0 equiv.) was 
reacted with (±)-BTM (12 mg, 0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and 
iPr2NH (47 μL, 0.34 mmol, 1.4 equiv.) in MeCN (3.5 mL). to give the title product (49 mg, 53%) as a 
pale yellow solid after flash column chromatography (10→20% EtOAc/hexanes); 
mp 88-90 °C; νmax (film, cm−1): 2938, 1755, 1589, 1516, 1485, 1344, 1276, 1195, 1120, 1098, 925, 
858;1H NMR (700 MHz, CDCl3) δH: 2.42 (6H, s, N(CH3)2), 3.78-3.85 (2H, m, C(2)H + C(3)H), 3.91 
(3H, s, OCH3), 4.96-5.38 (2H, m, C(5)H2), 5.95 (1H, dddd, J 17.1, 10.1, 7.0, 1.3, C(4)H), 6.93-7.06 
(3H, m, Ar(2,3,5)H), 7.28 (2H, d, J 9.1, Ar(2,6)H), 8.31 (2H, d, J 9.1, Ar(3,5)H); 19F NMR (659 MHz, 
CDCl3) δF: −134.7 (dd, J 12.3, 8.4, ArF); 13C{1H}NMR (179 MHz, CDCl3) δC: 41.5 (N(CH3)2), 49.3 
(C(3)H), 56.3 (OCH3), 70.8 (C(2)H), 113.6 (d, 3JCF 1.6, ArC(5)H), 115.5 (d, 2JCF 19, ArC(2)H), 117.6 
(C(5)H2), 122.8 (ArC(2,6)H), 123.6 (d, 4JCF 3.4, ArC(6)H), 125.4 (ArC(3,5)H), 133.1 (d, 3JCF 6.0, 
ArC(1)), 138.1 (C(4)H), 145.6 (ArC(1)-O), 146.6 (d, 2JCF 11, ArC(4)-OMe), 152.5 (d, 1JCF 246, ArC-
F), 155.2 (ArC(4)-NO2), 168.4 (C=O); HRMS (ESI+) C20H22O5N2F+ [M+H]+ found: 389.1499, requires: 
389.1507 (−2.12 ppm). 
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(±)-4-Nitrophenyl (syn)-3-(4-bromo-3-fluorophenyl)-2-(dimethylamino)pent-4-enoate 522 
 
Following general procedure M, (E)-3-(3-fluoro-4-bromo-phenyl)-N,N-dimethyl-N-(2-(4-
nitrophenoxy)-2-oxoethyl)prop-2-en-1-ammonium bromide 374 (124 mg, 0.24 mmol, 1.0 equiv.) was 
reacted with (±)-BTM (12 mg, 0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and 
iPr2NH (47 μL, 0.34 mmol, 1.4 equiv.) in MeCN (3.5 mL). to give the title product (92 mg, 88%) as a 
white solid after flash column chromatography (10→20% EtOAc/hexanes); 
mp 69-71 °C; νmax (film, cm−1): 2940, 1757, 1523, 1487, 1344, 1203, 1097, 925, 862;1H NMR (400 
MHz, CDCl3) δH: 2.38 (6H, s, N(CH3)2), 3.71-3.90 (2H, m, C(2)H + C(3)H), 5.11-5.33 (2H, m, C(5)H2), 
5.90 (1H, ddd, J 17.0, 10.1, 7.8, C(4)H), 6.94 (1H, dd, J 8.2, 2.0, Ar(6)H), 7.04 (1H, dd, J 9.6, 2.0, 
Ar(2)H), 7.26 (2H, d, J 9.1, Ar(2,6)H), 7.52 (1H,dd, J 8.2, 7.2, Ar(5)H), 8.29 (2H, d, J 9.1, Ar(3,5)H); 
19F {1H}NMR (376 MHz, CDCl3) δF: −107.1 (ArF); 13C{1H}NMR (126 MHz, CDCl3) δC: 41.4 
(N(CH3)2), 49.5 (C(3)H), 70.5 (C(2)H), 107.3 (d, 2JCF 21, ArC(4)-Br), 116.1 (d, 2JCF 22, ArC(2)H), 
118.4 (C(5)H2) 122.8 (ArC(2,6)H), 125.0 (d, 4JCF 3.3, ArC(6)H), 125.4 (ArC(3,5)H), 133.7 (ArC(5)H), 
137.4 (C(4)H), 142.1 (d, 3JCF 6.5, ArC(1)), 145.7 (ArC(1)-O), 155.1 (ArC(4)-NO2), 159.3 (d, 1JCF 245, 
ArC-F), 168.0 (C=O); HRMS (ESI+) C19H19O4N279BrF+ [M+H]+ found: 437.0496, requires; 437.0507 
(−2.46 ppm).  
(±)-4-Nitrophenyl (syn)-2-(dimethylamino)-3-(3-fluoro-4-iodophenyl)pent-4-enoate 523 
 
Following general procedure M, (E)-3-(3-fluoro-4-iodo-phenyl)-N,N-dimethyl-N-(2-(4-nitrophenoxy)-
2-oxoethyl)prop-2-en-1-ammonium bromide 375 (136 mg, 0.24 mmol, 1.0 equiv.) was reacted with 
(±)-BTM (12 mg, 0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and iPr2NH (47 μL, 
0.34 mmol, 1.4 equiv.) in MeCN (3.5 mL). to give the title product (109 mg, 94%) as a pale yellow 
solid after flash column chromatography (10→20% EtOAc/hexanes); 
mp 86-88 °C; νmax (film, cm−1): 2940, 1755, 1614, 1591, 1521, 1489, 1344, 1203, 1157, 1095, 1026, 
925, 880; 1H NMR (700 MHz, CDCl3) δH: 2.38 (6H, s, N(CH3)2), 3.73-3.91 (2H, m, C(2)H + C(3)H), 
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5.02-5.32 (2H, m, C(5)H), 5.90 (1H, ddd, J 17.0, 10.1, 8.2, C(4)H), 6.82 (1H, dd, J 8.1, 2.0, Ar(6)H), 
6.99 (1H, dd, J 9.0, 2.0, Ar(2)H ), 7.26 (2H, d, J 9.0, Ar(2,6)H), 7.71 (1H, dd, J 8.1, 6.6, Ar(5)H), 8.29 
(2H, d, J 9.0, Ar(2,6)H); 19F NMR (659 MHz, CDCl3) δF: −93.72-−93.90 (m, ArF); 13C{1H} NMR (176 
MHz, CDCl3) δC: 41.4 (N(CH3)2), 49.6 (C(3)H), 70.5 (C(2)H), 79.2 (d, 2JCF 26, ArC(4)-I), 115.4 (d, 2JCF 
24, ArC(2)H), 118.4 (C(5)H2), 122.8 (ArC(2,6)H), 125.4 (ArC(3,5)H), 125.5 (d, 3JCF 3.1, ArC(1)), 
137.4 (C(4)H), 139.5 (ArC(5)H), 143.3 (d, 4JCF 6.5, ArC(6)H), 145.7 (ArC(1)-O), 155.1 (ArC(4)-NO2), 
162.0 (d, 1JCF 245, ArC-F), 168.0 (C=O); HRMS (ESI+) C19H19O4N2FI+ [M+H]+ found: 485.0360, 
requires: 485.0368 (−1.66 ppm).  
(±)-4-Nitrophenyl (syn)-2-(dimethylamino)-3-(3-fluoro-4-methylphenyl)pent-4-enoate 524 
 
Following general procedure M, (E)-3-(3-fluoro-4-methyl-phenyl)-N,N-dimethyl-N-(2-(4-
nitrophenoxy)-2-oxoethyl)prop-2-en-1-ammonium bromide 376 (109 mg, 0.24 mmol, 1.0 equiv.) was 
reacted with (±)-BTM (12 mg, 0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and 
iPr2NH (47 μL, 0.34 mmol, 1.4 equiv.) in MeCN (3.5 mL). to give the title product (79 mg, 88%) as a 
pale yellow solid after flash column chromatography (10→20% EtOAc/hexanes); 
mp 73-75 °C; νmax (film, cm−1): 2940, 1757, 1616, 1591, 1523, 1489, 1456, 1344, 1204, 1159, 1113, 
1095, 923, 862; 1H NMR (400 MHz, CDCl3) δH: 2.26 (3H, d, J 1.8, ArCH3), 2.40 (6H, s, N(CH3)2), 
3.80-3.85 (2H, m, C(2)H + C(3)H), 5.12-5.25 (2H, m, C(5)H2), 5.8-6.01 (1H, m, C(4)H), 6.86-6.98 (2H, 
m, Ar(2)H + Ar(6)H), 7.16 (1H, td, J 7.9, 0.9, Ar(5)H), 7.26 (2H, d, J 9.2, Ar(2,6)H), 8.28 (2H, d, J 
9.2, Ar(3,5)H); 19F {1H}NMR (376 MHz, CDCl3) δF: −117.1 (ArF); 13C{1H} NMR (179 MHz, CDCl3) 
δC: 14.5 (d, 3JCF 3.3, ArCH3), 41.5 (N(CH3)2), 49.7 (C(3)H), 70.8 (C(2)H), 114.4 (d, 2JCF 23, ArC(2)H), 
117.8 (C(5)H2), 122.8 (ArC(2,6)H), 123.3 (d, 4JCF 3.1, ArC(6)H), 123.5 (d, 2JCF 17, ArC(4)-Me), 125.4 
(ArC(3,5)H), 131.8 (d, J 5.4, ArC(5)H), 138.1 (C(4)H), 139.9 (d, 3JCF 7.0, ArC(1)), 145.6 (ArC(1)-O), 
155.2 (ArC(4)-NO2), 161.5 (d, 1JCF 245, ArC-F), 168.4 (C=O); HRMS (ESI+) C20H22O4N2F+ [M+H]+ 
found: 373.1552, requires: 373.1558 (−1.64 ppm).  
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Stereochemical Model 
(E)-But-2-en-1-ol[122] 525 
 
A solution of LiAlH4 (4.0 M in Et2O, 12.1 mL, 48.2 mmol, 0.4 equiv.) in THF (30 mL) was cooled to 0 
°C then a solution of (E)-crotonaldehyde (10 mL, 120.7 mmol, 1.0 equiv.) in THF (20 mL) was added 
via dropping funnel. The resulting solution was allowed to warm to rt and stirred for 2 h, the reaction 
was quenched by the dropwise addition of aq. 1 M KOH (50 mL). The resulting biphasic mixture was 
stirred for 30 min at rt, the layers separated and the aqueous layer extracted with Et2O (2  30 mL). The 
combined organic layers were washed with aq. 2 M HCl (50 mL), then brine (50 mL), dried over MgSO4 
and concentrated in vacuo. The residue was distilled at atmospheric pressure to give the product as a 
colourless liquid (4.30 g, 59%, 98:2 E:Z) 
bp 128-130 °C @ 976 mbar {lit. 117-121 °C @ 976 mbar}, 1H NMR (500 MHz, CDCl3) δH: 1.68-170 
(3H, m, CH3), 4.06 (2H, d, J 5.2, C(1)H2), 5.59-5.79 (2H, m, C(2)H + C(3)H); data consistent with the 
literature.[122] 
tert-Butyl (E)-4-(but-2-en-1-yl)piperazine-1-carboxylate 526 
 
A solution of (E)-but-2-en-1-ol 525 (1.0 g, 13.9 mmol, 1.0 equiv.) in Et2O (42 mL) was cooled to 0 °C 
and treated with PBr3 (521 μL, 5.56 mmol, 0.4 equiv.) dropwise, the reaction mixture then stirred for 1 
h at 0 °C. The reaction was quenched by the addition of aq. NaHCO3 (20 mL) and allowed to warm to 
rt, the layers separated and the aqueous layer extracted with Et2O (2  20 mL), the combined organic 
layers washed with brine (20 mL) dried over MgSO4 and concentrated in vacuo. The residue was 
dissolved in THF (14 mL) and added to a solution of tert-butyl piperazine-1-carboxylate (6.45 g, 34.7 
mmol, 2.5 equiv.) in THF (14 mL) dropwise, the resulting mixture was stirred at rt for 15 min. The 
reaction mixture was treated with aq. 1 M NaOH (20 mL) and stirred for 15 min, Et2O (30 mL) as then 
added the layers separated and the aqueous extracted with Et2O(2  30 mL), the combined organics 
were washed with brine (20 mL), dried over MgSO4 and concentrated in vacuo. The residue was purified 
by flash chromatography on silica gel (5→20% Et2O/CH2Cl2) to give the product as a yellow oil (678 
mg, 20% over two steps, 97:3 E:Z); 
νmax (film, cm−1): 2934, 2905, 1694, 1417, 1364, 1244, 1168, 968, 830; 1H NMR (500 MHz, CDCl3) δH: 
1.45 (9H, s, C(CH3)3), 1.69 (d, J 6.3, CH3), 2.36 (4H, br. s, C(3)H2), 2.92 (2H, d, J 6.7, C(1ʹ)H2), 3.43 
(4H, br. s, C(2)H2), 5.43-5.54 (1H, m, C(2ʹ)H), 5.61 (1H, dd, J 12.7, 6.3, C(3ʹ)H); 13C{1H} NMR (126 
MHz, CDCl3) δC: 17.9 (CH3), 28.5 (C(CH3)3), 43.2 and 44.2 (rotameric C(3)H2), 52.9 (C(2)H2), 61.0 
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(C(1ʹ)H2) 79.7 (C(CH3)3), 127.2 (C(2ʹ)H), 129.7 (C(3ʹ)H), 154.9 (C=O); HRMS (NSI+) C13H25O2N2+ 
[M+H]+ found: 241.1904, requires: 241.1911 (−2.7 ppm). 
(E)-1-(But-2-en-1-yl)-4-(tert-butoxycarbonyl)-1-(2-(4-nitrophenoxy)-2-oxoethyl)piperazin-1-ium 
bromide 401 
 
Following general procedure G, p-nitrophenyl bromoacetate 213 (1.30 g, 5.0 mmol, 3.0 equiv.) was 
reacted with tert-butyl (E)-4-(but-2-en-1-yl)piperazine-1-carboxylate 526 (0.40 g, 1.67 mmol, 1.0 
equiv.) in MeCN (3.3 mL) to give the title product as a white solid (0.51 g, 60%, 94:6 E:Z) 
mp 132 °C (dec.); νmax (film, cm−1): 2974, 1757, 1697, 1526, 1489, 1346, 1149, 1010, 972, 858; 1H 
NMR (500 MHz, d6-DMSO) δH: 1.43 (9H, s, C(CH3)3), 1.81 (3H, d, J 6.3, CH3), 3.56-3.84 (8H, m, 
C(2,6 and 3,5)H2), 4.32 (2H, d, J 7.3 , C(1ʹ)H2), 4.86 (2H, s, COCH2), 5.78 (1H,dt, J 14.1, 7.3, C(2ʹ)H), 
6.13 (1H, dq, J 13.2, 6.3, C(3ʹ)H), 7.57 (2H, d, J 9.1, Ar(2,5)H), 8.39 (2H, d, J 9.1, Ar(3,5)H); 13C{1H} 
NMR (126 MHz, d6-DMSO) δC: 18.2 (CH3), 27.9 (C(CH3)3), 36.5 and 37.6 (rotameric C(2,6)H2), 55.5 
(COCH2), 57.7 (C(3,5)H2), 61.5 (C(1ʹ)H2), 80.1 (C(CH3)3), 117.4 (C(2ʹ)H), 123.1 (ArC(2,6)H), 125.6 
(ArC(3,5)H), 140.7 (C(3ʹ)H), 145.7 (ArC(4)-NO2), 153.5 (ArC(1)-O), 153.8 (NC=O), 162.1 
(C=OCH2); HRMS (NSI+) C21H30N3O6+ [M]+ found: 420.2121, requires: 420.2129 (−1.9 ppm).  
tert-Butyl 4-((2S,3R)-3-methyl-1-(4-nitrophenoxy)-1-oxopent-4-en-2-yl)piperazine-1-carboxylate 
402 
 
Following general procedure L, (E)-1-(but-2-en-1-yl)-4-(tert-butoxycarbonyl)-1-(2-(4-nitrophenoxy)-
2-oxoethyl)piperazin-1-ium bromide 401 (120 mg, 0.24 mmol, 1.0 equiv.) was reacted with (+)-
benzotetramisole (12 mg, 0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and iPr2NH 
(47 μL, 0.34 mmol, 1.4 equiv.) in MeCN (3.5 mL) at −20 °C for 16 h. Crude dr 82:18, flash coloumn 
chromatography (10→15% EtOAc/hexanes) gave the title product as a colourless oil (31 mg, 31%, 
82:18 dr). 
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[α]D
20 −20.4 (c 1, CHCl3); νmax (film, cm−1): 2978, 1757, 1686, 1525, 1346, 1247, 1113, 1009, 909; 1H 
NMR (500 MHz, CDCl3) δH: 1.15 (3H, d, J 6.7, CH3), 1.46 (9H, s, C(CH3)3), 2.53-2.86 (5H, m, C(3)H 
+ C(3ʹ,5ʹ)H2), 3.22 (1H, d, J 11.1, C(2)H), 3.33-3.54 (4H, m, C(2ʹ)H2), 5.09-5.22 (2H, m, C(5)H2), 5.74 
(1H, ddd, J 17.1, 10.2, 8.5, C(4)H), 7.21 (2H, d, J 9.2, Ar(2,6)H), 8.26 (2H, d, J 9.2, Ar(3,5)H); 13C{1H} 
NMR (126 MHz, CDCl3) δC: 17.1 (CH3), 28.6 (C(CH3)3), 37.6 (C(3)H), 43.8 and 44.8 (rotameric 
C(2ʹ,6ʹ)H2), 49.5 (C(3ʹ,5ʹ)H2), 72.2 (C(2)H), 79.9 (C(CH3)3), 117.1 (C(5)H2), 122.8 (ArC(2,6)H), 125.4 
(ArC(3,5)H), 139.8 (C(4)H), 145.6 (ArC(4)-NO2), 154.8 (ArC(1)-O), 155.2 (NC=O), 168.6 (C=O); 
HRMS (ESI+) C21H30O6N3+ [M+H]+ found: 420.2126, requires: 420.2129 (−0.7 ppm);  
tert-butyl 4-((2S,3R)-1-(benzylamino)-3-methyl-1-oxopent-4-en-2-yl)piperazine-1-carboxylate 
527 
 
A solution of tert-butyl 4-((2S,3R)-3-methyl-1-(4-nitrophenoxy)-1-oxopent-4-en-2-yl)piperazine-1-
carboxylate 402 (31 mg, 0.074 mmol, 1.0 equiv.) in CH2Cl2 (3.5 mL) was treated with benzylamine (41 
μL, 0.37 mmol, 5.0 equiv.) and iPr2NH (11 μL, 0.074 mmol, 1.0 equiv.) and stirred at rt for 16 h. Once 
complete the reaction was concentrated in vacuo. The residue was purified by flash chromatography on 
silica gel (5→20% Et2O/CH2Cl2) to give the product as a colourless oil (22 mg, 77%, 84:16 dr);  
HPLC analysis, Chiralpak OD-H (5% IPA/hexane, flow rate 1.5 mL/min, 211 nm, 40 °C) tR Major 19.7 
min, Minor 17.1 min, 83% ee;  
[α]D
20 +1.5 (c 1, CHCl3); νmax (film, cm−1): 3292, 2976, 1695, 1649, 1422, 1366, 1248, 1172, 1124, 1007; 
1H NMR (500 MHz, CDCl3) δH: 1.14 (3H, d, J 6.7, CH3), 1.47 (9H, s, C(CH3)3), 2.48-2.60 (4H, m, 
C(3’,5’)H2), 2.68-2.85 (2H, m, C(2)H + C(3)H), 3.38 (4H, br. s, C(2’,6’)H2), 4.40 (1H, dd, J 14.6, 5.5, 
PhCHAHB), 4.50 (1H, dd, J 14.6, 5.5, PhCHAHB), 5.08 (2H, m, C(5)H2), 5.82 (1H, ddd, J 17.4, 10.4, 
7.0, C(4)H), 6.50 (1H, t, J 5.5, NH), 7.25-7.32 (3H, m, ArH), 7.33-7.38 (2H, m, ArH); 13C{1H}NMR 
(126 MHz, CDCl3) δC: 17.3 (CH3), 28.5 (C(CH3)3), 36.2 (C(3)H), 43.3 (PhCH2), 43.5 and 44.4 
(rotameric C(2’6’)H2), 50.6 (C(3’,5’)H2), 74.6 (C(2)H), 79.9 (C(CH3)3, 116.1 (C(5)H2), 127.7 
(ArC(4)H), 128.1 (ArC(2,6)H), 128.8 (ArC(3,5)H), 138.4 (ArC(1)), 139.5 (C(4)H), 154.8 (Boc-C=O), 
170.4 (C=O); HRMS (ESI+) C22H34O3N3+ [M+H]+ found: 388.2585, requires: 388.2522 (−2.5 ppm).  
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Experimental Detials for Chapter 4 
(E)-N,N-Dibenzyl-3-phenylprop-2-en-1-amine 417 
 
A solution of N,N-dibenzylamine (6.1 mL, 31.7 mmol, 2.5 equiv.) in THF (12.5 mL) was treated 
dropwise with solution of cinnamyl bromide 210 (2.5 g, 12.7 mmol, 1.0 equiv.) in THF (26 mL) over 
10 mins at rt. The resulting mixture for stirred for 16 h, aq. 1 M NaOH (30 mL) added the mixture 
stirred for a further 5 min, Et2O (30 mL) was then added, the layers separated and the aqueous layer 
extracted with Et2O (2 × 50 mL). The combined organic layers were washed with brine (50 mL) dried 
over MgSO4 and concentrated in vacuo, the resulting residue was purified by flash column 
chromatography (5→20% EtOAc/PE) to give the title product as a yellow oil (4.23 g, quant., >98:2 
E:Z); 
1H NMR (500 MHz, CDCl3) δH: 3.24 (2H, dd, J 6.5, 1.,5 C(1)H2), 3.64 (4H, s, PhCH2), 6.24-6.38 (1H, 
m, C(2)H), 6.54 (1H, d, J 16.0, C(3)H), 7.14-7.49 (15H, m, ArH); data consistent with literature. 
(E)-N-Benzyl-N-methyl-3-phenylprop-2-en-1-amine 419 
 
A solution of N-benzyl-N-methylamine (8.2 mL, 63.5 mmol, 2.5 equiv.) in THF (26 mL) was treated 
dropwise with a solution of cinnamyl bromide 210 (5.0 g, 25.4 mmol, 1.0 equiv.) in THF (50 mL) over 
10 mins at rt. The resulting mixture was stirred for a further 15 mins, aq. 1 M NaOH (50 mL) added and 
the mixture stirred for a further 5 min, Et2O (50 mL) was then added, the layers separated and the 
aqueous layer extracted with Et2O (2 × 50 mL). The combined organic layers were washed with brine 
(50 mL) dried over MgSO4 and concentrated in vacuo, the resulting residue was purified by flash 
column chromatography (5→20% EtOAc/PE) to give the title product as an orange oil (5.2 g, 86%, 
98:2 E:Z); 
1H NMR (500 MHz, CDCl3) δH: 2.28 (3H, s, NCH3), 3.23 (2H, dd, J 6.7, 1.5, C(1)H2), 3.58 (2H, s, 
PhCH2), 6.36 (1H, dt, J 15.9, 6.7, C(2)H), 6.57 (1H, dd, J 15.9, 1.5, C(3)H), 7.20-7.47 (10H, m, ArH); 
data consistent with literature. 
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Methyl (2S,3S)-2-(benzyl(methyl)amino)-3-phenylpent-4-enoate 421 
 
Following general procedure J, 4-nitrophenyl -2-bromoacetate 213 (63 mg, 0.24 mmol, 1.0 equiv.) was 
reacted with (E)-N-Benzyl-N-methyl-3-phenylprop-2-en-1-amine 419 (60 mg, 0.252 mmol, 1.05 
equiv.) in MeCN (1.75 mL) for 24 h at rt, then cooled to −20 °C and reacted with (+)-BTM (12 mg, 
0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and iPr2NH (47 µL, 0.34 mmol, 1.4 
equiv.) in MeCN (1.75 mL) for 24 h, then quenched with NaOMe (1 M in MeOH, 0.72 mL, 0.72 mmo, 
3.0 equiv.) and stirred at rt for 1 h. Crude dr 80:20, the residue was purified by flash column 
chromatography (5% EtOAc/PE) to give the title product as a colourless oil (56 mg, 76%, 80:20 dr); 
HPLC analysis Chiralpak OJ-H (0.5% IPA/hexane, flow rate 1.5 mL/min, 211 nm, 40 °C) tR Major 9.5 
min, Minor 6.9 min, 76% ee; 
[α]D
20 −5.7 (c 1, CHCl3); υmax (film, cm−1): 2949, 1728, 1452, 1254, 1190, 1146, 1026, 984, 918; Major 
(syn) diastereoisomer; 1H NMR (500 MHz, CDCl3) δH: 2.15 (3H, s, NCH3), 3.39 (1H, d, J 13.7, 
PhCHAHB), 3.70 (1H, d, J 11.8, C(2)H), 3.75 (1H, d, J 13.7, PhCHAHB), 3.77 (3H, s, OCH3), 3.87 (1H, 
dd, J 11.8, 8.3, C(3)H), 4.94-5.12 (2H, m, C(5)H2), 5.85 (1H, ddd, J 17.1, 10.2, 8.3, C(4)H), 6.69-6.86 
(2H, m, ArH), 7.10-7.21 (5H, m, ArH), 7.22-7.40 (3H, m, ArH); 13C{1H} NMR (126 MHz, CDCl3) δC: 
38.1 (NCH3), 50.2 (C(3)H), 51.0 (C(2)H), 58.2 (PhCH2), 69.4 (OCH3), 116.7 (C(5)H2), 126.6 (ArCH), 
126.9 (ArCH), 128.1 (ArCH), 128.5 (ArCH), 128.5 (ArCH), 128.7 (ArCH), 138.8 (C(4)H), 139.2 
(ArC), 140.7 (ArC), 171.4 (C=O); Minor (anti) diastereoisomer;1H NMR (500 MHz, CDCl3) δH: 2.29 
(3H, s, NCH3), 3.48 (3H, s, OCH3), 3.51 (1H, d, J 13.6, PhCHAHB), 3.68 (1H, d, J 11.6, C(2)H)), 3.75 
(1H, d, J 13.6 PhCHAHB), 3.83-3.94 (1H, m, C(3)H), 5.04-5.10 (2H, m, C(5)H2), 6.20 (1H, ddd, J 17.2, 
10.2, 8.2, C(4)H), 6.69-6.86 (2H, m, ArH), 7.10-7.21 (5H, m, ArH), 7.22-7.40 (3H, m, ArH); 13C{1H} 
NMR (126 MHz, CDCl3) δC: 38.1 (NCH3), 49.6 (C(3)H), 50.8 (C(2)H), 58.3 (PhCH2), 70.5 (OCH3), 
116.1 (C(5)H2), 126.9 (ArCH), 127.1 (ArCH), 128.4 (ArCH), 128.4 (ArCH), 128.7 (ArCH), 128.9 
(ArCH), 138.8 (C(4)H), 139.4 (ArC), 141.1 (ArC), 170.6 (C=O); HRMS (ESI+) C20H24O2N+ [M+H]+ 
found: 310.1794, requires: 310.1802 (−2.4 ppm). 
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General Procedure O: Synthesis of N,N-diallylamines from Allylic Alcohols 
A solution of allylic alcohol (1.0 equiv.) in Et2O (0.33 M) was cooled to 0 °C and treated with PBr3 (0.4 
equiv.) and stirred for 1 h, the reaction was quenched by the dropwise addition of aq. sat. NaHCO3 
(equal volume), the mixture was allowed to warm to rt. The layers were then separated, the aqueous 
layer extracted with Et2O (2 × equal volume), the combined organic layers washed with brine, dried 
over MgSO4 and concentrated in vacuo. The residue was dissolved in THF (0.5 M) and added to N,N-
diallylamine (2.5 equiv.) in THF (2.5 M with respect to N,N-diallylamine) via dropping funnel, upon 
completion the dropping funnel was rinsed with THF (half volume) and the reaction was stirred at rt for 
15 min. The reaction was treated with aq. 1 M NaOH (equal volume) and stirred for 15 min, then Et2O 
(equal volume) was added, the layers separated and the aqueous layer extracted with Et2O (2 × equal 
volume). The combined organic layers were washed with brine, dried over MgSO4 then concentrated 
in vacuo, N, N-diallyl allylic amines were used without further purification.  
General Procedure P: Synthesis of N,N diallyl allylic ammonium salts 
A solution of N,N diallyl amine (1.0 equiv.) in MeCN (1 M) was treated with 4-nitrophenyl bromoacetate 
(1.2 equiv.) and the reaction mixture was stirred for 16 h. Et2O (5 × volume) was added and the mixture 
stirred for 1-16 h, the precipitate was filtered and dried in vacuo to give the salts. Ammonium salts were 
used directly or recrystallized from MeCN/Et2O if required.  
Amine Synthesis 
(E)-N,N-Diallyl-3-phenylprop-2-en-1-amine 424 
 
A solution of cinnamyl bromide 210 (25.0 g, 126.9 mmol, 1.0 equiv.) in THF (250 mL) was added 
dropwise to a solution of N,N diallylamine (39.1 mL, 317.0 mmol, 2.5 equiv.) in THF (125 mL) 
dropwise over 10 min at rt. The resulting solution was stirred at 15 min for a further 15 min. aq. 1 M 
NaOH (200 mL) was then added and the mixture stirred for a further 5 min, Et2O (200 mL) was then 
added, the layers separated and the aqueous layer extracted with Et2O (2 × 200 mL). The combined 
organic layers were washed with brine (200 mL) dried over MgSO4 and concentrated in vacuo, the 
resulting residue was purified by high vacuum distillation to give the title product as a colourless liquid 
(25.2 g, 93%).  
bp 136-138 °C @ 1mmbar; υmax (film, cm−1): 2800, 1641, 1494, 1448, 1417, 1352, 1119, 995, 964, 916, 
873; 1H NMR (500 MHz, CDCl3) δH: 3.17 (4H, d, J 6.5, diallyl-C(1)H2), 3.28 (2H, d, J 6.7, C(1)H2), 
5.13-5.27 (4H, m, diallyl-C(3)H2), 5.92 (2H, ddt, J 16.8, 10.2, 6.5, diallyl-C(2)H), 6.29 (1H, dt, J 15.8, 
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6.7, C(2)H), 6.54 (1H, d, J 15.8, C(3)H), 7.22-7.44 (5H, m, ArH); 13C{1H} NMR (75 MHz, CDCl3) δC: 
55.8 (C(1)H2), 56.6 (diallyl-C(1)H2), 117.7 (diallyl-C(5)H2), 126.3 (ArC(2,6)H), 127.3 (ArC(4)H), 
127.4 (C(2)H), 128.6 (ArC(3,5)H), 132.7 (C(3)H), 135.6 (diallyl-C(2)H), 137.1 (ArC(1)); HRMS 
(ESI+) C15H20N+ [M+H]+ found: 214.1590, requires: 214.1590 (−0.1 ppm). 
(E)-N,N-diallyl-3-(4-nitrophenyl)prop-2-en-1-amine 528 
 
Following general procedure O, 4-nitrocinnamyl alcohol 469 (2.86 g, 15.98 mmol, 1.0 equiv.) was 
reacted with PBr3 (601 µL, 6.39 mmol, 0.4 equiv.) in Et2O (48 mL), then with N,N-diallylamine (4.93 
mL, 40 mmol, 2.5 equiv.) in THF (32 mL) to give the title product as an orange oil (2.63 g, 64%) with 
was used without further purification. 
υmax (film, cm−1): 2978, 1595, 1512, 1339, 1109, 968, 918, 858; 1H NMR (400 MHz, CDCl3) δH: 3.14 
(4H, d, J 6.5, diallyl-C(1)H2), 3.28 (2H, dd, J 6.3, 1.4, C(1)H2), 5.12-5.25 (4H, m, diallyl-C(3)H2), 5.88 
(2H, ddt, J 16.8, 10.2, 6.5, diallyl-C(2)H), 6.45 (1H, dt, J 15.9, 6.3, C(2)H), 6.59 (1H, d, J 15.9, C(3)H), 
7.48 (2H, d, J 8.8, Ar(2,6)H), 8.17 (2H, d, J 8.8, Ar(3,5)H); 13C{1H} NMR (100 Mz, CDCl3) δC: 55.5 
(C(1)H2), 56.8 (diallyl-C(1)H2), 117.9 (diallyl-C(3)H2), 124.0 (ArC(3,5)H), 126.7 (ArC(2,6)H), 130.3 
(C(2)H), 133.1 (C(3)H, 135.3 (diallyl-C(2)H), 143.6 (ArC(1)), 146.8 (ArC(4)-NO2); HRMS (ESI+) 
C15H19O2N2+ [M+H]+ found: 259.1440, requires: 259.1447 (−0.4 ppm). 
(E)-N,N-diallyl-3-(4-bromophenyl)prop-2-en-1-amine 529 
 
Following general procedure O, 4-bromocinnamyl alcohol 463 (1.62 g, 7.59 mmol, 1.0 equiv.) was 
reacted with PBr3 (286 µL, 3.04 mmol, 0.4 equiv.) in Et2O (24 mL), then with N,N-diallylamine (2.53 
mL, 18.97 mmol, 2.5 equiv.) in THF (16 mL) to give the title product as a pale yellow oil (0.99 g, 45%) 
with was used without further purification. 
υmax (film, cm−1): 2976, 1487, 1400, 1072, 1009, 968, 918; 1H NMR (400 MHz, CDCl3) δH: 3.12 (4H, 
dt, J 6.5, 1.3, diallyl-C(1)H2), 3.22 (2H, dd, J 6.6, 1.4, C(1)H2), 5.09-5.25 (4H, m, diallyl-C(3)H2), 5.87 
(2H, ddt, J 16.8, 10.2, 6.5, diallyl-C(2)H), 6.25 (1H, dt, J 15.9, 6.6, C(2)H), 6.45 (dt, J 15.9, 1.4, C(3)H), 
7.23 (2H, d, J 8.5, Ar(2,6)H), 7.42 (2H, d, J 8.5, Ar(3,5)H); 13C{1H} NMR (100 Mz, CDCl3) δC: 55.8 
(C(1)H2), 56.8 (diallyl-C(1)H2), 117.9 (diallyl-C(3)H2), 121.2 (ArC(4)-Br), 127.9 (ArC(2,6)H), 128.5 
(C(2)H), 131.5 (C(3)H), 131.8 (ArC(3,5)H), 135.6 (diallyl-C(2)H), 136.2 (ArC(1)); HRMS (ESI+) 
C15H19N79Br+ [M+H]+ found: 292.0694, requires: 292.0701 (−0.1 ppm). 
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(E)-N,N-diallyl-3-(2-bromophenyl)prop-2-en-1-amine 530 
 
Following general procedure O, 2-bromocinnamyl alcohol 472 (1.36 g, 6.37 mmol, 1.0 equiv.) was 
reacted with PBr3 (240 µL, 2.55 mmol, 0.4 equiv.) in Et2O (20 mL), then with N,N-diallylamine (1.96 
mL, 15.93 mmol, 2.5 equiv.) in THF (13 mL) to give the title product as a pale yellow oil (1.10 g, 59%) 
with was used without further purification. 
υmax (film, cm−1): 2976, 1643, 1466, 1435, 1256, 1113, 1047, 1022, 966, 918; 1H NMR (400 MHz, 
CDCl3) δH: 3.15 (4H, dt, J 6.5, 1.3, diallyl-C(1)H2), 3.29 (2H, dd, J 6.7, 1.5, C(1)H2), 5.11-5.27 (4H, m, 
diallyl-C(3)H2), 5.89 (2H, ddt, J 16.8, 10.2, 6.5, diallyl-C(2)H), 6.19 (1H, dt, J 15.8, 6.7, C(2)H), 6.86 
(1H, d, J 15.8, C(3)H), 7.08 (1H, td, J 7.7, 1.6, Ar(6)H), 7.19-7.32 (1H, m, Ar(5)H), 7.53 (2H, td, J 8.0, 
1.6, Ar(3,4)H); 13C{1H} NMR (100 Mz, CDCl3) δC: 55.7 (C(1)H2), 56.7 (diallyl-C(1)H2), 118.0 (diallyl-
C(3)H2), 123.5 (ArC(2)-Br), 127.2 (ArC(4)H), 127.6 (ArC(5)H), 128.8 (ArC(6)H), 130.6 (C(2)H), 
131.6 (C(2)H), 133.0 (ArC(3)H), 135.6 (diallyl-C(2)H), 137.2 (ArC(1)); HRMS (ESI+) C15H19N79Br+ 
[M+H]+ found: 292.0694, requires: 292.0701 (−0.1 ppm). 
(E)-N,N-diallyl-3-(4-fluorophenyl)prop-2-en-1-amine 531 
 
Following general procedure O, 4-fluorocinnamyl alcohol 497 (1.36 g, 6.37 mmol, 1.0 equiv.) was 
reacted with PBr3 (240 µL, 2.55 mmol, 0.4 equiv.) in Et2O (20 mL), then with N,N-diallylamine (1.96 
mL, 15.93 mmol, 2.5 equiv.) in THF (13 mL) to give the title product as a pale yellow oil (1.10 g, 59%, 
96:4 E:Z) with was used without further purification. 
υmax (film, cm−1): 2918, 2803, 1603, 1508, 1227, 1157, 1119, 966, 917, 841; 1H NMR (400 MHz, CDCl3) 
δH: 3.13 (4H, dt, J 6.5, 1.3, diallyl-C(1)H2), 3.23 (2H, dd, J 6.7, 1.4, C(1)H2), 5.12-5.28 (4H, m, diallyl-
C(3)H2), 5.88 (2H, ddt, J 16.8, 10.2, 6.5, diallyl-C(2)H), 6.17 (1H, dt, J 15.8, 6.7, C(2)H), 6.47 (1H, dt, 
J 15.8, 1.4, C(2)H), 6.89-7.07 (2H, m, Ar(3,5)H), 7.28-7.37 (2H, m, Ar(2,6)H); 19F{1H} NMR (376 
MHz, CDCl3) δF: −114.9 (ArF); 13C{1H} NMR (100 Mz, CDCl3) δC: 55.7 (C(1)H2), 56.6 (diallyl-
C(1)H2), 115.4 (d, 2JCF 21.5, ArC(3,5)H), 117.9 (diallyl-C(3)H2), 127.0 (C(2)H), 127.7 (d, 3JCF 7.8, 
ArC(2,6)H), 131.5 (C(3)H), 131.9 (d, 4JCF 2.9, ArC(1)), 135.4 (diallyl-C(2)H), 162.2 (d, 1JCF 247, 
ArC(4)-F); HRMS (ESI+) C15H19NF+ [M+H]+ found: 232.1494, requires: 232.1502 (−0.9 ppm). 
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Ammonium Salt Synthesis 
(E)-N,N-Diallyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)-3-phenylprop-2-en-1-ammonium bromide 
425 
 
Following general procedure P: (E)-N,N-diallyl-3-(phenyl)prop-2-en-1-amine 424 (5.0 g, 23.47 mmol, 
1.0 equiv.) was reacted with 4-nitrophenyl bromoacetate 213 (7.32 g, 28.17 mmol, 1.2 equiv.) in MeCN 
(23.5 mL) to give the title product as a white solid (5.54 g, 50%).  
mp 128 °C (dec.); υmax (film, cm−1): 2945, 1771, 1616, 1591, 1528, 1452, 1346, 1996, 166, 1142, 988, 
937, 883; 1H NMR (500 MHz, d6-DMSO) δH: 4.27 (4H, d, J 7.3, diallyl-C(1)H2), 4.37 (2H, d, J 7.4, 
C(1)H2), 4.73 (2H, s, COCH2), 5.57-5.89 (4H, m, diallyl-C(3)H2), 6.24 (2H, ddt, J 17.3, 10.0, 7.3, 
diallyl-C(2)H), 6.60 (1H, dt, J 15.5, 7.4, C(2)H), 7.03 (1H, d, J 15.5, C(3)H), 7.34-7.46 (3H, m, ArH), 
7.49 (2H, d, J 9.1, Ar(3,5)H), 7.56-7.68 (2H, m, ArH), 8.37 (2H, d, J 9.1, Ar(2,6)H); 13C{1H} NMR 
(126 MHz, d6-DMSO) δC: 56.2 (COCH2), 62.3 (diallyl-C(1)H2), 62.5 (C(1)H2), 115.7 (C(2)H), 123.0 
(ArC(2,6)H), 125.4 (ArC(3,5)H), 125.6 (diallyl-C(3)H2), 127.4 (C(3)ArC(2,6)H), 128.6 (diallyl-
C(2)H), 128.8 (C(3)ArC(3,5)H), 129.2 (C(3)ArC(4)H), 135.1 (C(3)ArC(1)), 141.6 (C(3)H), 145.7 
(ArC(1)-O), 153.7 (ArC(4)-NO2), 163.3 (C=O); HRMS (ESI+) C23H25O4N2+ [M]+ found: 393.1801, 
requires: 393.1809 (−2.0 ppm). 
(E)-N,N-Diallyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)-3-(4-nitrophenyl)prop-2-en-1-ammonium 
bromide 436 
 
Following general procedure P: (E)-N,N-diallyl-3-(4-nitrophenyl)prop-2-en-1-amine 528 (1.0 g, 3.88 
mmol, 1.0 equiv.) was reacted with 4-nitrophenyl bromoacetate 213 (1.21 g, 4.66 mmol, 1.2 equiv.) in 
MeCN (4 mL) to give the title product as a white solid (0.55 g, 28%) after recrystallization from MeCN. 
mp 142 °C (dec.); υmax (film, cm−1): 29450, 1773, 1593, 1516, 1452, 1343, 1197, 1167, 1069, 1012, 
951, 880; 1H NMR (500 MHz, d6-DMSO) δH: 4.30 (4H, d, J 7.3, diallyl-C(1)H2), 4.43 (2H, d, J 7.4, 
C(1)H2), 4.7 (2H, s, COCH2), 5.71-5.84 (4H, m, diallyl-C(3)H2), 6.24 (2H, ddt, diallyl-C(2)H), 6.87 
(1H, dt, J 15.5, 7.4, C(2)H), 7.17 (1H, d, J 15.5, C(3)H), 7.51 (2H, d, J 9.1, Ar(2,6)H), 7.92 (2H, d, J 
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8.9, C(3)Ar(2,6)H), 8.29 (2H, d, J 8.9, C(3)Ar(3,5)H), 8.38 (2H, d, J 9.1, Ar(3,5)H); 13C{1H} NMR 
(126 MHz, d6-DMSO) δC: 56.3 (COCH2), 61.9 (C(1)H2), 62.5 (diallyl-C(1)H2), 120.9 (C(2)H), 123.0 
(ArC(2,6)H), 123.9 (ArC(3,5)H), 125.3 (diallyl-C(2)H), 125.6 (ArC(3,5)H), 128.5 (ArC(2,6)H), 128.8 
(diallyl-C(3)H2), 139.1 (C(3)H), 141.7 (C(3)ArC(4)-NO2), 145.7 (ArC(1)-O), 147.4 (C(3)ArC(1)), 
153.7 (ArC(4)-NO2), 163.2 (C=O); HRMS (ESI+) C23H24O6N3+ [M]+ found: 438.1651, requires: 
438.1660 (−2.0 ppm). 
(E)-N,N-Diallyl-3-(2-bromophenyl)-N-(2-(4-nitrophenoxy)-2-oxoethyl)prop-2-en-1-ammonium 
bromide 437 
 
Following general procedure P: (E)-N,N-diallyl-3-(2-bromophenyl)prop-2-en-1-amine 530 (1.1 g, 3.77 
mmol, 1.0 equiv.) was reacted with 4-nitrophenyl bromoacetate 213 (1.18 g, 4.53 mmol, 1.2 equiv.) in 
MeCN (4 mL) to give the title product as a white solid (0.80 g, 39%) after recrystallization from MeCN. 
mp 98 °C (dec.); υmax (film, cm−1): 2954, 1773, 1525, 1348, 1201, 1168, 1066, 1022, 943, 858; 1H NMR 
(400 MHz, d6-DMSO) δH: 4.31 (4H, d, J 7.2, diallyl-C(1)H2), 4.46 (2H, d, J 7.4, C(1)H2), 4.79 (2H, s, 
COCH2), 5.65.-5.84 (4H, m, diallyl-C(3)H2), 6.24 (2H, ddd, J 17.0, 9.8, 5.3, diallyl-C(2)H), 6.62 (1H, 
dt, J 15.3, 7.4, C(2)H), 7.24 (1H, d, J 15.3, C(3)H), 7.33 (1H, t, J 7.6, Ar(4)H), 7.47 (1H, t, J 7.7, 
Ar(5)H), 7.52 (2H, d, J 8.9, ArC(2,6)H), 7.69 (1H, d, J 8.0, Ar(6)H), 7.96 (1H, d, J 7.8, Ar(3)H), 8.37 
(2H, d, J 8.9, ArC(3,5)H); 13C{1H} NMR (126 MHz, d6-DMSO) δC: 56.2 (COCH2), 62.0 (C(1)H2), 62.4 
(diallyl-C(1)H2), 119.5 (C(2)H), 123.0 (ArC(2,6)H), 123.3 (C(3)ArC(2)-Br), 125.4 (ArC(3,5)H), 125.6 
(diallyl-C(3)H2), 128.1 (C(3)ArC(4)H), 128.6 (C(3)ArC(6)H), 128.6 (diallyl-C(2)H), 130.9 
(C(3)ArC(5)H), 132.9 (C(3)ArC(3)H), 134.8 (C(3)ArC(1)), 139.4 (C(3)H), 145.7 (ArC(1)-O), 153.7 
(ArC(4)-NO2), 163.2 (C=O); HRMS (ESI+) C23H24O4N279Br+ [M]+ found: 471.0904, requires: 471.0914 
(−2.1 ppm). 
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(E)-N,N-Diallyl-3-(4-fluorophenyl)-N-(2-(4-nitrophenoxy)-2-oxoethyl)prop-2-en-1-ammonium 
bromide 435 
 
Following general procedure P: (E)-N,N-diallyl-3-(4-fluorophenyl)prop-2-en-1-amine 531 (1.0 g, 4.33 
mmol, 1.0 equiv.) was reacted with 4-nitrophenyl bromoacetate (1.35 g, 5.19 mmol, 1.2 equiv.) in 
MeCN (4.3 mL) to give the title product as a white solid (1.23 g, 58%); 
mp 132 °C (dec.); υmax (film, cm−1): 2945, 1771, 1591, 1528, 1348, 1200, 1159, 1141, 988, 939, 837; 
1H NMR (500 MHz, d6-DMSO) δH: 4.28 (4H, d, J 7.3, diallyl-C(1)H2), 4.36 (2H, d, J 7.5, C(1)H2), 4.75 
(2H, s, COCH2), 5.71-5.82 (4H, m, diallyl-C(3)H2), 6.24 (2H, ddt, J 17.3, 10.1, 7.2, diallyl-C(2)H), 6.56 
(1H, dt, J 15.5, 7.5, C(2)H), 7.02 (1H, d, J 15.5, C(3)H), 7.27 (2H, t, J 8.8, Ar(3,5)H), 7.50 (2H, d, J 
9.1, Ar(2,6)H), 7.71 (2H, dd, J 8.7, 5.7, Ar(2,6)H), 8.37 (2H, d, J 9.1, Ar(3,5)H); 19F NMR (476 MHz, 
d6-DMSO) δF: −112.1 (ddt, J 14.4, 9.0, 5.6, ArF); 13C{1H} NMR (126 MHz, d6-DMSO) δC: 56.2 
(COCH2), 62.2 (diallyl-C(1)H2), 62.4 (C(1)H2), 115.6 (d, 2JCF 21.4, ArC(3,5)H) + C(2)H), 123.0 
(ArC(2,6)H), 125.4 (ArC(3,5)H), 125.6 (diallyl-C(3)H), 128.6 (diallyl-C(2)H), 129.6 (d, 3JCF 8.2, 
ArC(2,6)H), 131.8 (d, 4JCF 3.1, ArC(1)), 140.4 (C(3)H), 145.7 (ArC(1)-O)), 153.7 (ArC(4)-NO2), 162.5 
(d, 1JCF 247, ArC(4)-F), 163.3 (C=O); HRMS (ESI+) C23H24O4N2F+ [M]+ found: 411.1708, requires: 
411.1715 (−1.6 ppm). 
(E)-N,N-Diallyl-3-(4-bromophenyl)-N-(2-(4-nitrophenoxy)-2-oxoethyl)prop-2-en-1-ammonium 
bromide 438 
 
Following general procedure P: (E)-N,N-diallyl-3-(4-bromophenyl)prop-2-en-1-amine 529 (0.99 g, 
3.39 mmol, 1.0 equiv.) was reacted with 4-nitrophenyl bromoacetate (1.06 g, 4.06 mmol, 1.2 equiv.) in 
MeCN (4 mL) to give the title product as a white solid (1.12 g, 60%) 
mp 126 °C (dec.); υmax (film, cm−1): 2943, 1771, 1591, 1526, 1487, 1450, 1346, 1198, 1167, 1142, 939, 
883; 1H NMR (500 MHz, d6-DMSO) δH: 4.26 (4H, d, J 7.3, diallyl-C(1)H2), 4.35 (2H, d, J 7.4, C(1)H2), 
4.73 (2H, s, COCH2), 5.68-5.85 (4H, m, diallyl-C(3)H2), 6.12-6.31 (2H, m, diallyl-C(2)H), 6.63 (1H, 
dt, J 15.5, 7.4, C(2)H), 6.99 (1H, d, J 15.5, C(3)H), 7.49 (2H, d, J 9.1, Ar(2,6)H), 7.55-7.66 (4H, m, 
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Ar(2,3,5,6)H), 8.36 (2H, d, J 9.1, Ar(3,5)H); 13C{1H} {1H} NMR (126 MHz, d6-DMSO) δC: 56.2 
(COCH2), 62.3 (C(1)H2), 62.3 (diallyl-C(1)H2), 116.8 (C(2)H), 122.4 (ArC(4)-Br), 123.0 (ArC(2,6)H), 
125.4 (ArC(3,5)H), 125.6 (diallyl-C(3)H2), 128.7 (diallyl-C(2)H), 129.5 (ArC(2,6)H), 131.7 
(ArC(3,5)H), 134.4 (C(3)ArC(1)), 140.2 (C(3)H), 145.7 (ArC(1)-O), 153.7 (ArC(4)-NO2), 163.3 
(C=O); HRMS (ESI+) C23H24O4N279Br+ [M]+ found: 471.0904, requires: 471.0914 (−2.1 ppm).  
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[2,3]-Rearrangement Products 
General Procedure Q: Catalytic Asymmetric [2,3]-Rearrangement of N,N diallyl ammonium salts and 
subsequent nucleophilic quench 
A flame dried Schlenk flask was charged with solution of (+)-BTM (0.2 equiv.), HOBt (1.0 equiv.), 
iPr2NH (1.4 equiv.) and MeCN (0.07 M) and cooled to −20 °C and stirred for 5 mins. The solution was 
treated with the requisite ammonium salt (1.0 equiv.) and stirred for a further 16 h, after which the 
corresponding nucleophile (2.0 – 5.0 equiv.) was added and the reaction allowed to warm to rt and 
stirred for the time stated. The reaction was quenched with aq. 1 M NaOH (equal volume) and extracted 
with CH2Cl2 (3 × equal volume). The combined organic layers were washed with aq. 1 M NaOH (2 × 
equal volume), brine (equal volume), dried over MgSO4 and concentrated in vacuo. The residue was 
analysed by 1H NMR to determine dr, then purified by flash column chromatography to give the 
rearranged product. 
Ethyl (2S,3S)-2-(diallylamino)-3-phenylpent-4-enoate 426 
 
Following general procedure Q, (E)-N,N-diallyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)-3-phenylprop-2-
en-1-ammonium bromide 425 (1.0 g, 2.11 mmol, 1.0 equiv.) was reacted with (+)-BTM (107 mg, 0.42 
mmol, 0.2 equiv.), HOBt (285 mg, 2.11 mmol, 1.0 equiv.) and iPr2NH (413 µL, 2.95 mmol, 1.4 equiv.) 
in MeCN (30 mL), then quenched with NaOEt (1 M in EtOH, 10.55 mL, 10.55 mmol, 5.0 equiv.) and 
stirred for a further 24 h at rt. Crude dr >95:5. The residue purified by flash column chromatography 
on silica gel (5% EtOAc/hexanes) to give the title product (479 mg, 76%, >95:5 dr) as a colourless oil; 
HPLC analysis, Chiralpak AD-H (0.5% IPA/hexane, flow rate 1.5 mL/min, 211 nm, 40 °C) tR Major 
3.2 min, Minor 3.7 min, 97% ee;  
[α]D
20+18.8 (c 1, CHCl3); νmax (film, cm−1): 2980, 1726, 1640, 1445, 1417, 1246, 1152, 995, 916;1H 
NMR (500 MHz, CDCl3) δH: 1.33 (3H, t, J 7.1, OCH2CH3), 2.83 (2H, dd, J 14.5,8.3, NCHAHB), 3.37 
(2H, ddt, J 14.5, 4.1, 1.9, NCHAHB), 3.76-3.85 (2H, m, C(2)H + C(3)H), 4.14-4.30 (2H, OCH2CH3), 
4.88-5.16 (6H, m, C(5)H2 + diallyl-C(3)H2), 5.34-5.37 (2H, m, diallyl-C(2)H), 5.92 (1H, dddd, J 17.1, 
10.2, 7.0, 0.9, C(4)H), 7.13-7.19 (2H, m, ArH), 7.20-7.26 (1H, m, ArH), 7.26-7.35 (2H, m, ArH); 
13C{1H} NMR (179 MHz, CDCl3) δC: 14.7 (OCH2CH3), 50.4 (C(3)H), 53.2 (NCH2), 60.1 (OCH2CH3), 
65.4 (C(2)H), 116.7 (C(5)H2), 117.2 (diallyl-C(3)H2), 126.5 (ArC(4)H), 128.3 (ArC(2,6)H), 128.5 
(ArC(3,5)H), 128.5 (ArC(2,6)H), 136.4 (diallyl-C(2)H), 138.7 (C(4)H), 141.0 (ArC(1)), 171.5 (C=O); 
HRMS (ESI+) C19H26O2N+ [M+H]+ found: 300.1948, requires: 300.1958 (−3.4 ppm). 
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(2S,3S)-N-benzyl-2-(diallylamino)-3-phenylpent-4-enamide 431 
 
Following general procedure Q, (E)-N,N-diallyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)-3-phenylprop-2-
en-1-ammonium bromide 425 (114 mg, 0.24 mmol, 1.0 equiv.) was reacted with (+)-BTM (12 mg, 
0.048 mmol, 0.2 equiv.), HOBt (6.4 mg, 0.048 mmol, 0.2 equiv.) and iPr2NH (47 µL, 0.34 mmol, 1.4 
equiv.) in MeCN (3.5 mL), then quenched with BnNH2 (131 µL, 1.20 mmol, 5.0 equiv.) and stirred for 
a further 24 h. Crude dr 93:7. The residue purified by flash column chromatography on silica gel 
(0→2% Et2O/CH2Cl2) to give the title product (85 mg, 98%, 92:8 dr) as a colourless oil;  
HPLC analysis, Chiralpak OJ-H (5% IPA/hexane, flow rate 1.5 mL/min, 211 nm, 40 °C) tR Major 6.2 
min, Minor 5.2 min, 84% ee;  
[α]D
20+53.1 (c 1.0, CHCl3); νmax (film, cm−1): 3296, 2928, 1631, 1506, 1452, 1334, 1246, 1120, 912; 1H 
NMR (500 MHz, CDCl3) δH: 2.92 (2H, dd, J 14.6, 8.0, NCHAHB), 3.38-3.46 (2H, m, NCHAHB), 3.51 
(1H, d, J 9.9, C(2)H), 3.94-4.02 (1H, m, C(3)H), 4.51 (2H, dd, J 5.6, 2.9, PhCH2), 4.93-5.16 (6H, m, 
C(5)H2 + diallyl-CH2), 5.45 (2H, dddd, J 16.8, 10.5, 8.0, 4.4, diallyl-C(1)H), 5.95-6.06 (2H, m, C(4)H 
+ NH), 7.14-7.34 (10H, m, ArH); 13C{1H} NMR (75 MHz, CDCl3) δC: 43.4 (PhCH2), 49.7 (C(3)H), 
53.5 (diallyl-C(1)H2), 66.7 (C(2)H), 117.0 (C(5)H2 + diallyl-C(3)H2), 126.4 (C(3)Ar(C(4)H), 127.7 
(Ar(C(4)H), 128.2 (C(3)Ar(C(2,6)H), 128.3 (Ar(C(2,6)H), 128.6 (C(3)Ar(C(3,5)H), 128.8 
(Ar(C(3,5)H), 137.1 (diallyl-C(2)H), 138.4 (C(3)ArC(1)), 139.0 (C(4)H), 141.5 (Ar(C(1)), 170.2 
(C=O); HRMS (NSI+) C24H29N2O+ [M+H]+ found: 361.2277, requires 361.2274 (+0.7 ppm).  
(2S,3S)-2-(Diallylamino)-3-phenylpent-4-en-1-ol 430 
 
Following general procedure Q with slight modification (E)-N,N-diallyl-N-(2-(4-nitrophenoxy)-2-
oxoethyl)-3-phenylprop-2-en-1-ammonium bromide 425 (114 mg, 0.24 mmol, 1.0 equiv.) was reacted 
with (+)-BTM (12 mg, 0.048 mmol, 0.2 equiv.), HOBt (32 mg, 0.24 mmol, 1.0 equiv.) and iPr2NH (47 
µL, 0.34 mmol, 1.4 equiv.) in MeCN, then concentrated in vacuo and the solvent switched to THF (3.5 
mL, 2 cycles). The solution was cooled to 0 °C and treated with LiAlH4 (1.0 M in THF, 0.48 mL, 0.48 
mmol, 2.0 equiv.) dropwise. The reaction was stirred for 1 h, quenched by the addition of aq. 1 M KOH 
(10 mL) and extracted with EtOAc (3 × 20 mL). The combined organic layers were washed with aq. 1 
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M KOH (2 × 10 mL), dried over MgSO4 then concentrated in vacuo. Crude dr >95:5. The residue was 
purified by flash coloumn chromatography on silica gel (0→10% Et2O/CH2Cl2) to give the title product 
(54 mg, 88%, >95:5 dr) as a colourless oil  
HPLC analysis, Chiralpak OJ-H (0.5% IPA/hexane, flow rate 1.5 mL/min, 211 nm, 40 °C) tR Major 5.5 
min, Minor 4.5 min, 96% ee;  
[α]D
20+27.3 (c 1.0, CHCl3); νmax (film, cm−1) 3420, 2924, 1601, 1415, 1265, 1045, 991, 914; 1H NMR 
(400 MHz, CDCl3) δH: 2.70 (2H, dd, J 14.1, 8.0, NCHAHB), 3.23 (2H, ddt, J 14.1, 4.4, 1.7, NCHAHB), 
3.30 (1H, app. t, J 10.0, CHAHBOH), 3.37 (1H, td, J 9.5, 9.0, 4.1, C(2)H), 3.47 (1H, t, J 9.5, C(3)H), 
3.63 (1H, dd, J 10.0, 4.1, CHAHBOH), 4.84-5.11 (6H, m, diallyl-C(3)H2 + C(5)H2), 5.64 (2H, dddd, 
17.2, 10.2, 8.0, 4.8, diallyl-C(2)H), 5.79-6.01 (1H, m, C(4)H), 7.21-7.34 (5H, m, ArH); 13C{1H} NMR 
(101 MHz, CDCl3) δC: 51.4 (C(3)H), 52.6 (diallyl-C(1)H2), 60.3 (C(1)H2), 62.2 (C(2)H), 115.8 
(C(5)H2), 117.4 (diallyl-C(3)H2), 126.9 (ArC(4)H), 128.2 (ArC(2,6)H), 128.8 (ArC(3,5)H), 137.0 
(diallyl-C(2)H), 138.9 (C(4)H), 143.0 (ArC(1)); HRMS (NSI+) C17H24NO+ [M+H]+ found: 258.1853, 
requires 258.1852 (+0.2 ppm).  
(2S,3S)-2-(Diallylamino)-3-phenyl-1-(pyrrolidin-1-yl)pent-4-en-1-one 430 
 
Following general procedure Q, (E)-N,N-diallyl-N-(2-(4-nitrophenoxy)-2-oxoethyl)-3-phenylprop-2-
en-1-ammonium bromide 425 (114 mg, 0.24 mmol, 1.0 equiv.) was reacted with (+)-BTM (12 mg, 
0.048 mmol, 0.2 equiv.), HOBt (32 mg, 0.24 mmol, 1.0 equiv.) and iPr2NH (47 µL, 0.34 mmol, 1.4 
equiv.) in MeCN (3.5 mL), then quenched with pyyrolidine (100 µL, 1.20 mmol, 5.0 equiv.) and stirred 
for a further 24 h at rt. Crude dr >95:5. The residue purified by flash column chromatography on silica 
gel (0→5% Et2O/CH2Cl2) to give the title product (68 mg, 87%, >95:5 dr) as a colourless oil; 
HPLC analysis, Chiralpak AD-H (5% IPA/hexane, flow rate 1.5 mL/min, 211 nm, 40 °C) tR Major 3.8 
min, Minor 5.9 min, 98% ee;  
[α]D
20 +134.0 (c 1, CHCl3); υmax (film, cm−1): 2974, 1629, 1429, 1420, 1157, 991; 1H NMR (700 MHz, 
CDCl3) δH: 1.76-1.93 (4H, m, C(3ʹ + 4ʹ)H2), 2.96 (2H, dd, J 15.1, 7.9, NCHAHB), 3.36-3.45 (3H, m, 
NCHAHB +C(2ʹ)HAHB), 3.49 (2H, t, J 6.9, C(5ʹ)H2), 3.58 (1H, dt, J 9.8, 6.5, C(2ʹ)HAHB), 3.82-3.98 (2H, 
m, C(2)H + C(3)H), 4.84-5.09 (6H, m, C(5)H2 + diallyl-C(3)H2), 5.41 (2H, dddd, J 17.1, 10.2, 7.9, 4.2, 
diallyl-C(2)H), 5.90 (1H, ddd, J 17.0, 10.1, 7.7, C(4)H), 7.21 (3H, tt, J 8.2, 1.5, ArH), 7.30 (2H, dd, J 
8.6, 6.6, ArH); 13C{1H} NMR (179 MHz, CDCl3) δC: 24.4 (C(4ʹ)H2), 26.4 (C(3ʹ)H2), 45.4 (C(5ʹ)H2), 
51.3 (C(3)H), 53.3 (diallyl-C(1)H2), 63.5 (C(2)H), 116.1 (diallyl-C(3)H2), 116.9 (C(5)H2), 126.4 
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(ArC(4)H), 128.3 (ArC(2,6)H), 128.8 (ArC(3,5)H), 137.9 (diallyl-C(2)H), 138.7 (C(4)H), 141.4 
(ArC(1)), 171.0 (C=O); HRMS (ESI+) C21H29ON2+ [M+H]+ found: 325.2265, requires: 325.2274 (−2.9 
ppm). 
Ethyl (2S,3S)-3-(2-bromophenyl)-2-(diallylamino)pent-4-enoate 442 
 
Following general procedure Q, (E)-N,N-diallyl-3-(2-bromophenyl)-N-(2-(4-nitrophenoxy)-2-
oxoethyl)prop-2-en-1-ammonium bromide 437 (0.3 g, 0.54 mmol, 1.0 equiv.) was reacted with (+)-
BTM (27 mg, 0.11 mmol, 0.2 equiv.), HOBt (73 mg, 0.54 mmol, 1.0 equiv.) and iPr2NH (105 µL, 0.76 
mmol, 1.4 equiv.) in MeCN (7.7 mL), then quenched with NaOEt (1 M in EtOH, 2.70 mL, 2.70 mmol, 
5.0 equiv.) and stirred for a further 24 h at rt. Crude dr 92:8. The residue purified by flash column 
chromatography on silica gel (5% EtOAc/hexanes) to give the title product (173 mg, 85%, 92:8 dr) as 
a colourless oil; 
Enantiopurity determined after derivatisation to 532, 92% ee; 
[α]D
20 + 9.6 (c 1, CHCl3); υmax (film, cm−1): 2980, 1728, 1638, 1472, 1244, 1177, 1153, 1020, 918; 1H 
NMR (500 MHz, CDCl3) δH: 1.32 (3H, t, J 7.1, OCH2CH3), 2.79 2H, dd, J 14.4, 8.5, NCHAHB), 3.38 
(2H, ddt, J 14.4, 4.0, 1.9, NCHAHB), 3.85 (1H, d, J 11.6, C(2)H), 4.14-4.29 (2H, m, OCH2CH3), 4.47 
(1H, dd, J 11.6, 8.0, C(3)H), 4.93-5.17 (6H, m, C(5)H2 + diallyl-C(3)H2), 5.40 (2H, dddd, J 17.3, 11.3, 
8.5, 4.0, diallyl-C(2)H), 5.75 (1H, ddd, J 17.6, 10.1, 8.0, C(4)H), 7.05 (1H, ddd, J 8.1, 7.2, 1.7, 
ArC(4)H), 7.15 (1H, dd, J 7.7, 1.7, ArC(5)H), 7.28 (1H, dd, J 7.7, 1.3, ArC(6)H), 7.53 (1H, dd, J 8.0, 
1.3, ArC(3)H); 13C{1H} NMR (126 MHz, CDCl3) δC: 14.8 (OCH2CH3), 48.5 (C(3)H), 53.3 (NCH2), 
60.2 (OCH2CH3), 65.1 (C(2)H), 117.3 (diallyl-C(3)H2), 117.6 (C(5)H2), 125.3 (ArC(2)-Br), 127.2 
(ArC(5)H, 127.8 (ArC(4)H), 129.7 (ArC(6)H, 132.9 (ArC(3)H), 136.2 (diallyl-C(2)H), 137.3 (C(4)H), 
139.8 (ArC(1)), 171.2 (C=O); HRMS (ESI+) C19H25O2NBr+ [M+H]+ found: 378.1052,requires: 
378.1063 (−3.0 ppm). 
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Ethyl (2S,3S)-2-(diallylamino)-3-(4-nitrophenyl)pent-4-enoate 441 
 
Following general procedure Q, (E)-N,N-diallyl-3-(4-nitrophenyl)-N-(2-(4-nitrophenoxy)-2-
oxoethyl)prop-2-en-1-ammonium bromide 436 (0.2 g, 0.39 mmol, 1.0 equiv.) was reacted with (+)-
BTM (20 mg, 0.08 mmol, 0.2 equiv.), HOBt (53 mg, 0.39 mmol, 1.0 equiv.) and iPr2NH (76 µL, 0.55 
mmol, 1.4 equiv.) in MeCN (5.6 mL), then quenched with NaOEt (1 M in EtOH, 1.95 mL, 1.95 mmol, 
5.0 equiv.) and stirred for a further 24 h at rt. Crude dr 90:10. The residue purified by flash column 
chromatography on silica gel (5% EtOAc/hexanes) to give the title product (92 mg, 69%, 90:10 dr) as 
a yellow oil; 
Enantiopurity determined after derivatisation to 534, 96% ee; 
[α]D
20 +54.7 (c 1, CHCl3); υmax (film, cm−1): 2980, 1724, 1518, 1343, 1155, 920, 854; 1H NMR (500 
MHz, CDCl3) δH: 1.34 (3H, t, J 7.1, OCH2CH3), 2.81 (2H, dd, J 14.4, 8.4, NCHAHB), 3.35 (2H, ddt, J 
14.4, 4.0, 1.9, NCHAHB), 3.82 (1H, d, J 11.7, C(2)H), 3.98 (1H, dd, J 11.7, 7.9, C(3)H), 4.24 (2H, dddd, 
J 18.0, 10.8, 7.1, 3.7, OCH2CH3), 4.98-5.16 (6H, m, C(5)H2 + diallyl-C(3)H2), 5.36 (2H, dddd, J 16.9, 
10.3, 8.3, 4.1, diallyl-C(2)H), 5.86 (1H, ddd, J 17.0, 10.3, 7.9, C(4)H), 7.33 (2H, d, J 8.8, Ar(2,6)H), 
8.19 (2H, d, J 8.8, Ar(3,5)H); 13C{1H} NMR (126 MHz, CDCl3) δC: 14.7 (OCH2CH3), 50.1 (C(3)H), 
53.1 (NCH2), 60.4 (OCH2CH3), 64.9 (C(2)H), 117.9 (diallyl-C(3)H2), 118.2 (C(5)H2), 123.6 
(ArC(3,5)H), 129.4 (ArC(2,6)H), 135.6 (diallyl-C(2)H), 137.1 (C(4)H), 146.7 (ArC(1)), 149.1 (ArC(4)-
NO2), 170.6 (C=O); HRMS (ESI+) C19H25O4N2+ [M+H]+ found: 345.1802, requires: 345.1809 (−2.0 
ppm). 
Ethyl (2S,3S)-3-(4-bromophenyl)-2-(diallylamino)pent-4-enoate 443 
 
Following general procedure Q, (E)-N,N-diallyl-3-(4-bromophenyl)-N-(2-(4-nitrophenoxy)-2-
oxoethyl)prop-2-en-1-ammonium bromide 438 (400 mg, 0.73 mmol, 1.0 equiv.) was reacted with (+)-
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BTM (37 mg, 0.15 mmol, 0.2 equiv.), HOBt (99 mg, 0.73 mmol, 1.0 equiv.) and iPr2NH (142 µL, 1.02 
mmol, 1.4 equiv.) in MeCN (10.4 mL), then quenched with NaOEt (1 M in EtOH, 3.65 mL, 3.65 mmol, 
5.0 equiv.) and stirred for a further 24 h at rt. Crude dr 90:10. The residue purified by flash column 
chromatography on silica gel (5% EtOAc/hexanes) to give the title product (213 mg, 77%, 91:9 dr) as 
a yellow oil; 
HPLC analysis, Chiralpak AD-H (0.5% IPA/hexane, flow rate 1.5 mL/min, 211 nm, 40 °C) tR Major 
3.2 min, Minor 3.9 min, 96% ee;  
[α]D
20 +40.5 (c 1, CHCl3); υmax (film, cm−1): 2980, 1726, 1489, 1173, 1153, 1011, 918; 1H NMR (500 
MHz, CDCl3) δH: 1.30 (3H, t, J 7.1, OCH2CH3), 2.79 (2H, dd, J 14.4, 8.4, NCHAHB), 3.33 (2H, ddt, J 
14.4, 4.1, 1.9, NCHAHB), 3.67-3.81 (2H, m, C(2)H + C(3)H), 4.13-4.26 (2H, m, OCH2CH3), 4.96-5.09 
(6H, m, C(5)H2 + diallyl-C(3)H2), 5.38 (2H, dddd, J 16.5, 10.8, 8.4, 4.1, diallyl-C(2)H), 5.83 (1H, ddd, 
J 17.0, 10.2, 7.7, C(4)H), 7.02 (2H, d, J 8.4, Ar(2,6)H), 7.41 (2H, d, J 8.4, Ar(3,5)H); 13C{1H} NMR 
(126 MHz, CDCl3) δC: 14.7 (OCH2CH3), 49.7 (C(3)H), 53.1 (NCH2), 60.2 (OCH2CH3), 65.1 (C(2)H), 
117.1 (C(5)H2), 117.5 (diallyl-C(3)H2), 120.0 (ArC-Br), 130.3 (ArC(2,6)H), 131.3 (ArC(3,5)H), 136.1 
(diallyl-C(2)H), 138.1 (C(4)H), 140.1 (ArC(1)), 171.2 (C=O); HRMS (ESI+) C19H25O2NBr+ [M+H]+ 
found: 378.1054, requires: 378.1063 (−2.4 ppm). 
Ethyl (2S,3S)-2-(diallylamino)-3-(4-fluorophenyl)pent-4-enoate 440 
 
Following general procedure Q, (E)-N,N-diallyl-3-(4-nitrophenyl)-N-(2-(4-fluorophenoxy)-2-
oxoethyl)prop-2-en-1-ammonium bromide 435 (400 mg, 0.82 mmol, 1.0 equiv.) was reacted with (+)-
BTM (40 mg, 0.16 mmol, 0.2 equiv.), HOBt (111 mg, 0.82 mmol, 1.0 equiv.) and iPr2NH (160 µL, 1.15 
mmol, 1.4 equiv.) in MeCN (12 mL), then quenched with NaOEt (1 M in EtOH, 4.10 mL, 4.10 mmol, 
5.0 equiv.) and stirred for a further 24 h at rt. Crude dr 94:6. The residue purified by flash column 
chromatography on silica gel (5% EtOAc/hexanes) to give the title product (222 mg, 85%, 95:5 dr) as 
a colourless oil; 
HPLC analysis, Chiralpak AD-H (0.5% IPA/hexane, flow rate 1.5 mL/min, 211 nm, 40 °C) tR Major 
3.3 min, Minor 4.3 min, 96% ee;  
[α]D
20 +14.8 (c 1, CHCl3); υmax (film, cm−1): 2980, 1726, 1508, 1223, 1157, 918, 829; 1H NMR (300 
MHz, CDCl3) δH: 1.30 (3H, t, J 7.1, OCH2CH3), 2.79 (2H, dd, J 14.5, 8.3, NCHAHB), 3.34 (2H, ddt, J 
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14.5, 4.0, 1.9, NCHAHB), 3.65-3.84 (2H, m, C(2)H + C(3)H), 4.09-4.34 (2H, m, OCH2CH3), 4.86-5.14 
(6H, m, C(5)H2 + diallyl-C(3)H2), 5.26-5.50 (2H, m, diallyl-C(2)H), 5.85 (1H, ddd, J 17.1, 10.2, 7.6, 
C(4)H), 6.98 (2H, t, J 8.7, Ar(3,5)H), 7.09 (2H, ddt, 8.3, 5.2, 2.5, Ar(2,6)H); 19F{1H} NMR (272 MHz, 
CDCl3) δF: −116.9 (ArF); 13C{1H} NMR (126 MHz, CDCl3) δC: 14.7 (OCH2CH3), 49.5 (C(3)H), 53.1 
(NCH2), 60.2 (OCH2CH3), 65.3 (C(2)H), 115.1 (d, 2JCF 21.2, ArC(3,5)H), 116.8 (C(5)H2), 117.4 
(diallyl-C(3)H2), 129.9 (d, 3JCF 7.8, ArC(2,6)H), 136.2 (diallyl-C(2)H), 136.7 (d, 4JCF 3.2, ArC(1)), 
138.5 (C(4)H), 161.6 (d, 1JCF 244, ArC-F), 171.3 (C=O); HRMS (ESI+) C19H25O2NF+ [M+H]+ found: 
318.1854, requires: 318.1864 (−3.1 ppm). 
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Deallylation of Products 
General Procedure R: Bis-deallylation of α-N,N diallyl amino esters 
A flamed dried Schlenk tube was charged with Pd(dba)2 (0.1 equiv.), dppb (0.1 equiv.) and 
thiosalicyclic acid (5.0 equiv.) under Ar. A solution of N,N diallyl amino ester (1.0 equiv.) in degassed 
THF (0.1 M) was added and the resulting mixture heated to 60 °C under Ar for 3 h. Once complete the 
reaction was cooled to rt and aq. 1 M HCl and EtOAc added, the layers separated and the aqueous layer 
washed with EtOAc (2 × equal volume). The aqueous layer was then concentrated in vacuo to give the 
pure α-amino ester hydrochloride salt. 
General Procedure S: N-Boc protection of α-amino ester hydrochloride salts 
A solution of α-amino ester hydrochloride salt (1.0 equiv.) in CH2Cl2 (0.07 M) was treated with NEt3 
(3.0 equiv.) and Boc2O (5.0 equiv.) and stirred for 16 h at room temperature. The resulting mixture was 
concentrated in vacuo, dissolved in MeOH (3 × equal volume) and treated with 4-DMAP (0.1 equiv.) 
and stirred for 3 h. Once complete the solution was concentrated in vacuo, dissolved in EtOAc (5 × 
equal volume) washed with aq. 1 M HCl (equal volume) and brine (equal volume), dried over MgSO4 
and concentrated in vacuo to give the N-Boc α-amino ester.  
Ethyl (2S,3S)-2-amino-3-phenylpent-4-enoate hydrochloride 444 
 
Following general procedure R, Pd(dba)2 (19 mg, 0.033 mmol, 0.1 equiv), dppb (14 mg, 0.033 mmol, 
0.1 equiv.), thiosalicyclic acid (254 mg, 1.65 mmol, 5.0 equiv.) and ethyl (2S,3S)-2-(diallylamino)-3-
phenylpent-4-enoate 426 (100 mg, 0.33 mmol, 1.0 equiv.) were reacted in THF (3.3 mL) to give the 
title product as a colourless gum (65 mg, 77%, >95:5 dr).  
The corresponding free amine was prepared for HPLC analysis by dissolution in HPLC iPrOH and 
filtration through a pipette plug of K2CO3.  
HPLC analysis, Chiralpak AS-H (5% IPA/hexane, flow rate 1.5 mL/min, 211 nm, 40 °C) tR Major 3.5 
min, Minor 4.0 min, 94% ee;  
[α]D
20+59.2 (c 1, MeOH); υmax (film, cm−1): 3375, 2870, 1736, 1587, 1495, 1219, 1043, 993, 858; 1H 
NMR (400 MHz, d4-MeOH) δH: 1.24 (3H, t, J 7.1, OCH2CH3), 3.88 (1H, t, J 8.4, C(3)H), 4.23 (2H, q, 
J 7.1, OCH2CH3), 4.36 (1H, d, J 8.4, C(2)H), 5.20-5.33 (2H, m, C(5)H2), 6.13 (1H, ddd, J 17.2, 9.9, 
9.1, C(4)H), 7.28-7.47 (5H, m, ArH); 13C{1H} (126 MHz, d4-MeOH) δC: 14.3 (OCH2CH3), 52.9 
(C(3)H), 58.0 (C(2)H), 63.4 (OCH2CH3), 119.9 (C(5)H), 129.2 (ArC(4)H), 129.2 (ArC(3,5)H), 1303 
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(ArC(2,6)H), 136.1 (C(4)H), 138.7 (ArC(1)), 169.4 (C=O); HRMS (ESI+) C13H18O2N+ [M]+ found: 
220.1327, requires: 220.1332 (−2.3 ppm). 
Ethyl (2S,3S)-2-amino-3-(2-bromophenyl)pent-4-enoate hydrochloride 446 
 
Following general procedure R, Pd(dba)2 (16 mg, 0.027 mmol, 0.1 equiv), dppb (12 mg, 0.027 mmol, 
0.1 equiv.), thiosalicyclic acid (203 mg, 1.32 mmol, 5.0 equiv.) and ethyl (2S,3S)-3-(2-bromophenyl)-
2-(diallylamino)pent-4-enoate 442 (100 mg, 0.27 mmol, 1.0 equiv., 93:7 dr) were reacted in THF (2.7 
mL) to give the title product as a colourless gum (44 mg, 49%, 93:7 dr).  
Enantiopurity determined after derivatisation to 532, 92% ee; 
[α]D
20 +23.1 (c 1, MeOH); υmax (film, cm−1): 3350, 2982, 1736, 1470, 1242, 1219, 1022, 939, 854;1H 
NMR (500 MHz, d4-MeOH) δH: 1.17 (3H, t, J 7.2, OCH2CH3), 4.19 (2H, qd, J 7.2, 4.2, OCH2CH3), 
4.36 (1H, dd, J 9.4, 7.2, C(3)H), 4.47 (1H, d, J 7.2, C(2)H), 5.29-5.43 (2H, m, C(5)H2), 6.13 (1H, ddd, 
J 16.7, 10.2, 9.4, C(4)H), 7.26 (1H, ddd, J 8.0, 5.0, 4.0, Ar(5)H), 7.42 (1H, dd, J 4.0, 0.7, Ar(4)H), 7.68 
(1H, dt, J 8.0, 0.9, Ar(6)H); 13C{1H} NMR (179 MHz, d4-MeOH) δC: 14.2 (OCH2CH3), 51.5 (C(3)H), 
56.3 (C(2)H), 63.6 (OCH2CH3), 121.9 (C(5)H2), 125.4 (ArC(2)-Br), 129.4 (ArC(5)H), 130.7 
(ArC(4)H), 130.8 (ArC(6)H), 133.9 (ArC(3)H), 134.8 (C(4)H), 138.0 (ArC(1)), 169.0 (C=O); HRMS 
(ESI+) C13H17O2N79Br+ [M]+ found: 298.0434, requires: 298.0437 (−1.1 ppm). 
Ethyl (2S,3S)-2-amino-3-(4-nitrophenyl)pent-4-enoate hydrochloride 447 
 
Following general procedure R, Pd(dba)2 (8.4 mg, 0.015 mmol, 0.1 equiv), dppb (6.4 mg, 0.015 mmol, 
0.1 equiv.), thiosalicyclic acid (116 mg, 0.75 mmol, 5.0 equiv.) and ethyl (2S,3S)-3-(4-nitrophenyl)-2-
(diallylamino)pent-4-enoate 441 (50 mg, 0.15 mmol, 1.0 equiv., 90:10 dr) were reacted in THF (1.5 
mL) to give the title product as a colourless gum (24 mg, 53%, 88:12 dr)  
Enantiopurity determined after derivatisation to 534, 96% ee; 
[α]D
20 +93.6 (c 0.25, MeOH); υmax (film, cm−1): 3377, 2905, 1740, 1520, 1346, 1225, 1111, 1014, 852; 
1H NMR (500 MHz, d4-MeOH) δH: 1.24 (3H, t, J 7.1, OCH2CH3), 3.99-4.08 (1H, m, C(3)H), 4.25 (2H, 
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q, J 7.1, OCH2CH3), 4.51 (1H, d, J 7.9, C(2)H), 5.24-5.40 (2H, m, C(5)H2), 6.14 (1H, ddd, J 16.7, 103, 
9.2, C(4)H), 7.64 (2H, d, J 8.7, Ar(2,6)H), 8.28 (2H, d, J 8.7 Ar(3,5)H); 13C{1H} NMR (126 MHz, d4-
MeOH) δC: 14.3 (OCH2CH3), 52.5 (C(3)H), 57.6 (C(2)H), 63.7 (OCH2CH3), 121.5 (C(5)H2), 125.2 
(ArC(2,6)H), 130.6 (ArC(3,5)H), 134.6 (C(4)H), 146.4 (ArC(1)), 149.1 (ArC(4)-NO2), 169.0 (C=O); 
HRMS (ESI+) C13H17O4N2+ [M]+ found: 265.1176, requires: 265.1183 (−2.6 pm). 
Ethyl (2S,3S)-2-amino-3-(4-fluorophenyl)pent-4-enoate hydrochloride 445 
 
Following general procedure R, Pd(dba)2 (9.2 mg, 0.016 mmol, 0.1 equiv), dppb (12.8 mg, 0.016 mmol, 
0.1 equiv.), thiosalicyclic acid (122 mg, 0.75 mmol, 5.0 equiv.) and ethyl (2S,3S)-3-(4-fluorophenyl)-
2-(diallylamino)pent-4-enoate 440 (50 mg, 0.16 mmol, 1.0 equiv., 94:6 dr) were reacted in THF (1.5 
mL) to give the title product as a oily yellow solid (46 mg, quant., 92:8 dr); 
Enantiopurity determined after derivatisation to 533, 94% ee; 
[α]D
20 +40.8 (c 1, CHCl3); υmax (film, cm−1): 3397, 2864, 1736, 1603, 1508, 1223, 1014, 934, 836;1H 
NMR (400 MHz, d4-MeOH) δH: 1.26 (3H, t, J 7.1, OCH2CH3), 3.86 (1H, t, J 8.4, C(3)H), 4.24 (2H, q, 
J 7.1, OCH2CH3), 4.35 (1H, d, J 8.4, C(2)H), 5.21-5.31 (2H, m, C(5)H2), 6.11 (1H, ddd, J 16.8, 10.3, 
9.0, C(4)H), 7.14 (2H, t, J 8.8, Ar(3,5)H), 7.38 (2H, dd, J 8.8, 5.2, Ar(2,6)H); 19F{1H} NMR (376, d4-
MeOH) δF: −116.2 (ArF); 13C{1H} NMR (126 MHz, d4-MeOH) δC: 14.3 (OCH2CH3), 52.2 (C(3)H), 
58.0 (C(2)H), 63.5 (OCH2CH3), 117.1 (d, 2JCF 21.8, ArC(3,5)H), 120.0 (C(5)H2), 131.2 (d, 3JCF 8.2, 
ArC(2,6)H), 134.8 (d, 4JCF 3.3, ArC(1)), 135.9 (C(4)H), 163.9 (d, 1JCF 246, ArC(4)-F), 169.4 (C=O); 
HRMS (ESI+) C13H17O2NF+ [M]+ found: 238.1232, requires: 238.1238 (−2.5 ppm). 
Ethyl (2S,3S)-3-(2-bromophenyl)-2-((tert-butoxycarbonyl)amino)pent-4-enoate 532 
 
Following general procedure S ethyl (2S,3S)-2-amino-3-(2-bromophenyl)pent-4-enoate hydrochloride 
446 (48 mg, 0.14 mmol, 1.0 equiv.), NEt3 (58 µL, 0.42 mmol, 3.0 equiv.) and Boc2O (153 mg, 0.7 
mmol, 5.0 equiv.) were reacted in CH2Cl2 (2 mL) to give the title product as a yellow oil (40 mg, 72%, 
88:12 dr); 
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HPLC analysis, Chiralpak AD-H (2% IPA/hexane, flow rate 1.5 mL/min, 211 nm, 40 °C) tR Major 12.4 
min, Minor 9.4 min, 92% ee;  
[α]D
20 +38.4 (c 1, CHCl3); υmax (film, cm−1): 3345, 2930, 1717, 1506, 1368, 1161, 1022, 930; 1H NMR 
(500 MHz, CDCl3) δH: 1.20 (3H, t, J 7.1, OCH2CH3), 1.33 (9H, s, C(CH3)3), 4.06-4.18 (2H, m, 
OCH2CH3), 4.26 (1H, t, J 8.9, C(3)H), 4.68 (1H, t, J 8.9, C(2)H), 4.95 (1H, d, J 9.3, NH), 5.13-5.24 
(2H, m, C(5)H2), 6.01 (1H, ddd, J 16.9, 10.2, 8.6, C(4)H), 7.03-7.15 (1H, m, ArH), 7.25-7.34 (2H, m, 
ArH), 7.56 (1H, d, J 8.0, ArH); 13C{1H} NMR (126 MHz, CDCl3) δC: 14.1 (OCH2CH3), 28.2 (C(CH3)3), 
51.2 (C(3)H), 56.8 (C(2)H), 61.2 (OCH2CH3), 80.0 (C(CH3)3), 118.6 (C(5)H2), 125.1 (ArC(2)-Br), 
127.6 (ArC(5)H), 128.6 (ArC(4)H), 129.2 (ArC(6)H), 133.1 (ArC(3)H), 135.5 (C(4)H), 138.4 (ArC(1)), 
154.9 (NC=O), 171.5 (C=O); HRMS (ESI+) C18H24O4NBrNa+ [M+Na]+ found: 420.0773, requires: 
420.0781 (−1.9 ppm).  
Ethyl (2S,3S)-2-((tert-butoxycarbonyl)amino)-3-(4-fluorophenyl)pent-4-enoate 533 
 
Following general procedure S ethyl (2S,3S)-2-amino-3-(4-fluorophenyl)pent-4-enoate hydrochloride 
445 (46 mg, 0.16 mmol, 1.0 equiv.), NEt3 (67 µL, 0.48 mmol, 3.0 equiv.) and Boc2O (174 mg, 0.8 
mmol, 5.0 equiv.) were reacted in CH2Cl2 (2.3 mL) to give the title product as a colourless oil (24 mg, 
45%, >95:5 dr); 
HPLC analysis, Chiralpak AD-H (5% IPA/hexane, flow rate 1.5 mL/min, 211 nm, 40 °C) tR Major 7.4 
min, Minor 5.6 min, 94% ee;  
[α]D
20 +44.7 (c 1, CHCl3); υmax (film, cm−1): 3367, 2980, 2929, 1715, 1510, 1357, 1224, 1161, 1024, 
835; 1H NMR (400 MHz, CDCl3) δH: 1.23 (3H, J 7.1, OCH2CH3), 1.40 (9H, s, C(CH3)3), 3.79 (1H, t, J 
7.5, C(3)H), 4.14 (2H, qd, J 7.1, 1.1, OCH2CH3), 4.59-4.71 (1H, m, C(2)H), 4.88 (1H, d, J 9.2, NH), 
5.11-5.27 (2H, m, C(5)H2), 6.07 (1H, ddd, J 16.9, 10.3, 8.3, C(4)H), 7.03 (2H, t, J 8.7, Ar(3,5)H), 7.19 
(2H, dd, J 8.7, 5.4, Ar(2,6)H); 19F{1H} NMR (376 MHz, CDCl3) δF: −115.5 (ArF); 13C{1H} NMR (126 
MHz, CDCl3) δC: 14.3 (OCH2CH3), 28.4 (C(CH3)3), 51.8 (C(3)H), 57.5 (C(2)H), 61.4 (OCH2CH3), 80.2 
(C(CH3)3), 115.6 (d, 2JCF 21.3, ArC(3,5)H), 118.0 (C(5)H2), 130.0 (d, 3JCF 7.9, ArC(2,6)H), 134.8 (d, 
3JCF 2.4, ArC(1)), 136.4 (C(4)H), 155.3 (NC=O), 162.1 (d, 1JCF 246, ArC(4)-F), 171.5 (C=O); HRMS 
(ESI+) C18H24O4NFNa+ [M+Na]+ found: 360.1575, requires: 360.1582 (−1.8 ppm). 
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Ethyl (2S,3S)-2-((tert-butoxycarbonyl)amino)-3-(4-nitrophenyl)pent-4-enoate 534 
 
Following general procedure S ethyl (2S,3S)-2-amino-3-(4-nitrophenyl)pent-4-enoate hydrochloride 
447 (24 mg, 0.08 mmol, 1.0 equiv.), NEt3 (33 µL, 0.24 mmol, 3.0 equiv.) and Boc2O (87 mg, 0.40 
mmol, 5.0 equiv.) were reacted in CH2Cl2 (1.1 mL) to give the title product as a colourless oil (22 mg, 
76%); 
HPLC analysis, Chiralpak IB (1% IPA/hexane, flow rate 1.5 mL/min, 211 nm, 40 °C) tR Major 10.0 
min, Minor 8.7 min, 96% ee;  
[α]D
20 +52.7 (c 1, CHCl3); υmax (film, cm−1): 3360, 2980, 1736, 1715, 1522, 1346, 1163, 1024, 855;1H 
NMR (500 MHz, CDCl3) δH: 1.21 (3H, t, J 7.1, OCH2CH3), 1.37 (9H, s, C(CH3)3), 3.88 (1H, t, J 7.8, 
C(3)H), 4.13 (2H, qd, J 7.1, 1.3, OCH2CH3), 4.71 (1H, t, J 7.8, C(2)H), 4.96 (1H, d, J 9.2, NH), 5.10-
5.33 (2H, m, C(5)H2), 6.05 (1H, ddd, J 16.9, 10.2, 8.5, C(4)H), 7.41 (2H, d, J 8.6, Ar(2,6)H), 8.18 (2H, 
d, J 8.6, Ar(3,5)H); 13C{1H} NMR (126 MHz, CDCl3) δC: 14.3 (OCH2CH3), 28.3 (C(CH3)3), 52.8 
(C(3)H), 57.4 (C(2)H), 61.7 (OCH2CH3), 80.5 (C(CH3)3), 119.5 (C(5)H2), 123.8 (ArC(2,6)H), 129.4 
(ArC(3,5)H), 134.9 (C(4)H), 147.1 (ArC(1)), 147.2 (ArC(4)-NO2), 155.2 (NC=O), 171.0 (C=O); 
HRMS (ESI+) C18H24O6N2Na+ [M+Na]+ found: 387.1521, requires: 387.1532 (−1.4 ppm). 
Ethyl (2S,3S)-2-(allylamino)-3-phenylpent-4-enoate 456 
 
A flame dried two-necked flask was charged with Pd(dba)2 (58 mg, 0.1 mmol, 0.1 equiv.), dppb (43 
mg, 0.1 mmol, 0.1 equiv.) and thiosalicylic acid (184 mg, 1.2 mmol, 1.2 equiv.). A solution of ethyl 
(2S,3S)-2-(diallylamino)-3-phenylpent-4-enoate 426 (300 mg, 1.0 mmol, 1.0 equiv.) in degassed THF 
(10 mL) was added via cannula. The resulting solution was heated at reflux for 16 h, once complete the 
reaction was cooled to rt and treated with aq. 1 M HCl (30 mL) and EtOAc (30 mL). The layer separated 
and the organic layer extracted with aq. 1 M HCl (2 × 20 mL). The combined aqueous layers were 
basified to ~pH 14 with aq. 2 M NaOH, then extracted with EtOAc (5 × 50 mL), the organics combined, 
washed with brine (50 mL), dried over MgSO4 and concentrated in vacuo. The residue was purified by 
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flash column chromatography (5% EtOAc/PE) to give the title product as a colourless oil (118 mg, 
46%). 
[α]D
20 +56.9 (c 1, CHCl3); υmax (film, cm−1): 3335, 2980, 1728, 1640, 1454, 1178, 1152, 1024, 993, 918; 
1H NMR (500 MHz, CDCl3) δH: 1.21 (3H, t, J 7.1, OCH2CH3), 3.05 (1H, ddt, J 14.0, 6.5, 1.4, NCHAHB), 
3.23 (1H, ddt, J 14.0, 5.6, 1.4, NCHAHB), 3.57-3.65 (2H, m, C(2)H + C(3)H), 4.13 (2H, qd, J 7.1, 3.8, 
OCH2CH3), 5.01-5.19 (4H, m, C(5)H2 + NCH2CHCH2), 5.74 (1H, dddd, J 16.9, 10.2, 6.5, 5.7, 
NCH2CH), 6.03-6.17 (1H, m, C(4)H), 7.19-7.25 (3H, m, ArH), 7.27-7.33 (2H, m, ArH); 13C{1H} NMR 
(126 MHz, CDCl3) δC: 14.3 (OCH2CH3), 50.9 (NCH2), 53.6 (C(3)H), 60.7 (OCH2CH3), 65.3 (C(2)H), 
116.9 (C(5)H), 117.2 (NCH2CHCH2), 127.1 (ArC(4)H), 128.2 (ArC(2,6)H), 128.7 (ArC(3,5)H), 136.2 
(NCH2CH), 137.6 (C(4)H), 140.3 (ArC(1)), 173.9 (C=O); HRMS (ESI+) C16H22O2N+ [M+H]+ found: 
260.1638, requires: 260.1645 (−2.7 ppm). 
Ethyl (2S,3S)-2-(allyl(benzyl)amino)-3-phenylpent-4-enoate 457 
 
A solution of ethyl (2S,3S)-2-(allylamino)-3-phenylpent-4-enoate 456 (202 mg, 0.78 mmol, 1.0 equiv.) 
in MeCN (11.2 mL), was treated with K2CO3 (215 mg, 1.56 mmol, 2.0 equiv.), KI (26 mg, 0.156 mmol, 
0.2 equiv.), and benzyl bromide (140 µL, 1.17 mmol, 1.5 equiv.), the resulting solution was heated to 
reflux for 16 h. Once complete the reaction was cooled to rt, and aq. 1 M NaOH (20 mL) and CH2Cl2 
(20 mL), the layers separated and the aqueous layer extracted with CH2Cl2 (2 × 20 mL). The combined 
organic layers were washed with brine (50 mL), dried over MgSO4 and concentrated in vacuo. The 
residue was purified by flash column chromatography (1→10% EtOAc/PE) to give the title product as 
a colourless oil (233 mg, 86%, 94:6 dr).  
[α]D
20 −6.1 (c 1, CHCl3); υmax (film, cm−1): 2978, 1726, 1495, 1454, 1248, 1173, 1153, 1136, 1028, 970; 
1H NMR (500 MHz, CDCl3) δH: 1.35 (3H, t, J 7.1, OCH2CH3), 2.82 (1H, dd, J 14.2, 8.7, NCHAHB), 
3.27 (1H, d, J 14.1, PhCHAHB), 3.31 (1H, ddt, J 14.2, 4.0, 1.9, NCHAHB), 3.73 (1H, d, J 11.6, C(2)H), 
3.86 (1H, dd, J 11.6, 8.1, C(3)H), 3.95 (1H, d, J 14.1, PhCHAHB), 4.18-4.32 (2H, m, OCH2CH3), 4.94-
5.11 (4H, m, C(5)H2 + NCH2CHCH2), 5.47 (1H, dddd, J 17.0, 10.3, 8.7, 4.0, NCH2CH), 5.83 (1H, ddd, 
J 17.0, 10.2, 8.1, C(4)H), 6.69-6.84 (2H, m, ArH), 7.03-7.08 (2H, m, ArH), 7.10-7.18 (3H, m, ArH), 
7.22-7.32 (3H, m, ArH); 13C{1H} NMR (126 MHz, CDCl3) δC: 14.8 (OCH2CH3), 50.3 (C(3)H), 53.4 
(NCH2), 54.0 (PhCH2), 60.1 (OCH2CH3), 65.1 (C(2)H), 116.7 (C(5)H2), 117.7 (NCH2CHCH2), 126.6 
(ArCH), 126.8 (ArCH), 128.0 (ArCH), 128.4 (ArCH), 128.7 (ArCH), 128.9 (ArCH), 136.2 (NCH2CH), 
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138.7 (C(4)H), 139.3 (C(3)ArC(1)), 140.7 (ArC(1)), 171.3 (C=O); HRMS (ESI+) C23H28O2N+ [M+H]+ 
found: 350.2106, requires: 350.2115 (−2.4 ppm).  
Ethyl (2S,3S)-1-benzyl-3-phenyl-1,2,3,6-tetrahydropyridine-2-carboxylate 458 
 
A two-neck flask equipped with a reflux condenser with charged with p-TsOH (191 mg, 1.01 mmol, 
1.5 equiv.) followed by a solution of ethyl (2S,3S)-2-(allyl(benzyl)amino)-3-phenylpent-4-enoate 457 
(233 mg, 0.67 mmol, 1.0 equiv., 94:6 dr) in degassed PhMe (67 mL), the solution was heated to 80 °C 
and stirred until full dissolution. After which the reaction was treated with Hoveyda-Grubbs 2nd 
generation catalyst (21 mg, 0.034 mmol, 5 mol%) and the reaction mixture stirred at 80 °C for 16 h. 
Once complete by TLC, the reaction was cooled to rt and concentrated in vacuo, CH2Cl2 (50 mL) and 
aq. 1 M NaOH (50 mL) were added the layers separated and the aqueous layer extracted with CH2Cl2 
(2 × 50 mL). The combined organic layers were washed with brine (50 mL) dried over MgSO4 and 
concentrated in vacuo. The residue was purified by Biotage® IsoleraTM 4 [SNAP Ultra 10 g, 36 mL/min, 
PE:EtOAc (99:1 1 CV, 99:1 → 90:10 10 CV, 80:20 2 CV)] to give the title product as a yellow oil (161 
mg, 75%, 92:8 dr); 
 [α]D
20 −127.1 (c 1, CHCl3); υmax (film, cm−1): 2978, 1728, 1493, 1452, 1177, 1144, 1029, 845; 1H NMR 
(500 MHz, CDCl3) δH: 0.81 (3H, t, J 7.1, OCH2CH3), 3.26 (1H, ddt, J 17.0, 4.4, 2.4, C(6)HAHB), 3.57 
(1H, ddt, J 17.0, 3.8, 2.4, C(6)HAHB), 3.62-3.81 (4H, m, OCH2CH3 + C(3)H + PhCHAHB), 3.84, (1H, 
d, J 6.9, PhCHAHB), 4.00-4.08 (1H, m, C(2)H), 5.85 (1H, dq, J 10.2, 2.4, C(5)H), 5.99 (1H, ddt, J 10.2, 
4.1, 2.5, C(4)H), 7.15-7.24 (3H, m, ArH), 7.25-7.31 (3H, m, ArH), 7.31-7.39 (4H, m, ArH); 13C{1H} 
NMR (126 MHz, CDCl3) δC: 13.9 (OCH2CH3), 44.1 (C(2)H), 48.6 (NCH2), 59.5 (PhCH2), 60.2 
(OCH2CH3), 64.7 (C(3)H), 124.9 (C(5)H), 126.9 (C(4)H), 127.0 (ArC(4)H), 127.4 (ArC(4)H), 128.3 
(ArCH), 128.5 (ArCH), 128.7 (ArCH), 129.0 (ArCH), 138.2 (ArC(1)), 140.4 (ArC(1)), 170.7 (C=O); 
HRMS (ESI+) C21H24O2N+ [M+H]+ found: 322.1795, requires: 322.1802 (−2.0 ppm). 
Ethyl (2S,3S)-3-phenylpiperidine-2-carboxylate 459 
 
A solution of ethyl (2S,3S)-1-benzyl-3-phenyl-1,2,3,6-tetrahydropyridine-2-carboxylate 458 (143 mg, 
0.45 mmol, 1.0 equiv., 92:8 dr) in EtOAc (4.5 mL) was treated with AcOH (27 µL, 0.45 mmol, 1.0 
equiv.) and Pd/C (47 mg, 10% wt., 0.045 mmol, 0.1 equiv.). The resulting suspension was degassed 
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with H2 for 15 min, then left stirring under an atmosphere of H2 (balloon, 1 atm) for 48 h at rt. The 
reaction was diluted with EtOAc (30 mL), filtered through Celite® (eluent EtOAc), washed with aq. sat. 
NaHCO3 (30 mL), dried over MgSO4 and concentrated in vacuo. The crude residue was purified by 
flash column chromatography (10→15% Et2O/CH2Cl2) to give the product as a colourless oil (63 mg, 
60%, >95:5 dr). 
HPLC analysis, Chiralpak AS-H (1% IPA/hexane, flow rate 1.5 mL/min, 211 nm, 40 °C) tR Major 3.7 
min, Minor 3.4 min, 94% ee;  
[α]D
20 +11.0 (c 1, CHCl3); υmax (film, cm−1): 3348, 2932, 1728, 1493, 14522, 1370, 1246, 1200, 1179, 
1128, 1032, 862; 1H NMR (500 MHz, CDCl3) δH: 0.94 (3H, t, J 7.1, OCH2CH3), 1.52 (1H, ddp, J 14.5, 
7.3, 3.8, C(6)HAHB), 1.78 (1H, dddt, J 12.8, 9.0, 7.7, 3.7, C(6)HAHB), 1.89 (1H, ddt, J 13.2, 8.8, 4.3, 
C(5)HAHB), 1.98 (1H, br. s, NH), 2.11 (1H, dtd, J 13.6, 7.1, 3.7, C(5)HAHB), 2.82 (1H, ddd, J 11.6, 7.9, 
3.6, C(4)HAHB), 3.20-3.34 (2H, m, C(3)H + C(4)HAHB), 3.82 (1H, d, J 4.5, C(2)H), 3.92 (2H, qd, J 7.1, 
3.0, OCH2CH3), 7.12-7.21 (1H, m, Ar(4)H), 7.22-7.31 (2H, m, Ar(2,6)H), 7.40-7.48 (2H, m, Ar(3,5)H); 
13C{1H} NMR (126 MHz, CDCl3) δC: 14.0 (OCH2CH3), 23.3 (C(6)H2), 28.9 (C(5)H2), 42.2 (C(3)H), 
44.5 (C(4)H2), 60.3 (OCH2CH3), 61.5 (C(2)H), 126.3 (ArC(4)H), 128.1 (ArC(2,6)H), 128.7 
(ArC(3,5)H), 142.7 (ArC(1)), 172.7 (C=O); HRMS (ESI+) C14H20O2N+ [M+H] found: 234.1483, 
requires: 234.1489 (−2.4 ppm). 
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